<SEC-DOCUMENT>0001213900-25-026434.txt : 20250331
<SEC-HEADER>0001213900-25-026434.hdr.sgml : 20250331
<ACCEPTANCE-DATETIME>20250331172340
ACCESSION NUMBER:		0001213900-25-026434
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		52
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250331
DATE AS OF CHANGE:		20250331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Plum Acquisition Corp, IV
		CENTRAL INDEX KEY:			0002030482
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				981795710
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42472
		FILM NUMBER:		25795133

	BUSINESS ADDRESS:	
		STREET 1:		2021 FILLMORE ST. #2089
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115
		BUSINESS PHONE:		(929) 529-7125

	MAIL ADDRESS:	
		STREET 1:		2021 FILLMORE ST. #2089
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ea0235316-10k_plumacq4.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:53 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:plmk="http://www.plumpartners.com/20241231" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-7295">10-K</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-7296">&#9746;</ix:nonNumeric> <b>ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-7297"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-7298">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-7299">2024</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="ixv-7300">&#9744;</ix:nonNumeric> <b>TRANSITION REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>For the transition
period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to </b>  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Commission File Number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-7301">001-42472</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-58"><b>PLUM ACQUISITION CORP. IV</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="vertical-align: top; width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-68"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman Islands</b></span></ix:nonNumeric></td> <td style="vertical-align: bottom; width: 2%">&#160;</td> <td style="vertical-align: top; width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-73"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>98-1795710</b></span></ix:nonNumeric></td></tr> <tr> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<br/>
incorporation or organization)</span></td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<br/>
Identification Number)</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-88"><b>2021 Fillmore St. #2089</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-7302">San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-7303">California</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-7304">94115</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Zip Code)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-7305">(929)</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-7306">529-7125</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(b)
of the Exchange Act:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol (s)</b></span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Each Exchange on Which Registered</b></span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c1" name="dei:Security12bTitle" id="ixv-127"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A ordinary shares, $0.0001 par value per share</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:TradingSymbol" id="ixv-7307">PLMK</ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c1" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-135"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-7308">Warrants to purchase one share of Class A ordinary shares</ix:nonNumeric> </span></td> <td style="text-align: center">&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-7309">PLMKW</ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-146"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-150"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-154"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLMKU</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-158"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(g)
of the Exchange Act: None</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if the Registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-7310">No</ix:nonNumeric> &#9746;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if the Registrant is not
required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes &#9744; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-7311">No</ix:nonNumeric> &#9746;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the Registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. <ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-7312">Yes</ix:nonNumeric> &#9746; No &#9744;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of
this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-7313">Yes</ix:nonNumeric> &#9746;
No &#9744;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See
definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging
growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-7314">Non-accelerated filer</ix:nonNumeric> &#9746;</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Smaller reporting company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="ixv-7315">&#9746;</ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-7316">&#9746;</ix:nonNumeric></p></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-7317">&#9744;</ix:nonNumeric></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting
under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its
audit report. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-7318">&#9744;</ix:nonNumeric></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-7319">&#9744;</ix:nonNumeric></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the Registrant is
a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="ixv-7320">&#9746;</ix:nonNumeric> No &#9744;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The registrant was <ix:nonFraction contextRef="c4" decimals="0" format="ixt:fixed-zero" name="dei:EntityPublicFloat" scale="0" unitRef="usd" id="ixv-7321">no</ix:nonFraction>t a public company as of June
30, 2024, and therefore it cannot calculate the aggregate market value of its voting and non-voting common equity held by non-affiliates
as of such date.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2025, there
were <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-7322">18,492,875</ix:nonFraction> Class A ordinary shares, par value $0.0001 per share, and <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-7323">5,750,000</ix:nonFraction> Class B ordinary shares, par value $0.0001 per share,
issued and outstanding.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 10%">&#160;</td>
    <td style="width: 80%">&#160;</td>
    <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART I</b></span></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td style="vertical-align: top"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business&#160;</span></a></td>
    <td style="vertical-align: bottom; text-align: center">1</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A.</span></td>
    <td style="vertical-align: top"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors </span></a></td>
    <td style="vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1B.</span></td>
    <td style="vertical-align: top"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unresolved Staff Comments </span></a></td>
    <td style="vertical-align: bottom; text-align: center">41</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1C.</span></td>
    <td style="vertical-align: top"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cybersecurity</span></a></td>
    <td style="vertical-align: bottom; text-align: center">41</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.</span></td>
    <td><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties </span></a></td>
    <td style="text-align: center">41</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings&#160;</span></a></td>
    <td style="text-align: center">41</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4.</span></td>
    <td><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine Safety Disclosures </span></a></td>
    <td style="text-align: center">41</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART II</b></span></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5.</span></td>
    <td style="vertical-align: top"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </span></a></td>
    <td style="vertical-align: bottom; text-align: center">42</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6.</span></td>
    <td style="vertical-align: top"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]&#160;</span></a></td>
    <td style="vertical-align: bottom; text-align: center">42</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 7.</span></td>
    <td style="vertical-align: top"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></a></td>
    <td style="vertical-align: bottom; text-align: center">43</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 7A.</span></td>
    <td style="vertical-align: top"><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk </span></a></td>
    <td style="vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 8.</span></td>
    <td style="vertical-align: top"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements and Supplementary Data </span></a></td>
    <td style="vertical-align: bottom; text-align: center">44</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9.</span></td>
    <td style="vertical-align: top"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure </span></a></td>
    <td style="vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9A.</span></td>
    <td style="vertical-align: top"><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures </span></a></td>
    <td style="vertical-align: bottom; text-align: center">45</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9B.</span></td>
    <td style="vertical-align: top"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information </span></a></td>
    <td style="vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9C.</span></td>
    <td style="vertical-align: top"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections </span></a></td>
    <td style="vertical-align: bottom; text-align: center">45</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART III</b></span></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 10.</span></td>
    <td style="vertical-align: top"><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors, Executive Officers and Corporate Governance&#160;</span></a></td>
    <td style="vertical-align: bottom; text-align: center">46</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 11.</span></td>
    <td style="vertical-align: top"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation </span></a></td>
    <td style="vertical-align: bottom; text-align: center">50</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 12.</span></td>
    <td style="vertical-align: top"><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </span></a></td>
    <td style="vertical-align: bottom; text-align: center">51</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 13.</span></td>
    <td style="vertical-align: top"><a href="#a_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence </span></a></td>
    <td style="vertical-align: bottom; text-align: center">52</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 14.</span></td>
    <td style="vertical-align: top"><a href="#a_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services </span></a></td>
    <td style="vertical-align: bottom; text-align: center">54</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART IV</b></span></a></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 15.</span></td>
    <td style="vertical-align: top"><a href="#a_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits and Financial Statement Schedules </span></a></td>
    <td style="vertical-align: bottom; text-align: center">55</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16.</span></td>
    <td style="vertical-align: top"><a href="#a_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 10-K Summary </span></a></td>
    <td style="vertical-align: bottom; text-align: center">56</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td colspan="2" style="vertical-align: top"><a href="#a_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></a></td>
    <td style="vertical-align: bottom; text-align: center">57</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN TERMS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless otherwise stated in this Annual Report on Form 10-K (&#8220;Annual
Report&#8221;) or unless the context otherwise requires, references to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;amended and restated memorandum and articles of association&#8221; are to our amended and restated memorandum and articles of association in effect as of the date hereof;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Cohen&#8221; are to Cohen&#160;&amp; Company Capital Markets, a division of J.V.B.&#160;Financial Group, LLC, a representative of the underwriters in the initial public offering;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Companies Act&#8221; are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">directors&#8221; are to our directors named in this Annual Report;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;founder shares&#8221; are to our Class&#160;B ordinary shares initially purchased by our sponsor in a private placement prior to the initial public offering, an aggregate of 75,000 of which was transferred to our three independent directors prior to the effectiveness of the registration statement in connection with our initial public offering, and our Class&#160;A ordinary shares that will be issued upon conversion thereof;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;initial shareholders&#8221; are to sponsor and the three independent directors that held our founder shares prior to the initial public offering;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">initial public offering&#8221; are to our initial public offering, which was consummated on January 16, 2025.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">management&#8221; or our &#8220;management team&#8221; are to our directors and officers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;non-managing investors&#8221; are to certain institutional investors (none of which are affiliated with any member of our management or any other investor) that purchased through investments in our sponsor, an aggregate of 285,000 private placement units and 570,000 restricted private placement shares at a combined price of $10.00 per non-managing investor private placement security ($2,850,000 in the aggregate). Our sponsor issued membership interests at a nominal purchase price to the non-managing investors at the closing of our initial public offering reflecting interests in an aggregate of 2,280,000 founder shares held by our sponsor;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;non-managing investor private placement securities&#8221; are to the private placement units and restricted private placement shares, collectively, purchased by the non-managing investors through the sponsor;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares&#8221; are to our Class A ordinary shares and our Class B ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;private placement shares&#8221; are to the Class&#160;A ordinary shares sold as part of the private placement units;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;private placement units&#8221; are to the units issued to our sponsor and the underwriters in private placements simultaneously with the closing of the initial public offering, which private placement units are identical to the units sold in the initial public offering, subject to certain limited exceptions as described in this Annual Report;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;private placement securities&#8221; are to the private placement units and the non-managing investor private placement securities, collectively;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;private placement warrants&#8221; are to the warrants sold as part of the private placement units;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public shareholders&#8221; are to the holders of our public shares, including our sponsor, any non-managing investors, directors and officers to the extent such persons purchase public shares, provided their status as a &#8220;public shareholder&#8221; shall only exist with respect to such public shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public shares&#8221; are to our Class&#160;A ordinary shares sold as part of the units in the initial public offering (whether they were purchased in the initial public offering or thereafter in the open market);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public warrants&#8221; are to our warrants sold as part of the units in the initial public offering (whether they were purchased in the initial public offering or thereafter in the open market);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;restricted private placement shares&#8221; are to 570,000 restricted Class A ordinary shares purchased by the non-managing investors through our sponsor, which shares would be transferred to the non-managing investors only upon consummation of an initial business combination;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Seaport&#8221; are to Seaport Global Securities LLC, a representative of the underwriters in the initial public offering ;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;sponsor&#8221; are to Plum Partners&#160;IV, LLC, a Delaware limited liability company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;underwriters&#8221; are, collectively, to Cohen and Seaport;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;warrants&#8221; are, collectively, to the public warrants and the private placement warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;warrant agreement&#8221; are, together, to our warrant agreement governing the warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or our &#8220;company&#8221; are to Plum Acquisition Corp.&#160;IV, a Cayman Islands exempted company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;$,&#8221; &#8220;US$&#8221; and &#8220;U.S.&#160;dollar&#8221; each refer to the United&#160;States dollar.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some statements contained in this Annual Report
are forward-looking in nature. Our forward-looking statements and risk factors include, but are not limited to, statements and risk factors
regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition,
any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying
assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221;
&#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking
statements and risk factors in this Annual Report may include, for example, statements and risk factors about:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to select an appropriate target business or businesses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to complete our initial business combination, which is impacted by various factors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our expectations around the performance of a prospective target business or businesses or of markets or industries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our directors and officers allocating their time to other businesses and potentially having conflicts of interest with or otherwise conflicting contractual obligations in connection with our business or in approving or consummating our initial business combination;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our potential ability to obtain additional financing to complete our initial business combination;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our pool of prospective target businesses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability of our directors and officers to generate a number of potential business combination opportunities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential liquidity and trading of our public securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the lack of a market for our securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict, the recent escalation of the Israel-Hamas conflict and the upcoming elections in the United&#160;States in 2024;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the trust account not being subject to claims of third parties;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial performance following the initial public offering; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the other risk and uncertainties discussed in &#8220;Item 1A. Risk Factors,&#8221; elsewhere in this Annual Report and in our other filings with the SEC.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The forward-looking statements and risk factors
contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects
on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements
involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or
performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties
include, but are not limited to, those factors described under the heading &#8220;Risk Factors.&#8221; Should one or more of these risks
or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those
projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="clear: both; display: block;"><br/></span></span></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.75in"><b><span style="text-decoration:underline">PART I</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.75in">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1. BUSINESS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a blank check company, incorporated as
a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our efforts to identify a prospective initial
business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial
business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify,
acquire and operate a business or businesses that can benefit from our management team&#8217;s established global relationships, sector
expertise and active management and operating experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 26, 2024, our sponsor paid $25,000, or
approximately $0.003 per share, to cover certain of our offering and formation costs in exchange for an aggregate of 7,665,900 Class B
ordinary shares. During July and August 2024, our sponsor transferred 25,000 founder shares to each of our independent directors (an aggregate
of 75,000 founder shares) at their original purchase price. On December 6, 2024, our sponsor surrendered 1,915,900 founder shares for
no consideration. Our initial shareholders currently hold an aggregate of 5,750,000 founder shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to each non-managing investor purchasing,
through an investment in our sponsor, the non-managing investor private placement securities allocated to it in connection with the closing
of the initial public offering, our sponsor issued membership interests at a nominal purchase price to the non-managing investors reflecting
interests in an aggregate of 2,280,000 founder shares held by our sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the initial investment in the company
of $25,000 by our sponsor, we had no assets, tangible or intangible. The purchase price of these founder shares was determined by dividing
the amount of cash contributed to us by the number of founder shares issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2025, we consummated the initial
public offering of 17,250,000 units, which included the full exercise of the underwriters&#8217; over-allotment option. Each unit consists
of one Class A ordinary share and one-half of one redeemable public warrant, each whole public warrant entitling the holder thereof to
purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment. The units were sold at an offering
price of $10.00 per unit, generating gross proceeds of $172,500,000 (before underwriting discounts and commissions and offering expenses).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the consummation of the initial
public offering and the issuance and sale of the units, on January 16, 2025, we consummated the private placement of an aggregate of 672,875
private placement units and 570,000 restricted private placement shares at a price of $10.00 per private placement unit or $10.00 per
non-managing investor private placement security, as applicable, generating gross proceeds of $6,728,750, as follows: (A) 440,000 private
placement units and 570,000 restricted private placement shares ($4,400,000 in the aggregate) with the sponsor, (B) 186,300 private placement
units ($1,863,000 in the aggregate) with Cohen and (C) 46,575 private placement units ($465,750 in the aggregate) with Seaport (collectively,
the &#8220;private placement&#8221;). The private placement units, which were purchased by the sponsor, Cohen and Seaport, are identical
to the units, except that, they (including the underlying securities) are (i) subject to certain limited exceptions, subject to transfer
restrictions until 180 days following the consummation of our initial business combination and (ii) entitled to registration rights. The
restricted private placement shares are held by the sponsor and will be transferred to the non-managing investors (or their designees)
only upon the consummation of an initial business combination. Other than such permitted transfer, the restricted private placement shares
are (i) subject to transfer restrictions until 90 days following the consummation of our initial business combination and (ii) entitled
to registration rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A total of $174,225,000 of the net proceeds from
the initial public offering and the private placement (which includes the underwriters&#8217; deferred discount of up to $6,900,000) was
placed in a trust account, with Continental Stock Transfer &amp; Trust Company acting as trustee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Selection of a Target Business and Structuring
of our Initial Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq listing rules require that our initial
business combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets
held in the trust account (excluding any deferred underwriters&#8217; fees and taxes payable on the income earned on the trust account).
We refer to this as the 80% fair market value test. The fair market value of the target or targets will be determined by our board of
directors based upon one or more standards generally accepted by the financial community, such as discounted cash flow valuation or value
of comparable businesses. If our board of directors is not able independently to determine the fair market value of the target business
or businesses, we will obtain an opinion from an independent investment banking firm, or another independent entity that commonly renders
valuation opinions, with respect to the satisfaction of such criteria. We do not currently intend to purchase multiple businesses in unrelated
industries in conjunction with our initial business combination, although there is no assurance that will be the case. Subject to this
requirement, our management will have virtually unrestricted flexibility in identifying and selecting one or more prospective target businesses,
although we will not be permitted to effectuate our initial business combination solely with another blank check company or a similar
company with nominal operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In any case, we will only complete an initial
business combination if the post-transaction&#160;company owns or acquires 50% or more of the issued and outstanding voting securities
of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as
an investment company under the Investment Company Act. If less than 100% of the equity interests or assets of a target business or businesses
are owned or acquired by the post-transaction&#160;company, the portion of such business or businesses that is owned or acquired is what
will be valued for purposes of the 80% fair market value test. There is no basis for investors in the initial public offering to evaluate
the possible merits or risks of any target business with which we may ultimately complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent we effect our initial business combination
with a company or business that may be financially unstable or in its early stages of development or growth we may be affected by numerous
risks inherent in such company or business. Although our management will endeavor to evaluate the risks inherent in a particular target
business, we cannot assure you that we will properly ascertain or assess all significant risk factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In evaluating a prospective target business, we
expect to conduct a thorough due diligence review which may encompass, among other things, meetings with incumbent management and employees,
document reviews, inspection of facilities, as well as a review of financial, operational, legal and other information, which will be
made available to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The time required to select and evaluate a target
business and to structure and complete our initial business combination, and the costs associated with this process, are not currently
ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target
business with which our initial business combination is not ultimately completed will result in our incurring losses and will reduce the
funds we can use to complete another business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Redemption Rights for Public Shareholders Upon
Completion of our Initial Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide our public shareholders with the
opportunity to redeem, regardless of whether they abstain, vote for, or against, our initial business combination, all or a portion of
their public shares upon the completion of our initial business combination at a per-share&#160;price, payable in cash, equal to the aggregate
amount then on deposit in the trust account calculated as of two&#160;business days prior to the consummation of the initial business
combination, including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public
shares, subject to the limitations described herein. At the completion of our initial business combination, we will be required to purchase
any ordinary shares properly delivered for redemption and not withdrawn. The amount in the trust account is initially anticipated to be
$10.10 per public share. The per-share&#160;amount we will distribute to investors who properly redeem their shares will not be reduced
by the deferred underwriting commissions we will pay to the underwriters. The redemption rights will include the requirement that a beneficial
holder must identify itself in order to validly redeem its public shares. There will be no redemption rights upon the completion of our
initial business combination with respect to our public warrants. Our initial shareholders, directors and officers have entered into a
letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public
shares held by them in connection with the completion of our initial business combination. The non-managing&#160;investors are not required
to (i)&#160;hold any units, Class&#160;A ordinary shares or public warrants they may purchase in the initial public offering or thereafter
for any amount of time, (ii)&#160;vote any Class&#160;A ordinary shares they may own at the applicable time in favor of our initial business
combination or (iii)&#160;refrain from exercising their right to redeem their public shares at the time of our initial business combination.
The non-managing&#160;investors will have the same rights to the funds held in the trust account with respect to the Class&#160;A ordinary
shares underlying the units they may purchase in the initial public offering as the rights afforded to our other public shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitation on Redemption Upon Completion of
our Initial Business Combination If we Seek Shareholder Approval</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing redemption rights,
if we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public
shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a &#8220;group&#8221; (as defined under Section&#160;13 of the Exchange&#160;Act), will be restricted from redeeming its shares with respect
to Excess Shares, without our prior consent. We believe this restriction will discourage shareholders from accumulating large blocks of
shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed business combination
as a means to force us, our sponsor or its affiliates to purchase their shares at a significant premium to the then-current&#160;market
price or on other undesirable terms. Absent this provision, a public shareholder holding more than an aggregate of 15% of the shares sold
in the initial public offering could threaten to exercise its redemption rights if such holder&#8217;s shares are not purchased by us,
our sponsor or its affiliates at a premium to the then-current&#160;market price or on other undesirable terms. By limiting our shareholders&#8217;
ability to redeem no more than 15% of the shares sold in the initial public offering, we believe we will limit the ability of a small
group of shareholders to unreasonably attempt to block our ability to complete our initial business combination, particularly in connection
with a business combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of
cash. However, we would not be restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or
against our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Redemption of Public Shares and Liquidation
if No Initial Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sponsor, our directors and officers have agreed
that we will have only until July 16, 2026 or until such earlier liquidation date as our board of directors may approve to complete our
initial business combination, or during any Extension Period, subject to applicable law. If we have not completed our initial business
combination by July 16, 2026, we will: (1)&#160;cease all operations except for the purpose of winding up; (2)&#160;as promptly as reasonably
possible but not more than 10&#160;business days thereafter, redeem the public shares, at a per-share&#160;price, payable in cash, equal
to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which
interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released to us to
pay our taxes, if any, divided by the number of then-outstanding&#160;public shares, which redemption will completely extinguish public
shareholders&#8217; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable
law; and (3)&#160;as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders
and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims
of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect
to our public warrants, which will expire worthless if we fail to complete our initial business combination by July 16, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to encounter intense competition from
other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships),
other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire.
Many of these individuals and entities are well established and have extensive experience in identifying and effecting, directly or indirectly,
acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical,
human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted
with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net
proceeds of the initial public offering and, our ability to compete with respect to the acquisition of certain target businesses that
are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing
the acquisition of certain target businesses. Furthermore, in the event we seek shareholder approval of our initial business combination
and we are obligated to pay cash for our Class&#160;A ordinary shares, it will potentially reduce the resources available to us for our
initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating a business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently have two officers and do not intend
to have any full-time&#160;employees prior to the completion of our initial business combination. Members of our management team are not
obligated to devote any specific number of&#160;hours to our matters but they intend to devote as much of their time as they deem necessary
to our affairs until we have completed our initial business combination. The amount of time that any such person will devote in any time
period will vary based on whether a target business has been selected for our initial business combination and the current stage of the
business combination process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Periodic Reporting and Financial Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have registered our units, Class&#160;A ordinary
shares and public warrants under the Exchange&#160;Act and have reporting obligations, including the requirement that we file annual,
quarterly and current reports with the SEC.&#160;In accordance with the requirements of the Exchange&#160;Act, our annual reports will
contain financial statements audited and reported on by our independent registered public accounting firm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide shareholders with audited financial
statements of the prospective target business as part of the tender offer materials or proxy solicitation materials sent to shareholders
to assist them in assessing the target business. These financial statements may be required to be prepared in accordance with, or be reconciled
to, U.S.&#160;GAAP or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance
with PCAOB standards. These financial statement requirements may limit the pool of potential target businesses we may acquire because
some targets may be unable to provide such financial statements in time for us to disclose such financial statements in accordance with
federal proxy rules and complete our initial business combination within the prescribed time frame. While this may limit the pool of potential
business combination candidates, we do not believe that this limitation will be material.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will be required to evaluate our internal control
procedures for the fiscal year ending December&#160;31, 2025 as required by the Sarbanes-Oxley&#160;Act. Only in the event we are deemed
to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to comply
with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. A target
business may not be in compliance with the provisions of the Sarbanes-Oxley&#160;Act regarding adequacy of their internal controls. The
development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley&#160;Act may increase the time and
costs necessary to complete any such acquisition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We filed a Registration Statement on Form&#160;8-A&#160;with
the SEC to voluntarily register our securities under Section&#160;12 of the Exchange&#160;Act. As a result, we are subject to the rules
and regulations promulgated under the Exchange&#160;Act. We have no current intention of filing a Form&#160;15 to suspend our reporting
or other obligations under the Exchange&#160;Act prior or subsequent to the consummation of our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of
certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth
companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley&#160;Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding&#160;advisory vote on executive compensation and shareholder approval of
any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be
a less active trading market for our securities and the prices of our securities may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Section&#160;107 of the JOBS Act
also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B)&#160;of
the Securities Act for complying with new or revised accounting standards. In other words, an &#8220;emerging growth company&#8221; can
delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take
advantage of the benefits of this extended transition period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an emerging growth company until
the earlier of (1)&#160;the last&#160;day of the fiscal year (a)&#160;following the fifth anniversary of the completion of the initial
public offering, (b)&#160;in which we have total annual gross revenue of at least $1.235&#160;billion, or (c)&#160;in which we are deemed
to be a large accelerated filer, which means the market value of our ordinary shares that is held by non-affiliates&#160;exceeds $700&#160;million
as of the end of that year&#8217;s second fiscal quarter, and (2)&#160;the date on which we have issued more than $1.00&#160;billion in
non-convertible&#160;debt securities during the prior three-year&#160;period. References herein to &#8220;emerging growth company&#8221;
will have the meaning associated with it in the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we are a &#8220;smaller reporting
company&#8221; as defined in Item&#160;10(f)(1)&#160;of Regulation&#160;S-K.&#160;Smaller reporting companies may take advantage of certain
reduced disclosure obligations, including, among other things, providing only two&#160;years of audited financial statements. We will
remain a smaller reporting company until the last&#160;day of the fiscal year in which (1)&#160;the market value of our ordinary shares
held by non-affiliates&#160;equals or exceeds $250&#160;million as of the end of that year&#8217;s second fiscal quarter, or (2)&#160;our
annual revenues equaled or exceeded $100&#160;million during such completed fiscal year and the market value of our ordinary shares held
by non-affiliates&#160;equals or exceeds $700&#160;million as of the end of that year&#8217;s second fiscal quarter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1A. RISK FACTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summary of Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>An investment in our securities involves a high degree of risk.
You should consider carefully all of the risks described below, together with the other information contained in this Annual Report, before
making a decision to invest in our units. If any of the following events occur, our business, financial condition and operating results
may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part
of your investment. Such risks include, but are not limited to</i>:</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we seek shareholder approval of our initial business combination, our initial shareholders, directors and officers have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek shareholder approval of such business combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.10 per share, or less than such amount in certain circumstances, and our warrants will expire worthless.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our search for an initial business combination, and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected by current global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial condition of potential target companies, which could make it more difficult for us to consummate an initial business combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent increases in inflation in the United States and elsewhere could make it more difficult for us to consummate a business combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to complete an initial business combination since such initial business combination may be subject to regulatory review and approval requirement, including foreign investment regulations and review by government entities such as the Committee on Foreign Investment in the United States (&#8220;CFIUS&#8221;), or may be ultimately prohibited.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not completed our initial business combination within the required time period, our public shareholders may receive only approximately $10.10 per share, or less in certain circumstances, on our redemption of their shares, and our warrants will expire worthless</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the funds not being held in the trust account are insufficient to allow us to operate for at least the 18 months following the closing of the initial public offering, we may be unable to complete our initial business combination.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to our completion of our initial business combination, we may be required to subsequently take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which could cause you to lose some or all of your investment.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If, after we distribute the proceeds in the trust account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or bankruptcy or insolvency petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If, before distributing the proceeds in the trust account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or bankruptcy or insolvency petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.</span></td></tr>
  </table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions, could adversely affect our business, financial condition or results of operations, or our prospects.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to our Search for, Consummation
of, or Inability to Consummate, a Business Combination and Post-Business Combination Risks</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have no operating history and no revenues,
and you have no basis on which to evaluate our ability to achieve our business objective.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an exempted company incorporated under
the laws of the Cayman Islands with no operating results. Because we lack an operating history to date, you have no basis upon which to
evaluate our ability to achieve our business objective of completing our initial business combination with one or more target businesses.
We may be unable to complete our initial business combination. If we fail to complete our initial business combination, we will never
generate any operating revenues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our public shareholders may not be afforded
an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though
a majority of our public shareholders do not support such a combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not hold a shareholder vote to approve
our initial business combination unless the business combination would require shareholder approval under applicable law or stock exchange
rules or if we decide to hold a shareholder vote for business or other reasons. For instance, Nasdaq listing rules currently allow us
to engage in a tender offer in lieu of a general meeting, but would still require us to obtain shareholder approval if we were seeking
to issue more than 20% of our issued and outstanding shares to a target business as consideration in any business combination. Therefore,
if we were structuring a business combination that required us to issue more than 20% of our issued and outstanding shares, we would seek
shareholder approval of such business combination. However, except as required by applicable law or stock exchange rules, the decision
as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to
us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the
transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Accordingly, we may consummate
our initial business combination even if holders of a majority of the issued and outstanding ordinary shares do not approve of the business
combination we consummate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we seek shareholder approval of our initial
business combination, our initial shareholders, directors and officers have agreed to vote in favor of such initial business combination,
regardless of how our public shareholders vote.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unlike many other blank check companies in which
the initial shareholders agree to vote their founder shares, private placement shares and restricted private placement shares in accordance
with the majority of the votes cast by the public shareholders in connection with an initial business combination, our initial shareholders,
directors and officers have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into
with us, to vote their founder shares and any public shares held by them in favor of our initial business combination. Our directors and
officers have also entered into the letter agreement, imposing similar obligations on them with respect to public shares acquired by them,
if any. Our initial shareholders and their permitted transferees currently own 27.6% of our issued and outstanding ordinary shares. Accordingly,
if we seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder approval will be
received than would be the case if such persons agreed to vote their founder shares in accordance with the majority of the votes cast
by our public shareholders. The non-managing investors are not required to (i)&#160;hold any units, Class&#160;A ordinary shares or public
warrants they may purchase, (ii)&#160;vote any Class&#160;A ordinary shares they may own at the applicable time in favor of our initial
business combination or (iii)&#160;refrain from exercising their right to redeem their public shares at the time of our initial business
combination. The non-managing investors have the same rights to the funds held in the trust account with respect to the Class&#160;A ordinary
shares underlying the units purchased as the rights afforded to our other public shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Your only opportunity to affect the investment
decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash,
unless we seek shareholder approval of such business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may not be provided with an opportunity to
evaluate the specific merits or risks of any target businesses. Additionally, since our board of directors may complete a business combination
without seeking shareholder approval, public shareholders may not have the right or opportunity to vote on the business combination, unless
we seek such shareholder approval. Accordingly, if we do not seek shareholder approval, your only opportunity to affect the investment
decision regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which
will be at least 20&#160;business days) set forth in our tender offer documents mailed to our public shareholders in which we describe
our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The ability of our public shareholders to
redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it
difficult for us to enter into a business combination with a target.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may seek to enter into a business combination
transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount
of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such closing condition and, as
a result, would not be able to proceed with the business combination. The amount of the deferred underwriting commissions payable to the
underwriters will not be adjusted for any shares that are redeemed in connection with a business combination and such amount of deferred
underwriting commissions is not available for us to use as consideration in an initial business combination. If we are able to consummate
an initial business combination, the per-share value of shares held by non-redeeming shareholders will reflect our obligation to pay and
the payment of the deferred underwriting commissions. Consequently, if accepting all properly submitted redemption requests would not
allow us to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination
and may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus, may be reluctant
to enter into a business combination transaction with us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The ability of our public shareholders to
exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination
or optimize our capital structure.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the time we enter into an agreement for our
initial business combination, we will not know how many shareholders may exercise their redemption rights and, therefore, we will need
to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If our initial
business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us
to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet such requirements,
or arrange for third-party financing. In addition, if a larger number of shares is submitted for redemption than we initially expected,
we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third-party financing.
Raising additional third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable
levels. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize
our capital structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The ability of our public shareholders to
exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination
would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our initial business combination agreement
requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash
at closing, the probability that our initial business combination would be unsuccessful increases. If our initial business combination
is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in
need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a
discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment
or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your shares in the
open market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The requirement that we complete our initial
business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business
combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular
as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that
would produce value for our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any potential target business with which we enter
into negotiations concerning a business combination will be aware that we must complete our initial business combination by July 16, 2026
or such earlier liquidation date as our board of directors may approve, or during any Extension Period. Consequently, such target business
may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination
with that particular target business, we may be unable to complete our initial business combination with any target business. This risk
will increase as we get closer to the end of such time period. In addition, we may have limited time to conduct due diligence and may
enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to complete our initial
business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up
and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.10 per share, or less
than such amount in certain circumstances, and our warrants will expire worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sponsor and our directors and officers have
agreed that we must complete our initial business combination by July 16, 2026, or such earlier liquidation date as our board of directors
may approve, or during any Extension Period. We may not be able to find a suitable target business and complete our initial business combination
within such time period. Our ability to complete our initial business combination may be negatively impacted by general market conditions,
volatility in the capital and debt markets and the other risks described herein. For example, geopolitical instability emanating from
the ongoing conflict between Russia and the Ukraine as well as tensions in the Middle East following Hamas&#8217; invasion of Israel on
October&#160;7, 2023, could limit our ability to complete our initial business combination, including as a result of increased market
volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Additionally,
geopolitical stability may negatively impact businesses we may seek to acquire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we have not completed our initial business
combination within such time period, we will: (1)&#160;cease all operations except for the purpose of winding up; (2)&#160;as promptly
as reasonably possible but not more than 10&#160;business days thereafter, redeem the public shares, at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account
(which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released
to us to pay our taxes, if any, divided by the number of then-outstanding public shares, which redemption will completely extinguish public
shareholders&#8217; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable
law; and (3)&#160;as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders
and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims
of creditors and the requirements of other applicable law. In such case, our public shareholders may receive only $10.10 per share, or
less than $10.10 per share, on the redemption of their shares, and our warrants will expire worthless. See &#8220;&#8212;&#160;<i>If third
parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.10 per share</i>&#8221; and other risk factors herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to complete an initial business
combination within the 18-month period, we may seek an amendment to our amended and restated memorandum and articles of association to
extend the period of time we have to complete an initial business combination beyond 18&#160;months. Any amendment of our amended and
restated memorandum and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands
law, meaning that such an amendment must be approved by holders of at least two-thirds of our ordinary shares who attend and vote (whether
in person or by proxy) at a general meeting of the company. If we seek shareholder approval to extend the initial 18-month period in which
to complete an initial business combination to a later date, we will offer our public shareholders the right to have their public ordinary
shares redeemed for a pro rata share of the aggregate amount then on deposit in the trust account, as described in greater detail in this
Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our search for an initial business combination,
and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected
by current global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas
conflict.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United&#160;States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation
of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#8220;NATO&#8221;)
deployed additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain
countries, including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine
and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of the
Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United&#160;States,
the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that
could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable,
they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply
chain interruptions and increased cyber-attacks against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect
the global economy and financial markets and lead to instability and lack of liquidity in capital markets. Any of the abovementioned factors,
or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion
of Ukraine, the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect our search
for an initial business combination and any target business with which we may ultimately consummate an initial business combination. The
extent and duration of the ongoing conflicts, resulting sanctions and any related market disruptions are impossible to predict, but could
be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in
expanded military operations on a global scale. Any such disruptions may also have the effect of heightening many of the other risks described
in this section. If these disruptions or other matters of global concern continue for an extensive period of time, our ability to consummate
an initial business combination, or the operations of a target business with which we may ultimately consummate an initial business combination,
may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Military or other conflicts in Ukraine,
the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations
or financial condition of potential target companies, which could make it more difficult for us to consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Military or other conflicts in Ukraine, the Middle
East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial
condition of potential target companies, and to other company or industry-specific, national, regional or international economic disruptions
and economic uncertainty, any of which could make it more difficult for us to identify a business combination target and consummate an
initial business combination on acceptable commercial terms, or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent increases in inflation in the United&#160;States
and elsewhere could make it more difficult for us to consummate a business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recent increases in inflation in the United Stated
and elsewhere may be leading to increased price volatility in publicly traded securities, including ours, and may lead to other national,
regional and international economic disruptions, any of which could make it more difficult for us to consummate a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in the market for directors and
officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, the market for directors
and officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and our management team.
The premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. These
trends may continue into the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The increased cost and decreased availability
of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate an initial business
combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public company,
the post-business combination entity might need to incur greater expense, accept less favorable terms or both. However, any failure to
obtain adequate directors and officers liability insurance could have an adverse impact on the post-business combination&#8217;s ability
to attract and retain qualified officers and directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, even after we were to complete an
initial business combination, our directors and officers could still be subject to potential liability from claims arising from conduct
alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors and officers, the post-business
combination entity may need to purchase additional insurance with respect to any such claims (&#8220;run-off insurance&#8221;). The need
for run-off insurance would be an added expense for the post-business combination entity, and could interfere with or frustrate our ability
to consummate an initial business combination on terms favorable to our investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we seek shareholder approval of our initial
business combination, our sponsor, directors, officers, advisors or any of their affiliates may elect to purchase shares or public warrants
from public shareholders, which may increase the likelihood of closing our initial business combination and reduce the public &#8220;float&#8221;
of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our sponsor, directors, officers, advisors or any of their affiliates may purchase public shares or public warrants in privately
negotiated transactions or in the open market either prior to or following the completion of our initial business combination. Any such
price per share may be different than the amount per share a public shareholder would receive if it elected to redeem its shares in connection
with our initial business combination. Additionally, at any time at or prior to our initial business combination, subject to applicable
securities laws (including with respect to material nonpublic information), our sponsor, directors, officers, advisors or any of their
affiliates may enter into transactions with investors and others to provide them with incentives to acquire public shares, vote their
public shares in favor of our initial business combination or not redeem their public shares. However, our sponsor, directors, officers,
advisors or any of their affiliates are under no obligation or duty to do so and they have no current commitments, plans or intentions
to engage in such transactions and have not formulated any terms or conditions for any such transactions. See &#8220;Proposed Business&#160;&#8212;&#160;Permitted
purchases and other transactions with respect to our securities&#8221; for a description of how our sponsor, directors, officers, advisors
or any of their affiliates will select which shareholders to enter into private transactions with.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of such purchases would be to (1)&#160;increase
the likelihood of closing the business combination or (2)&#160;satisfy a closing condition in an agreement with a target that requires
us to have a minimum net worth or a certain amount of cash at the closing of the business combination, where it appears that such requirement
would otherwise not be met. This may result in the consummation of an initial business combination that may not otherwise have been possible.
To the extent that any public shares are purchased such purchases will be in compliance with all of the requirements set forth in Tender
Offers and Schedules Compliance and Disclosure Interpretations Question 166.01&#160;promulgated by the SEC, including that such public
shares will not be voted. In addition, if such purchases are made, the public &#8220;float&#8221; of our securities and the number of
beneficial holders of our securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading
of our securities on a national securities exchange.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such purchases will be reported pursuant to
Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. Additionally,
in the event our sponsor, directors, officers, advisors and/or any of their respective affiliates were to purchase public shares or warrants
from public shareholders, such purchases would be structured in compliance with the requirements of Rule 14e-5 under the Exchange Act
including, in pertinent part, through adherence to the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our registration statement/proxy statement filed for our
business combination transaction would disclose the possibility that our sponsor, directors, officers, advisors and/or any of their respective
affiliates may purchase shares or warrants from public shareholders outside the redemption process, along with the purpose of such purchases;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">if our sponsor, directors, officers, advisors and/or any
of their respective affiliates were to purchase public shares or warrants from public shareholders, they would do so at a price no higher
than the price offered through our redemption process;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our registration statement/proxy statement filed for our
business combination transaction would include a representation that any of our securities purchased by our sponsor, directors, officers,
advisors and/or any of their respective affiliates would not be voted in favor of approving the business combination transaction;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our sponsor, directors, officers, advisors and/or any of
their respective affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess
redemption rights, they would waive such rights; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">we would disclose in a Form 8-K, before our security holder
meeting to approve the business combination transaction, the following material items:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the amount of our securities purchased outside of the redemption
offer by our sponsor, directors, officers, advisors and/or any of their respective affiliates, along with the purchase price;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the purpose of the purchases by our sponsor, directors, officers,
advisors and/or any of their respective affiliates;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the impact, if any, of the purchases by our sponsor, directors,
officers, advisors and/or any of their respective affiliates on the likelihood that the business combination transaction will be approved;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the identities of our security holders who sold to our sponsor,
directors, officers and/or any of their respective affiliates (if not purchased on the open market) or the nature of our security holders
(e.g., 5% security holders) who sold to our sponsor, directors, officers, advisors and/or any of their respective affiliates; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the number of our securities for which we have received redemption
requests pursuant to our redemption offer.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to complete an initial
business combination since such initial business combination may be subject to regulatory review and approval requirement, including foreign
investment regulations and review by government entities such as the Committee on Foreign Investment in the United&#160;States (&#8220;CFIUS&#8221;),
or may be ultimately prohibited.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sponsor is a Delaware limited liability company,
and is not controlled by, nor has substantial ties with any non-U.S. person.<sup>&#160;</sup>Our initial business combination may be subject
to regulatory review and approval requirements by governmental entities, or ultimately prohibited. For example, CFIUS has authority to
review direct or indirect foreign investments in U.S.&#160;companies. Among other things, CFIUS is empowered to require certain foreign
investors to make mandatory filings, to charge filing fees related to such filings, and to self-initiate national security reviews of
foreign direct and indirect investments in U.S.&#160;companies if the parties to that investment choose not to file voluntarily. In the
case that CFIUS determines an investment to be a threat to national security, CFIUS has the power to unwind or place restrictions on the
investment. Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on&#160;&#8212;&#160;among other
factors&#160;&#8212;&#160;the nature and structure of the transaction, including the level of beneficial ownership interest and the nature
of any information or governance rights involved. For example, investments that result in &#8220;control&#8221; of a U.S.&#160;business
by foreign person always are subject to CFIUS jurisdiction. CFIUS&#8217;s expanded jurisdiction under the Foreign Investment Risk Review
Modernization Act&#160;of&#160;2018 and implementing regulations that became effective on February&#160;13, 2020 further includes investments
that do not result in control of a U.S.&#160;business by a foreign person but afford certain foreign investors certain information or
governance rights in a U.S.&#160;business that has a nexus to &#8220;critical technologies,&#8221; &#8220;critical infrastructure&#8221;
and/or &#8220;sensitive personal data.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a particular proposed initial business combination
with a U.S.&#160;business falls within CFIUS&#8217;s jurisdiction, we may determine that we are required to make a mandatory filing or
that we will submit to CFIUS review on a voluntary basis, or to proceed with the transaction without submitting to CFIUS and risk CFIUS
intervention, before or after closing the transaction. CFIUS may decide to block or delay our proposed initial business combination, impose
conditions with respect to such initial business combination or request the President of the United&#160;States to order us to divest
all or a portion of the U.S.&#160;target business of our initial business combination that we acquired without first obtaining CFIUS approval,
which may limit the attractiveness of, delay or prevent us from pursuing certain target companies that we believe would otherwise be beneficial
to us and our shareholders. As a result, the pool of potential targets with which we could complete an initial business combination may
be limited and we may be adversely affected in terms of competing with other special purpose acquisition companies which do not have similar
foreign ownership issues. In addition, certain federally licensed businesses may be subject to rules or regulations that limit foreign
ownership.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The process of government review, whether by CFIUS
or otherwise, could be lengthy. Because we have only a limited time to complete our initial business combination, our failure to obtain
any required approvals within the requisite time period may require us to liquidate. If we are unable to consummate our initial business
combination within the applicable time period required under our amended and restated memorandum and articles of association, including
as a result of extended regulatory review of a potential initial business combination, we will, as promptly as reasonably possible but
not more than ten&#160;business days thereafter, redeem the public shares for a pro rata portion of the funds held in the trust account
and as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board
of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law. In such event, our shareholders will miss the opportunity to benefit from an investment
in a target company and the appreciation in value of such investment. Additionally, our warrants will be worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because of our limited resources and the
significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination.
If we have not completed our initial business combination within the required time period, our public shareholders may receive only approximately
$10.10 per share, or less in certain circumstances, on our redemption of their shares, and our warrants will expire worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to encounter intense competition from
other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships),
other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire.
Many of these individuals and entities are well established and have extensive experience in identifying and effecting, directly or indirectly,
acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical,
human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted
with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net
proceeds of our initial public offering and the sale of the private placement securities, our ability to compete with respect to the acquisition
of certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation
gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, in the event we seek shareholder approval
of our initial business combination and we are obligated to pay cash for our Class&#160;A ordinary shares, it will potentially reduce
the resources available to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage
in successfully negotiating a business combination. If we have not completed our initial business combination within the required time
period, our public shareholders may receive only approximately $10.10 per share, or less in certain circumstances, on the liquidation
of our trust account and our warrants will expire worthless. See &#8220;&#8212;&#160;<i>If third parties bring claims against us, the
proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.10
per share</i>&#8221; and other risk factors herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Uncertainty in connection with certain international
economic and political relationships, including the imposition of tariffs on international trade, political disputes, regulatory changes
and other international matters could have a material adverse effect on our ability to identify potential targets and to consummate our
initial business combination, and could adversely affect the financial performance of any target, either foreign or domestic.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The international economic and political environment
is dynamic and subject to change. There is currently significant uncertainty about the future economic and political relationships between
the United States and a number of other countries. These uncertainties include, among other things, the actual or potential imposition
of protective tariffs on goods imported from other countries and reciprocal tariffs other countries may impose on United States products,
political disputes that may affect relationships between the United States and other countries and the imposition of regulatory or other
restrictions on trade and commerce. Any such matters could potentially limit the number of potential targets we may consider, and could
also have a material adverse effect on the financial performance of such potential targets. Among other things, historical financial performance
of companies affected by these international matters may not provide as accurate a barometer of future performance as would pertain in
a more stable economic environment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As the number of special purpose acquisition
companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets
or such attractive targets may not be interested to consummate a business combination with a SPAC due to a negative public perception
of mergers involving SPACs. This could increase the cost of our initial business combination and could even result in our inability to
find a target or to consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, the number of special purpose
acquisition companies that have been formed has increased substantially. Many potential targets for special purpose acquisition companies
have already entered into an initial business combination, and there are still many special purpose acquisition companies preparing for
an initial public offering, as well as many such companies currently in registration. As a result, at times, fewer attractive targets
may be available to consummate an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, because there are more special purpose
acquisition companies seeking to enter into an initial business combination with available targets, the competition for available targets
with attractive fundamentals or business models may increase, which could cause targets companies to demand improved financial terms.
Attractive deals could also become scarcer for other reasons, such as economic or industry sector downturns (including a negative public
perception of mergers involving SPACs), geopolitical tensions, or increases in the cost of additional capital needed to close business
combinations or operate targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate
our ability to find and consummate an initial business combination and may result in our inability to consummate an initial business combination
on terms favorable to our investors altogether.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If the funds not being held in the trust
account are insufficient to allow us to operate for at least the 18 months following the closing of our initial public offering, we may
be unable to complete our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The funds available to us outside of the trust
account may not be sufficient to allow us to operate for at least the 18&#160;months following the closing of our initial public offering,
assuming that our initial business combination is not completed during that time. We expect to incur significant costs in pursuit of our
acquisition plans. Management&#8217;s plans to address this need for capital through our initial public offering and potential loans from
certain of our affiliates are discussed in the section of this Annual Report titled &#8220;<i>Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations</i>.&#8221; However, our affiliates are not obligated to make loans to us in the future,
and we may not be able to raise additional financing from unaffiliated parties necessary to fund our expenses. Any such event in the future
may negatively impact the analysis regarding our ability to continue as a going concern at such time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that, upon the closing of our initial
public offering, the funds available to us outside of the trust account, will be sufficient to allow us to operate for at least the 18&#160;months
following the closing of our initial public offering; however, we cannot assure you that our estimate is accurate. Of the funds available
to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business.
If we have not completed our initial business combination within the required time period, our public shareholders may receive only approximately
$10.10 per share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. See
&#8220;&#8212;&#160;<i>If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share
redemption amount received by shareholders may be less than $10.10 per share</i>&#8221; and other risk factors herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If the net proceeds of our initial public
offering and the sale of the private placement securities not being held in the trust account are insufficient, it could limit the amount
available to fund our search for a target business or businesses and complete our initial business combination and we may depend on loans
from our sponsor or management team to fund our search, to pay our taxes and to complete our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Of the net proceeds of our initial public offering
and the sale of the private placement securities, only approximately $953,750 are available to us outside the trust account to fund our
working capital requirements. In the event that our offering expenses exceed our estimate of $600,000 (excluding underwriting commissions),
we may fund such excess with funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside
the trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than our estimate
of $600,000, the amount of funds we intend to be held outside the trust account would increase by a corresponding amount. If we are required
to seek additional capital, we would need to borrow funds from our sponsor, management team or other third parties to operate or may be
forced to liquidate. Neither our sponsor, members of our management team nor any of their affiliates is under any obligation to loan funds
to, or otherwise invest in, us in such circumstances. Any such loans may be repaid only from funds held outside the trust account or from
funds released to us upon completion of our initial business combination. If we have not completed our initial business combination within
the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate
the trust account. In such case, our public shareholders may receive only $10.10 per share, or less in certain circumstances, and our
warrants will expire worthless. See &#8220;&#8212;&#160;<i>If third parties bring claims against us, the proceeds held in the trust account
could be reduced and the per-share redemption amount received by shareholders may be less than $10.10 per share</i>&#8221; and other risk
factors herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Subsequent to our completion of our initial
business combination, we may be required to subsequently take write-downs or write-offs, restructuring and impairment or other charges
that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which
could cause you to lose some or all of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even if we conduct extensive due diligence on
a target business with which we combine, we cannot assure you that this diligence will identify all material issues that may be present
with a particular target business that it would be possible to uncover all material issues through a customary amount of due diligence,
or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be
forced to later write down or write off assets, restructure our operations, or incur impairment or other charges that could result in
our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known
risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and
not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions
about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be
subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining post-combination debt financing.
Accordingly, any shareholder or warrant holder who chooses to remain a shareholder or warrant holder, respectively, following our initial
business combination could suffer a reduction in the value of their securities. Such shareholders and warrant holders are unlikely to
have a remedy for such reduction in value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If, after we distribute the proceeds in
the trust account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or
bankruptcy or insolvency petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and
the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members
of our board of directors and us to claims of punitive damages.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, after we distribute the proceeds in the trust
account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or bankruptcy
or insolvency petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable
debtor/creditor and/or insolvency laws as a voidable performance. As a result, a liquidator could seek to recover some or all amounts
received by our shareholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors
and/or having acted in bad faith by paying public shareholders from the trust account prior to addressing the claims of creditors, thereby
exposing itself and us to claims of punitive damages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If, before distributing the proceeds in
the trust account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or
bankruptcy or insolvency petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority
over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our
liquidation may be reduced.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, before distributing the proceeds in the trust
account to our public shareholders, we file a winding-up or bankruptcy or insolvency petition or an involuntary winding-up or bankruptcy
or insolvency petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable
insolvency law, and may be included in our liquidation estate and subject to the claims of third parties with priority over the claims
of our shareholders. To the extent any liquidation claims deplete the trust account, the per-share amount that would otherwise be received
by our shareholders in connection with our liquidation would be reduced.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Adverse developments affecting the financial
services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions, could adversely
affect our business, financial condition or results of operations, or our prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The funds in our operating account and our trust
account will be held in banks or other financial institutions and will be invested or held only in either (i)&#160;U.S.&#160;government
treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7
under the Investment Company Act which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash,
or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank. To mitigate the risk that we might be deemed
to be an investment company for purposes of the Investment Company Act, which risk increases the longer we hold investments in the trust
account, we may, at any time (and will no later than 18&#160;months from the closing of our initial public offering) instruct the trustee
to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing
demand deposit account. For more information about the risk of the company being considered to be operating as an unregistered investment
company, see &#8220;&#8212;<i>&#160;If we are deemed to be an investment company under the Investment Company Act, we may be required
to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our
initial business combination</i>.&#8221; Our cash held in non-interest bearing and interest-bearing accounts may exceed any applicable
Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits. Should events, including limited liquidity, defaults, non-performance
or other adverse developments occur with respect to the banks or other financial institutions that hold our funds, or that affect financial
institutions or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks,
the value of the assets in our trust account could be impaired, which could have a material impact on our operating results, liquidity,
financial condition and prospects. For example, on March&#160;10, 2023, the FDIC announced that Silicon Valley Bank had been closed by
the California Department of Financial Protection and Innovation. We cannot guarantee that the banks or other financial institutions that
will hold our funds will not experience similar issues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are deemed to be an investment company
under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted,
which may make it difficult for us to complete our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are deemed to be an investment company under
the Investment Company Act, our activities may be restricted, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">restrictions on the nature of our investments; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">restrictions on the issuance of securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">each of which may make it difficult for us to
complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we may have imposed upon us burdensome
requirements, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">registration as an investment company;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adoption of a specific form of corporate structure; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reporting, record keeping, voting, proxy and disclosure requirements
and other rules and regulations.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&#160;24, 2024, the SEC adopted a series
of new rules relating to SPACs. The SEC&#8217;s adopted rules do not provide a safe harbor for SPACs from the definition of &#8220;investment
company&#8221; under the Investment Company Act. Instead, the SEC&#8217;s adopting release provided guidance describing circumstances
in which a SPAC could become subject to regulation under the Investment Company Act, including as a result of its duration, asset composition,
business purpose, and the activities of the SPAC and its management team in furtherance of such goals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order not to be regulated as an investment
company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business
other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding
or trading &#8220;investment securities&#8221; constituting more than 40% of our total assets (exclusive of U.S.&#160;government securities
and cash items) on an unconsolidated basis. Our business will be to identify and complete an initial business combination and thereafter
to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale
or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not believe that our anticipated principal
activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account will be invested or held
only in either (i)&#160;U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting
certain conditions under Rule&#160;2a-7 under the Investment Company Act which invest only in direct U.S.&#160;government treasury obligations,
(ii)&#160;as uninvested cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank. To mitigate the
risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer we
hold investments in the trust account, we may, at any time (and will no later than 18&#160;months from the closing of our initial public
offering) instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account
in cash or in an interest bearing demand deposit account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the trust agreement, the trustee is
not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having
a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner
of a merchant bank or private equity fund), we intend to avoid being deemed an &#8220;investment company&#8221; within the meaning of
the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of:&#160;(i)&#160;the
completion of our initial business combination; (ii)&#160;the redemption of any public shares properly submitted in connection with a
shareholder vote to amend our amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of
our obligation to offer redemption rights in connection with any proposed initial business combination or certain amendments to our amended
and restated memorandum and articles of association prior thereto or to redeem 100% of our public shares if we do not complete our initial
business combination within the prescribed timeframe; or (B)&#160;with respect to any other material provision relating to shareholders&#8217;
rights or pre-initial business combination activity; or (iii)&#160;absent an initial business combination within the prescribed timeframe,
from the closing of our initial public offering, our return of the funds held in the trust account to our public shareholders as part
of our redemption of the public shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are aware of litigation against certain special
purpose acquisition companies asserting that notwithstanding the foregoing, those special purpose acquisition companies should be considered
investment companies. Although we believe that these claims are without merit, we cannot guarantee that we will not be deemed to be an
investment company and thus subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance
with these additional regulatory burdens would require additional expenses for which we have not allotted funds, may require us to otherwise
change our operations and may hinder our ability to complete an initial business combination or may result in our liquidation and the
winding up of our operations. If we are unable to complete our initial business combination and are required to liquidate, our public
shareholders would lose their opportunity to invest in a target business or businesses through our initial business combination, including
any price appreciation of the combined company&#8217;s securities following such initial business combination, and may receive only approximately
$10.10 per share on the liquidation of our trust account as well as our warrants will expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Holders of Class&#160;A ordinary shares
will not be entitled to vote on any appointment of directors we hold prior to our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to our initial business combination, only
holders of our founder shares will have the right to vote on the appointment of directors. Holders of our public shares will not be entitled
to vote on the appointment of directors during such time; provided, however, that if all of the founder shares are converted prior to
the date of the initial business combination, the holders of our public shares will have the right to vote on the election of directors.
In addition, prior to our initial business combination, holders of a majority of our founder shares may remove a member of the board of
directors for any reason. Accordingly, as holders of our Class&#160;A ordinary shares, our public shareholders will not have any say in
the management of our company prior to the consummation of an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we are not limited to a particular
industry or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the
merits or risks of any particular target business&#8217;s operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may seek to complete a business combination
with an operating company of any size (subject to our satisfaction of the 80% of net assets test) and in any industry, sector or geography.
However, we will not, under our amended and restated memorandum and articles of association, be permitted to effectuate our initial business
combination solely with another blank check company or similar company with nominal operations. Because we have not yet selected or approached
any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or risks of any
particular target business&#8217;s operations, results of operations, cash flows, liquidity, financial condition or prospects. To the
extent we complete our initial business combination, we may be affected by numerous risks inherent in the business operations with which
we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings,
we may be affected by the risks inherent in the business and operations of a financially unstable or development stage entity. Although
our directors and officers will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we
will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore,
some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will
adversely impact a target business. We also cannot assure you that an investment in our units will not ultimately prove to be less favorable
to our investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any shareholder
or warrant holder who chooses to remain a shareholder or warrant holder, respectively, following our initial business combination could
suffer a reduction in the value of their securities. Such shareholders and warrant holders are unlikely to have a remedy for such reduction
in value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Although we have identified general criteria
and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination
with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial
business combination may not have attributes entirely consistent with our general criteria and guidelines.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we have identified general criteria and
guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial business
combination will not have all of these positive attributes. If we complete our initial business combination with a target that does not
meet some or all of these criteria and guidelines, such combination may not be as successful as a combination with a business that does
meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination with a target that does
not meet our general criteria and guidelines, a greater number of shareholders may exercise their redemption rights, which may make it
difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain amount
of cash. In addition, if shareholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or we decide to obtain shareholder approval for business or other reasons, it may be more difficult for us to attain shareholder approval
of our initial business combination if the target business does not meet our general criteria and guidelines. If we have not completed
our initial business combination within the required time period, our public shareholders may receive only approximately $10.10 per share,
or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may seek acquisition opportunities with
an early stage company, a financially unstable business or an entity lacking an</i></b><i>&#160;<b>established record of revenue or earnings.</b></i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent we complete our initial business
combination with an early stage company, a financially unstable business or an entity lacking an established record of sales or earnings,
we may be affected by numerous risks inherent in the operations of the business with which we combine. These risks include investing in
a business without a proven business model and with limited historical financial data, volatile revenues or earnings, intense competition
and difficulties in obtaining and retaining key personnel. Although our directors and officers will endeavor to evaluate the risks inherent
in a particular target business, we may not be able to properly ascertain or assess all of the significant risk factors and we may not
have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability
to control or reduce the chances that those risks will adversely impact a target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are not required to obtain an opinion
from an independent investment banking firm or from an independent accounting firm regarding fairness.&#160;Consequently,
you may have no assurance from an independent source that the price we are paying </i></b><i>for the <b>business is fair to our company
from a financial point of view.</b></i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless we complete our initial business combination
with an affiliated entity, we are not required to obtain an opinion that the price we are paying is fair to our company from a financial
point of view. If no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will determine
fair market value based on standards generally accepted by the financial community. Such standards used will be disclosed in our tender
offer documents or proxy solicitation materials, as applicable, related to our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Resources could be wasted in researching
acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another
business. If we have not completed our initial business combination within the required time period, our public shareholders may receive
only approximately $10.10 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our
warrants will expire worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that the investigation of each specific
target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require
substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a
specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable.
Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination
for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred
which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed
our initial business combination within the required time period, our public shareholders may receive only approximately $10.10 per share,
or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may have limited ability to assess the
management of a prospective target business and, as a result, may affect our initial business combination with a target business whose
management may not have the skills, qualifications or abilities to manage a public company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When evaluating the desirability of effecting
our initial business combination with a prospective target business, our ability to assess the target business&#8217;s management may
be limited due to a lack of time, resources or information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our assessment of the capabilities of the target&#8217;s
management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should
the target&#8217;s management not possess the skills, qualifications or abilities necessary to manage a public company, the operations
and profitability of the post-combination business may be negatively impacted. Accordingly, any shareholder or warrant holder who chooses
to remain a shareholder or warrant holder, respectively, following our initial business combination could suffer a reduction in the value
of their securities. Such shareholders and warrant holders are unlikely to have a remedy for such reduction in value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors and officers of an acquisition candidate
may resign upon completion of our initial business combination. The departure of a business combination target&#8217;s key personnel could
negatively impact the operations and profitability of our post-combination business. The role of an acquisition candidate&#8217;s key
personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain
members of an acquisition candidate&#8217;s management team will remain associated with the acquisition candidate following our initial
business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue notes or other debt securities,
or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition
and thus negatively impact the value of our shareholders&#8217; investment in us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we have no commitments as of the date
of this Annual Report to issue any notes or other debt securities, or to otherwise incur outstanding debt, we may choose to incur substantial
debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained from
the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance
of debt will affect the per-share amount available for redemption from the trust account. Nevertheless, the incurrence of debt could have
a variety of negative effects, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">default and foreclosure on our assets if our operating revenues
after an initial business combination are insufficient to repay our debt obligations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">acceleration of our obligations to repay the indebtedness
even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial
ratios or reserves without a waiver or renegotiation of that covenant;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our immediate payment of all principal and accrued interest,
if any, if the debt is payable on demand;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our inability to obtain necessary additional financing if
the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our inability to pay dividends on our ordinary shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">using a substantial portion of our cash flow to pay principal
and interest on our debt, which will reduce the funds available for dividends on our ordinary shares if declared, expenses, capital expenditures,
acquisitions and other general corporate purposes;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">limitations on our flexibility in planning for and reacting
to changes in our business and in the industry in which we operate;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">increased vulnerability to adverse changes in general economic,
industry and competitive conditions and adverse changes in government regulation; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">limitations on our ability to borrow additional amounts for
expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages
compared to our competitors who have less debt.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be able to complete only one business
combination with the proceeds of our initial public offering and the sale of the private placement securities, which will cause us to
be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively
impact our operations and profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds from our initial public offering
and the sale of the private placement securities are or approximately $179.2&#160;million that we may use to complete our initial business
combination (which includes up to $6,900,000 of deferred underwriting commissions being held in the trust account, and excludes estimated
offering expenses of $600,000 (other than underwriting commissions) relating to our initial public offering)).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may effectuate our initial business combination
with a single target business or multiple target businesses simultaneously or within a short period of time. However, we may not be able
to effectuate our initial business combination with more than one target business because of various factors, including the existence
of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating
results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial
business combination with only a single entity our lack of diversification may subject us to numerous economic, competitive and regulatory
risks. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses,
unlike other entities which may have the resources to complete several business combinations in different industries or different areas
of a single industry. Accordingly, the prospects for our success may be:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">solely dependent upon the performance of a single business,
property or asset; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">dependent upon the development or market acceptance of a
single or limited number of products, processes or services.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This lack of diversification may subject us to
numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry
in which we may operate subsequent to our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may attempt to simultaneously complete
business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and
give rise to increased costs and risks that could negatively impact our operations and profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we determine to simultaneously acquire several
businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent
on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete
our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens
and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional
risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating
business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may attempt to complete our initial business
combination with a private company about which little information is available, which may result in a business combination with a company
that is not as profitable as we suspected, if at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In pursuing our acquisition strategy, we may seek
to effectuate our initial business combination with a privately held company. Very little public information generally exists about private
companies, and we could be required to make our decision on whether to pursue a potential initial business combination on the basis of
limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not have a specified maximum redemption
threshold. The absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial
majority of our shareholders do not agree.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association do not provide a specified maximum redemption threshold. As a result, we may be able to complete our initial business combination
even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if
we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor,
directors, officers, advisors or any of their affiliates. In the event the aggregate cash consideration we would be required to pay for
all public shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms
of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination
or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search
for an alternate business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In order to effectuate an initial business
combination, blank check companies have, in the past, amended various provisions of their charters and modified governing instruments,
including their warrant agreements. We cannot assure you that we will not seek to amend our amended and restated memorandum and articles
of association or governing instruments in a manner that will make it easier for us to complete our initial business combination that
some of our shareholders may not support.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to effectuate an initial business combination,
blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments, including
their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption
thresholds and extended the time to consummate an initial business combination and, with respect to their warrants, amended their warrant
agreements to require the warrants to be exchanged for cash and/or other securities. Amending our amended and restated memorandum and
articles of association requires at least a special resolution of our shareholders as a matter of Cayman Islands law. A resolution is
deemed to be a special resolution as a matter of Cayman Islands law where it has been approved by either (1)&#160;holders of at least
two-thirds (or any higher threshold specified in a company&#8217;s articles of association) of a company&#8217;s ordinary shares who attend
and vote at a general meeting for which notice specifying the intention to propose the resolution as a special resolution has been given
or (2)&#160;if so authorized by a company&#8217;s articles of association, by a unanimous written resolution of all of the company&#8217;s
shareholders. Our amended and restated memorandum and articles of association provide that special resolutions must be approved either
by holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting (i.e. the lowest threshold permissible
under Cayman Islands law) (other than amendments relating to provisions governing the appointment or removal of directors prior to our
initial business combination, which require the approval of a majority of at least 90% of our ordinary shares attending and voting in
a general meeting), or by a unanimous written resolution of all of our shareholders. The warrant agreement provides that (a)&#160;the
terms of the public warrants may be amended without the consent of any holder for the purpose of (i)&#160;curing any ambiguity or correct
any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the public warrants and the
warrant agreement set forth in this Annual Report, or defective provision (ii)&#160;removing or reducing the Company&#8217;s ability to
redeem the public warrants and, if applicable, a corresponding amendment to the Company&#8217;s ability to redeem the private placement
warrants or (iii)&#160;adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the
parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered
holders of the public warrants under the warrant agreement in any material respect, (b)&#160;the terms of the warrants may be amended
with the vote or written consent of at least 50% of the then outstanding public warrants and private placement warrants, voting together
as a single class, to allow for the warrants to be, or continue to be, as applicable, classified as equity in our financial statements
and (c)&#160;all other modifications or amendments to our warrant agreement with respect to (i)&#160;the public warrants require the vote
or written consent of holders of at least 50% of the then outstanding public warrants, and (ii)&#160;the private placement warrants require
the vote or written consent of holders of at least 50% of the then outstanding private placement warrants. We cannot assure you that we
will not seek to amend our amended and restated memorandum and articles of association or governing instruments, including the warrant
agreement, or extend the time to consummate an initial business combination in order to effectuate our initial business combination. To
the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered through this registration
statement, we would register, or seek an exemption from registration for, the affected securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain provisions of our amended and restated
memorandum and articles of association that relate to our pre-business combination activity (and corresponding provisions of the agreement
governing the release of funds from our trust account) may be amended with the approval of holders of at least two-thirds of our ordinary
shares who attend and vote at a general meeting, which is a lower amendment threshold than that of some other blank check companies. It
may be easier for us, therefore, to amend our amended and restated memorandum and articles of association and the trust agreement to facilitate
the completion of an initial business combination that some of our shareholders may not support.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association provide that any of its provisions, including those related to pre-business combination activity (including the requirement
to deposit proceeds of our initial public offering and the sale of private placement securities into the trust account and not release
such amounts except in specified circumstances), may be amended if approved by holders of at least two-thirds of our ordinary shares who
attend and vote in a general meeting, and corresponding provisions of the trust agreement governing the release of funds from our trust
account may be amended if approved by holders of 65% of our ordinary shares (other than amendments relating to provisions governing the
appointment or removal of directors prior to our initial business combination, which require the approval of a majority of at least 90%
of our ordinary shares attending and voting in a general meeting). Our initial shareholders, who collectively beneficially own approximately
25% of our ordinary shares, may participate in any vote to amend our amended and restated memorandum and articles of association and/or
trust agreement and will have the discretion to vote in any manner they choose. As a result, we may be able to amend the provisions of
our amended and restated memorandum and articles of association which govern our pre-business combination behavior more easily than some
other blank check companies, and this may increase our ability to complete our initial business combination with which you do not agree.
In certain circumstances, our shareholders may pursue remedies against us for any breach of our amended and restated memorandum and articles
of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be unable to obtain additional financing
to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure
or abandon a particular business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we believe that the net proceeds of our
initial public offering and the sale of the private placement securities will be sufficient to allow us to complete our initial business
combination, because we have not yet selected any target business we cannot ascertain the capital requirements for any particular transaction.
If the net proceeds of our initial public offering prove to be insufficient, either because of the size of our initial business combination,
the depletion of the available net proceeds in search of a target business, the obligation to redeem for cash a significant number of
shares from shareholders who elect redemption in connection with our initial business combination or the terms of negotiated transactions
to purchase shares in connection with our initial business combination, we may be required to seek additional financing in the form of
proceeds of the sale of our shares in connection with our initial business combination, shares issued to the owners of the target, debt
issued to bank or other lenders or the owners of the target, other securities issuances, or a combination of the foregoing. We cannot
assure you that such financing will be available on acceptable terms, if at all. To the extent that additional financing proves to be
unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon
that particular business combination and seek an alternative target business candidate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, even if we do not need additional
financing to complete our initial business combination, we may require such financing to fund the operations or growth of the target business.
The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target business.
None of our directors, officers or shareholders is required to provide any financing to us in connection with or after our initial business
combination. If we have not completed our initial business combination within the required time period, our public shareholders may receive
only approximately $10.10 per share, or less in certain circumstances, on the liquidation of our trust account, and our warrants will
expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we must furnish our shareholders
with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination
with some prospective target businesses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The federal proxy rules require that a proxy statement
with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial
statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer
documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in
accordance with, or be reconciled to, accounting principles generally accepted in the United&#160;States of America, or U.S.&#160;GAAP,
or international financial reporting standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances
and the historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting
Oversight Board (United&#160;States), or PCAOB.&#160;These financial statement requirements may limit the pool of potential target businesses
we may acquire because some targets may be unable to provide such financial statements in time for us to disclose such financial statements
in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compliance obligations under the Sarbanes-Oxley
Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources,
and increase the time and costs of completing an acquisition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&#160;404 of the Sarbanes-Oxley Act requires
that we evaluate and report on our system of internal controls beginning with our Annual Report on Form&#160;10-K for the year ending
December&#160;31, 2025. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify
as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement
on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of
the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a target business with which we seek
to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy
of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act
may increase the time and costs necessary to complete any such acquisition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>After our initial business combination,
our results of operations and prospects could be subject, to a significant extent, to the economic, political, social and government policies,
developments and conditions in the country in which we operate.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The economic, political and social conditions,
as well as government policies, of the country in which our operations are located could affect our business. Economic growth could be
uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the future
such country&#8217;s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in
certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find
an attractive target business with which to consummate our initial business combination and if we effect our initial business combination,
the ability of that target business to become profitable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The outbreak of infectious diseases, endemics,
pandemics and other public health crises and the impact on businesses and debt and equity markets could have a material adverse effect
on our search for an initial business combination, and any target business with which we ultimately consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beginning in late 2019, the COVID-19 pandemic
caused substantial disruption to global economies and markets and, since then, the virus has continued to spread on a global scale. A
significant outbreak of the COVID-19 and other infectious diseases, including the resurgence or variants thereof, could result in a widespread
health crisis that could adversely affect economies and financial markets worldwide, business operations and the conduct of commerce generally
and could have a material adverse effect on the business of any potential target business with which we complete a business combination.
Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 or other public health crises
restrict travel, limit the ability to have meetings with potential investors or the target company&#8217;s personnel, vendors and services
providers are unavailable to negotiate and consummate a transaction in a timely manner or even to conduct requisite due diligence. In
addition, countries or supranational organizations in our target markets may develop and implement legislation that makes it more difficult
or impossible for entities outside such countries or target markets to acquire or otherwise invest in companies or businesses deemed essential
or otherwise vital. The extent to which COVID-19 or other public health crises impact our search for a business combination will depend
on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the
severity and new variants of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. While vaccines for COVID-19
have been developed, there is no guarantee that such vaccines will be durable. The treatment or vaccine for COVID-19 and any potentially
emerging variants may be ineffective or underutilized. If the disruptions posed by COVID-19 or other matters of global concern continue
for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which we
ultimately consummate a business combination, may be materially adversely affected. In addition, our ability to consummate a transaction
may be dependent on the ability to raise equity and debt financing which may be impacted by COVID-19 and other public health events, including
as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable
to us or at all. Finally, the outbreak of COVID-19 or the emergence of new or other public health crises may also have the effect of heightening
many of the other risks described in this &#8220;Risk Factors&#8221; section.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to our Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue our shares to investors in
connection with our initial business combination at a price which is less than the prevailing market price of our shares at that time.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with our initial business combination,
we may issue shares to investors in private placement transactions (so-called PIPE transactions). The purpose of such issuances will be
to enable us to provide sufficient liquidity to the post-business combination entity. The price of the shares we issue may therefore be
less, and potentially significantly less, than the market price for our shares at such time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is currently no market for our securities
and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is currently no market for our securities.
Shareholders therefore have no access to information about prior market history on which to base their investment decision. Following
our initial public offering, the price of our securities may vary significantly due to one or more potential business combinations and
general market or economic conditions. Furthermore, an active trading market for our securities may never develop or, if developed, it
may not be sustained. You may be unable to sell your securities unless a market can be established and sustained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If a shareholder fails to receive notice
of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for
tendering its shares, such shares may not be redeemed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will comply with the tender offer rules or
proxy rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with
these rules, if a shareholder fails to receive our tender offer or proxy materials, as applicable, such shareholder may not become aware
of the opportunity to redeem its shares. In addition, the tender offer documents or proxy materials, as applicable, that we will furnish
to holders of our public shares in connection with our initial business combination will describe the various procedures that must be
complied with in order to validly tender or redeem public shares. In the event that a shareholder fails to comply with these procedures,
its shares may not be redeemed. See &#8220;<i>Proposed Business&#160;&#8212;&#160;Effecting Our Initial Business Combination&#160;&#8212;&#160;Tendering
share certificates in connection with a tender offer or redemption rights</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>You will not have any rights or interests
in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced
to sell your public shares and/or warrants, potentially at a loss.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our public shareholders will be entitled to receive
funds from the trust account only upon the earliest to occur of:&#160;(1)&#160;our completion of an initial business combination, and
then only in connection with those Class&#160;A ordinary shares that such shareholder properly elected to redeem, subject to the limitations
described herein; (2)&#160;the redemption of any public shares properly submitted in connection with a shareholder vote to amend our amended
and restated memorandum and articles of association (A)&#160;to modify the substance or timing of our obligation to allow redemption in
connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination
by July 16, 2026 or such earlier liquidation date as our board of directors may approve, or any Extension Period, or (B)&#160;with respect
to any other provision relating to shareholders&#8217; rights or pre-initial business combination activity; and (3)&#160;the redemption
of our public shares if we have not completed an initial business combination by July 16, 2026 or such earlier liquidation date as our
board of directors may approve, or during any Extension Period, subject to applicable law. In no other circumstances will a shareholder
have any right or interest of any kind to or in the trust account. Holders of warrants will not have any right to the proceeds held in
the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares
and/or warrants, potentially at a loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq may delist our securities from trading
on its exchange, which could limit investors&#8217; ability to make transactions in our securities and subject us to additional trading
restrictions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our units have been approved for listing on Nasdaq
on or promptly after the date of this Annual Report and our Class&#160;A ordinary shares and public warrants listed on or promptly after
their date of separation. Although after giving effect to our initial public offering we met the minimum initial listing standards set
forth in the Nasdaq listing standards, we cannot assure you that our securities will continue to be listed on Nasdaq in the future or
prior to our initial business combination. In order to continue listing our securities on Nasdaq prior to our initial business combination,
we must maintain certain financial, distribution and stock price levels. In general, we must maintain an average global market capitalization
and a minimum of 400 public holders. Additionally, in connection with our initial business combination, we will be required to demonstrate
compliance with Nasdaq&#8217;s initial listing requirements, which are more rigorous than Nasdaq&#8217;s continued listing requirements,
in order to continue to maintain the listing of our securities on Nasdaq. For instance, our share price would generally be required to
be at least $4.00 per share and we would be required to have a minimum of 400 round lot holders of our unrestricted securities. We cannot
assure you that we will be able to meet those initial listing requirements at that time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Nasdaq delists any of our securities from trading
on its exchange and we are not able to list our securities on another national securities exchange, we expect such securities could be
quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a limited availability of market quotations for our securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced liquidity for our securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a determination that our Class&#160;A ordinary shares are
a &#8220;penny stock&#8221; which will require brokers trading in our Class&#160;A ordinary shares to adhere to more stringent rules
and possibly result in a reduced level of trading activity in the secondary trading market for our securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a limited amount of news and analyst coverage; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a decreased ability to issue additional securities or obtain
additional financing in the future.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The National Securities Markets Improvement Act&#160;of&#160;1996,
which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as &#8220;covered
securities.&#8221; Because our units are listed, and eventually our Class&#160;A ordinary shares and public warrants will be listed, on
Nasdaq, our units qualify, and our Class&#160;A ordinary shares and public warrants will qualify, as covered securities under such statute.
Although the states are preempted from regulating the sale of covered securities, the federal statute does allow the states to investigate
companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the
sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the
sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check
companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies
in their states. Further, if we were no longer listed on Nasdaq, our securities would not qualify as covered securities under such statute
and we would be subject to regulation in each state in which we offer our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we seek shareholder approval of our initial
business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a &#8220;group&#8221; of shareholders
are deemed to hold in excess of 15% of our Class&#160;A ordinary shares, you will lose the ability to redeem all such shares in excess
of 15% of our Class&#160;A ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under
Section&#160;13 of the Exchange&#160;Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15%
of the shares sold in our initial public offering, which we refer to as the &#8220;Excess Shares,&#8221; without our prior consent. However,
we would not be restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business
combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally,
you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as
a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to
sell your shares in open market transactions, potentially at a loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If third parties bring claims against us,
the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than
$10.10 per share.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our placing of funds in the trust account may
not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers (other than our
independent registered public accounting firm), prospective target businesses and other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public
shareholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing
claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims
to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will enter into
an agreement with a third party that has not executed a waiver only if management believes that such third party&#8217;s engagement would
be in the best interests of the company under the circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Examples of possible instances where we may engage
a third party that refuses to execute a waiver include the engagement&#160;of a third-party consultant whose particular expertise or skills
are believed by management to be&#160;significantly superior to those of other consultants that would agree to execute a waiver or in
cases where we are unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities
will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements
with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we have not completed
our initial business combination within the required time period, or upon the exercise of a redemption right in connection with our initial
business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against
us within the 10&#160;years following redemption. Accordingly, the per-share redemption amount received by public shareholders could be
less than the $10.10 per public share initially held in the trust account, due to claims of such creditors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sponsor has agreed that it will be liable
to us if and to the extent any claims by a third party (other than our independent registered public accounting firm) for services rendered
or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the
amount of funds in the trust account to below (1)&#160;$10.10 per public share or (2)&#160;such lesser amount per public share held in
the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case
net of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights
to seek access to the trust account and except as to any claims under our indemnity of the underwriters of our initial public offering
against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed
to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims.
We have not independently verified whether our sponsor has sufficient funds to satisfy their respective indemnity obligations and believe
that our sponsor&#8217;s only assets are securities of our company. Our sponsor may not have sufficient funds available to satisfy those
obligations. We have not asked our sponsor to reserve for such obligations, and therefore, no funds are currently set aside to cover any
such obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial
business combination and redemptions could be reduced to less than $10.10 per public share. In such event, we may not be able to complete
our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your public
shares. None of our directors or officers will indemnify us for claims by third parties including, without limitation, claims by vendors
and prospective target businesses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our directors may decide not to enforce
the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution
to our public shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the proceeds in the trust account
are reduced below the lesser of (1)&#160;$10.10 per public share or (2)&#160;such lesser amount per share held in the trust account as
of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of interest which
may be withdrawn for working capital purposes and to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations or
that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal
action against the sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would
take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent
directors in exercising their business judgment may choose not to do so in any particular instance. If our independent directors choose
not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public shareholders
may be reduced below $10.10 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we have not completed our initial business
combination within 18 months of the closing of our initial public offering, our public shareholders may be forced to wait beyond such
18 months before redemption from our trust account.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we have not completed our initial business
combination by July 16, 2026 or such earlier liquidation date as our board of directors may approve or during any Extension Period, we
will distribute the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account
(which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released
to us to pay our taxes, if any, pro rata to our public shareholders by way of redemption and cease all operations except for the purposes
of winding up of our affairs, as further described herein. Any redemption of public shareholders from the trust account shall be effected
automatically by function of our amended and restated memorandum and articles of association prior to any voluntary winding up. If we
are required to wind up, liquidate the trust account and distribute such amount therein, pro rata, to our public shareholders, as part
of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies
Act. In that case, investors may be forced to wait beyond the initial 18&#160;months before the redemption proceeds of our trust account
become available to them and they receive the return of their pro rata portion of the proceeds from our trust account. We have no obligation
to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto, we consummate our initial business
combination or amend certain provisions of our amended and restated memorandum and articles of association and then only in cases where
investors have properly sought to redeem their Class&#160;A ordinary shares. Only upon our redemption or any liquidation will public shareholders
be entitled to distributions if we have not completed our initial business combination within the required time period and do not amend
certain provisions of our amended and restated memorandum and articles of association prior thereto.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to complete an initial business
combination within the 18-month period, we may seek an amendment to our amended and restated memorandum and articles of association to
extend the period of time we have to complete an initial business combination beyond 18&#160;months. Any amendment of our amended and
restated memorandum and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands
law, meaning that such an amendment must be approved by at least two-thirds of our ordinary shares who attend and vote (whether in person
or by proxy) at a general meeting of the company. If we seek shareholder approval to extend the initial 18-month period in which to complete
an initial business combination to a later date, we will offer our public shareholders the right to have their public ordinary shares
redeemed for a pro rata share of the aggregate amount then on deposit in the trust account, as described in greater detail in this Annual
Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our shareholders may be held liable for
claims by third parties against us to the extent of distributions received by them upon redemption of their shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are forced to enter into an insolvent liquidation,
any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date
on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result,
a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed as having
breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, and thereby exposing themselves and our company
to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that
claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted
any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course
of business would be guilty of an offence under Cayman Islands law and may be liable for a fine of up to approximately $18,300 and to
imprisonment for five&#160;years in the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are not registering the Class&#160;A
ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration
may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants
except on a cashless basis and potentially causing such warrants to expire worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not registering the Class&#160;A ordinary
shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. In no event will we
be required to net cash settle any public warrant, or issue securities or other compensation in exchange for the public warrants in the
event that we are unable to register or qualify the shares underlying the public warrants under applicable state securities laws and no
exemption is available. If the issuance of the shares upon exercise of the public warrants is not so registered or qualified or exempt
from registration or qualification, the holder of such public warrant shall not be entitled to exercise such public warrant and such public
warrant may have no value and expire worthless. In such event, holders who acquired their public warrants as part of a purchase of units
will have paid the full unit purchase price solely for the Class&#160;A ordinary shares included in the units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, we have agreed that, as soon as practicable,
but in no event later than 15&#160;business days after the closing of our initial business combination, we will use our commercially reasonable
efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class&#160;A ordinary shares
issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within
60&#160;business days after the closing of our initial business combination and to maintain the effectiveness of such registration statement
and a current prospectus relating thereto until the expiration of the warrants in accordance with the provisions of the warrant agreement.
We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in
the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference
therein are not current, complete or correct or the SEC issues a stop order. If the shares issuable upon exercise of the public warrants
are not registered under the Securities Act in accordance with the above requirements, we will be required to permit holders to exercise
their public warrants on a cashless basis. However, no public warrant will be exercisable for cash or on a cashless basis, and we will
not be obligated to issue any shares to holders seeking to exercise their public warrants, unless the issuance of the shares upon such
exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration
is available. Additionally, if, at the time that a public warrant is exercised, our Class&#160;A ordinary shares are not listed on a national
securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the
Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a cashless basis in
accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event we so elect, we will not be required to file or maintain
in effect a registration statement, but will use our commercially reasonable efforts to register or qualify the shares under applicable
blue sky laws to the extent an exemption is not available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a cashless exercise pursuant to
the preceding paragraph, each public warrant holder would pay the exercise price by surrendering the public warrants for that number of
Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying
the warrants, multiplied by the excess of the &#8220;fair market value&#8221; (defined below) less the exercise price of the warrants
by (y) the fair market value. The &#8220;fair market value&#8221; as used in the preceding sentence shall mean the volume weighted average
price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise
is received by the warrant agent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The grant of registration rights to our
initial shareholders, the underwriters and their permitted transferees may make it more difficult to complete our initial business combination,
and the future exercise of such rights may adversely affect the market price of our Class&#160;A ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to an agreement to be entered at or after
the time of our initial business combination, our initial shareholders, the underwriters and their permitted transferees can demand that
we register the Class&#160;A ordinary shares into which founder shares are convertible, holders of our private placement units, private
placement shares, restricted private placement shares, private placement warrants and their permitted transferees can demand that we register
the private placement units, private placement shares, restricted private placement shares, private placement warrants and the Class&#160;A
ordinary shares issuable upon exercise of the private placement warrants and holders of warrants that may be issued upon conversion of
working capital loans may demand that we register such shares, warrants or the Class&#160;A ordinary shares issuable upon conversion of
such warrants. The registration rights will be exercisable with respect to the founder shares and the private placement units, private
placement shares, restricted private placement shares, private placement warrants and the Class&#160;A ordinary shares issuable upon exercise
of such private placement warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will bear the cost of registering these securities.
The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect
on the market price of our Class&#160;A ordinary shares. In addition, the existence of the registration rights may make our initial business
combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity stake
they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our Class&#160;A
ordinary shares that is expected when the ordinary shares owned by our initial shareholders, holders of our restricted private placement
shares, holders of our private placement units or holders of our working capital units (if any) or their permitted transferees are registered
for resale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Members of our management team and board
of directors have significant experience as founders, board members, officers, executives or employees of other companies. Certain of
those persons have been, may be, or may become, involved in litigation, investigations or other proceedings, including related to those
companies or otherwise. The defense or prosecution of these matters could be time-consuming and could divert our management&#8217;s attention,
and may have an adverse effect on us, which may impede our ability to consummate an initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the course of their careers, members of
our management team and board of directors have had significant experience as founders, board members, officers, executives or employees
of other companies. As a result of their involvement and positions in these companies, certain of those persons have been, may be or may
in the future become involved in litigation, investigations or other proceedings, including relating to the business affairs of such companies,
transactions entered into by such companies, or otherwise. Individual members of our management team and board of directors also may become
involved in litigation, investigations or other proceedings involving claims or allegations related to or as a result of their personal
conduct, either in their capacity as a corporate officer or director or otherwise, and may be personally named in such actions and potentially
subject to personal liability. Any such liability may or may not be covered by insurance and/or indemnification, depending on the facts
and circumstances. The defense or prosecution of these matters could be time-consuming. Any litigation, investigations or other proceedings
and the potential outcomes of such actions may divert the attention and resources of our management team and board of directors away from
identifying and selecting a target business or businesses for our initial business combination and may negatively affect our reputation,
which may impede our ability to complete an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue additional Class&#160;A ordinary
shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial
business combination. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association authorizes the issuance of up to 200,000,000 Class&#160;A ordinary shares, par value $0.0001 per share, 20,000,000 Class&#160;B
ordinary shares, par value $0.0001 per share, and 1,000,000 undesignated preference shares, par value $0.0001 per share. Immediately after
our initial public offering, there were 181,507,125 and 14,250,000 authorized but unissued Class&#160;A ordinary shares and Class&#160;B
ordinary shares, respectively, available for issuance, which amount does not take into account shares reserved for issuance upon exercise
of outstanding warrants, or shares reserved for issuance upon conversion of the Class&#160;B ordinary shares. Class&#160;B ordinary shares
are convertible into Class&#160;A ordinary shares, initially at a one-for-one ratio but subject to adjustment as set forth herein. There
are currently no preference shares issued and outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue a substantial number of additional
Class&#160;A ordinary shares, and may issue preference shares, in order to complete our initial business combination or under an employee
incentive plan after completion of our initial business combination. We may also issue Class&#160;A ordinary shares to redeem public warrants.
However, our amended and restated memorandum and articles of association provide, among other things, that prior to our initial business
combination, we may not issue additional ordinary shares that would entitle the holders thereof to (1)&#160;receive funds from the trust
account or (2)&#160;vote as a class with our public shares on any initial business combination. The issuance of additional ordinary shares
or preference shares:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">may significantly dilute the equity interest of investors
in our initial public offering;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">may subordinate the rights of holders of ordinary shares
if preference shares are issued with rights senior to those afforded our ordinary shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">could cause a change of control if a substantial number of
our ordinary shares is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any,
and could result in the resignation or removal of our present directors and officers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">may have the effect of delaying or preventing a change of
control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">may adversely affect prevailing market prices for our units,
ordinary shares and/or public warrants; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">may not result in adjustment to the exercise price of our
warrants.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Holders of our founder shares will control
the appointment of our board of directors until consummation of our initial business combination and will hold a substantial interest
in us. As a result, they will appoint all of our directors prior to our initial business combination and may exert a substantial influence
on actions requiring shareholder vote, potentially in a manner that you do not support.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial shareholders own approximately 25%
of our issued and outstanding ordinary shares (not including the Class&#160;A ordinary shares underlying the private placement units and
the restricted private placement shares). In addition, prior to our initial business combination, holders of the founder shares will have
the right to vote to appoint all of our directors and may remove members of the board of directors for any reason. Non-managing investors
will only be issued membership interests in our sponsor, with no right to control our sponsor or vote or dispose of any securities held
by our sponsor. Holders of our public shares will have no right to vote on the appointment of directors during such time; provided, however,
that if all of the founder shares are converted prior to the date of the initial business combination, the holders of our public shares
will have the right to vote on the election of directors. These provisions of our amended and restated memorandum and articles of association
may only be amended by a special resolution passed by a majority of at least 90% of our ordinary shares attending and voting in a general
meeting. As a result, you will not have any influence over the appointment of directors prior to our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither our initial shareholders nor, to our knowledge,
any of our directors or officers, have any current intention to purchase additional securities, other than as disclosed in this Annual
Report. Factors that would be considered in making such additional purchases would include consideration of the current trading price
of our Class&#160;A ordinary shares. In addition, as a result of their substantial ownership in our company, our initial shareholders
may exert a substantial influence on other actions requiring a shareholder vote, potentially in a manner that you do not support, including
amendments to our amended and restated memorandum and articles of association and approval of major corporate transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our board of directors is comprised
of directors who will generally serve a three-year term. We may not hold an annual general meeting to appoint new directors prior to the
completion of our initial business combination, in which case all of the current directors will continue in office until at least the
completion of the business combination. If there is an annual general meeting, our sponsor and initial shareholders, because of their
beneficial ownership, will control the outcome, as only holders of our Class&#160;B ordinary shares will have the right to vote on the
appointment of directors and to remove directors prior to our initial business combination. Accordingly, holders of our founder shares
will exert significant influence over actions requiring a shareholder vote at least until the completion of our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may amend the terms of the warrants in
a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public
warrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our public warrants will be issued in registered
form under a warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and us. The warrant agreement
provides that (a)&#160;the terms of the public warrants may be amended without the consent of any holder for the purpose of (i)&#160;curing
any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of
the public warrants and the warrant agreement set forth in this Annual Report, or defective provision (ii)&#160;removing or reducing the
Company&#8217;s ability to redeem the public warrants and, if applicable, a corresponding amendment to the Company&#8217;s ability to
redeem the private placement warrants or (iii)&#160;adding or changing any provisions with respect to matters or questions arising under
the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely
affect the rights of the registered holders of the public warrants under the warrant agreement in any material respect, (b)&#160;the terms
of the warrants may be amended with the vote or written consent of at least 50% of the then outstanding public warrants and private placement
warrants, voting together as a single class, to allow for the warrants to be or continue to be, as applicable, classified as equity in
our financial statements and (c)&#160;all other modifications or amendments to our warrant agreement with respect to (i)&#160;the public
warrants require the vote or written consent of holders of at least 50% of the then outstanding public warrants and (ii)&#160;the private
placement warrants require the vote or written consent of holders of at least 50% of the then outstanding private placement warrants.
Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder of public warrants if holders of at least 50%
of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants with
the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to,
among other things, increase the exercise price of the warrants, shorten the exercise period or decrease the number of ordinary shares
purchasable upon exercise of a warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our warrant agreement designates the courts
of the State of New&#160;York or the United&#160;States District Court for the Southern District of New&#160;York as the sole and exclusive
forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of
warrant holders to obtain a favorable judicial forum for disputes with our company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our warrant agreement provides that, subject to
applicable law, (i)&#160;any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including
under the Securities Act, will be brought and enforced in the courts of the State of New&#160;York or the United&#160;States District
Court for the Southern District of New&#160;York, and (ii)&#160;that we irrevocably submit to such jurisdiction, which jurisdiction shall
be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, these provisions
of the warrant agreement do not apply to suits brought to enforce any liability or duty created by the Exchange&#160;Act or any other
claim for which the federal district courts of the United&#160;States of America are the sole and exclusive forum. Any person or entity
purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum
provisions in our warrant agreement. If any action, the subject matter of which is within the scope the forum provisions of the warrant
agreement, is filed in a court other than a court of the State of New&#160;York or the United&#160;States District Court for the Southern
District of New&#160;York (a &#8220;foreign action&#8221;) in the name of any holder of our warrants, such holder shall be deemed to have
consented to: (x)&#160;the personal jurisdiction of the state and federal courts located in the State of New&#160;York in connection with
any action brought in any such court to enforce the forum provisions (an &#8220;enforcement action&#8221;), and (y)&#160;having service
of process made upon such warrant holder in any such enforcement action by service upon such warrant holder&#8217;s counsel in the foreign
action as agent for such warrant holder. This choice-of-forum provision may limit a warrant holder&#8217;s ability to bring a claim in
a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court
were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types
of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially
and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of
our management and board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unlike some other similarly structured blank
check companies, our initial shareholders will beneficially own 25% of our issued and outstanding ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial shareholders beneficially own approximately
25% of our issued and outstanding ordinary shares. This is different than some other similarly situated bank check companies in which
the initial shareholders will only be issued an aggregate of 20% of the total number of shares to be outstanding prior to the initial
business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may redeem your unexpired public warrants
prior to their exercise at a time that is disadvantageous to you, thereby making your public warrants worthless.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have the ability to redeem outstanding warrants
at any time after they become exercisable and prior to their expiration, at a price of $0.01 per public warrant if, among other things,
the last reported sale price of our Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted to the number of shares
issuable upon exercise or the exercise price of a public warrant) for any 20&#160;trading days within a 30 trading-day period ending on
the third&#160;trading day prior to the date on which we send the notice of redemption to the warrant holders. If and when the public
warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities
for sale under all applicable state securities laws. As a result, we may redeem the public warrants as set forth above even if the holders
are otherwise unable to exercise the public warrants. Redemption of the issued and outstanding public warrants could force you to: (1)&#160;exercise
your public warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so; (2)&#160;sell your
public warrants at the then-current market price when you might otherwise wish to hold your public warrants; or (3)&#160;accept the nominal
redemption price which, at the time the outstanding public warrants are called for redemption, we expect would be substantially less than
the market value of your public warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management&#8217;s ability to require
holders of our public warrants to exercise such public warrants on a cashless basis will cause holders to receive fewer Class&#160;A ordinary
shares upon their exercise of the public warrants than they would have received had they been able to exercise their public warrants for
cash.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we call our public warrants for redemption
after the redemption criteria described elsewhere in this Annual Report has been satisfied, our management will have the option to require
any holder that wishes to exercise its public warrants (including any public warrants held by our sponsor, officers, directors or their
permitted transferees) to do so on a cashless basis. If our management chooses to require holders to exercise their public warrants on
a cashless basis, the number of Class&#160;A ordinary shares received by a holder upon exercise will be fewer than it would have been
had such holder exercised their public warrants for cash. This will have the effect of reducing the potential &#8220;upside&#8221; of
the holder&#8217;s investment in us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our warrants, founder shares, private placement
units and restricted private placement shares may have an adverse effect on the market price of our Class&#160;A ordinary shares and make
it more difficult to effectuate our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We issued public warrants to purchase 8,625,000
Class&#160;A ordinary shares at a price of $11.50 per whole share (subject to adjustments as provided in the registration statement) as
part of the units offered by this Annual Report and, also issued in a private placement an aggregate of 672,875 private placement units,
which include private placement warrants to purchase an aggregate of 336,428 Class&#160;A ordinary shares at $11.50 per share, in addition
to 570,000 restricted private placement shares. Our initial shareholders currently hold 5,750,000 Class&#160;B ordinaryshares. The Class&#160;B
ordinary shares are convertible into Class&#160;A ordinary shares on a one-for-one basis, subject to adjustment as set forth herein. In
addition, if our sponsor, any of its affiliates or certain of our directors and officers make any working capital loans, up to $1,500,000
of such loans may be converted into private placement units, at the price of $10.00 per unit at the option of the lender. To the extent
we issue Class&#160;A ordinary shares to effectuate a business combination, the potential for the issuance of a substantial number of
additional Class&#160;A ordinary shares upon exercise of these warrants or conversion rights could make us a less attractive acquisition
vehicle to a target business. Any such issuance will increase the number of issued and outstanding Class&#160;A ordinary shares and reduce
the value of the Class&#160;A ordinary shares issued to complete the business combination. Therefore, our warrants and founder shares
may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The private placement warrants are identical to
the warrants sold as part of the units in our initial public offering except that: (1)&#160;they will not be redeemable by us; (2)&#160;they
(including the Class&#160;A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions,
be transferred, assigned or sold until 30&#160;days after the completion of our initial business combination; (3)&#160;they may be exercised
by the holders on a cashless basis and (4)&#160;they (including the ordinary shares issuable upon exercise of these warrants) are entitled
to registration rights. In addition, with respect to private placement warrants held by the underwriters and/or their designees, such
private placement warrants will be subject to the lock-up and registration rights limitations imposed by FINRA Rule&#160;5110 and will
not be exercisable more than five&#160;years from the commencement of sales in our initial public offering in accordance with FINRA Rule&#160;5110(g)(8).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because each unit contains one-half of one
public warrant and only a whole public warrant may be exercised, the units may be worth less than units of other blank check companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each unit contains one-half of one public warrant.
Pursuant to the warrant agreement, no fractional public warrants will be issued upon separation of the units, and only whole public warrants
will trade. This is different from other offerings similar to ours whose units include one ordinary share and one whole public warrant
to purchase one share. We have established the components of the units in this way in order to reduce the dilutive effect of the public
warrants upon completion of a business combination since the public warrants will be exercisable in the aggregate for a third of the number
of shares compared to units that each contain a whole public warrant to purchase one whole share, thus making us, we believe, a more attractive
business combination partner for target businesses. Nevertheless, this unit structure may cause our units to be worth less than if they
included a public warrant to purchase one whole share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A provision of our warrant agreement may
make it more difficult for us to consummate an initial business combination. Unlike many blank check companies, if:</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">we issue additional ordinary shares or equity-linked securities
for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than
$9.20 per ordinary share;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">the aggregate gross proceeds from such issuances represent
more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the
date of the completion of our initial business combination (net of redemptions); and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">the Market Value is below $9.20 per share,</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then the exercise price of the warrants will be
adjusted to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and, in the case of the public warrants only,
the $18.00 per share redemption trigger prices described in the registration statement will be adjusted (to the nearest cent) to be equal
to 180% of the higher of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial
business combination with a target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we are incorporated under the laws
of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S.&#160;federal
courts may be limited.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an exempted company incorporated under
the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United&#160;States
upon our directors or officers, or enforce judgments obtained in the United&#160;States courts against our directors or officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate affairs will be governed by our
amended and restated memorandum and articles of association, the Companies Act (as the same may be supplemented or amended from time to
time) and the common law of the Cayman Islands. The rights of shareholders to take action against the directors, actions by minority shareholders
and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of
the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman
Islands as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court
in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are
different from what they would be under statutes or judicial precedent in some jurisdictions in the United&#160;States. In particular,
the Cayman Islands has a different body of securities laws as compared to the United&#160;States, and certain states, such as Delaware,
may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing
to initiate a shareholders derivative action in a federal court of the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The courts of the Cayman Islands are unlikely
(1)&#160;to recognize or enforce against us judgments of courts of the United&#160;States predicated upon the civil liability provisions
of the federal securities laws of the United&#160;States or any state; and (2)&#160;in original actions brought in the Cayman Islands,
to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United&#160;States
or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no
statutory enforcement in the Cayman Islands of judgments obtained in the United&#160;States, the courts of the Cayman Islands will recognize
and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle
that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been
given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and
conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment
in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is,
contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be
contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of all of the above, public shareholders
may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or
controlling shareholders than they would as public shareholders of a United&#160;States company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Provisions in our amended and restated memorandum
and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future
for our Class&#160;A ordinary shares and could entrench management.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best
interests. These provisions include three-year director terms and the ability of the board of directors to designate the terms of and
issue new series of preference shares, which may make more difficult the removal of management and may discourage transactions that otherwise
could involve payment of a premium over prevailing market prices for our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to our sponsor and Management
Team</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Past performance by our management team
and their affiliates may not be indicative of future performance of an investment in the company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information regarding performance by our management
team and their affiliates is presented for informational purposes only. Past performance by our management team and their affiliates is
not a guarantee either (1)&#160;that we will be able to identify a suitable candidate for our initial business combination or (2)&#160;of
success with respect to any business combination we may consummate. You should not rely on the historical record of our management team
or their affiliates or any related investment&#8217;s performance as indicative of our future performance of an investment in the company
or the returns the company will, or is likely to, generate going forward.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our directors and officers will allocate
their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs.
This conflict of interest could have a negative impact on our ability to complete our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors and officers are not required to,
and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations
and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion
of our initial business combination. Our officers are engaged in several other business endeavors for which they may be entitled to substantial
compensation and our officers are not obligated to contribute any specific number of&#160;hours per week to our affairs. Certain of our
independent directors also serve as officers and board members for other entities. If our officers&#8217; and directors&#8217; other business
affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit
their ability to devote time to our affairs, which may have a negative impact on our ability to complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are dependent upon our directors and
officers and their departure could adversely affect our ability to operate.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations are dependent upon a relatively
small group of individuals and in particular, Kanishka Roy, our Chairman and Chief Executive Officer, and Steven Handwerker, our Chief
Financial Officer and Director. We believe that our success depends on the continued service of our directors and officers, at least until
we have completed our initial business combination. In addition, our directors and officers are not required to commit any specified amount
of time to our affairs and, accordingly, will have conflicts of interest in allocating their time among various business activities, including
identifying potential business combinations and monitoring the related due diligence. We do not have an employment agreement with, or
key-man insurance on the life of, any of our directors or officers. The unexpected loss of the services of one or more of our directors
or officers could have a detrimental effect on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our ability to successfully effect our initial
business combination and to be successful thereafter will be dependent upon the efforts of our key personnel, some of whom may join us
following our initial business combination. The loss of our or a target&#8217;s key personnel could negatively impact the operations and
profitability of our post-combination business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to successfully effect our initial
business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however,
cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management or advisory
positions following our initial business combination, it is likely that some or all of the management of the target business will remain
in place. While we intend to closely scrutinize any individuals we engage after our initial business combination, we cannot assure you
that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the&#160;requirements of operating
a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the directors and officers of an
acquisition candidate may resign upon completion of our initial business combination. The departure of a business combination target&#8217;s
key personnel could negatively impact the operations and profitability of our post-combination business. The role of an acquisition candidate&#8217;s
key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that
certain members of an acquisition candidate&#8217;s management team will remain associated with the acquisition candidate following our
initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.
The loss of key personnel could negatively impact the operations and profitability of our post-combination business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our key personnel may negotiate employment
or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for
them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest
in determining whether a particular business combination is the most advantageous.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our key personnel may be able to remain with the
company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements
in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination
and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would
render to us after the completion of our initial business combination. The personal and financial interests of such individuals may influence
their motivation in identifying and selecting a target business, subject to his or her fiduciary duties under Cayman Islands law. However,
we believe the ability of such individuals to remain with us after the completion of our initial business combination will not be the
determining factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty,
however, that any of our key personnel will remain with us after the completion of our initial business combination. We cannot assure
you that any of our key personnel will remain in senior management or advisory positions with us. The determination as to whether any
of our key personnel will remain with us will be made at the time of our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain of our directors and officers are
now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be
conducted by us and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should
be presented.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until we consummate our initial business combination,
we intend to engage in the business of identifying and combining with one or more businesses. Our sponsor and directors and officers are,
or may in the future become, affiliated with entities that are engaged in a similar business. For example, Kanishka Roy, our Chairman
and Chief Executive Officer, currently serves as Chairman, President and CEO of Plum Acquisition Corp.&#160;III, and is also the manager
of Mercury Capital, its sponsor, and Steven Handwerker, our Chief Financial Officer and Director, currently serves as CFO of Plum Acquisition
Corp.&#160;III.&#160;Our sponsor and directors and officers are also not prohibited from sponsoring, or otherwise becoming involved with,
any other blank check companies prior to us completing our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors and officers also may become aware
of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or
contractual duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity
should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to other entities
prior to its presentation to us, subject to his or her fiduciary duties under Cayman Islands law. Our amended and restated memorandum
and articles of association provide that, to the fullest extent permitted by applicable law: (i)&#160;no individual serving as a director
or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly
in the same or similar business activities or lines of business as us; and (ii)&#160;we renounce any interest or expectancy in, or in
being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director
or officer, on the one hand, and us, on the other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our directors, officers, security holders
and their respective affiliates may have competitive pecuniary interests that conflict with our interests.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not adopted a policy that expressly prohibits
our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment
to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business
combination with a target business that is affiliated with either of our sponsor and our directors or officers, although we do not intend
to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities
of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affiliates of our sponsor have invested in a diverse
set of industries. As a result, there may be substantial overlap between companies that would be a suitable business combination for us
and companies that would make an attractive target for such other affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, members of our management team and
our board of directors directly or indirectly own founder shares, and, accordingly, may have a conflict of interest in determining whether
a particular target business is an appropriate business with which to effectuate our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may engage in a business combination
with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, our non-managing investors,
and our directors or officers which may raise potential conflicts of interest.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In light of the involvement of our directors and
officers with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, our non-managing investors,
and our directors and officers. Certain of our directors and officers also serve as officers and board members for other entities. Such
entities may compete with us for business combination opportunities. Our sponsor, our directors and officers are not currently aware of
any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there
have been no preliminary discussions concerning a business combination with any such entity or entities. Although we will not be specifically
focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such
affiliated entity met our criteria and guidelines for a business combination and such transaction was approved by a majority of our independent
and disinterested directors. Despite our agreement that we, or a committee of independent and disinterested directors, will obtain an
opinion from an independent investment banking firm that is a member of FINRA or from a valuation or appraisal firm, regarding the fairness
to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated
with our sponsor, our non-managing investors, and our directors or officers, potential conflicts of interest still may exist and, as a
result, the terms of the business combination may not be as advantageous to our public shareholders as they would be absent any conflicts
of interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Since our sponsor, officers and directors
and any other holder of our founder shares, including any non-managing investor, and the underwriters will lose their entire investment
in us if our initial business combination is not completed (other than with respect to any public shares they may acquire), and because
our sponsor, officers and directors and any other holder of our founder shares, including any non-managing investor, directly or indirectly
may profit substantially from a business combination as a result of their ownership of founder shares even under circumstances where our
public shareholders would experience losses in connection with their investment, a conflict of interest may arise in determining whether
a particular business combination target is appropriate for our initial business combination, including in connection with the shareholder
vote in respect thereto.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;26, 2024, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain of our offering and formation costs in exchange for an aggregate of 7,665,900 founder
shares. Prior to this initial investment in us by our sponsor, we had no assets, tangible or intangible. During July and August 2024,
our sponsor transferred 25,000 founder shares to each of our independent directors (an aggregate of 75,000 founder shares) at their original
purchase price. On December&#160;6, 2024, our sponsor surrendered 1,915,900 founder shares for no consideration. Our initial shareholders
currently hold an aggregate of 5,750,000 founder shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial shareholders collectively beneficially
own approximately 25% of our issued and outstanding shares (not including the Class&#160;A ordinary shares underlying the private placement
units and the restricted private placement shares). The founder shares will be worthless if we do not complete an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our sponsor purchased an aggregate
of 440,000 private placement units and 570,000 restricted private placement shares at a price of $10.00 per private placement unit or
a combined price of $10.00 per non-managing investor private placement security, as applicable, or $4,400,000 in the aggregate, in a private
placement that closed simultaneously with the closing of our initial public offering. The underwriters committed to use a portion of their
underwriting discount and commission to purchase an aggregate of 232,875 private placement units at a price of $10.00 per unit, or $2,328,750
in the aggregate, in said private placement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The non-managing investors have purchased, indirectly
through the purchase of non-managing sponsor membership interests, an aggregate of 285,000 private placement units and 570,000 restricted
private placement shares at a combined price of $10.00 per non-managing investor private placement security ($2,850,000 in the aggregate)
in a private placement that closed simultaneously with the closing of our initial public offering. The non-managing investors paid no
additional consideration for the restricted private placement shares, which allowed them to invest in our company on more favorable terms
than other investors. Subject to each non-managing investor purchasing, through an investment in our sponsor, the non-managing investor
private placement securities allocated to it in connection with the closing of our initial public offering, our sponsor issued membership
interests at a nominal purchase price to the non-managing investors reflecting interests in an aggregate of 2,280,000 founder shares held
by our sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given the differential in the purchase price paid
for the founder shares as compared to our initial public offering price of the public shares and the substantial number of Class&#160;A
ordinary shares that holders of our founder shares would receive upon conversion of the founder shares upon a business combination, the
founder shares may have significant value after the business combination even if our Class&#160;A ordinary shares trade below our initial
public offering price and holders of our public shares have a substantial loss on their investment. Our initial shareholders have agreed
(A)&#160;to vote any shares owned by them in favor of any proposed business combination and (B)&#160;not to redeem any founder shares
in connection with a shareholder vote to approve a proposed initial business combination. In addition, we may obtain loans from either
of our sponsor, any of its affiliates or certain of our directors and officers. The non-managing investors are not required to (i)&#160;hold
any units, Class&#160;A ordinary shares or public warrants they may purchase in our initial public offering or thereafter for any amount
of time, (ii)&#160;vote any Class&#160;A ordinary shares they may own at the applicable time in favor of our initial business combination
or (iii)&#160;refrain from exercising their right to redeem their public shares at the time of our initial business combination. The non-managing
investors will have the same rights to the funds held in the trust account with respect to the Class&#160;A ordinary shares underlying
the units they may purchase in our initial public offering as the rights afforded to our other public shareholders. However, if the non-managing
investors purchase all of the units for which they have expressed to us an interest in purchasing or otherwise hold a substantial number
of our units, then the non-managing investors will potentially have different interests than our other public shareholders in approving
our initial business combination and otherwise exercising their rights as public shareholders because of their indirect ownership of founder
shares as further discussed in this Annual Report. The non-managing investors will share in any appreciation of the founder shares and
restricted private placement shares through their membership interests in our sponsor if we successfully complete a business combination.
Accordingly, non-managing investors&#8217; interests in the founder shares and restricted private placement shares owned by them indirectly
through their membership interests in our sponsor may provide them with an incentive to vote any public shares they own in favor of a
business combination, and make a substantial profit on such interests, even if the business combination is with a target that ultimately
declines in value and is not profitable for other public shareholders. Further, in light of the non-managing investors&#8217; interests
in the founder shares, private placement units and restricted private placement shares, in the event we pursue an initial business combination
with a company that is affiliated with one or more non-managing investors, such non-managing investors would have a conflict of interest
in approving such initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The personal and financial interests of our sponsor
and our directors and officers and any holders of our founder shares or our private placement securities may influence their motivation
in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of
the business following the initial business combination and may result in a misalignment of interests between the holders of our founder
shares, including any non-managing investors, and our officers and directors, on the one hand, and our public shareholders, on the other.
These risks may become more acute as the deadline to complete our initial business combination nears. In particular, because the founder
shares were purchased at a purchase price of approximately $0.003 per share, the holders of our founder shares, including any non-managing
investors, and certain of our directors and officers that directly or indirectly own founder shares) could make a substantial profit after
our initial business combination even if our public shareholders lose money on their investment as a result of a decrease in the post-combination&#160;
value of their Class&#160;A ordinary shares (after accounting for any adjustments in connection with an exchange or other transaction
contemplated by the business combination). For example, a holder of 1,000 founder shares would have paid approximately $3.00 to purchase
such shares. At the time of an initial business combination, such holder would be able to convert such founder shares into 1,000 Class&#160;A
ordinary shares, and would receive the same consideration in connection with our initial business combination as a public shareholder
for the same number of Class&#160;A ordinary shares. If the trading price of our Class&#160;A ordinary shares on a post-combination basis
(after accounting for any adjustments in connection with an exchange or other transaction contemplated by the business combination) were
to decrease to $5.00 per Class&#160;A ordinary share, such holder of our founder shares would obtain a profit of approximately $4,997
on account of the 1,000 founder shares that the holder had converted into Class&#160;A ordinary shares in connection with the initial
business combination. By contrast, a public shareholder holding 1,000 Class&#160;A ordinary shares acquired in our initial public offering
would lose approximately $5,000 in connection with the same transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, each of our officers and directors may
have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers
and directors were to be included by a target business as a condition to any agreement with respect to our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The nominal purchase price paid by our sponsor
and certain of our independent directors for the founder shares may result in significant dilution to the implied value of your public
shares upon the consummation of our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We sold our units at an offering price of $10.00
per unit and the amount in our trust account is initially $10.10 per public share, implying an initial value of $10.10 per public share.
However, prior to our initial public offering, our sponsor, and certain of our independent directors paid a nominal aggregate purchase
price of $25,000 for the founder shares, or approximately $0.003 per share. As a result, the value of your public shares may be significantly
diluted upon the consummation of our initial business combination, when the founder shares are converted into public shares. For example,
the following table shows the dilutive effect of the founder shares on the implied value of the public shares upon the consummation of
our initial business combination, assuming that our equity value at that time is $145,500,000 which is the amount we would have for our
initial business combination in the trust account after payment of up to $6,000,000 of deferred underwriting commissions, assuming the
underwriters&#8217; over-allotment option was not exercised, no interest is earned on the funds held in the trust account, and no public
shares are redeemed in connection with our initial business combination, and without taking into account any other potential impacts on
our valuation at such time, such as the trading price of our public shares, the business combination transaction costs, any equity issued
or cash paid to the target&#8217;s sellers or other third parties, or the target&#8217;s business itself, including its assets, liabilities,
management and prospects, as well as the value of our public and private warrants. At such valuation, each of our ordinary shares would
have an implied value of $6.86 per share upon consummation of our initial business combination, which would be an approximate 32.1% decrease
as compared to the initial implied value per public share of $10.10.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may approve an amendment or waiver of
the letter agreement that would allow our sponsor to directly, or members of our sponsor to indirectly, transfer founder shares and private
placement units in a transaction in which the sponsor removes itself as our sponsor before identifying a business combination, which may
deprive us of key personnel.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While there is no current intention to do so,
and the members of our management team and sponsor have not done so with any previously formed special purpose acquisition companies,
we may approve an amendment or waiver of the letter agreement that would allow the sponsor to directly, or members of our sponsor to indirectly,
transfer founder shares and private placement units in a transaction in which the sponsor removes itself as our sponsor before identifying
a business combination. As a result, there is a risk that our sponsor and our officers and directors may divest their ownership or economic
interests in us or in our sponsor, which would likely result in our loss of certain key personnel, including Kanishka Roy and Steven Handwerker.
There can be no assurance that any replacement sponsor or key personnel will successfully identify a business combination target for us,
or, even if one is so identified, successfully complete such business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management may not be able to maintain
control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target
business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may structure our initial business combination
so that the post-transaction company in which our public shareholders own shares will own less than 100% of the equity interests or assets
of a target business, but we will complete such business combination only if the post-transaction company owns or acquires 50% or more
of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient
for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction
that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our shareholders
prior to our initial business combination may collectively own a minority interest in the post business combination company, depending
on valuations ascribed to the target and us in our initial business combination transaction. For example, we could pursue a transaction
in which we issue a substantial number of new ordinary shares in exchange for all of the issued and outstanding capital stock, shares
or other equity securities of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance
of a substantial number of new ordinary shares, our shareholders immediately prior to such transaction could own less than a majority
of our issued and outstanding ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently
combine their holdings resulting in a single person or group obtaining a larger share of the company&#8217;s shares than we initially
acquired. Accordingly, this may make it more likely that our management will not be able to maintain our control of the target business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our initial business combination will require
approval of a majority of our board of directors, as well as a majority of our independent directors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our amended and restated memorandum
and articles of association, our initial business combination will require the approval of a majority of our board of directors and, under
Nasdaq rules, our initial business combination will also require the approval of a majority of our independent directors. Unless we receive
the requisite board member approvals, we will not be able to enter into a definitive merger or similar agreement relating to our initial
business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Associated with Acquiring and Operating
a Business in Foreign Countries</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our management team pursues a company
with operations or opportunities outside of the United&#160;States for our initial business combination, we may face additional burdens
in connection with investigating, agreeing to and completing such combination, and if we effect such initial business combination, we
would be subject to a variety of additional risks that may negatively impact our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our management team pursues a company with
operations or opportunities outside of the United&#160;States for our initial business combination, we would be subject to risks associated
with cross-border business combinations, including in connection with investigating, agreeing to and completing our initial business combination,
conducting due diligence in a foreign market, having such transaction approved by any local governments, regulators or agencies and changes
in the purchase price based on fluctuations in foreign exchange rates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we effect our initial business combination
with such a company, we would be subject to any special considerations or risks associated with companies operating in an international
setting, including any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">costs and difficulties inherent in managing cross-border
business operations and complying with commercial and legal requirements of overseas markets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">rules and regulations regarding currency redemption;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">complex corporate withholding taxes on individuals;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">laws governing the manner in which future business combinations
may be effected;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">tariffs and trade barriers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">regulations related to customs and import/export matters;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">longer payment cycles;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">tax consequences, such as tax law changes, including termination
or reduction of tax and other incentives that the applicable government provides to domestic companies, and variations in tax laws as
compared to the United&#160;States;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">currency fluctuations and exchange controls;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">rates of inflation;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">challenges in collecting accounts receivable;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">cultural and language differences;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">employment regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">crime, strikes, riots, civil disturbances, terrorist attacks,
natural disasters and wars;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">deterioration of political relations with the United&#160;States;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">obligatory military service by personnel; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">government appropriation of assets.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not be able to adequately address these
additional risks. If we were unable to do so, we may be unable to complete such combination or, if we complete such combination, our operations
might suffer, either of which may adversely impact our results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our management following our initial
business combination is unfamiliar with U.S.&#160;securities laws, they may have to expend time and resources becoming familiar with such
laws, which could lead to various regulatory issues.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following our initial business combination, any
or all of our management could resign from their positions as officers of the company, and the management of the target business at the
time of the business combination could remain in place. Management of the target business may not be familiar with U.S.&#160;securities
laws. If new management is unfamiliar with U.S.&#160;securities laws, they may have to expend time and resources becoming familiar with
such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a working capital deficiency and
a weak cash position.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, we had $4,767 in cash
and a working capital deficiency of $427,641. Further, we expect to incur significant costs in pursuit of our acquisition plans. Following
the initial public offering, we had $971,550 of cash held outside of the Trust Account. Our plans to raise capital and to consummate our
initial business combination may not be successful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>You will not be entitled to protections
normally afforded to investors of many other blank check companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the net proceeds of our initial public offering
are intended to be used to complete an initial business combination with a target business that has not been selected, we may be deemed
to be a &#8220;blank check&#8221; company under the U.S.&#160;securities laws. However, because we will have net tangible assets in excess
of $5,000,000 upon the successful completion of our initial public offering and will file a Current Report on Form&#160;8-K, including
an audited balance sheet of the company demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors
in blank check companies, such as Rule&#160;419. Accordingly, investors will not be afforded the benefits or protections of those rules.
Among other things, this means our units will be immediately tradable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in laws or regulations, or a failure
to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial
business combination, and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements.
Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations
and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our
business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business
combination, and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&#160;24, 2024, the SEC adopted a series
of new rules relating to SPACs requiring, among other items, (i)&#160;additional disclosures relating to SPAC business combination transactions;
(ii)&#160;additional disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC
initial public offerings and SPAC initial business combinations; (iii)&#160;the use of projections by SPACs in SEC filings in connection
with proposed business combination transactions; and (iv)&#160;both the SPAC and the target company&#8217;s status as co-registrants on
de-SPAC transaction registration statements. In addition, the SEC&#8217;s adopting release provided guidance describing circumstances
in which a SPAC could become subject to regulation under the Investment Company Act, including as a result of its duration, asset composition,
business purpose, and the activities of the SPAC and its management team in furtherance of such goals. Compliance with such rules and
related guidance may increase the costs and the time needed to negotiate and complete an initial business combination, may constrain the
circumstances under which we could complete an initial business combination or otherwise impair our ability to complete a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not hold an annual general meeting
until after the consummation of our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing
on Nasdaq. There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors.
Until we hold an annual general meeting, public shareholders may not be afforded the opportunity to discuss company affairs with management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be a passive foreign investment company,
or &#8220;PFIC,&#8221; which could result in adverse U.S.&#160;federal income tax consequences to U.S.&#160;investors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used herein, the term &#8220;U.S. Holder&#8221;
means a beneficial owner of units, ordinary shares or warrants who or that is for U.S. federal income tax purposes: (1) an individual
citizen or resident of the United States; (2) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes)
that is created or organized (or treated as created or organized) in or under the laws of the United States, any state thereof or the
District of Columbia; (3) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (4) a
trust if (A) a court within the United States is able to exercise primary supervision over the administration of the trust and one or
more U.S. persons have the authority to control all substantial decisions of the trust, or (B) it has in effect a valid election to be
treated as a U.S. person.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a PFIC for any taxable year (or portion
thereof) that is included in the holding period of a U.S.&#160;Holder of our ordinary shares or warrants, the U.S.&#160;Holder may be
subject to adverse U.S.&#160;federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status
for our current and subsequent taxable&#160;years may depend upon the status of an acquired company pursuant to a business combination
and whether we qualify for the PFIC start-up exception. Depending on the particular circumstances, the application of the start-up exception
may be subject to uncertainty, and there cannot be any assurance that we will qualify for the start-up exception. Accordingly, there can
be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year. Our actual PFIC status
for any taxable year, moreover, will not be determinable until after the end of such taxable year(and if the start-up exception may be
applicable, potentially not until after the two taxable&#160;years following). Moreover, if we determine we are a PFIC for any taxable
year, we will endeavor upon written request to provide to a U.S.&#160;Holder such information as the Internal Revenue Service (&#8220;IRS&#8221;)
may require, including a PFIC Annual Information Statement, in order to enable the U.S.&#160;Holder to make and maintain a &#8220;qualified
electing fund&#8221; election, but there can be no assurance that we will timely provide such required information, and such election
would likely be unavailable with respect to our warrants in all cases. We urge U.S.&#160;Holders to consult their tax advisors regarding
the possible application of the PFIC rules to holders of our ordinary shares and warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If a U.S.&#160;person is treated as owning
at least 10% of our stock, such person may be subject to adverse U.S.&#160;federal income tax consequences.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder is treated as owning (directly,
indirectly or constructively) at least 10% of the value or voting power of our stock, such holder may be treated as a &#8220;United&#160;States
shareholder&#8221; with respect to us if we are a &#8220;controlled foreign corporation,&#8221; (&#8220;CFC&#8221;), for U.S.&#160;federal
income tax purposes. A non-U.S.&#160;corporation is considered a CFC if more than 50% of (1)&#160;the total combined voting power of all
classes of stock of such corporation entitled to vote, or (2)&#160;the total value of the stock of such corporation is owned, or is considered
as owned by applying certain constructive ownership rules, by 10% &#8220;United&#160;States shareholders&#8221; on any&#160;day during
the taxable year of such non-U.S.&#160;corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a CFC, 10% &#8220;United&#160;States
shareholders&#8221; will be subject to adverse income inclusion and reporting requirements with respect to us. No assurance can be provided
that we will assist holders in determining whether we are treated as a CFC or whether any holder is treated as a 10% &#8220;United&#160;States
shareholder&#8221; with respect to us or furnish to any holder information that may be necessary to comply with reporting and tax payment
obligations with respect to our status as a CFC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may reincorporate in another jurisdiction
in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders or warrant holders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may, subject to requisite shareholder approval
by special resolution under our amended and restated memorandum and articles of association, effect a business combination with a target
company in another jurisdiction, reincorporate in the jurisdiction in which the target company or business is located, or reincorporate
in another jurisdiction. Such transactions may result in tax liability for a shareholder or warrant holder in the jurisdiction in which
the shareholder or warrant holder is a tax resident (or in which its members are resident if it is a tax transparent entity), in which
the target company is located, or in which we reincorporate. In the event of a reincorporation pursuant to our initial business combination,
such tax liability may attach prior to the consummation of redemptions of any of our public shares properly submitted to us for redemption
in connection with such business combination. We do not intend to make any cash distributions to shareholders to pay such taxes. Shareholders
or warrant holders may be subject to withholding taxes or other taxes with respect to their ownership of us after the reincorporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our initial business combination involves
a company organized under the laws of the United&#160;States (or any subdivision thereof), a U.S.&#160;federal excise tax could be imposed
on us in connection with any redemptions of our Class&#160;A ordinary shares after or in connection with such initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Inflation Reduction Act&#160;of&#160;2022
provides for, among other things, a new 1% U.S.&#160;federal excise tax on certain repurchases (including redemptions) of stock by publicly
traded U.S.&#160;corporations after December&#160;31, 2022 (the &#8220;stock buyback tax&#8221;), subject to certain exceptions. If applicable,
the amount of the stock buyback tax is generally 1% of the aggregate fair market value of any stock repurchased by the corporation during
a taxable year, net of the aggregate fair market value of certain new stock issuances by the repurchasing corporation during the same
taxable year. The Biden administration has proposed increasing the stock buyback tax rate from 1% to 4%; however, it is unclear whether
such a change will be enacted and, if enacted, how soon it could take effect. In addition, the U.S.&#160;Treasury Department and IRS have
released preliminary guidance that would potentially cause a non-U.S.&#160;corporation&#8217;s U.S.&#160;subsidiaries to be subject to
the stock buyback tax with respect to any share repurchases made by the non-U.S.&#160;corporation under certain circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an entity incorporated as a Cayman Islands
exempted company, the stock buyback tax is currently not expected to apply to redemptions of our Class&#160;A ordinary shares (absent
any regulations or other additional guidance that may be issued in the future).However, in connection with an initial business combination
involving a company organized under the laws of the United&#160;States (or any subdivision thereof), it is possible that we domesticate
and continue as a Delaware corporation prior to certain redemptions. Because we expect that, following such a domestication, our securities
would continue to trade on Nasdaq, in such a case we could be subject to the stock buyback tax with respect to any subsequent redemptions
(including redemptions in connection with the initial business combination) that are treated as repurchases for this purpose. In all cases,
whether and to what extent we would be subject to the stock buyback tax will depend on a number of factors, including (i)&#160;the structure
of the initial business combination, including the extent to which the initial business combination involves a U.S.&#160;corporation and
the extent to which we issue shares in the initial business combination or otherwise during the same taxable year that are eligible to
offset any redemptions or other repurchases, (ii)&#160;the fair market value of the shares redeemed and (iii)&#160;the extent such redemptions
could be treated as dividends and not as repurchases. The applicability of the stock buyback tax to us could be further affected by the
content of any regulations, clarifications or other additional guidance from the U.S.&#160;Treasury Department that may be issued and
applicable to the redemptions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any stock buyback tax that becomes payable as
a result of any redemptions of our Class&#160;A ordinary shares (or other shares into which such Class&#160;A ordinary shares may be converted)
in connection with our initial business combination or otherwise would be payable by us and not by the redeeming holder. To the extent
such taxes are applicable, the amount of cash available to pay redemptions or to transfer to the target business in connection with our
initial business combination may be reduced, which could result in our inability to meet conditions in the agreement relating to our initial
business combination related to a minimum cash requirement, if any, or otherwise result in the shareholders of the combined company (including
any of our shareholders who do not exercise their redemption rights in connection with the initial business combination) to economically
bear the impact of such stock buyback tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an emerging growth company and a
smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements
available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and
may make it more difficult to compare our performance with other public companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company&#8221;
within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being
required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result,
our shareholders may not have access to certain information they may deem important. We could be an emerging growth company for up to
five&#160;years, although circumstances could cause us to lose that status earlier, including if the market value of our ordinary shares
held by non-affiliates exceeds $700&#160;million as of the end of any second quarter of a fiscal year, in which case we would no longer
be an emerging growth company as of the end of such fiscal year. We cannot predict whether investors will find our securities less attractive
because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions,
the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities
and the trading prices of our securities may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when
a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has
opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards
used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we are a &#8220;smaller reporting
company&#8221; as defined in Item&#160;10(f)(1)&#160;of Regulation&#160;S-K.&#160;Smaller reporting companies may take advantage of certain
reduced disclosure obligations, including, among other things, providing only two&#160;years of audited financial statements. We will
remain a smaller reporting company until the last&#160;day of the fiscal year in which (1)&#160;the market value of our ordinary shares
held by non-affiliates equals or exceeds $250&#160;million as of the end of that year&#8217;s second fiscal quarter, or (2)&#160;our annual
revenues equaled or exceeded $100&#160;million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates
equals or exceeds $700&#160;million as of the end of that year&#8217;s second fiscal quarter. To the extent we take advantage of such
reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Since only holders of our founder shares
will have the right to vote on the appointment of directors, upon the listing of our shares, Nasdaq may consider us to be a &#8220;controlled
company&#8221; within the meaning of the Nasdaq rules and, as a result, we may qualify for exemptions from certain corporate governance
requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only holders of our founder shares have the right
to vote on the appointment of directors. As a result, Nasdaq may consider us to be a &#8220;controlled company&#8221; within the meaning
of the Nasdaq corporate governance standards. Under the Nasdaq corporate governance standards, a company of which more than 50% of the
voting power is held by an individual, group or another company is a &#8220;controlled company&#8221; and may elect not to comply with
certain corporate governance requirements, including the requirements that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">we have a board that includes a majority of &#8220;independent
directors,&#8221; as defined under the rules of Nasdaq;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">we have a compensation committee of our board that is comprised
entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a majority of the independent directors recommend director
nominees for selection by the board of directors.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not intend to utilize these exemptions and
intend to comply with the corporate governance requirements of Nasdaq, subject to applicable phase-in rules. However, if we determine
in the future to utilize some or all of these exemptions, you will not have the same protections afforded to shareholders of companies
that are subject to all of the Nasdaq corporate governance requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1B. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1C. CYBERSECURITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-3846"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although, as a blank check company, we do not
have any operations, we are nonetheless subject to the risk of cybersecurity incidents. Among other things, the investments in our Trust
Account and bank deposits may be vulnerable to such incidents, and we may depend on the digital technologies of third parties. We and
<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="ixv-7324">third parties</ix:nonNumeric> may be subject to cybersecurity attacks or security breaches. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" id="ixv-7325">To the extent that we rely on the technologies of third parties,
we depend upon the personnel and the processes of such third parties to protect against cybersecurity incidents, and we have no personnel
or processes of our own for this purpose.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="ixv-7326"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="ixv-7327">In the event of a cybersecurity incident impacting us, our management team will report to the
<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" id="ixv-7328">board of directors</ix:nonNumeric> and provide updates on the management team&#8217;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences.</ix:nonNumeric> We also lack sufficient resources to adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse
consequences on our business and lead to financial loss.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" id="ixv-7329">We have <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-7330">not</ix:nonNumeric> encountered any cybersecurity incidents since our initial public
offering.</ix:nonNumeric> In addition to our own cybersecurity risks, any proposed business combination target may have been subject to, or may in the
future be subject to, cybersecurity incidents.<b>&#160;</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>ITEM 2. PROPERTIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently maintain our executive offices at 2021 Fillmore St. #2089,
San Francisco, California 94115. We consider our current office space adequate for our current operations.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>ITEM 3. LEGAL PROCEEDINGS</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is no material litigation, arbitration or governmental proceeding
currently pending against us or any members of our management team in their capacity as such.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>&#160;</b></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>ITEM 4. MINE SAFETY DISCLOSURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">PART II</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_010"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our equity securities trade on Nasdaq. Each of our units consists of
one share of Class A ordinary shares and one-half of one redeemable warrant and, commencing on January 15, 2025, trades on Nasdaq under
the symbol &#8220;PLMKU.&#8221; The Class A ordinary shares and warrants underlying our units began trading separately on Nasdaq under
the symbols &#8220;PLMK&#8221; and &#8220;PLMKW,&#8221; respectively, on January 15, 2025.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Holders of Record</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2025, there were 4 holders of record
of our units, 2 holders of record of our Class A ordinary shares, 4 holders of record of our Class B ordinary shares and 1 holder of record
of our warrants. Such numbers do not include beneficial owners holding our securities through nominee names.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not paid any cash dividends on our ordinary shares to date
and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in
the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to
completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will
be within the discretion of our board of directors at such time. Further, if we incur any indebtedness in connection with our initial
business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Proceeds from our Initial Public Offering</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 16, 2025, we consummated our initial public offering of
17,250,000 units , which included the full exercise of the underwriters&#8217; over-allotment option at an offering price of $10.00 per
unit, generating total gross proceeds of $172,500,000. The securities sold in our initial public offering were registered under the Securities
Act on registration statement on Form S-1 (File No. 333-281144). The registration statement became effective on January 14, 2025.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 6. RESERVED</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_012"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The following discussion and analysis of our
financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related
thereto which are included in &#8220;Item 8. Financial Statements and Supplementary Data&#8221; of this Annual Report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially
from those anticipated in these forward-looking statements as a result of many factors, including those set forth under &#8220;Cautionary
Note Regarding Forward-Looking Statements,&#8221; &#8220;Item 1A. Risk Factors&#8221; and elsewhere in this Annual Report. </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We are a blank check company incorporated
in the Cayman Islands on June&#160;10, 2024, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or other similar business combination with one or more businesses. We intend to effectuate our business combination using
cash derived from the proceeds of the initial public offering and the sale of the private placement unit, our shares, debt or a combination
of cash, shares and debt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We expect to continue to incur significant
costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We have neither engaged in any operations
nor generated any operating revenues to date. Our only activities from inception through December 31, 2024 were organizational activities
and those necessary to prepare for the initial public offering, described below and, after our initial public offering, identifying a
target company for a business combination. We do not expect to generate any operating revenues until after the completion of our initial
business combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the
initial public offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the period from June&#160;10, 2024 (inception)
through December&#160;31, 2024, we had a net loss of $91,980, which consisted of formation and operating expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we had cash of $3,864.
Until the consummation of the initial public offering, our only source of liquidity was an initial purchase of ordinary shares by the
sponsor and loans from our sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">On January 16, 2025, we consummated
the initial public offering of 17,250,000 units, at a price of $10.00 per unit, which included the full exercise by the underwriters of
their over-allotment option in the amount of 2,250,000 units, generating gross proceeds of $172,500,000. Simultaneously with the closing
of the initial public offering, we consummated the sale of an aggregate of 672,875 private placement units to the sponsor at a price of
$10.00 per private placement unit generating gross proceeds of $6,728,750.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">Following the initial public offering,
on January 16, 2025, the full exercise of the over-allotment option, and the sale of the private placement units, a total of $174,225,000
was placed in the trust account, and we had $971,550 of cash held outside of the trust account, after payment of costs related to the
initial public offering, and available for working capital purposes. We incurred $10,932,289 in transaction costs, including $3,450,000
of underwriting fees, $6,900,000 of deferred underwriting fees and $582,289 of other offering costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We intend to use substantially all of
the funds held in the trust account, including any amounts representing interest earned on the trust account, which interest shall be
net of taxes payable, to complete our business combination. We may withdraw interest from the trust account to pay taxes, if any. To the
extent that our share capital or debt is used, in whole or in part, as consideration to complete a business combination, the remaining
proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make
other acquisitions and pursue our growth strategies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We intend to use the funds held outside
the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses,
travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review
corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">In order to fund working capital deficiencies
or finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor or certain of our officers
and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we may repay such
loaned amounts out of the proceeds of the trust account released to us. In the event that a business combination does not close, we may
use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account
would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit, at the
option of the lender. The units would be identical to the private placement units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">We do not believe we will need to raise
additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying
a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary
to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may
need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant
number of our public shares upon completion of our business combination, in which case we may issue additional securities or incur debt
in connection with such business combination.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Off-Balance Sheet Financing Arrangements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34.1pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of December 31, 2024. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Contractual Obligations </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34.1pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay each officer an aggregate of $20,833
per month, subject to availability of sufficient funds from working capital held outside the trust account. We began incurring these fees
on January 16, 2025, and will continue to incur these fees monthly until the earlier of the completion of the business combination and
our liquidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriters were entitled to (1) an underwriting
discount of $0.20 per unit, or $3,450,000 in the aggregate, of which (i)&#160;$0.065 per unit was paid to the underwriters in cash at
the closing of the initial public offering and (ii)&#160;$0.135 per unit was used by the underwriters to purchase private placement units,
and (2) a deferred fee of $0.40&#160;per&#160;unit, or $6,900,000. The deferred fee will become payable to the underwriters from the amounts
held in the trust account solely in the event that the Company completes a business combination, subject to the terms of the underwriting
agreement and will be based on the amount of funds remaining in the trust account after shareholder redemptions of public shares in connection
with the consummation of a business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements and related
disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
We have not identified any critical accounting policies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recent Accounting Standards</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management does not believe that any other recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_013"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not required for smaller reporting companies.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_014"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><b>ITEM 8. FINANCIAL STATEMENTS AND
SUPPLEMENTARY DATA</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This information appears following Item 15 of this Annual Report and
is included herein by reference.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
AND FINANCIAL DISCLOSURE</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9A. CONTROLS AND PROCEDURES</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Evaluation of Disclosure Controls and Procedures</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Disclosure controls and procedures are controls and other procedures
that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures
include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed
or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief
Financial Officer, to allow timely decisions regarding required disclosure.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the supervision and with the participation of our management,
including our CEO and CFO, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of
the fiscal year ended December 31, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that
evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that as of the end of that fiscal year, our disclosure
controls and procedures are effective.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It should also be noted that the Chief Executive Officer and Chief
Financial Officer believe that our disclosure controls and procedures provide a reasonable assurance that they are effective, they do
not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and fraud.
A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of
the control system are met.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Management&#8217;s Annual Report on Internal Control Over Financial
Reporting</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Annual Report does not include a report of management&#8217;s
assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting
firm due to a transition period established by rules of the SEC for newly public companies.&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Changes in Internal Control Over Financial Reporting</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no changes in our internal controls over financial reporting
that occurred during the fourth quarter of the fiscal year covered by this Annual Report that have materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9B. OTHER INFORMATION</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Trading Arrangements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">During the quarterly
period ended December 31, 2024, none of our directors or officers (as defined in Rule&#160;16a-1(f) promulgated under the&#160;Exchange
Act)&#160;<ix:nonNumeric contextRef="c22" format="ixt:fixed-false" name="ecd:NonRule10b51ArrAdoptedFlag" id="ixv-7331"><ix:nonNumeric contextRef="c22" format="ixt:fixed-false" name="ecd:Rule10b51ArrAdoptedFlag" id="ixv-7332">adopted</ix:nonNumeric></ix:nonNumeric>&#160;or&#160;<ix:nonNumeric contextRef="c22" format="ixt:fixed-false" name="ecd:Rule10b51ArrTrmntdFlag" id="ixv-7333"><ix:nonNumeric contextRef="c22" format="ixt:fixed-false" name="ecd:NonRule10b51ArrTrmntdFlag" id="ixv-7334">terminated</ix:nonNumeric></ix:nonNumeric>&#160;any &#8220;Rule 10b5-1 trading arrangement&#8221; or any &#8220;non-Rule 10b5-1 trading
arrangement,&#8221; as each term is defined in Item&#160;408(a)&#160;of&#160;Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Additional Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">None.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_018"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">PART III</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors and Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 3pt; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kanishka Roy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Handwerker</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Director</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allan Chou</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anjai Gandhi</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avanish Sahai</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors and officers are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Kanishka Roy</i></b>&#160;&#8212;&#160;Since
June 2024, Mr.&#160;Roy has served as our Chairman and Chief Executive Officer. Mr.&#160;Roy is a technology and finance veteran, with
over 25&#160;years of experience as a technology investment banker, public company executive, and growth investor. Since March 2021, Mr.&#160;Roy
has served as a co-founder and Managing Partner of Plum Partners, a late-stage investment company. He served as Chairman and CEO of Plum
Acquisition Corp.&#160;I from March 2021 until September 2024 when it completed its business combination with Veea Inc., and currently
serves as a director of Veea Inc.. Since January 2024, Mr.&#160;Roy has served as Chairman, President and CEO of Plum Acquisition Corp.&#160;III&#160;&#8212;&#160;a
special purpose acquisition company traded on Nasdaq, and is also the manager of Mercury Capital, its sponsor. From 2010 to 2019, Mr.&#160;Roy
advised leading Software and Internet companies with mergers and acquisitions (M&amp;A) and capital markets transactions. Mr.&#160;Roy
served as the Global Head of Tech M&amp;A Origination for Morgan Stanley, where he was responsible for initiating large, industry-transforming
mergers, helping clients take a long-term view of the competitive landscape and implementing large, industry-shaping M&amp;A transactions.
Over his career, Mr.&#160;Roy has participated in over $100&#160;billion of M&amp;A transactions. From 2019 to 2020, he was Global CFO
at SmartNews, a multi-billion-dollar AI company with over 20&#160;million monthly average users, and led the strategic finance and growth
of a rapidly growing company across multiple geographies. Mr.&#160;Roy started his career as a software engineer at two software startups,
both of which were acquired by larger public companies, and also worked in executive strategy roles at IBM.&#160;Mr.&#160;Roy holds an
undergraduate degree in Electrical&#160;&amp; Computer Engineering and an MBA from the Tuck School of Business at Dartmouth.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Steven Handwerker</i></b>&#160;&#8212;&#160;Since
July 2024, Mr.&#160;Handwerker has served as our Chief Financial Officer and Director. Mr.&#160;Handwerker has also served as Chief Financial
Officer of Plum Acquisition Corp.&#160;III since March&#160;2024. Mr.&#160;Handwerker also serves as a Financial Consultant to Events.com,
a software company building a comprehensive event management platform. Mr.&#160;Handwerker was the Chief Financial Officer of FinServ
Acquisition Corp.&#160;II from 2021 until 2023. From 2019 to 2021, Mr.&#160;Handwerker served as a consultant for FinServ Acquisition
Corp., and was involved in all aspects of its business and operations. Mr.&#160;Handwerker has more than 15&#160;years of experience investing
in and covering the financial services and FinTech industries. From 2013 to 2017, he was an Analyst at Citadel&#8217;s equity long/short
hedge fund platform, covering companies within the financial services and FinTech sectors. Prior to Citadel, Mr.&#160;Handwerker was an
Investment Banking Analyst in Barclays&#8217; Financial Institutions Group from 2010 to 2013. He received his BBA from Emory University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Allan Chou</i></b>&#160;&#8212;&#160;Mr.
Chou has served as an independent director since the closing of our initial public offering. Mr.&#160;Chou currently serves as a Partner
at Northgate Capital LLC&#8217;s Bay Area office, where he has held various other positions since 2006. Mr.&#160;Chou began his professional
career at Cambridge Associates, LLC in 1999 as an analyst. During his tenure which ended in 2003, he was promoted to team leader and alternative
assets associate. He returned to Cambridge Associates in 2005 as a specialist consultant after obtaining an MBA, focusing on venture capital
and private equity non-marketable alternative asset programs. While in business school, Mr.&#160;Chou served as a summer associate at
Northgate Capital LLC in 2004. Mr.&#160;Chou graduated with a Bachelor of Arts degree in Economics from Pomona College, received an MBA
from the Amos Tuck School of Business at Dartmouth College and has earned the Chartered Financial Analyst designation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Anjai Gandhi</i></b>&#160;&#8212;&#160;Mr.
Gandhi has served as an independent director since the closing of our initial public offering. Mr.&#160;Gandhi currently serves as Chief
Growth Officer at Marlin Equity Partners, a private equity fund that invests primarily in B2B software companies since 2020. During his
more than 30-year career, he has helped implement growth acceleration strategies and go-to-market productivity improvements at more than
100 companies, primarily in the technology industry. Previously, Mr.&#160;Gandhi was a member of the go-to-market (&#8220;GTM&#8221;)
leadership teams at RingCentral, from 2016 to 2019, and at Salesforce.com, from 2010 and 2012, where he guided acceleration in the enterprise
segment, global expansion and the growth of multiple new product lines. He began his career in management consulting at Bain, McKinsey
and The Alexander Group serving clients primarily on B2B marketing and sales strategy/effectiveness. Mr.&#160;Gandhi serves on multiple
non-profit boards, including the HBS Club of Northern California. Mr.&#160;Gandhi earned a BS in Business Administration from University
of California, Berkeley and an MBA from Harvard Business School.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Avanish Sahai</i></b>&#160;&#8212;&#160;Mr.
Sahai has served as an independent director since the closing of our initial public offering. Mr.&#160;Sahai is a former technology executive
with experience in product, marketing, and ecosystems. From December 2019 until December 2021, Mr.&#160;Sahai served as vice president,
ISV and apps partner ecosystem of Google. Previously, from December 2016 to December 2019, he served as global vice president, ISV and
technology alliances at ServiceNow. From May 2015 to December 2016, Mr.&#160;Sahai was the senior vice president of channels and alliances
at InsideSales.com. From April 2014 to May 2015, he was the senior vice president and chief product officer at Demandbase. Prior to Demandbase,
Mr.&#160;Sahai held leadership positions at Salesforce.com, Oracle, and McKinsey &amp; Company, as well as various early-to-mid stage
startups in Silicon Valley. Mr.&#160;Sahai previously served on the boards of technology companies, including HubSpot (NYSE:HUBS) from
April 2018 to September 2023, and currently serves on the boards of Birdie.ai (venture backed), and Scribe (PE-backed, acquired by TIBCO),
as well as on the boards of nonprofit organizations, including Commonwealth Club World Affairs, Brazil at Silicon Valley and BayBrazil.
Mr.&#160;Sahai holds an MBA from UCLA Anderson, an MSCE from Boston University, and a BSEE from the Universidade de S&#227;o Paulo,
Brazil.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Select Leadership Council Members</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ursula Burns and Mike Dinsdale serve as our leadership
council members.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ursula Burns.</b>&#160;&#160;&#160;&#160;Ms.
Burns is the co-founder of Integrum Holdings LP, an investment firm focused on partnering with technology-enabled services companies.
From March 2021 until July 2023, Ms. Burns served as Executive Chairwoman and a director of Plum Acquisition Corp. I, and was a manager
of Plum Partners, its sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Mike Dinsdale.</b>&#160;&#160;&#160;&#160;Mr.&#160;Dinsdale
has strategic expertise in helping to build high-growth international companies. From March 2021 until the completion of its business
combination September 2024, Mr.&#160;Dinsdale served as Co-Chief Executive Officer, Chief Financial Officer and a director of Plum Acquisition
Corp. I, and was a manager of Plum Partners, its sponsor. From January 2024 to January 2025, Mr.&#160;Dinsdale also served as a board
member of Plum Acquisition Corp III.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Number and Terms of Office of Officers and Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors consists of five members.
Prior to our initial business combination, holders of our founder shares will have the right to vote to appoint all of our directors and
remove members of the board of directors for any reason, and holders of our public shares will not have the right to vote on the appointment
of directors during such time; provided, however, that if all of the founder shares are converted to Class A ordinary shares prior to
the date of the initial business combination, the holders of our public shares will have the right to vote on the election of directors.
These provisions of our amended and restated memorandum and articles of association may only be amended by a special resolution passed
by a majority of at least 90% of our ordinary shares attending and voting in a general meeting. Each of our directors will hold office
for a three-year term. Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may
be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our board of directors or by a majority
of the holders of our ordinary shares (or, prior to our initial business combination, holders of our founder shares).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our officers are appointed by the board of directors
and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized
to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate.
Our amended and restated memorandum and articles of association provide that our officers may consist of a Chairman, a Vice-Chairman,
a Chief Executive Officer, a President, a Chief Operating Officer, a Chief Financial Officer, Vice Presidents, a Secretary, Assistant
Secretaries, a Treasurer and such other offices as may be determined by the board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to Nasdaq listing rules, we have established three standing
committees &#8212; an audit committee in compliance with Section 3(a)(58)(A) of the Exchange Act, a compensation committee, and a nominating
and corporate governance committee, each comprised of independent directors. &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of our audit committee are Allan Chou,
Anjai Gandhi and Avanish Sahai. Allan Chou serves as chairman of the audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each member of the audit committee is financially
literate and our board of directors has determined that Allan Chou qualifies as an &#8220;audit committee financial expert&#8221; as defined
in applicable SEC rules and has accounting or related financial management expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted an audit committee charter, which
details the purpose and principal functions of the audit committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">assisting board oversight of (1)&#160;the integrity of our
financial statements, (2)&#160;our compliance with legal and regulatory requirements, (3)&#160;our independent registered public accounting
firm&#8217;s qualifications and independence, and (4)&#160;the performance of our internal audit function and independent registered
public accounting firm;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the appointment, compensation, retention, replacement, and
oversight of the work of the independent registered public accounting firm and any other registered public accounting firm engaged by
us;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">pre-approving all audit and non-audit services to be provided
by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval
policies and procedures;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and discussing with the independent registered
public accounting firm all relationships the independent registered public accounting firm has with us in order to evaluate their continued
independence;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">setting clear hiring policies for employees or former employees
of the independent registered public accounting firm;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">setting clear policies for audit partner rotation in compliance
with applicable laws and regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">obtaining and reviewing a report, at least annually, from
the independent registered public accounting firm describing (1)&#160;the independent registered public accounting firm&#8217;s internal
quality-control procedures and (2)&#160;any material issues raised by the most recent internal quality-control review, or peer review,
of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five&#160;years
respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">meeting to review and discuss our annual audited financial
statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing
our specific disclosures under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations;&#8221;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of our compensation committee are
Allan Chou, Anjai Gandhi and Avanish Sahai. Avanish Sahai &#160;serves as chairman of the compensation committee. We have adopted a compensation
committee charter, which details the purpose and responsibility of the compensation committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and approving on an annual basis the corporate
goals and objectives relevant to our Chief Executive Officer&#8217;s compensation, evaluating our Chief Executive Officer&#8217;s performance
in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on
such evaluation;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and making recommendations to our board of directors
with respect to the compensation, and any incentive-compensation and equity-based plans that are subject to board approval of all of
our other officers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing our executive compensation policies and plans;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">implementing and administering our incentive compensation
equity-based remuneration plans;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">assisting management in complying with our proxy statement
and annual report disclosure requirements;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">approving all special perquisites, special cash payments
and other special compensation and benefit arrangements for our officers and employees;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">producing a report on executive compensation to be included
in our annual proxy statement; and</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing, evaluating and recommending changes, if appropriate,
to the remuneration for directors.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser
and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging
or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider
the independence of each such adviser, including the factors required by Nasdaq and the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating and Corporate Governance Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of our nominating and corporate governance
committee are Allan Chou, Anjai Gandhi and Avanish Sahai. Anjai Gandhi serves as chair of the nominating and corporate governance committee.
We have adopted a nominating and corporate governance committee charter, which details the purpose and responsibilities of the nominating
and corporate governance committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">identifying, screening and reviewing individuals qualified
to serve as directors, consistent with criteria approved by the board of directors, and recommending to the board of directors candidates
for nomination for election at the annual general meeting or to fill vacancies on the board of directors;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">developing and recommending to the board of directors and
overseeing implementation of our corporate governance guidelines;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">coordinating and overseeing the annual self-evaluation of
the board of directors, its committees, individual directors and management in the governance of Inc company; and</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing on a regular basis our overall corporate governance
and recommending improvements as and when necessary.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter also provides that the nominating
and corporate governance committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm to be used
to identify director candidates, and will be directly responsible for approving the search firm&#8217;s fees and other retention terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination
to our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Code of Ethics and Committee Charters</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a code of ethics and business
conduct (our &#8220;Code of Ethics&#8221;) applicable to our directors, officers and employees. You can review this document by accessing
our public filings at the SEC&#8217;s website at <i>www.sec.gov. </i>In addition, a copy of our Code of Ethics will be provided without
charge upon request from us. We have filed our audit committee, compensation committee, and nominating and corporate governance committee
charters as exhibits to our most recent S-1, and you may review these documents by accessing our public filings at the SEC&#8217;s web
site at <i><span style="text-decoration:underline">www.sec.gov</span></i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Trading Policies</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">We <ix:nonNumeric contextRef="c22" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-7335">adopted</ix:nonNumeric> insider trading
policies and procedures&#160;governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees,
which are reasonably designed to promote compliance with insider trading laws, rules and regulations, and the applicable Nasdaq Rules
(the &#8220;Insider Trading Policy&#8221;). We have filed our Insider Trading Policy as an exhibit to this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Compensation Recovery
and Clawback Policy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Under the Sarbanes-Oxley
Act, in the event of misconduct that results in a financial restatement that would have reduced a previously paid incentive amount, we
can recoup those improper payments from our executive officers. We have adopted the Executive Officer Clawback Policy to comply with the
rules adopted by the SEC under Rule 10D-1 under the Exchange Act, and the listing standards, as set forth in Nasdaq Listing Rule. We have
filed our Executive Officer Clawback Policy as an exhibit to this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 11. EXECUTIVE COMPENSATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officer and Director Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of our directors or officers have received
any cash compensation for services rendered to us. During July and August 2024, the sponsor transferred 25,000 founder shares to each
of our independent directors (an aggregate of 75,000 founder shares), in each case at their original purchase price of $0.003 per share.
Our sponsor, directors and officers, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred
in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business
combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, directors, officers
or our or any of their respective affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not prohibited from paying any fees (including
advisory fees), reimbursements or cash payments to our sponsor, officers or directors, or our or their affiliates, for services rendered
to us prior to or in connection with the completion of our initial business combination, including the following payments, all of which,
if made prior to the completion of our initial business combination, will be paid from funds held outside the trust account:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">repayment of an aggregate of up to $500,000 in loans made
to us by our sponsor to cover offering-related and organizational expenses;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">payments to each of our Chief Executive Officer and Chief
Financial Officer of $20,833 per month for consulting services rendered to us, commencing upon closing of our initial public offering,
through the closing of our initial business combination, subject to availability of sufficient funds from working capital held outside
the trust account;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">engagement of our sponsor, or one or more affiliates of our
sponsor, as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such persons
or entities a salary or fee in an amount that constitutes a market standard for comparable transactions;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">payment of customary fees for financial advisory services;
and</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reimbursement for any out-of-pocket expenses related to identifying,
investigating and completing an initial business combination; and repayment of loans which may be made by any of our sponsor, any of
its affiliates or certain of our directors and officers to finance transaction costs in connection with an intended initial business
combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000
of such loans may be convertible into units at a price of $10.00 per unit at the option of the lender.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the completion of our initial business combination,
directors or members of our management team who remain with us may be paid consulting, management or other compensation from the combined
company. All compensation will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation
materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation
will be known at the time, because the directors of the post-combination business will be responsible for determining executive officer
and director compensation. Any compensation to be paid to our officers after the completion of our initial business combination will be
determined by a compensation committee constituted solely by independent directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not party to any agreements with our directors
and officers that provide for benefits upon termination of employment. The existence or terms of any such employment or consulting arrangements
may influence our management&#8217;s motivation in identifying or selecting a target business, and we do not believe that the ability
of our management to remain with us after the consummation of our initial business combination should be a determining factor in our decision
to proceed with any potential business combination.<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_022"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
the beneficial ownership of our ordinary shares as of March 30, 2025 by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">each person known by us to be the beneficial owner of more
than 5% of our issued and outstanding ordinary shares;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">each of our directors and officers that beneficially owns
ordinary shares; and</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">all our directors and officers as a group.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, we believe that all
persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following
table does not reflect record or beneficial ownership of the private placement warrants underlying the private placement units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of <br/>
Shares <br/>
Beneficially <br/>
Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Approximate <br/>
Percentage&#160;of <br/>
Outstanding <br/>
Ordinary <br/>
Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plum Partners&#160;IV, LLC<sup>(2)(3)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,685,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kanishka Roy<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,685,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Steven Handwerker</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Allan Chou</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Anjai Gandhi</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Avanish Sahai</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,000</td><td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">All directors and officers as a group (5 individuals)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">6,760,000</td><td style="padding-bottom: 2.5pt; text-align: left"><sup>(4)</sup></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">27.9</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Less than one percent.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Unless otherwise noted, the business address of each of the
following entities or individuals is c/o Plum Acquisition Corp.&#160;IV, 2021 Fillmore St. #2089, San Francisco, California 94115.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Our sponsor is the record holder of 5,675,000 founder shares,
440,000 private placements shares included as part of the private placement units and 570,000 restricted private placement shares. Kanishka
Roy, our Chairman and Chief Executive Officer, is the managing member of our sponsor, therefore, he may be deemed to have beneficial
ownership of the Class B ordinary shares, private placement shares and restricted private placement shares held directly by our sponsor.
Each member of our management team is a member of our sponsor and has direct and/or indirect economic interests in our sponsor, and each
of them disclaims any beneficial ownership other than to the extent of his pecuniary interest.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">The non-managing investors purchased&#160;through investments
in our sponsor, an aggregate of 285,000 private placement units and 570,000 restricted private placement shares at a combined price of
$10.00 per non-managing investor private placement security ($2,850,000 in the aggregate) and our sponsor issued membership interests
at a nominal purchase price to the non-managing investors at the closing of our initial public offering reflecting interests in an aggregate
of 2,280,000 founder shares held by our sponsor. The non-managing investors paid no additional consideration for the restricted private
placement shares. The non-managing investors were not granted any shareholder or other rights in addition to those afforded to our other
public shareholders, and were only issued membership interests our sponsor, with no right to control our sponsor or vote or dispose of
any securities held by our sponsor, including the founder shares held by our sponsor.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Represents 5,750,000 founder shares directly held by our initial
shareholders plus 440,000 private placements shares included as part of the private placement units and 570,000 restricted private placement
shares to be issued at the closing of our initial public offering.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Relationships and Related Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;26, 2024, our sponsor paid $25,000
to cover certain of our offering and formation costs in exchange for the issuance of 7,665,900 founder shares to our sponsor, or approximately
$0.003 per share. The number of founder shares issued was determined based on the expectation that the founder shares would represent
25% of the issued and outstanding ordinary shares upon completion of our initial public offering (not including the Class&#160;A ordinary
shares underlying the private placement units and the restricted private placement shares). Subsequently, during July and August, 2024,
our sponsor transferred 25,000 founder shares to each of our independent directors (an aggregate of 75,000 founder shares) at their original
purchase price. On December&#160;6, 2024, our sponsor surrendered 1,915,900 founder shares for no consideration. Our initial shareholders
currently hold an aggregate of 5,750,000 founder shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the initial public offering,
our sponsor purchased an aggregate of 440,000 private placement units and 570,000 restricted private placement shares at a price of $10.00
per private placement unit or a combined price of $10.00 per non-managing investor private placement security, as applicable, or $4,400,000
in the aggregate, in a private placement that closed simultaneously with the closing of our initial public offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in connection with the initial public
offering, the underwriters used a portion of their underwriting discount and commission to purchase an aggregate of 232,875 private placement
units at a price of $10.00 per unit, or $2,328,750 in the aggregate, in a private placement that closed simultaneously with the closing
of our initial public offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The private placement units are identical to the
units sold in our initial public offering except that private placement units (including the underlying securities) may not, subject to
certain limited exceptions, be transferred, assigned or sold by the holders until 30&#160;days after the completion of our initial business
combination and will be entitled to registration rights. The restricted private placement shares are held by the sponsor and will be transferred
to the non-managing investors (or their designees) only upon the consummation of an initial business combination. Other than such permitted
transfer, the restricted private placement shares will be subject to transfer restrictions for 90 days following our initial business
combination and will be entitled to registration rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of our directors or officers becomes aware
of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary
or contractual obligations, he or she may be required to present such business combination opportunity to such entity prior to presenting
such business combination opportunity to us. Our directors and officers currently have certain relevant fiduciary duties or contractual
obligations that may take priority over their duties to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Members of our management team, our board of directors
directly or indirectly own founder shares and/or private placement units and, accordingly, may have a conflict of interest in determining
whether a particular target business is an appropriate business with which to effectuate our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Chief Executive Officer and Chief Financial
Officer will each be paid $20,833 per month for consulting services rendered to us, commencing upon closing of our initial public offering,
through the closing of our initial business combination, subject to availability of sufficient funds from working capital held outside
the trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sponsor, directors and officers, or any of
their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such
as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review
on a quarterly basis all payments that were made to our sponsor, directors, officers or our or any of their respective affiliates and
will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket
expenses incurred by such persons in connection with activities on our behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the closing of our initial public offering,
our sponsor agreed to loan us up to $500,000 under an unsecured promissory note, dated June&#160;26, 2024 (as amended on January&#160;6,
2025). This promissory note was used for a portion of the expenses of our initial public offering. The loans were non-interest bearing,
unsecured and were due at the earlier of February&#160;1, 2025 and the closing of our initial public offering. The loans were repaid upon
completion of our initial public offering out of the $953,750 of offering proceeds that was allocated for the payment of offering expenses
(other than underwriting commissions) not held in the trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in order to finance transaction costs
in connection with an intended initial business combination, either of our sponsor, any of its affiliates or certain of our directors
and officers may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may
repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds
held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working
capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such
loaned amounts. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit at the option of the lender.
The units would be identical to the units sold in our initial public offering, subject to certain limited exceptions as described in this
Annual Report. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. We
do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will
be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After our initial business combination, members
of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all
amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable,
furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender
offer materials or at the time of a general meeting held to consider our initial business combination, as applicable, as it will be up
to the directors of the post-combination business to determine executive officer and director compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into a registration rights agreement
with respect to the founder shares, restricted private placement shares, private placement units and units issued upon conversion of working
capital loans (if any).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Party Policy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not yet adopted a formal policy for the
review, approval or ratification of related party transactions. Accordingly, the transactions discussed above were not reviewed, approved
or ratified in accordance with any such policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the closing of our initial public offering,
we adopted our Code of Ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions
approved by our board of directors (or the appropriate committee of our board of directors) or as disclosed in our public filings with
the SEC.&#160;Under our Code of Ethics, conflict of interest situations include any financial transaction, arrangement or relationship
(including any indebtedness or guarantee of indebtedness) involving the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our audit committee is responsible
for reviewing and approving related party transactions to the extent that we enter into such transactions. An affirmative vote of a majority
of the members of the audit committee present at a meeting at which a quorum is present will be required in order to approve a related
party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without a meeting, the unanimous
written consent of all of the members of the audit committee will be required to approve a related party transaction. Our audit committee
will review on a quarterly basis all payments that were made to our sponsor, directors or officers, or our or any of their respective
affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These procedures are intended to determine whether
any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director,
employee or officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To further minimize conflicts of interest, we
have agreed not to consummate an initial business combination with an entity that is affiliated with any of our sponsor, directors or
officers unless we, or a committee of independent and disinterested directors, have obtained an opinion from an independent investment
banking firm which is a member of FINRA or an independent accounting firm that our initial business combination is fair to our shareholders
from a financial point of view. In addition, pursuant to Nasdaq listing rules, our initial business combination must be approved by a
majority of our independent directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not prohibited from paying any fees (including
advisory fees), reimbursements or cash payments to our sponsor, officers or directors, or our or their affiliates, for services rendered
to us prior to or in connection with the completion of our initial business combination, including the following payments, all of which,
if made prior to the completion of our initial business combination, will be paid from funds held outside the trust account:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">payments to each of our Chief Executive Officer and Chief
Financial Officer of $20,833 per month for consulting services rendered to us, commencing upon closing of our initial public offering,
through the closing of our initial business combination, subject to availability of sufficient funds from working capital held outside
the trust account;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">engagement of our sponsor, or one or more affiliates of our
sponsor, as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such persons
or entities a salary or fee in an amount that constitutes a market standard for comparable transactions;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">payment of customary fees for financial advisory services;
and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reimbursement for any out-of-pocket expenses related to identifying,
investigating and completing an initial business combination; and repayment of loans which may be made by any of our sponsor, any of
its affiliates or certain of our directors and officers to finance transaction costs in connection with an intended initial business
combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000
of such loans may be convertible into units at a price of $10.00 per unit at the option of the lender.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above payments may be funded using the net
proceeds of our initial public offering and the sale of the private placement securities not held in the trust account or, upon completion
of the initial business combination, from any amounts remaining from the proceeds of the trust account released to us in connection therewith.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq listing standards require that a majority
of our board of directors be independent within one year of our initial public offering. An &#8220;independent director&#8221; is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of independent judgment
in carrying out the responsibilities of a director. We have three &#8220;independent directors&#8221; as defined in the Nasdaq listing
standards and applicable SEC rules. Our board has determined that each of Allan Chou, Anjai Gandhi and Avanish Sahai is an independent
director under applicable SEC rules and the Nasdaq listing standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our independent directors will have regularly scheduled meetings at
which only independent directors are present.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The firm of WithumSmith+Brown, PC, or Withum,
acts as our independent registered public accounting firm. The following is a summary of fees paid to Withum for services rendered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Fees</i>. During the period from June&#160;10,
2024 (inception) through December 31, 2024, fees for our independent registered public accounting firm were approximately $93,600 for
the services Withum performed in connection with our initial public offering and the audit of our December 31, 2024 financial statements
included in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit-Related Fees.</i> During the period from
June&#160;10, 2024 (inception) through December 31, 2024, our independent registered public accounting firm did not render assurance and
related services related to the performance of the audit or review of financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax Fees</i>. During the period from June&#160;10,
2024 (inception) through December 31, 2024, our independent registered public accounting firm did not render services to us for tax compliance,
tax advice and tax planning.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>All Other Fees</i>. During the period from
June&#160;10, 2024 (inception) through December 31, 2024, there were no fees billed for products and services provided by our independent
registered public accounting firm other than those set forth above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pre-Approval Policy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our audit committee was formed in connection with the effectiveness
of our registration statement for our initial public offering. As a result, the audit committee did not pre-approve all of the foregoing
services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since
the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all audit services and
permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the <i>de minimis
</i>exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion
of the audit).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">PART
IV</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            following documents are filed as part of this report or incorporated herein by reference:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Financial Statements are listed on page F-1 of this Annual Report</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report
    of Independent Registered Public Accounting Firm</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Balance
    Sheet as of December 31, 2024</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_003">Statement
    of Operations for the period from June 10, 2024 (inception) through December 31, 2024</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Statement
    of Changes in Shareholder&#8217;s Deficit for the period from June 10, 2024 (inception) through   December 31,
    2024</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Statement
    of Cash Flows for the period from June 10, 2024 (inception) through December 31, 2024</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Notes
    to Financial Statements</a></span></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            Statements Schedule</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.5pt"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are included as exhibits to this Annual Report:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: left; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex3-1_plum4.htm">Amended
    and Restated Memorandum and Articles of Association</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1<sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2030482/000121390024108964/ea021020405ex4-1_plumacq4.htm">Specimen
    Unit Certificate</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2<sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2030482/000121390024108964/ea021020405ex4-2_plumacq4.htm">Specimen
    Class&#160;A Ordinary Share Certificate</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3<sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex4-1_plum4.htm">Specimen
    Warrant Certificate (included in Exhibit 4.4)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex4-1_plum4.htm">Warrant
    Agreement, dated January 14, 2025, between the Company and Odyssey Transfer and Trust Company</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea023531601ex4-5_plumacq4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities of the Registrant.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-1_plum4.htm">Units
    and Restricted Shares Subscription Agreement, dated January 14, 2025, between the Company and Plum Partners IV, LLC</a> </span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-2_plum4.htm">Units
    Subscription Agreement, dated January 14, 2025, between the Company and Cohen &amp; Company Capital Markets, a division of J.V.B.
    Financial Group, LLC</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-3_plum4.htm">Units
    Subscription Agreement, dated January 14, 2025, between the Company and Seaport Global Securities LLC</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-6_plum4.htm">Letter
    Agreement, dated January 14, 2025, among the Company, the sponsor and each of the initial shareholders, directors and officers of
    the Company</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-4_plum4.htm">Investment
    Management Trust Account Agreement, dated January 14, 2025, between the Company and Continental Stock Transfer &amp; Trust Company</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-5_plum4.htm">Registration
    Rights Agreement, dated January 14, 2025, among the Company, the sponsor and the other Holders (as defined therein) signatory thereto</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7<sup>(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025004228/ea022788201ex10-7_plum4.htm">Form
    of Indemnity Agreement, January 14, 2025, between the Company and each of the officers and directors of the Company</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8<sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2030482/000121390025001644/ea021020408ex10-12_plumacq4.htm">Amended
    And Restated Promissory Note, dated January 6, 2025, issued to Plum Partners IV, LLC</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea023531601ex19_plumacq4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider Trading Policy</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea023531601ex31-1_plumacq4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left">31.2*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea023531601ex31-2_plumacq4.htm">Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea023531601ex32-1_plumacq4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea023531601ex97-1_plumacq4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clawback Policy</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension
    Schema.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Calculation
    Linkbase.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Label
    Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Definition
    Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Definition
    Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
                                            herewith.</span></td>
</tr></table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
                                            herewith.</span></td>
</tr></table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
                                            by reference to an exhibit to the Registrant&#8217;s Current Report on Form 8-K (File No.
                                            001-42472), filed with the SEC on January 16, 2025.</span></td>
</tr></table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
                                            by reference to an exhibit to the Registrant&#8217;s Registration Statement on Form S-1,
                                            as amended (File No. 333-281144), filed with the SEC on January 7, 2025.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16. FORM 10-K SUMMARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 1.05pt; width: 90%"><a href="#f_001"><span style="font-size: 10pt">Report of Independent Registered Public Accounting Firm PCAOB ID Number 100</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center; width: 10%"><span style="font-size: 10pt">F-2</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.05pt"><span style="font-size: 10pt">Financial Statements:</span></td>
    <td style="padding-right: 1.05pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 0.95pt; text-indent: 8.65pt"><a href="#f_002"><span style="font-size: 10pt">Balance Sheet as of December 31, 2024</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-size: 10pt">F-3</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.95pt; text-indent: 8.65pt"><a href="#f_003"><span style="font-size: 10pt">Statement of Operations for
the period from June 10, 2024 (inception) through December 31, 2024</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-size: 10pt">F-4</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 0.95pt; text-indent: 8.65pt"><a href="#f_004"><span style="font-size: 10pt">Statement of Changes in
    Shareholder&#8217;s Deficit for the period from June 10, 2024 (inception) through December 31, 2024&#160;</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-size: 10pt">F-5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.95pt; text-indent: 8.65pt"><a href="#f_005"><span style="font-size: 10pt">Statement of Cash Flows for
    the period from June 10, 2024 (inception) through December 31, 2024</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-size: 10pt">F-6</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 0.95pt; text-indent: 8.65pt"><a href="#f_006"><span style="font-size: 10pt">Notes to Financial Statements</span></a></td>
    <td style="padding-right: 1.05pt; text-align: center"><span style="font-size: 10pt">F-7 to F-17</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 61; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">To the Shareholder and the Board of Directors
of</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Plum Acquisition Corp. IV</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-5789"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Opinion on the Financial Statements</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have audited the accompanying balance
sheet of Plum Acquisition Corp. IV (the &#8220;Company&#8221;) as of December 31, 2024 and the related statement of operations, changes
in shareholder&#8217;s deficit and cash flows for the period from June 10, 2024 (inception) through December 31, 2024 and the related
notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows
for the period from June 10, 2024 (inception) through December 31, 2024, in conformity with accounting principles generally accepted in
the United States of America.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit.
We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and
are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-7336">WithumSmith+Brown, PC</ix:nonNumeric></span> &#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have served as the Company&#8217;s auditor
since 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">New York, <ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-7337">New York</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 31, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PCAOB ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-7338">100</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="f_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BALANCE SHEET</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Current asset - cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-7339">3,864</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Deferred offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:DeferredOfferingCost" scale="0" unitRef="usd" id="ixv-7340">438,352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">TOTAL ASSETS</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-7341">442,216</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">LIABILITIES AND SHAREHOLDER&#8217;S DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 15.15pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-7342">42,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 15.15pt">Due to officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-7343">12,374</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 15.15pt">Accrued offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:AccruedOfferingCosts" scale="0" unitRef="usd" id="ixv-7344">304,904</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 15.15pt">Promissory note &#8212; related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-7345">149,473</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-7346">509,196</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Shareholder&#8217;s Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -6.45pt; padding-left: 6.45pt"><div style="-sec-ix-hidden: hidden-fact-2"><div style="-sec-ix-hidden: hidden-fact-3">Preference shares, $<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-7347">0.0001</ix:nonFraction> par value; <ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-7348">1,000,000</ix:nonFraction> shares authorized; none issued or outstanding</div></div></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Class A ordinary shares, $<ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-7349">0.0001</ix:nonFraction> par value; <ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-7350">200,000,000</ix:nonFraction> shares authorized; <span style="-sec-ix-hidden: hidden-fact-5"><span style="-sec-ix-hidden: hidden-fact-6">no</span></span> shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Class B ordinary shares, $<ix:nonFraction contextRef="c10" decimals="4" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction> par value; <ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">20,000,000</ix:nonFraction> shares authorized; <ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">5,750,000</ix:nonFraction></ix:nonFraction> shares issued and outstanding <sup>(1)(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">575</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd" id="ixv-7356">24,425</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-7357">91,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Total Shareholder&#8217;s Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-7358">66,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">TOTAL LIABILITIES AND SHAREHOLDER&#8217;S DEFICIT</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-7359">442,216</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-size: 10pt">(1)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt">&#160;</td> <td style="padding-right: 0.8pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 10pt">(2)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></ix:footnote></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>The accompanying notes are an integral part
of the financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>STATEMENT OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FOR THE PERIOD FROM JUNE 10, 2024 (INCEPTION)
THROUGH DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Formation and operating costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-7360">91,980</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 14.55pt">Net Loss</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-7361">91,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt"><span style="font-size: 10pt">Weighted average shares outstanding, basic and diluted <sup>(1)(2)</sup></span></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">5,000,000</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">Basic and diluted net loss per ordinary shares</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-7364"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-7365">0.02</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-size: 10pt">(1)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-size: 10pt">Excluded an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt">&#160;</td> <td style="padding-right: 0.8pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 10pt">(2)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively&#160;&#160;presented (see Note 5).</span></ix:footnote></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>The accompanying notes are an integral part
of the financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><div><a id="f_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>STATEMENT OF CHANGES IN SHAREHOLDER&#8217;S
DEFICIT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FOR THE PERIOD FROM JUNE 10, 2024 (INCEPTION)
THROUGH DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Class B</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Ordinary Shares</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional Paid-in</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><b>Total Shareholder&#8217;s</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.45pt; padding-left: 6.45pt">Balance &#8212; June 10, 2024 (inception)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -6.5pt; padding-left: 6.5pt"><span style="font-size: 10pt">Issuance of Class B ordinary shares to Sponsor<sup>(1)(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">5,750,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">575</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">24,425</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 6.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-7370">91,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-7371">91,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">Balance &#8212; December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-7372">5,750,000</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-7373">575</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-7374">24,425</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-7375">91,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-7376">66,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-size: 10pt">(1)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt">&#160;</td> <td style="padding-right: 0.8pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 0.8pt"><span style="font-size: 10pt">(2)</span></td> <td style="padding-right: 0.8pt; text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></ix:footnote></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>The accompanying notes are an integral part
of the financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><div><a id="f_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>STATEMENT OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FOR THE PERIOD FROM JUNE 10, 2024 (INCEPTION)
THROUGH DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-7377">91,980</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 14.55pt">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 14.55pt">Payment of formation and operating costs through promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" scale="0" unitRef="usd" id="ixv-7378">20,820</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 14.55pt">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.5pt; padding-left: 23.8pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="0" unitRef="usd" id="ixv-7379">42,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 23.8pt">Due to officer</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToAffiliates" scale="0" unitRef="usd" id="ixv-7380">12,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 33.15pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-7381">16,341</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from sale of founder shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:ProceedsFromSaleOfFounderShares" scale="0" unitRef="usd" id="ixv-7382">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment of promissory note - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="usd" id="ixv-7383">1,295</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd" id="ixv-7384">3,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 33.15pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-7385">20,205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Net Change in Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd" id="ixv-7386">3,864</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.45pt; padding-left: 6.45pt">Cash &#8211; Beginning</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">Cash &#8211; Ending</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-7387">3,864</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.45pt; padding-left: 6.45pt">Non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">Deferred offering costs included in accrued offering costs</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="0" unitRef="usd" id="ixv-7388">304,904</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -6.45pt; padding-left: 6.45pt">Deferred offering costs paid through promissory note - related party</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" scale="0" unitRef="usd" id="ixv-7389">129,948</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>The accompanying notes are an integral part
of the financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PLUM ACQUISITION CORP. IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="f_006"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-6572"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 1&#8201;&#8212;&#8201;DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Plum Acquisition Corp.&#160;IV (the &#8220;Company&#8221;)
is a blank check company incorporated as a Cayman Islands exempted corporation on June&#160;10, 2024. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
<ix:nonFraction contextRef="c11" decimals="0" format="ixt-sec:numwordsen" name="plmk:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" scale="0" unitRef="pure" id="ixv-7390">one</ix:nonFraction> or more businesses (&#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is not limited to a particular industry
or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and,
as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company had not commenced
any operations. All activity for the period from <ix:nonNumeric contextRef="c11" name="plmk:YearOfInception" id="ixv-7391">June&#160;10, 2024 (inception) through December 31, 2024</ix:nonNumeric> relates to the Company&#8217;s
formation and the initial public offering (&#8220;Initial Public Offering&#8221;), which is described below. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31
as its fiscal year end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The registration statement for the Company&#8217;s
Initial Public Offering was declared effective on January 14, 2025. On January 16, 2025, the Company consummated the Initial Public Offering
of <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7392">17,250,000</ix:nonFraction> units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered, the
&#8220;Public Shares&#8221;), which includes the full exercise by the underwriters of their over-allotment option in the amount of <ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7393">2,250,000</ix:nonFraction>
Units, at $<ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7394">10.00</ix:nonFraction> per Unit, generating gross proceeds of $<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-7395">172,500,000</ix:nonFraction>, which is discussed in Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of <ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7396">672,875</ix:nonFraction> private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $<ix:nonFraction contextRef="c28" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7397">10.00</ix:nonFraction> per Private Placement Unit, generating gross proceeds of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7398">6,728,750</ix:nonFraction>, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of <ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7399">232,875</ix:nonFraction> private placement units for an aggregate
purchase price of $<ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7400">2,328,750</ix:nonFraction> and (ii) by and between the Company and Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase
by the Sponsor of an aggregate of <ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7401">440,000</ix:nonFraction> private placement units and <ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" unitRef="shares" id="ixv-7402">570,000</ix:nonFraction> restricted Class A ordinary shares for an aggregate purchase
price of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="plmk:AggregatePurchasePrice" scale="0" unitRef="usd" id="ixv-7403">4,400,000</ix:nonFraction>. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Transaction costs amounted to $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:TransactionCosts" scale="0" unitRef="usd" id="ixv-7404">10,932,289</ix:nonFraction>, consisting
of $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:SaleOfStockUnderwritingFees" scale="0" unitRef="usd" id="ixv-7405">3,450,000</ix:nonFraction> of cash underwriting fee, $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:DeferredUnderwritingFee" scale="0" unitRef="usd" id="ixv-7406">6,900,000</ix:nonFraction> of deferred underwriting fee, and $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:OtherOfferingCosts" scale="0" unitRef="usd" id="ixv-7407">582,289</ix:nonFraction> of other offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company&#8217;s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Securities,
although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company
must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least
<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" scale="-2" unitRef="pure" id="ixv-7408">80</ix:nonFraction>% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting commissions held in the Trust
Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires <ix:nonFraction contextRef="c32" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure" id="ixv-7409">50</ix:nonFraction>% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act&#160;of&#160;1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company
will be able to successfully effect a Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Following the closing of the Initial Public Offering,
on January 16, 2025, an amount of $<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7410">174,225,000</ix:nonFraction> ($<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7411">10.10</ix:nonFraction> per Unit) from the net proceeds of the sale of the Units and the sale of the Private
Placement Securities was placed in the trust account (the &#8220;Trust Account&#8221;) and invested or held in either (i)&#160;U.S.&#160;government
treasury bills with a maturity of 185&#160;days or less or in money market funds investing solely in U.S.&#160;Treasuries, (ii)&#160;uninvested
cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank, as determined by the Company, until the
earlier of: (i)&#160;the completion of a Business Combination or (ii)&#160;the distribution of the funds in the Trust Account to the Company&#8217;s
shareholders, as described below. No later than 18&#160;months after the closing of the Initial Public Offering or such earlier liquidation
date as the Company&#8217;s board of directors may approve, or such later time as provided for in any amendment to the Company&#8217;s
Amended and Restated Memorandum and Articles of Association, (an &#8220;Extension Period&#8221;), subject to applicable law, the amounts
held in the Trust Account are held as cash or cash items, including in demand deposit accounts.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will provide its shareholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection
with a general meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether
the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders
will be entitled to redeem their shares for a pro&#160;rata portion of the amount held in the Trust Account (initially $<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="plmk:InitialAmountHeldInTrustAccount" scale="0" unitRef="usdPershares" id="ixv-7412">10.10</ix:nonFraction> per share),
calculated as of two&#160;business days prior to the completion of a Business Combination, including any pro&#160;rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#8217;s public warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If the Company seeks shareholder approval in connection
with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires
the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required
under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or
other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions
pursuant to the tender offer rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), and file tender offer documents containing
substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares
(as defined in Note&#160;5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination
and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination.
Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether
they vote for or against a proposed Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Notwithstanding the foregoing, if the Company
seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company&#8217;s
Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder
or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the
Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#8220;Exchange&#160;Act&#8221;)), will be restricted from redeeming its
shares with respect to more than an aggregate of <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:AggregatePublicShareRate" scale="-2" unitRef="pure" id="ixv-7413">15</ix:nonFraction>% of the Public Shares without the Company&#8217;s prior written consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed to (i)&#160;waive its redemption
rights with respect to its private placement shares in connection with the completion of the initial business combination, (ii)&#160;waive
its redemption rights with respect to its private placement shares in connection with a shareholder vote to approve an amendment to the
amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the obligation to allow redemption
in connection with the initial Business Combination or to redeem <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" scale="-2" unitRef="pure" id="ixv-7414">100</ix:nonFraction>% of the public shares if the Company fails to complete the initial
Business Combination within 18&#160;months from the closing of the Initial Public Offering or such earlier liquidation date as the Company&#8217;s
board of directors may approve, or during any Extension Period, subject to applicable law or (B)&#160;with respect to any other provision
relating to shareholders&#8217; rights or pre-initial business combination activity and (iii)&#160;waive its rights to liquidating distributions
from the Trust Account with respect to its private placement shares if the Company fails to complete the initial Business Combination
within the prescribed timeframe. In addition, the Sponsor has agreed to vote any private placement shares held by it in favor of the initial
Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will have until 18&#160;months from
the closing of the Initial Public Offering (the &#8220;Combination Period&#8221;) to complete a Business Combination. If the Company is
unable to complete a Business Combination within the Combination Period, the Company will (i)&#160;cease all operations except for the
purpose of winding up, (ii)&#160;as promptly as reasonably possible but no more than 10&#160;business days thereafter, redeem <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" scale="-2" unitRef="pure" id="ixv-7415">100</ix:nonFraction>% of
the outstanding Public Shares, at a per-share price, payable in cash, including interest earned on the funds held in the Trust Account
(which interest shall be net of taxes payable and up to $<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:InterestUsedToPayDissolutionExpensesMaximum" scale="0" unitRef="usd" id="ixv-7416">100,000</ix:nonFraction> of interest to pay dissolution expenses) and not previously released
to the Company to pay its taxes, if any, divided by the number of then-outstanding Public Shares, which redemption will completely extinguish
public shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii)&#160;as
promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company&#8217;s
board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of
creditors and the requirements of other applicable law.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed to waive its liquidation rights with respect
to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires
Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust
Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their
rights to their deferred underwriting commission (see Note&#160;6) held in the Trust Account in the event the Company does not complete
a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust
Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the
per share value of the assets remaining available for distribution will be less than the initial amount held in the Trust Account ($<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="plmk:InitialAmountHeldInTrustAccount" scale="0" unitRef="usdPershares" id="ixv-7417">10.10</ix:nonFraction>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed that it will be liable
to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective
target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account
to below (1)&#160;$<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:SharePricePerPublicShare" scale="0" unitRef="usdPershares" id="ixv-7418">10.10</ix:nonFraction> per Public Share or (2)&#160;such lesser amount per Public Share held in the Trust Account as of the date of
the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which
may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any
and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended
(the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party,
the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than the Company&#8217;s independent auditors), prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The United&#160;States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the
Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#8220;NATO&#8221;)
deployed additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries,
including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel,
increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting
measures that have been taken, and could be taken in the future, by NATO, the United&#160;States, the United Kingdom, the European Union,
Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional
and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased
cyber-attacks against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect the global economy and financial
markets and lead to instability and lack of liquidity in capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company&#8217;s search for an initial
business combination and any target business with which the Company may ultimately consummate an initial business combination.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-6657"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 2&#8201;&#8212;&#8201;SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-6661"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Basis of Presentation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="plmk_LiquidityAndCapitalResourcesPolicyTextBlock-c0_cont_1" escape="true" name="plmk:LiquidityAndCapitalResourcesPolicyTextBlock" id="ixv-6668"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Liquidity and Capital Resources</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="plmk_LiquidityAndCapitalResourcesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company had $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-7419">3,864</ix:nonFraction>
in cash and a working capital deficit of $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="plmk:WorkingCapitalDeficit" scale="0" unitRef="usd" id="ixv-7420">505,332</ix:nonFraction>. Further, the Company has incurred and expects to continue to incur significant costs
in pursuit of its acquisition plans. There is no assurance that the Company&#8217;s plans to raise capital will be successful. In connection
with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, &#8220;Going
Concern,&#8221; as of December 31, 2024, and including the closing of the Initial Public Offering on January 16, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements. The Company cannot assure that its plans to raise capital or to consummate an Initial Business Combination will be successful.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="plmk_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1" escape="true" name="plmk:EmergingGrowthCompanyPolicyTextBlock" id="ixv-6676"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Emerging Growth Company</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="plmk_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2" id="plmk_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the
&#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="plmk_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-6686"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Use of Estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial statement in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
periods.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-6696"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Cash and Cash Equivalents</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers all short-term investments
with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-7421">3,864</ix:nonFraction> in cash and no cash
equivalents as of December 31, 2024.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock" id="ixv-6720"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Deferred Offering Costs</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation id="_DeferredChargesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company complies
with the requirements of the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 340-10-S99 and SEC Staff Accounting
Bulletin (&#8220;SAB&#8221;) Topic 5A &#8212; &#8220;Expenses of Offering.&#8221; Deferred offering costs consist principally of
professional and registration fees that are directly related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with
Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and
debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of
the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary
equity, and offering costs allocated to Public Warrants (as defined below) and Private Placement Units were charged to
shareholders&#8217; deficit as the Public and Private Placement Warrants (as defined below), after management&#8217;s evaluation,
were accounted for under equity treatment. On January 16, 2025, deferred offering costs amounting to $<ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="0" unitRef="usd" id="ixv-7422">582,289</ix:nonFraction> were charged to
shareholder&#8217;s equity upon the completion of the Initial Public Offering (see Note 1). As of December 31, 2024, there were
$<ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="0" unitRef="usd" id="ixv-7423">438,352</ix:nonFraction> of deferred offering costs recorded in the accompanying balance sheet.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 14.55pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-6727"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Income Taxes</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for income taxes under ASC&#160;740,
&#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). ASC&#160;740 requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">ASC&#160;740 also clarifies the accounting for
uncertainty in income taxes recognized in an enterprise&#8217;s financial statement and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of December 31, 2024. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is considered an exempted Cayman Islands
Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States.
As such, the Company&#8217;s tax provision was <ix:nonFraction contextRef="c11" decimals="0" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-7424">zero</ix:nonFraction> for the period presented.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-6740"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Net Loss Per Ordinary Share</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Net loss per ordinary
share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period,
excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares" id="ixv-7425">750,000</ix:nonFraction>
Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment
option is exercised (see Note 5). At December 31, 2024, the Company did not have any dilutive securities and other contracts that
could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result,
diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-6747"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Concentration of Credit Risk</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage of $<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashFDICInsuredAmount" scale="0" unitRef="usd" id="ixv-7426">250,000</ix:nonFraction>. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company&#8217;s financial condition, results of operations, and cash flows.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-6754"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Fair Value of Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The fair value of the Company&#8217;s assets and
liabilities, which qualify as financial instruments under ASC Topic&#160;820, &#8220;Fair Value Measurement,&#8221; approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DerivativesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock" id="ixv-6761"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Warrant Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_DerivativesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will account for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering, on January 16, 2025 and the private placement in accordance
with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging.&#8221; Accordingly, the Company evaluated and
classified the warrant instruments under equity treatment at their assigned values.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-6787"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Share-Based Compensation</b>&#160;</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company records share-based compensation in
accordance with FASB ASC Topic 718, &#8220;Compensation-Share Compensation&#8221; (&#8220;ASC 718&#8221;), guidance to account for its
share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument.
The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number
of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of
share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment,
which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which
is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed
in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending
on the nature of the services provided in the statement of operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="plmk_DerivativeFinancialInstrumentsPolicyTextBlock-c0_cont_1" escape="true" name="plmk:DerivativeFinancialInstrumentsPolicyTextBlock" id="ixv-6794"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative financial instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in">&#160;</p>

<ix:continuation id="plmk_DerivativeFinancialInstrumentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates its financial instruments to determine if such
instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives
and Hedging.&#8221; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially
recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in
the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance
sheet date. The underwriters&#8217; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently
redeemable shares and would have been accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial
Public Offering.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-6801"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Recently Issued Accounting Standards</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The amendments in this ASU require disclosures, on an annual and interim
basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;), as well
as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public
entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures
currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures
required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning
after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The
Company has adopted ASU 2023-07 for the year ended December 31, 2024. ASU 2023-07 does not have a material effect on the Company&#8217;s
financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management does not
believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#8217;s financial statement.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="plmk:InitialPublicOfferingTextBlock" id="ixv-6813"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 3&#8201;&#8212; INITIAL PUBLIC OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant to the Initial Public Offering on January
16, 2025, the Company sold <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7427">17,250,000</ix:nonFraction>&#160;Public Shares, which includes a full exercise by the underwriter of their over-allotment option
at a purchase price of $<ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7428">10.00</ix:nonFraction> per Unit. Each Unit consists of <ix:nonFraction contextRef="c23" decimals="0" format="ixt-sec:numwordsen" name="plmk:NumberOfSharesIssuedPerUnit" scale="0" unitRef="shares" id="ixv-7429">one</ix:nonFraction> Class&#160;A ordinary share and one-half of one redeemable public warrant
(&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase <ix:nonFraction contextRef="c40" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares" id="ixv-7430">one</ix:nonFraction> Class&#160;A ordinary share at an exercise
price of $<ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-7431">11.50</ix:nonFraction> per share, subject to adjustment (see Note&#160;6).</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="plmk_PrivatePlacementTextBlock-c0_cont_1" escape="true" name="plmk:PrivatePlacementTextBlock" id="ixv-6821"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 4&#8201;&#8212;&#8201;PRIVATE PLACEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of <ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7432">672,875</ix:nonFraction> private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $<ix:nonFraction contextRef="c28" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7433">10.00</ix:nonFraction> per Private Placement Unit, or Non-Managing Investor Private Placement Security (as defined below) generating
gross proceeds of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7434">6,728,750</ix:nonFraction>, as follows: (i) by and among the Company and each of the Underwriters for the purchase by the Underwriters
of an aggregate of <ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7435">232,875</ix:nonFraction> Private Placement units for an aggregate purchase price of $<ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7436">2,328,750</ix:nonFraction> and (ii) by and between the Company and
Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase by the Sponsor of an aggregate of <ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7437">440,000</ix:nonFraction> Private Placement Units and
<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" unitRef="shares" id="ixv-7438">570,000</ix:nonFraction> restricted Class A ordinary shares (the &#8220;Restricted Private Placement Shares,&#8221; the Restricted Private Placement Shares
together with the Private Placement Units purchased by the Sponsor, collectively, the &#8220;Non-Managing Investor Private Placement Securities&#8221;)
for an aggregate purchase price of $<ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7439">4,400,000</ix:nonFraction>.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 16.2pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 16.2pt"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:continuation id="plmk_PrivatePlacementTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Each Private Placement Unit has an offering price
of $<ix:nonFraction contextRef="c43" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7440">10.00</ix:nonFraction> and consists of one Class&#160;A ordinary share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles
the holder to purchase one Class&#160;A ordinary share at a price of $<ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-7441">11.50</ix:nonFraction> per share. The proceeds from the sale of the Private Placement
Units and the Non-Managing Investor Private Placement Securities were added to the net proceeds from the Initial Public Offering held
in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale
of the Private Placement Units and the Non-Managing Investor Private Placement Securities held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants expire worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Restricted Private Placement Shares are held
by the Sponsor and will be transferred to the non-managing investors (or their designees) only upon the consummation of an initial business
combination. Other than such permitted transfer, the Restricted Private Placement Shares will be subject to transfer restrictions for
<ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" id="ixv-7442">90</ix:nonNumeric> days following our initial business combination and will be entitled to registration rights.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 16.2pt">&#160;&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-6850"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 5&#8201;&#8212;&#8201;RELATED PARTY
TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On June&#160;26, 2024, the Sponsor paid $<ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-7443">25,000</ix:nonFraction>,
or approximately $<ix:nonFraction contextRef="c46" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7444">0.003</ix:nonFraction> per share in consideration for <ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7445">7,665,900</ix:nonFraction> Class&#160;B ordinary shares (the &#8220;Founder Shares&#8221;) issued
to the Sponsor. On December 6, 2024, the Sponsor surrendered <ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="plmk:NumberOfSharesSurrendered" scale="0" unitRef="shares" id="ixv-7446">1,915,900</ix:nonFraction> Founder Shares for no consideration. All share and per share amounts
have been retroactively restated. The initial shareholders currently hold an aggregate of <ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7447">5,750,000</ix:nonFraction> Founder Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Founder Shares include an aggregate of up
to <ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares" id="ixv-7448">750,000</ix:nonFraction> shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters&#8217; over-allotment
option is exercised, so that the number of Founder Shares will collectively represent <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" scale="-2" unitRef="pure" id="ixv-7449">25</ix:nonFraction>% of the Company&#8217;s issued and outstanding
shares upon the completion of the Initial Public Offering. On January 16, 2025, the underwriters exercised their over-allotment option
in full as part of the closing of the Initial Public Offering. As such, the <ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="plmk:NumberOfSharesNoLongerSubjectToForfeiture" scale="0" unitRef="shares" id="ixv-7450">750,000</ix:nonFraction> Founder Shares are no longer subject to forfeiture.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed, subject to limited exceptions,
not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of a Business
Combination; and (B)&#160;subsequent to a Business Combination, (x)&#160;if the last reported sale price of the Class&#160;A ordinary
shares equals or exceeds $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" scale="0" unitRef="usdPershares" id="ixv-7451">12.00</ix:nonFraction> per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" id="ixv-7452">20</ix:nonNumeric>&#160;trading days within any <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" id="ixv-7453">30</ix:nonNumeric>-trading&#160;day period commencing at least 150&#160;days after a Business Combination,
or (y)&#160;the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction that results in all of the Company&#8217;s shareholders having the right to exchange their Class&#160;A ordinary shares for
cash, securities or other property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During July and August 2024, the Sponsor transferred
<ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="plmk:CommonStockSharesTransferred" scale="0" unitRef="shares" id="ixv-7454">75,000</ix:nonFraction> Founder Shares to <ix:nonFraction contextRef="c51" decimals="0" format="ixt-sec:numwordsen" name="plmk:NumberOfIndependentDirector" scale="0" unitRef="pure" id="ixv-7455">three</ix:nonFraction> director nominees (<ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="plmk:CommonStockSharesTransferred" scale="0" unitRef="shares" id="ixv-7456">25,000</ix:nonFraction> shares each) for an aggregate amount of $<ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="plmk:CommonStockValueTransferred" scale="0" unitRef="usd" id="ixv-7457">225</ix:nonFraction>, or approximately $<ix:nonFraction contextRef="c54" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7458">0.003</ix:nonFraction> per share.
The sale of the Founders Shares to the Company&#8217;s directors and director&#8217;s nominees is in the scope of FASB ASC Topic 718,
&#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified
awards is measured at fair value upon the grant date. The fair value of the <ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:FairValueOfSharesGranted" scale="0" unitRef="shares" id="ixv-7459">75,000</ix:nonFraction> shares granted to the Company&#8217;s director nominees
was $<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="plmk:FairValueOfSharesGrantedAmount" scale="0" unitRef="usd" id="ixv-7460">36,750</ix:nonFraction> or $<ix:nonFraction contextRef="c55" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7461">0.49</ix:nonFraction> per share. The Founders Shares were granted subject to a performance condition (i.e., named as directors at the occurrence
of the Initial Public Offering). Compensation expense related to the Founders Shares is recognized only when the performance condition
is probable of occurrence under the applicable accounting literature. Stock-based compensation was recognized upon the consummation of
the Initial Public Offering in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently
modified) less the amount initially received for the purchase of the Founder Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Promissory Note&#160;&#8212;&#160;Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;26, 2024, the Company issued an unsecured
promissory note to the Sponsor (as amended on January 6, 2025, the &#8220;Promissory Note&#8221;), pursuant to which the Company may borrow
up to an aggregate principal amount of $<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnsecuredDebt" scale="0" unitRef="usd" id="ixv-7462">500,000</ix:nonFraction>. The Promissory Note was non-interest bearing and payable on the earlier of (i)&#160;February
1, 2025 (as amended) or (ii)&#160;the consummation of the Initial Public Offering. As of December 31, 2024, the Company owed $<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayable" scale="0" unitRef="usd" id="ixv-7463">149,473</ix:nonFraction>
under the promissory note. Subsequent to the balance sheet date, on January 16, 2025, the Company overpaid the Sponsor by $<ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilities" scale="0" unitRef="usd" id="ixv-7464">1,295</ix:nonFraction> resulting
in a due from Sponsor. On January 22, 2025, the Sponsor returned the $<ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="0" unitRef="usd" id="ixv-7465">1,295</ix:nonFraction> to the Company (Note 9).</p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Due to Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company owes an officer
of the Company $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="0" unitRef="usd" id="ixv-7466">12,374</ix:nonFraction> for travel related expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Consulting Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Chief Executive officer and the Chief Financial
Officer entered into agreements with the Company, commencing on January 16, 2025 through the closing of the Company&#8217;s Business Combination,
to pay each officer an aggregate of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalAndContractServicesExpense" scale="0" unitRef="usd" id="ixv-7467">20,833</ix:nonFraction> per month, subject to availability of sufficient funds from working capital held outside the
Trust Account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, any of their respective affiliates or certain of the Company&#8217;s
directors and officers may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;).
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s
discretion, up to $<ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="usd" id="ixv-7468">1,500,000</ix:nonFraction> of such Working Capital Loans may be convertible into units at a price of $<ix:nonFraction contextRef="c60" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-7469">10.00</ix:nonFraction> per unit. The units would
be identical to the Private Placement Units. As of December 31, 2024, there are no Working Capital Loans outstanding.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-6906"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 6&#8201;&#8212;&#8201;COMMITMENTS AND
CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The holders of the (i)&#160;Founder Shares, (ii)
Restricted Private Placement Shares, (iii)&#160;Private Placement Units, issued in a private placement simultaneously with the closing
of the Initial Public Offering, private placement shares, private placement warrants and the Class&#160;A ordinary shares underlying such
private placement warrants and (iv)&#160;private placement units that may be issued upon conversion of working capital loans are entitled
to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring
the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class&#160;A ordinary
shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that
the Company register such securities. In addition, the holders have certain piggy-back registration rights with respect to registration
statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such
securities pursuant to Rule&#160;415 under the Securities Act. However, the registration rights agreement provides that the Company will
not be required to effect or permit any registration or cause any registration statement to become effective until termination of the
applicable lock-up period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions
resulting from delays in registering the Company&#8217;s securities. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Underwriting Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company has granted the underwriters a 45-day
option to purchase up to <ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="plmk:NumberOfAdditionalUnitsPurchased" scale="0" unitRef="shares" id="ixv-7470">2,250,000</ix:nonFraction> additional Units&#160;to cover over-allotments at the Initial Public Offering price, less the underwriting
commissions. As of January 16, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully
exercise the over-allotment option to purchase the additional <ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="plmk:NumberOfAdditionalUnitsPurchased" scale="0" unitRef="shares" id="ixv-7471">2,250,000</ix:nonFraction> Units at a price of $<ix:nonFraction contextRef="c62" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7472">10.00</ix:nonFraction> per Unit</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The underwriters were entitled to (1) an underwriting
discount of $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:UnderwritingDiscountPricePerUnit" scale="0" unitRef="usdPershares" id="ixv-7473">0.20</ix:nonFraction> per Unit, or $<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForUnderwritingExpense" scale="0" unitRef="usd" id="ixv-7474">3,450,000</ix:nonFraction> in the aggregate, of which (i)&#160;$<ix:nonFraction contextRef="c11" decimals="3" format="ixt:num-dot-decimal" name="plmk:CashUnderwritingPaidPerUnit" scale="0" unitRef="usdPershares" id="ixv-7475">0.065</ix:nonFraction> per unit was paid to the underwriters in cash at
the closing of the Initial Public Offering and (ii)&#160;$<ix:nonFraction contextRef="c11" decimals="3" format="ixt:num-dot-decimal" name="plmk:PurchaseOfPrivatePlacementOfUnderwritersPerUnit" scale="0" unitRef="usdPershares" id="ixv-7476">0.135</ix:nonFraction> per Unit was used by the underwriters to purchase Private Placement Units,
and (2) a deferred fee of $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:DeferredFeePerUnit" scale="0" unitRef="usdPershares" id="ixv-7477">0.40</ix:nonFraction>&#160;per&#160;Unit, or $<ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForUnderwritingExpense" scale="0" unitRef="usd" id="ixv-7478">6,900,000</ix:nonFraction>. The deferred fee will become payable to the underwriters from the amounts
held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting
agreement and will be based on the amount of funds remaining in the Trust Account after shareholder redemptions of public shares in connection
with the consummation of a Business Combination.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-6936"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 7&#8201;&#8212;&#8201;SHAREHOLDER&#8217;S
DEFICIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Preference Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-7479">1,000,000</ix:nonFraction> preference shares with a par value of $<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-7480">0.0001</ix:nonFraction> per share, with such designations, voting and other
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At December 31, 2024, there were
<span style="-sec-ix-hidden: hidden-fact-17"><span style="-sec-ix-hidden: hidden-fact-18">no</span></span> preference shares issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Class&#160;A Ordinary Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue <ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-7481">200,000,000</ix:nonFraction> Class&#160;A ordinary shares, with a par value of $<ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-7482">0.0001</ix:nonFraction> per share. Holders of Class&#160;A
ordinary shares are entitled to <ix:nonNumeric contextRef="c64" name="us-gaap:CommonStockVotingRights" id="ixv-7483">one</ix:nonNumeric> vote for each share. At December 31, 2024, there are <span style="-sec-ix-hidden: hidden-fact-19"><span style="-sec-ix-hidden: hidden-fact-20">no</span></span> Class&#160;A ordinary shares issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Class&#160;B Ordinary Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue <ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-7484">20,000,000</ix:nonFraction> Class&#160;B ordinary shares, with a par value of $<ix:nonFraction contextRef="c10" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-7485">0.0001</ix:nonFraction> per share. Holders of the Class&#160;B
ordinary shares are entitled to <ix:nonNumeric contextRef="c38" name="us-gaap:CommonStockVotingRights" id="ixv-7486">one</ix:nonNumeric> vote for each share. At December 31, 2024, there were <ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-7487"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-7488">5,750,000</ix:nonFraction></ix:nonFraction> Class&#160;B ordinary shares issued
and outstanding (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Only holders of Class&#160;B ordinary shares will
have the right to vote on the election of directors prior to the Business Combination. Holders of Class&#160;A ordinary shares and holders
of Class&#160;B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company&#8217;s shareholders
except as otherwise required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares at the time of a Business Combination or earlier at the option of the holder, on a one-for-one
basis, subject to adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants&#160;&#8212;</b>&#160;There are no warrants
issued or outstanding as of December 31, 2024. Public Warrants may only be exercised for a whole number of shares. No fractional shares
will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a)&#160;<ix:nonNumeric contextRef="c11" format="ixt-sec:durwordsen" name="plmk:PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" id="ixv-7489">30&#160;days</ix:nonNumeric>
after the completion of a Business Combination and (b)&#160;12&#160;months from the closing of the Initial Public Offering. The Public
Warrants will expire <span style="-sec-ix-hidden: hidden-fact-16">seven</span>&#160;years from the completion of a Business Combination or earlier upon redemption or liquidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will not be obligated to deliver any Class&#160;A
ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless
a registration statement under the Securities Act covering the issuance of the Class&#160;A ordinary shares issuable upon exercise of
the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations
with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless
basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of
the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has agreed that as soon as practicable,
but in no event later than <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" id="ixv-7490">15</ix:nonNumeric>&#160;business days, after the closing of a Business Combination, it will use its commercially reasonable
efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class&#160;A ordinary shares
issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective
within <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" id="ixv-7491">60</ix:nonNumeric>&#160;business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.
Notwithstanding the above, if the Class&#160;A ordinary shares are, at the time of any exercise of a warrant, not listed on a national
securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the
Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless
basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will
not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or
qualify the shares under applicable blue sky laws to the extent an exemption is not available.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 75; Options: NewSection; Value: 15 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Redemption of Public Warrants</i>&#160;&#8212;&#160;Once
the warrants become exercisable, the Company may redeem the outstanding Public Warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="plmk:ClassOfWarrantsOrRightsRedemptionPricePerWarrant" scale="0" unitRef="usdPershares" id="ixv-7492">0.01</ix:nonFraction> per Public Warrant;</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than <ix:nonNumeric contextRef="c11" format="ixt-sec:durwordsen" name="plmk:NoticePeriodToBeGivenPriorToRedemption" id="ixv-7493">30&#160;days</ix:nonNumeric>&#8217; prior written notice of redemption to each warrant holder; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the closing price of the Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-7494">18.00</ix:nonFraction> per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" id="ixv-7495">20</ix:nonNumeric>&#160;trading days within a <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockRedemptionPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7496">30</ix:nonFraction>-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company sends the notice of redemption to warrant holders.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will not redeem the warrants for cash
unless a registration statement under the Securities Act covering the issuance of the shares of Class&#160;A ordinary shares issuable
upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout
the <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" id="ixv-7497">30</ix:nonNumeric>-day redemption period or the Company has elected to require the exercise of the public warrants on a cashless basis. If and when
the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Company calls the warrants for redemption as
described in this paragraph, its management will have the option to require any holder that wishes to exercise his, her or its warrant
following the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise
price by surrendering the Public Warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the
product of the number of Class&#160;A ordinary shares underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221;
less the exercise price of the warrants by (y)&#160;the fair market value. The &#8220;fair market value&#8221; as used in the preceding
sentence shall mean the volume weighted average price of the Class&#160;A ordinary shares for the 10&#160;trading days ending on the&#160;trading
day prior to the date on which the notice of redemption is sent to the holders of the public warrants. If its management takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class&#160;A ordinary
shares to be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has established the $<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="plmk:EstablishedPerShare" scale="0" unitRef="usdPershares" id="ixv-7498">18.00</ix:nonFraction> per share (as
adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium
to the public warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public
Warrants, each Public Warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date.
However, the price of the Class&#160;A ordinary shares may fall below the $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" unitRef="usdPershares" id="ixv-7499">18.00</ix:nonFraction> redemption trigger price as well as the $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PublicWarrantExercisePrice" scale="0" unitRef="usdPershares" id="ixv-7500">11.50</ix:nonFraction> Public
Warrant exercise price after the redemption notice is issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, if (x)&#160;the Company issues additional
ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its Initial Business Combination
at an issue price or effective issue price of less than $<ix:nonFraction contextRef="c65" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7501">9.20</ix:nonFraction> per ordinary share (with such issue price or effective issue price to be
determined in good faith by its board of directors and, in the case of any such issuance to either of the Sponsor or its affiliates, without
taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly
Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:TotalEquityProceedsPercentage" scale="-2" unitRef="pure" id="ixv-7502">60</ix:nonFraction>% of the total equity proceeds,
and interest thereon, available for the funding of its Initial Business Combination on the date of the completion of its Initial Business
Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the <ix:nonNumeric contextRef="c11" format="ixt-sec:durday" name="plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" id="ixv-7503">20</ix:nonNumeric>&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial business combination (such
price, the &#8220;Market Value&#8221;) is below $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" scale="0" unitRef="usdPershares" id="ixv-7504">9.20</ix:nonFraction> per share, the exercise price of the public warrants will be adjusted (to the nearest
cent) to be equal to <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:PublicWarrantsAdjustedPercentage" scale="-2" unitRef="pure" id="ixv-7505">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, the $<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" unitRef="usdPershares" id="ixv-7506">18.00</ix:nonFraction> per share redemption trigger price
will be adjusted (to the nearest cent) to be equal to <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="plmk:MarketValueInPercentage" scale="-2" unitRef="pure" id="ixv-7507">180</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Private Placement Warrants are identical to the
Public Warrants underlying the Units&#160;being sold in the Initial Public Offering, except that the Private Placement Warrants and the
Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until 30&#160;days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-7037"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8&#8201;&#8212;&#8201;SEGEMENT REPORTING
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 280, &#8220;Segment Reporting,&#8221; establishes
standards for companies to report in their financial statement information about operating segments, products, services, geographic areas,
and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may
recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#8217;s
chief operating decision maker, or group, in deciding how to allocate resources and assess performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s chief operating decision maker
(&#8220;CODM&#8221;) has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has
determined that there is only <ix:nonFraction contextRef="c11" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure" id="ixv-7508">one</ix:nonFraction> reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The CODM assesses performance for the single
segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as
net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfSegmentReportingInformationBySegmentTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="ixv-7509">the
Company&#8217;s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included
in net income or loss:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:continuation id="_ScheduleOfSegmentReportingInformationBySegmentTextBlock-c0_cont_1"><table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the<br/>
    period from<br/>
    June 10,<br/>
    2024 (inception)<br/>
    through<br/>
    December&#160;31,&#160;2024</b></span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formation
    and operating costs </span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-7510">91,980</ix:nonFraction></span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Formation and operating costs are reviewed and monitored
by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction
within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual
agreements to ensure costs are aligned with all agreements and budget. Formation and operating costs, as reported on the statement of
operations, are the significant segment expenses provided to the CODM on a regular basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0; font: 10pt/107% Times New Roman, Times, Serif">All other segment items included in net income or loss are reported
on the statement of operations and described within their respective disclosures.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-7083"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 9&#8201;&#8212;&#8201;SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than
as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial
statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 16, 2025, the underwriters exercised
their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the <ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="plmk:NumberOfSharesNoLongerSubjectToForfeiture" scale="0" unitRef="shares" id="ixv-7511">750,000</ix:nonFraction> Founder Shares are no
longer subject to forfeiture.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of January 16, 2025, the Company owed $<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-7512">284,023</ix:nonFraction>,
which were repaid simultaneously with the closing of the Initial Public Offering. The Company paid the Sponsor a note balance of $<ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SponsorFees" scale="0" unitRef="usd" id="ixv-7513">285,318</ix:nonFraction>
causing an overpayment of $<ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilities" scale="0" unitRef="usd" id="ixv-7514">1,295</ix:nonFraction> due from Sponsor. Subsequent to the balance sheet date, on January 22, 2025, the Sponsor returned the
$<ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="0" unitRef="usd" id="ixv-7515">1,295</ix:nonFraction> to the Company. Borrowings under this note are no longer available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2025, the Company consummated the
Initial Public Offering of <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7516">17,250,000</ix:nonFraction> units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the
Units being offered, the &#8220;Public Shares&#8221;), which includes the full exercise by the underwriters of their over-allotment option
in the amount of <ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7517">2,250,000</ix:nonFraction> Units, at $<ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7518">10.00</ix:nonFraction> per Unit, which is discussed in Note 3, generating gross proceeds of $<ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd" id="ixv-7519">172,500,000</ix:nonFraction>. .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of <ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7520">672,875</ix:nonFraction> private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $<ix:nonFraction contextRef="c28" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-7521">10.00</ix:nonFraction> per Private Placement Unit, generating gross proceeds of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7522">6,728,750</ix:nonFraction>, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of <ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7523">232,875</ix:nonFraction> private placement units for an aggregate
purchase price of $<ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-7524">2,328,750</ix:nonFraction> and (ii) by and between the Company and Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase
by the Sponsor of an aggregate of <ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="plmk:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-7525">440,000</ix:nonFraction> private placement units and <ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" unitRef="shares" id="ixv-7526">570,000</ix:nonFraction> restricted Class A ordinary shares for an aggregate purchase
price of $<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="plmk:AggregatePurchasePrice" scale="0" unitRef="usd" id="ixv-7527">4,400,000</ix:nonFraction>. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">SIGNATURES</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>Plum Acquisition Corp. IV</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><span style="font-size: 10pt">Dated: March 31, 2025</span></td>
    <td style="width: 4%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 36%"><span style="font-size: 10pt">/s/ Kanishka Roy</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Kanishka Roy</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on March 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-right: 3pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;Kanishka Roy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kanishka Roy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;Steven Handwerker</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Director</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Handwerker</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer)</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Allan Chou</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allan Chou</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Anjai Gandhi</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anjai Gandhi</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Avanish Sahai</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avanish Sahai</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">57</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c7" id="hidden-fact-0" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-1" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-2" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-3" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-4" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-5" name="us-gaap:CommonStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-6" name="us-gaap:CommonStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-7" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-8" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-9" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-10" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-11" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-12" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-13" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-14" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-15" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c7" id="hidden-fact-16" name="us-gaap:WarrantsAndRightsOutstandingTerm">P7Y</ix:nonNumeric>
<ix:nonFraction contextRef="c7" id="hidden-fact-17" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-18" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-19" name="us-gaap:CommonStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-20" name="us-gaap:CommonStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-7551">0002030482</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-7552">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-7553">FY</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="plmk-20241231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_5_fact ix_6_fact" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_5_fact ix_6_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_7_fact ix_8_fact ix_9_fact hidden-fact-12 ix_10_fact" toRefs="ix_4_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_7_fact ix_8_fact ix_9_fact hidden-fact-12 ix_10_fact" toRefs="ix_5_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:ClassAOrdinaryShares00001ParValuePerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-16</xbrli:startDate>
    <xbrli:endDate>2025-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-16</xbrli:startDate>
    <xbrli:endDate>2025-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-16</xbrli:startDate>
    <xbrli:endDate>2025-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:PlumPartnersIVLLCMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-16</xbrli:startDate>
    <xbrli:endDate>2025-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1v+aM7LOWqft7aJTxeV5OADc=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-26</xbrli:startDate>
    <xbrli:endDate>2024-06-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-06</xbrli:startDate>
    <xbrli:endDate>2024-12-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2024-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2024-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2024-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2024-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">plmk:PromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:WorkingCapitalLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">plmk:WorkingCapitalLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">plmk:UnderwritingAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-16</xbrli:startDate>
    <xbrli:endDate>2025-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002030482</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-10</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>ea023531601ex4-5_plumacq4.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.5</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>As of December 31, 2024, Plum Acquisition Corp.
IV (&ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us&rdquo; or the &ldquo;company&rdquo;) had the following three classes of securities
registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;): (i) its Units, each consisting
of one Class A ordinary share and one-half of one redeemable&nbsp;public</I>&nbsp;<I>warrant, (ii) Class A ordinary shares, par value
$0.0001 per share, and (iii) redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of
$11.50. In addition, this Description of Securities also references the company&rsquo;s Class B ordinary shares, par value $0.0001 per
share (the &ldquo;Class B ordinary shares&rdquo; or &ldquo;founder shares&rdquo;), which are not registered pursuant to Section 12 of
the Exchange Act but are convertible into Class A ordinary shares. The description of the Class B ordinary shares is included to assist
in the description of the Class A ordinary shares. Unless the context otherwise requires, references to &ldquo;Sponsor&rdquo; are Plum
Partners IV, LLC and references to our &ldquo;initial stockholders&rdquo; are to Sponsor and our independent directors, as they held our
founder shares prior to our initial public offering (our &ldquo;IPO&rdquo;).</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a Cayman Islands exempted company and our
affairs are governed by our amended and restated memorandum and articles of association, the Companies Act and common law of the Cayman
Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 200,000,000 Class A ordinary
shares, $0.0001 par value each, 20,000,000 Class B ordinary shares, $0.0001 par value each, and 1,000,000 undesignated preference shares,
$0.0001 par value each. The following description summarizes the material terms of our share capital as set out more particularly in our
amended and restated memorandum and articles of association. Because it is only a summary, it may not contain all the information that
is important to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Units</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Public Units</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each public unit consists of one Class A ordinary
share and one-half of one redeemable public warrant. Each whole public warrant entitles the holder thereof to purchase one Class A ordinary
share at a price of $11.50 per share, subject to adjustment as described below. Pursuant to the warrant agreement that governs the warrants
(the &ldquo;warrant agreement&rdquo;), a public warrant holder may exercise its public warrants only for a whole number of the company&rsquo;s
Class A ordinary shares. This means only a whole public warrant may be exercised at any given time by a public warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders have the option to continue to hold Units
or separate their Units into the component securities. Holders will need to have their brokers contact our transfer agent in order to
separate the Units into Class A ordinary shares and public warrants. Additionally, the Units will automatically separate into their component
parts and will not be traded after completion of our initial business combination. No fractional public warrants are issued upon separation
of the Units and only whole public warrants trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Private Placement Units</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each private placement unit consists of one Class
A ordinary share and one-half of one private placement warrant. Each whole private placement warrant entitles the holder thereof to purchase
one Class A ordinary share at a price of $11.50 per share, subject to adjustment as provided herein, and only whole warrants are exercisable.
If we do not complete our initial business combination within 18 months from the closing of this offering or such earlier liquidation
date as our board of directors may approve, or during any Extension Period, subject to applicable law, the proceeds of the sale of the
private placement securities held in the trust account will be used to fund the redemption of our public shares, and the private placement
units will expire worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The private placement units (including the private
placement shares, the private placement warrants or private placement shares issuable upon exercise of such warrants) will not be transferable,
assignable or salable until 30 days after the completion of our initial business combination, subject to certain limited exceptions. Otherwise,
the private placement units are identical to the public units except that the private placement warrants will be entitled to registration
rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance transaction costs in connection
with an intended initial business combination, the Sponsor or an affiliate of the Sponsor or certain of our officers and directors may,
but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into units at a price of
$10.00 per unit at the option of the lender. The units would be identical to the private placement units, subject to certain limited exceptions
as described in this prospectus. The terms of such loans, if any, have not been determined and no written agreements exist with respect
to such loans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ordinary Shares</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Class A ordinary shareholders and Class B ordinary
shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as
a single class, except as required by law; provided, that, prior to our initial business combination, holders of our Class B ordinary
shares will have the right to appoint all of our directors and remove members of the board of directors for any reason, and holders of
our Class A ordinary shares will not be entitled to vote on the appointment of directors during such time; provided, however, that if
all of the founder shares are converted prior to the date of the initial business combination, the holders of our public shares will have
the right to vote on the election of directors. These provisions of our amended and restated memorandum and articles of association may
only be amended by a special resolution passed by a majority of at least 90% of our ordinary shares attending and voting in a general
meeting. Unless specified in the Companies Act, our amended and restated memorandum and articles of association or applicable stock exchange
rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our
shareholders (other than the appointment or removal of directors prior to our initial business combination), and, prior to our initial
business combination, the affirmative vote of a majority of our founder shares is required to approve the appointment or removal of directors.
Approval of certain actions will require a special resolution under Cayman Islands law and pursuant to our amended and restated memorandum
and articles of association; such actions include amending our amended and restated memorandum and articles of association and approving
a statutory merger or consolidation with another company. The members of our board of directors each generally serve a term of three years.
There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than 50% of the founder
shares voted for the appointment of directors can appoint all of the directors prior to our initial business combination. Our shareholders
are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.
Prior to our initial business combination, only holders of our founder shares have the right to vote on the appointment of directors.
Holders of our Public Shares are not entitled to vote on the appointment of directors during such time; provided, however, that if all
of the founder shares are converted prior to the date of the initial business combination, the holders of our public shares will have
the right to vote on the election of directors. In addition, prior to our initial business combination, holders of a majority of our founder
shares may remove a member of the board of directors for any reason. These provisions of our amended and restated memorandum and articles
of association may only be amended by a special resolution passed by at least 90% of our ordinary shares who attend and vote in a general
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because our amended and restated memorandum and articles of association
authorize the issuance of up to 200,000,000 Class A ordinary shares, if we were to enter into a business combination, we may (depending
on the terms of such a business combination) be required to increase the number of Class A ordinary shares which we are authorized to
issue at the same time as our shareholders vote on the business combination to the extent we seek shareholder approval in connection with
our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with corporate governance requirements
of The Nasdaq Global Market (&ldquo;Nasdaq&rdquo;), we are not required to hold an annual general meeting until one year after our first
fiscal year end following our listing on Nasdaq. There is no requirement under the Companies Act for us to hold annual or extraordinary
general meetings to appoint directors. We may not hold an annual general meeting prior to the consummation of our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide our public shareholders with the
opportunity to redeem, regardless of whether they abstain, vote for, or against, our initial business combination, all or a portion of
their Public Shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination,
including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares,
subject to the limitations described herein. The per-share amount we will distribute to investors who properly redeem their shares will
not be reduced by the deferred underwriting commissions we will pay to the underwriter. The redemption rights will include the requirement
that a beneficial owner must identify itself in order to validly redeem its shares. Our initial shareholders, directors and officers have
entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder
shares and Public Shares held by them in connection with the completion of our initial business combination or certain amendments to our
amended and restated memorandum and articles of association. Permitted transferees of our initial shareholders, directors or officers
will be subject to the same obligations with respect to their founder shares. The non-managing investors are not required to (i) hold
any Units, Class A ordinary shares or public warrants they may have purchased in our IPO or thereafter for any amount of time, (ii) vote
any Class A ordinary shares they may own at the applicable time in favor of our initial business combination or (iii) refrain from exercising
their right to redeem their Public Shares at the time of our initial business combination. The non-managing investors will have the same
rights to the funds held in the trust account with respect to the Class A ordinary shares underlying the Units they may have purchased
in our IPO as the rights afforded to our other public shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unlike many blank check companies that hold shareholder
votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of Public
Shares for cash upon completion of such initial business combinations even when a vote is not required by applicable law or stock exchange
listing requirements, if a shareholder vote is not required by applicable law or stock exchange listing requirements and we do not decide
to hold a shareholder vote for business or other reasons, we will, pursuant to our amended and restated memorandum and articles of association,
conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing
our initial business combination. Our amended and restated memorandum and articles of association require these tender offer documents
to contain substantially the same financial and other information about the initial business combination and the redemption rights as
is required under the SEC&rsquo;s proxy rules. If, however, a shareholder approval of the transaction is required by applicable law or
stock exchange listing requirements, or we decide to obtain shareholder approval for business or other reasons, we will, like many blank
check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender
offer rules. Our initial business combination must be approved by each of our Chairman, a majority of our board of directors, and a majority
of our independent directors. If we seek shareholder approval, we will complete our initial business combination only if we obtain the
approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who
attend and vote at a general meeting of the company. However, the participation of Sponsor, directors, officers, advisors or any of their
affiliates in privately-negotiated transactions, if any, could result in the approval of our initial business combination even if a majority
of our public shareholders vote, or indicate their intention to vote, against such business combination. For purposes of seeking approval
of the majority of our issued and outstanding ordinary shares, non-votes will have no effect on the approval of our initial business combination
once a quorum is obtained. We intend to give not less than 10 days nor more than 60 days prior written notice of any such meeting, if
required, at which a vote shall be taken to approve our initial business combination. These quorum and voting thresholds, and the voting
agreements of our initial shareholders, may make it more likely that we will consummate our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &ldquo;group&rdquo; (as defined under
Section 13 of the&nbsp;Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the
ordinary shares sold in our IPO without our prior consent, which we refer to as the &ldquo;Excess Shares&rdquo;. However, we would not
be restricting our shareholders&rsquo; ability to vote all of their shares (including Excess Shares) for or against our initial business
combination. Our shareholders&rsquo; inability to redeem the Excess Shares will reduce their influence over our ability to complete our
initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares on
the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we complete
our initial business combination. As a result, such shareholders will continue to hold that number of shares exceeding 15% and, in order
to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we seek shareholder approval in connection
with our initial business combination, our initial shareholders have agreed (and their permitted transferees will agree), pursuant to
the terms of a letter agreement entered into with us, to vote their founder shares and any Public Shares held by them in favor of our
initial business combination. Our directors and officers have also entered into the letter agreement, imposing similar obligations on
them with respect to Public Shares acquired by them, if any. Additionally, each public shareholder may elect to redeem its Public Shares
without voting and, if they do vote, irrespective of whether they vote for or against the proposed transaction. The non-managing investors
are not required to (i) hold any Units, Class A ordinary shares or public warrants they may have purchased in our IPO or thereafter for
any amount of time, (ii) vote any Class A ordinary shares they may own at the applicable time in favor of our initial business combination
or (iii) refrain from exercising their right to redeem their Public Shares at the time of our initial business combination. The non-managing
investors will have the same rights to the funds held in the trust account with respect to the Class A ordinary shares underlying the
Units they may have purchased in our IPO as the rights afforded to our other public shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our amended and restated memorandum
and articles of association, if we have not completed our initial business combination within 18 months from the closing of our IPO or
such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law, we will
(1) cease all operations except for the purpose of winding up, (2) as promptly as reasonably possible but not more than 10 business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust
account, including interest earned on the funds held in the trust account, which interest shall be net of taxes payable and up to $100,000
of interest to pay dissolution expenses and not previously released to us to pay our taxes, if any, divided by the number of then outstanding
Public Shares, which redemption will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to receive
further liquidating distributions, if any), subject to applicable law, and (3) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our
obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Our initial shareholders
have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from
the trust account with respect to their founder shares and private placement shares if we fail to complete our initial business combination
within 18 months from the closing of our IPO or such earlier liquidation date as our board of directors may approve, or during any Extension
Period, subject to applicable law. However, if our initial shareholders, directors acquire Public Shares, they will be entitled to liquidating
distributions from the trust account with respect to such Public Shares if we fail to complete our initial business combination within
the prescribed time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to complete an initial business
combination within the 18-month period, we may seek an amendment to our amended and restated memorandum and articles of association to
extend the period of time we have to complete an initial business combination beyond 18 months. Any amendment of our amended and restated
memorandum and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands law,
meaning that such an amendment must be approved by holders of at least two-thirds of our ordinary shares who attend and vote (whether
in person or by proxy) at a general meeting of the company. If we seek shareholder approval to extend the initial 18-month period in which
to complete an initial business combination to a later date, we will offer our public shareholders the right to have their public ordinary
shares redeemed for a pro rata share of the aggregate amount then on deposit in the trust account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a liquidation, dissolution or
winding up of the company after a business combination, our shareholders at such time will be entitled to share ratably in all assets
remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any,
having preference over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund
provisions applicable to the ordinary shares, except that we will provide our shareholders with the opportunity to redeem their Public
Shares, regardless of whether they abstain, vote for, or against, our initial business combination, for cash equal to their pro rata share
of the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable), divided
by the number of then issued and outstanding public shares, upon the completion of our initial business combination, subject to the limitations
described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restricted private placement shares are
held by the Sponsor and will be transferred to the non-managing investors (or their designees) only upon the consummation of an
initial business combination. Other than such permitted transfer, the restricted private placement shares are subject to transfer
restrictions for 90 days following our initial business combination and are entitled to the registration rights. <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Founder Shares</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The founder shares are designated as Class B ordinary
shares and are identical to the Class A ordinary shares included in the Units sold in our IPO, and holders of founder shares have the
same shareholder rights as public shareholders, except that: (1) prior to our initial business combination, only holders of the founder
shares have the right to vote on the appointment of directors and holders of a majority of our founder shares may remove a member of the
board of directors for any reason; provided, however, that if all of the founder shares are converted prior to the date of the initial
business combination, the holders of our public shares will have the right to vote on the election of directors; (2) founder shares are
subject to certain transfer restrictions, as described in more detail below; (3) our initial shareholders, directors and officers have
entered into a letter agreement with us, pursuant to which they have agreed to waive: (i) their redemption rights with respect to any
founder shares, private placement shares, restricted private placement shares and Public Shares held by them, as applicable, in connection
with the completion of our initial business combination; (ii) their redemption rights with respect to any founder shares and Public Shares
held by them in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify
the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of
our Public Shares if we do not complete our initial business combination within 18 months from the closing of our IPO or such earlier
liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law or (B) with respect
to any other provision relating to shareholders&rsquo; rights or pre-initial business combination activity; and (iii) their rights to
liquidating distributions from the trust account with respect to any founder shares, private placement shares and restricted private placement
shares they hold if we fail to complete our initial business combination within 18 months from the closing of our IPO or such earlier
liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law (although they will
be entitled to liquidating distributions from the trust account with respect to any Public Shares they hold if we fail to complete our
initial business combination within the prescribed time frame); (4) the founder shares will automatically convert into our Class A ordinary
shares at the time of our initial business combination, or earlier at the option of the holder, on a one-for-one basis, as described in
more detail below; and (5) the founder shares and restricted private placement shares are entitled to registration rights. If we submit
our initial business combination to our public shareholders for a vote, our initial shareholders have agreed (and their permitted transferees
will agree), pursuant to the terms of a letter agreement entered into with us, to vote their founder shares, private placement shares,
restricted private placement shares and any Public Shares held by them purchased during or after our IPO in favor of our initial business
combination. The non-managing investors are not required to (i) hold any Units, Class A ordinary shares or public warrants they may have
purchased in our IPO or thereafter for any amount of time, (ii) vote any Class A ordinary shares they may own at the applicable time in
favor of our initial business combination or (iii) refrain from exercising their right to redeem their Public Shares at the time of our
initial business combination. The non-managing investors will have the same rights to the funds held in the trust account with respect
to the Class A ordinary shares underlying the Units they may have purchased in our IPO as the rights afforded to our other public shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Class B ordinary shares will automatically
convert into Class A ordinary shares at the time of our initial business combination, or earlier at the option of the holder, on a one-for-one
basis, subject to adjustment for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like,
and subject to further adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With certain limited exceptions, the founder shares
are not transferable, assignable or salable until the earlier of: (A) one year after the completion of our initial business combination;
and (B) subsequent to our initial business combination (x) if the last reported sale price of our Class A ordinary shares equals or exceeds
$12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like)
for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination or (y) the
date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our
public shareholders having the right to exchange their ordinary shares for cash, securities or other property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except in certain limited circumstances, no member
of Sponsor (including the non-managing investors) may Transfer all or any portion of its membership interests in Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Register of Members</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Cayman Islands law, we must keep a register
of members and there shall be entered therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered
    as paid, on the shares of each member and the voting rights of the shares of each member;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    voting rights are attached to the share in issue;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which the name of any person was entered on the register as a member; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">the date on which any person ceased to be a member.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Cayman Islands law, the register of members
of our company is prima facie evidence of the matters set out therein (i.e. the register of members will raise a presumption of fact on
the matters referred to above unless rebutted) and a person who has agreed to become a member and who is registered in the register of
members is deemed, as a matter of Cayman Islands law, to be a member. Furthermore, under the Companies Act, the registration of any person
in the register of members as holder of any shares is prima face evidence of such person having legal title to the shares as set against
its name in the register of members. Upon the closing of our IPO, the register of members was updated to reflect the issue of shares by
us. Once our register of members was updated, the shareholders recorded in the register of members shall be deemed to have legal title
to the shares set against their name. However, there are certain limited circumstances where an application may be made to a Cayman Islands
court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has
the power to order that the register of members maintained by a company should be rectified where it considers that the register of members
does not reflect the correct legal position. If an application for an order for rectification of the register of members were made in
respect of our ordinary shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preference Shares</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association authorize 1,000,000 preference shares and provide that preference shares may be issued from time to time in one or more
series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating,
optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series.
Our board of directors is able to, without shareholder approval, issue preference shares with voting and other rights that could adversely
affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. The ability of our
board of directors to issue preference shares without shareholder approval could have the effect of delaying, deferring or preventing
a change of control of us or the removal of existing management. We have no preference shares issued and outstanding at the date hereof.
Although we do not currently intend to issue any preference shares, we cannot assure you that we will not do so in the future. No preference
shares were issued or registered in our IPO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Warrants</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Public Shareholders&rsquo; Warrants</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each whole public warrant entitles the registered
holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing
on the later of 30 days after the completion of our initial business combination and 12 months from the closing of our IPO, except as
described below. Pursuant to the warrant agreement, a public warrant holder may exercise its warrants only for a whole number of Class
A ordinary shares. This means only a whole public warrant may be exercised at a given time by a public warrant holder. No fractional public
warrants are issued upon separation of the Units and only whole public warrants trade. The public warrants will expire seven years after
the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not be obligated to deliver any Class
A ordinary shares pursuant to the exercise of a public warrant and will have no obligation to settle such public warrant exercise unless
a registration statement under the&nbsp;Securities Act&nbsp;covering the issuance of the Class A ordinary shares issuable upon exercise
of the public warrants is then effective and a current prospectus relating thereto is current, subject to our satisfying our obligations
described below with respect to registration, or a valid exemption from registration is available, including in connection with a cashless
exercise permitted as described. Except as described below, no public warrant will be exercisable for cash or on a cashless basis, and
we will not be obligated to issue any shares to holders seeking to exercise their public warrants, unless the issuance of the shares upon
such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a public warrant, the holder
of such public warrant will not be entitled to exercise such warrant and such public warrant may have no value and expire worthless. In
the event that a registration statement is not effective for the exercised public warrants, the purchaser of a Unit containing such public
warrant will have paid the full purchase price for the Unit solely for the Class A ordinary share underlying such Unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have agreed that as soon as practicable, but
in no event later than 15 business days, after the closing of our initial business combination, we will use our commercially reasonable
efforts to file with the SEC a registration statement covering the issuance, under the&nbsp;Securities Act, of the Class A ordinary shares
issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within
60 business days after the closing of our initial business combination and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a registration statement covering the Class
A ordinary shares issuable upon exercise of the public warrants does not become effective within 60 business days after the closing of
our initial business combination, holders of public warrants will have the right, during any period thereafter when there is no such effective
registration statement, to exercise the public warrants on a cashless basis. Additionally, if, at the time that a public warrant is exercised,
if our Class A ordinary shares are not listed on a national securities exchange such that they satisfy the definition of a &ldquo;covered
security&rdquo; under Section 18(b)(1) of the&nbsp;Securities Act, we may, at our option, require holders of public warrants who exercise
their warrants to do so on a &ldquo;cashless basis&rdquo; in accordance with Section 3(a)(9) of the&nbsp;Securities Act&nbsp;and, in the
event we so elect, we will not be required to file or maintain in effect a registration statement, but will use our commercially reasonable
efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a cashless exercise pursuant to
the preceding paragraph, each holder would pay the exercise price by surrendering the public warrants for that number of Class A ordinary
shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied
by the excess of the &rdquo; fair market value&rdquo; (defined below) less the exercise price of the warrants by (y) the fair market value.
The &rdquo; fair market value&rdquo; as used in the preceding sentence shall mean the volume weighted average price of the Class A ordinary
shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Redemption of public warrants.</I>&nbsp;Once
the public warrants become exercisable, we may redeem the public warrants:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">at a price of $0.01 per public warrant;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than 30 days&rsquo; prior written notice of redemption to each public warrant holder; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted to the number of shares
    issuable upon exercise or the exercise price of a warrant as described under the heading &ldquo;- Anti-dilution Adjustments&rdquo;)
    for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice
    of redemption to the public warrant holders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not redeem the public warrants as described
above unless a registration statement under the&nbsp;Securities Act&nbsp;covering the issuance of the Class A ordinary shares issuable
upon exercise of the public warrants is then effective and a current prospectus relating to those Class A ordinary shares is available
throughout the 30-day redemption period or we have elected to require the exercise of the public warrants on a cashless basis as described
below. If and when the public warrants become redeemable by us, we may exercise our redemption right even if we are unable to register
or qualify the underlying securities for sale under all applicable state securities laws. As a result, we may redeem warrants even if
the holders are otherwise unable to exercise their warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we call the warrants for redemption as described
in this paragraph, our management will have the option to require any holder that wishes to exercise his, her or its warrant following
the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise price
by surrendering the public warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product
of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the &ldquo;fair market value&rdquo; less
the exercise price of the warrants by (y) the fair market value. The &ldquo;fair market value&rdquo; as used in the preceding sentence
shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to
the date on which the notice of redemption is sent to the holders of the public warrants. If our management takes advantage of this option,
the notice of redemption will contain the information necessary to calculate the number of Class A ordinary shares to be received upon
exercise of the warrants, including the &ldquo;fair market value&rdquo; in such case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have established the $18.00 per share (as adjusted)
redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the
public warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the public warrants, each
public warrant holder will be entitled to exercise his, her or its public warrant prior to the scheduled redemption date. However, the
price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted to the number of shares issuable
upon exercise or the exercise price of a public warrant as described under the heading &ldquo;- Anti-dilution Adjustments&rdquo;) as well
as the $11.50 public warrant exercise price after the redemption notice is issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Redemption procedures and cashless exercise.</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder of a public warrant may notify us in
writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such public warrant,
to the extent that after giving effect to such exercise, such person (together with such person&rsquo;s affiliates), to the warrant agent&rsquo;s
actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A ordinary shares issued
and outstanding immediately after giving effect to such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Anti-dilution Adjustments.</I>&nbsp;If the
number of issued and outstanding Class A ordinary shares is increased by a capitalization or share dividend payable in Class A ordinary
shares, or by a split-up of Class A ordinary shares or other similar event, then, on the effective date of such capitalization or share
dividend, split-up or similar event, the number of Class A ordinary shares issuable on exercise of each public warrant will be increased
in proportion to such increase in the issued and outstanding Class A ordinary shares. A rights offering made to all holders of Class A
ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the &ldquo;historical fair market value&rdquo;
(as defined below) will be deemed a share dividend of a number of Class A ordinary shares equal to the product of (1) the number of Class
A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that
are convertible into or exercisable for Class A ordinary shares) and (2) one minus the quotient of (x) the price per Class A ordinary
share paid in such rights offering and (y) the historical fair market value. For these purposes, (1) if the rights offering is for securities
convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will
be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion
and (2) &ldquo;historical fair market value&rdquo; means the volume weighted average price of Class A ordinary shares during the 10 trading
day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on the applicable exchange or
in the applicable market, regular way, without the right to receive such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if we, at any time while the public
warrants are outstanding and unexpired, pay to all of the holders of Class A ordinary shares a dividend or make a distribution in cash,
securities or other assets to the holders of Class A ordinary shares on account of such Class A ordinary shares (or other securities into
which the public warrants are convertible), other than (a) as described above, (b) any cash dividends or cash distributions which, when
combined on a per share basis with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day
period ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (as adjusted for share sub-divisions,
share dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) but only with respect
to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption
rights of the holders of Class A ordinary shares in connection with a proposed initial business combination, (d) to satisfy the redemption
rights of the holders of Class A ordinary shares in connection with a shareholder vote to amend our amended and restated memorandum and
articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business
combination or to redeem 100% of our Public Shares if we do not complete our initial business combination within 18 months from the closing
of our IPO or such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable
law or (B) with respect to any other provision relating to shareholders&rsquo; rights or pre-initial business combination activity, or
(C) in connection with the redemption of our Public Shares upon our failure to complete our initial business combination, then the public
warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the
fair market value of any securities or other assets paid on each Class A ordinary share in respect of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the number of issued and outstanding Class
A ordinary shares is decreased by a consolidation, combination, reverse share subdivision or reclassification of Class A ordinary shares
or other similar event, then, on the effective date of such consolidation, combination, reverse share sub-division, reclassification or
similar event, the number of Class A ordinary shares issuable on exercise of each public warrant will be decreased in proportion to such
decrease in issued and outstanding Class A ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever the number of Class A ordinary shares
purchasable upon the exercise of the public warrants is adjusted, as described above, the public warrant exercise price will be adjusted
by multiplying the public warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be
the number of Class A ordinary shares purchasable upon the exercise of the public warrants immediately prior to such adjustment and (y)
the denominator of which will be the number of Class A ordinary shares so purchasable immediately thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if (x) we issue additional ordinary
shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at
an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined
in good faith by our board of directors and, in the case of any such issuance to either of our Sponsor or its affiliates, without taking
into account any founder shares held by our Sponsor or such affiliates, as applicable, prior to such issuance) (the &ldquo;Newly Issued
Price&rdquo;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of our initial business combination on the date of the completion of our initial business combination
(net of redemptions), and (z) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period
starting on the trading day prior to the day on which we consummate our initial business combination (such price, the &ldquo;Market Value&rdquo;)
is below $9.20 per share, the exercise price of the public warrants will be adjusted (to the nearest cent) to be equal to 115% of the
higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger prices described above under &ldquo;- Redemption
of warrants when the price per Class A ordinary share equals or exceeds $18.00&rdquo; and &ldquo;- Redemption of public warrants&rdquo;
will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In case of any reclassification or reorganization of the issued and
outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A ordinary shares),
or in the case of any merger or consolidation of us with or into another corporation (other than a merger or consolidation in which we
are the continuing corporation and that does not result in any reclassification or reorganization of our issued and outstanding Class
A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as
an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the public warrants will thereafter
have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the public warrants and in lieu
of our Class A ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby,
the kind and amount of shares, stock or other equity securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the public warrants would have
received if such holder had exercised their public warrants immediately prior to such event. However, if such holders were entitled to
exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such merger or consolidation,
then the kind and amount of securities, cash or other assets for which each public warrant will become exercisable will be deemed to be
the weighted average of the kind and amount received per share by such holders in such merger or consolidation that affirmatively make
such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange
or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in the
company&rsquo;s amended and restated memorandum and articles of association or as a result of the redemption of Class A ordinary shares
by the company if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances
in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning
of&nbsp;Rule 13d-5(b)(1) under the&nbsp;Exchange Act) of which such maker is a part, and together with any affiliate or associate of such
maker (within the meaning of&nbsp;Rule 12b-2&nbsp;under the&nbsp;Exchange Act) and any members of any such group of which any such affiliate
or associate is a part, own beneficially (within the meaning of&nbsp;Rule 13d-3&nbsp;under the&nbsp;Exchange Act) more than 50% of the
issued and outstanding Class A ordinary shares, the holder of a warrant will be entitled to receive the highest amount of cash, securities
or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant
prior to the expiration of such tender or exchange offer, accepted such offer and all of the Class A ordinary shares held by such holder
had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such tender or
exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement. Additionally, if less than
70% of the consideration receivable by the holders of Class A ordinary shares in such a transaction is payable in the form of ordinary
shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter
market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly
exercises the public warrant within 30 days following public disclosure of such transaction, the public warrant exercise price will be
reduced as specified in the warrant agreement based on the per share consideration minus Black-Scholes Warrant Value (as defined in the
warrant agreement) of the public warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The public warrants were issued in registered
form under the warrant agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and us. The warrant agreement
provides that (a) the terms of the public warrants may be amended without the consent of any holder for the purpose of (i) curing any
ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the
public warrants and the warrant agreement set forth in the prospectus related to our IPO, or defective provision (ii) removing or reducing
the Company&rsquo;s ability to redeem the public warrants or (iii) adding or changing any provisions with respect to matters or questions
arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem
to not adversely affect the rights of the registered holders of the public warrants under the warrant agreement in any material respect,
(b) the terms of the warrants may be amended with the vote or written consent of at least 50% of the then outstanding public warrants
to allow for the warrants to be, or continue to be, as applicable, classified as equity in our financial statements and (c) all other
modifications or amendments to our warrant agreement with respect to (i) the public warrants require the vote or written consent of holders
of at least 50% of the then outstanding public warrants, and (ii) the private placement warrants (including, for the avoidance of doubt,
the forfeiture or cancellation of any private placement warrants) require the vote or written consent of holders of at least 50% of the
then outstanding private placement warrants. You should review a copy of the warrant agreement for a complete description of the terms
and conditions applicable to the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The public warrant
holders do not have the rights or privileges of holders of Class A ordinary shares and any voting rights until they exercise their public
warrants and receive Class A ordinary shares. After the issuance of Class A ordinary shares upon exercise of the public warrants, each
holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional public warrants are issued upon
separation of the Units and only whole public warrants trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have agreed that, subject to applicable law, any action, proceeding
or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State
of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction,
which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the&nbsp;Securities
Act&nbsp;but does not apply to claims under the&nbsp;Exchange Act&nbsp;or any claim for which the federal district courts of the United
States of America are the sole and exclusive forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dividends</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating
and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness in connection with
our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Transfer Agent and Warrant Agent</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent for our ordinary shares and
warrant agent for our warrants is Continental Stock Transfer &amp; Trust Company. We have agreed to indemnify Continental Stock Transfer
&amp; Trust Company in its roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and
employees against all liabilities, including judgments, costs and reasonable counsel fees that may arise out of acts performed or omitted
for its activities in that capacity, except for any liability due to any gross negligence, willful misconduct or bad faith of the indemnified
person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Differences in Corporate Law</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cayman Islands companies are governed by the Companies
Act. The Companies Act is modeled on English Law but does not follow recent English Law statutory enactments, and differs from laws applicable
to United States corporations and their shareholders. Set forth below is a summary of the material differences between the provisions
of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mergers and Similar Arrangements.</I>&nbsp;In
certain circumstances, the Companies Act allows for mergers or consolidations between two Cayman Islands companies, or between a Cayman
Islands exempted company and a company incorporated in another jurisdiction (provided that is facilitated by the laws of that other jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the merger or consolidation is between two
Cayman Islands companies, the directors of each company must approve a written plan of merger or consolidation containing certain prescribed
information. That plan of merger or consolidation must then be authorized by either (a) a special resolution (usually a majority of 662&#8725;3%
in value who attend and vote at a general meeting) of the shareholders of each company; or (b) such other authorization, if any, as may
be specified in such constituent company&rsquo;s articles of association. No shareholder resolution is required for a merger between a
parent company (i.e. a company that owns at least 90% of the issued shares of each class in a subsidiary company) and its subsidiary company.
The consent of each holder of a fixed or floating security interest of a constituent company must be obtained, unless the court waives
such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Companies Act (which includes
certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the merger or consolidation involves a foreign
company, the procedure is similar, save that with respect to the foreign company, the directors of the Cayman Islands exempted company
are required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements set out
below have been met: (1) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign
company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of
those constitutional documents have been or will be complied with; (2) that no petition or other similar proceeding has been filed and
remains outstanding or order made or resolution adopted to wind up or liquidate the foreign company in any jurisdictions; (3) that no
receiver, trustee, administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign
company, its affairs or its property or any part thereof; and (4) that no scheme, order, compromise or other similar arrangement has been
entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the surviving company is the Cayman Islands
exempted company, the directors of the Cayman Islands exempted company are further required to make a declaration to the effect that,
having made due enquiry, they are of the opinion that the requirements set out below have been met: (1) that the foreign company is able
to pay its debts as they fall due and that the merger or consolidated is bona fide and not intended to defraud unsecured creditors of
the foreign company; (2) that in respect of the transfer of any security interest granted by the foreign company to the surviving or consolidated
company (a) consent or approval to the transfer has been obtained, released or waived; (b) the transfer is permitted by and has been approved
in accordance with the constitutional documents of the foreign company; and (c) the laws of the jurisdiction of the foreign company with
respect to the transfer have been or will be complied with; (3) that the foreign company will, upon the merger or consolidation becoming
effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction; and (4) that there is no
other reason why it would be against the public interest to permit the merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the above procedures are adopted, the Companies
Act provides for a right of dissenting shareholders to be paid a payment of the fair value of his or her shares upon their dissenting
to the merger or consolidation if they follow a prescribed procedure. In essence, that procedure is as follows: (a) the shareholder must
give his or her written objection to the merger or consolidation to the constituent company before the vote on the merger or consolidation,
including a statement that the shareholder proposes to demand payment for his or her shares if the merger or consolidation is authorized
by the vote; (b) within 20 days following the date on which the merger or consolidation is approved by the shareholders, the constituent
company must give written notice to each shareholder who made a written objection; (c) a shareholder must within 20 days following receipt
of such notice from the constituent company, give the constituent company a written notice of his or her intention to dissent including,
among other details, a demand for payment of the fair value of his or her shares; (d) within seven days following the date of the expiration
of the period set out in paragraph (b) above or seven days following the date on which the plan of merger or consolidation is filed, whichever
is later, the constituent company, the surviving company or the consolidated company must make a written offer to each dissenting shareholder
to purchase his or her shares at a price that the company determines is the fair value and if the company and the shareholder agrees to
the price within 30 days following the date on which the offer was made, the company must pay the shareholder such amount; and (e) if
the company and the shareholder fails to agree to a price within such 30-day period, within 20 days following the date on which such 30-day
period expires, the company must (and any dissenting shareholder may) file a petition with the Grand Court of the Cayman Islands to determine
the fair value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements
as to the fair value of their shares have not been reached by the company. At the hearing of that petition, the court has the power to
determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon the amount determined
to be the fair value. Any dissenting shareholder whose name appears on the list filed by the company may participate fully in all proceedings
until the determination of fair value is reached. These rights of a dissenting shareholder are not to be available in certain circumstances,
for example, to dissenters holding shares of any class in respect of which an open market exists on a recognized stock exchange or recognized
interdealer quotation system at the relevant date and where the consideration for such shares to be contributed are shares of any company
listed on a national securities exchange or shares of the surviving or consolidated company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, Cayman Islands law also has separate
statutory provisions that facilitate the reconstruction or amalgamation of companies in certain circumstances. Such schemes of arrangement
will generally be more suited for complex mergers or other transactions involving widely held companies. In the Cayman Islands, these
are commonly referred to as a &ldquo;scheme of arrangement&rdquo;, which may be tantamount to a merger. The procedures of a scheme of
arrangement are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United
States. For a shareholder scheme, the arrangement in question must be approved by each class of shareholders with whom the arrangement
is to be made who represent three-fourths in value of each such class of shareholders or creditors, and for a creditor scheme, the arrangement
in question must be approved by a majority in number of each class of creditors with whom the arrangement is to be made and who must in
addition represent three-fourths in value of each such class of creditors, in each case, that are present and voting either in person
or by proxy at a general meeting summoned for that purpose. The convening of the meetings and subsequently the terms of the arrangement
must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder would have the right to express to the court
the view that the transaction should not be approved, the court can be expected to approve the arrangement if it is satisfied that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">we are not proposing to act illegally or beyond the scope of
our corporate authority and we have complied with the statutory provisions as to majority vote;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the shareholders have been fairly represented at the meeting
in question;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the arrangement is such as a business-person would reasonably
approve; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;<FONT STYLE="font-size: 10pt"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the arrangement is not one that
would more properly be sanctioned under some other provision of the Companies Act or that would amount to a &ldquo;fraud on the minority.&rdquo;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a scheme of arrangement or takeover offer (as
described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily
be available to dissenting shareholders of U.S. corporations, providing rights to receive payment in cash for the judicially determined
value of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Squeeze-out Provisions.</I>&nbsp;When a takeover
offer is made and accepted by holders of 90% of the shares to whom the offer relates within four months, the offeror may, within a two-month
period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the
Grand Court of the Cayman Islands, but this is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable
treatment of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, transactions similar to a merger, reconstruction
and/or an amalgamation may in some circumstances be achieved through other means to these statutory provisions, such as a share capital
exchange, asset acquisition or control, through contractual arrangements, of an operating business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Shareholders&rsquo; Suits.</I>&nbsp;Our Cayman
Islands legal counsel, is not aware of any reported class action having been brought in a Cayman Islands court. Derivative actions have
been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability of such actions. In most cases,
we will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our directors or
officers usually may not be brought by a shareholder. However, based both on Cayman Islands authorities and on English authorities, which
would in all likelihood be of persuasive authority and applied by a court in the Cayman Islands, exceptions to the foregoing principle
apply in circumstances in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    company is acting, or proposing to act, illegally or beyond the scope of its authority;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of
    votes that have actually been obtained; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    who control the company are perpetrating a &ldquo;fraud on the minority.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shareholder may have a direct right of action
against us where the individual rights of that shareholder have been infringed or are about to be infringed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Enforcement of Civil Liabilities.</I>&nbsp;The
Cayman Islands has a different body of securities laws as compared to the United States and provides less protection to investors. Additionally,
Cayman Islands companies may not have standing to sue before the federal courts of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The courts of the Cayman Islands are unlikely
(1) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the
federal securities laws of the United States or any state and (2) in original actions brought in the Cayman Islands, to impose liabilities
against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as
the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in
the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money
judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent
foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions
are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated
sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter,
impeachable on the grounds of fraud or obtained in a manner, and or be of a kind the enforcement of which is, contrary to natural justice
or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy).
A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Special Considerations for Exempted Companies.</I>&nbsp;We
are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies
and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands
may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary
company except for the exemptions and privileges listed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company does not have to file an annual return of
its shareholders with the Registrar of Companies;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company&rsquo;s register of members is not open
to inspection;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company does not have to hold an annual general
meeting;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company may issue shares with no par value;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company may obtain an undertaking against the imposition
of any future taxation (such undertakings are usually given for 20 years in the first instance);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company may register by way of continuation in another
jurisdiction and be deregistered in the Cayman Islands;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company may register as a limited duration company;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exempted company may register as a segregated portfolio company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used above, &ldquo;limited liability&rdquo;
means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in
exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other
circumstances in which a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Amended and Restated Memorandum and Articles
of Association</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association contain certain requirements and restrictions relating to our IPO that will apply to us until the completion of our initial
business combination. These provisions (other than amendments relating to provisions governing the appointment or removal of directors
prior to our initial business combination, which require the approval of a majority of at least 90% of our ordinary shares attending and
voting in a general meeting) cannot be amended without a special resolution. As a matter of Cayman Islands law, a resolution is deemed
to be a special resolution where it has been approved by either (1) holders of at least two-thirds (or any higher threshold specified
in a company&rsquo;s articles of association) of a company&rsquo;s ordinary shares who attend and vote at a general meeting for which
notice specifying the intention to propose the resolution as a special resolution has been given or (2) if so authorized by a company&rsquo;s
articles of association, by a unanimous written resolution of all of the company&rsquo;s shareholders. Other than as described above,
our amended and restated memorandum and articles of association provide that special resolutions must be approved either by holders of
at least two-thirds of our ordinary shares who attend and vote at a general meeting (i.e. the lowest threshold permissible under Cayman
Islands law) (other than amendments relating to provisions governing the appointment or removal of directors prior to our initial business
combination, which require the approval of a majority of at least 90% of our ordinary shares attending and voting in a general meeting),
or by a unanimous written resolution of all of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial shareholders may participate in any
vote to amend our amended and restated memorandum and articles of association and will have the discretion to vote in any manner they
choose. Specifically, our amended and restated memorandum and articles of association provide, among other things, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">if we have not completed our initial business combination within 18 months from the closing of our IPO or such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law, we will: (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released to us to pay our taxes, if any, divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">prior to our initial business combination, we may not issue additional ordinary shares that would entitle the holders thereof to (1) receive funds from the trust account or (2) vote as a class with our Public Shares on any initial business combination;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">although we do not intend to enter into a business combination with a target business that is affiliated with our Sponsor or our directors or our officers, or the non-managing investors, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent and disinterested directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm that such a business combination is fair to our company from a financial point of view;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">if a shareholder vote on our initial business combination is not required by law and we do not decide to hold a shareholder vote for business or other reasons, we will offer to redeem our Public Shares pursuant to&nbsp;Rule 13e-4&nbsp;and Regulation 14E of the&nbsp;Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the&nbsp;Exchange Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">as long as our securities are listed on Nasdaq, our initial business combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in trust (excluding any deferred underwriter fees and taxes payable on the income earned on the trust account);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">if our shareholders approve an amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 18 months from the closing of this offering or such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law or (B) with respect to any other provision relating to shareholders&rsquo; rights or pre-initial business combination activity, we will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of taxes payable) and not previously released to us to pay our taxes, if any, divided by the number of then issued and outstanding public shares; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">we will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Companies Act permits a company incorporated
in the Cayman Islands to amend its memorandum and articles of association with the approval of the holders of at least two-thirds of such
company&rsquo;s issued and outstanding ordinary shares attending and voting at a general meeting. A company&rsquo;s articles of association
may specify that the approval of a higher majority is required but, provided the approval of the required majority is obtained, any Cayman
Islands exempted company may amend its memorandum and articles of association regardless of whether its memorandum and articles of association
provide otherwise. Accordingly, although we could amend any of the provisions relating to our IPO, structure and business plan which are
contained in our amended and restated memorandum and articles of association, we view all of these provisions as binding obligations to
our shareholders and neither we, nor our directors or officers, will take any action to amend or waive any of these provisions unless
we provide dissenting public shareholders with the opportunity to redeem their Public Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Anti-Money Laundering&thinsp;-&thinsp;Cayman
Islands</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any person in the Cayman Islands knows or suspects
or has reasonable grounds for knowing or suspecting that another person is engaged in criminal conduct or money laundering or is involved
with terrorism or terrorist financing and property and the information for that knowledge or suspicion came to their attention in the
course of business in the regulated sector, or other trade, profession, business or employment, the person will be required to report
such knowledge or suspicion to (1) the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Act (As
Revised) of the Cayman Islands if the disclosure relates to criminal conduct or money laundering or (2) a police officer of the rank of
constable or higher, or the Financial Reporting Authority, pursuant to the Terrorism Act (As Revised) of the Cayman Islands, if the disclosure
relates to involvement with terrorism or terrorist financing and property. Such a report shall not be treated as a breach of confidence
or of any restriction upon the disclosure of information imposed by any enactment or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Data Protection&thinsp;-&thinsp;Cayman Islands</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have certain duties under the Data Protection
Act (As Revised) of the Cayman Islands (the &ldquo;DPA&rdquo;) based on internationally accepted principles of data privacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this subsection, &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our&rdquo; and the &ldquo;Company&rdquo; refers to GP-Act III Acquisition Corp. or our affiliates and/or delegates, except where
the context requires otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Privacy Notice</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Introduction</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This privacy notice puts our shareholders on notice
that through your investment in the Company you will provide us with certain personal information which constitutes personal data within
the meaning of the DPA (&ldquo;personal data&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Investor Data</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will collect, use, disclose, retain and secure
personal data to the extent reasonably required only and within the parameters that could be reasonably expected during the normal course
of business. We will only process, disclose, transfer or retain personal data to the extent legitimately required to conduct our activities
of on an ongoing basis or to comply with legal and regulatory obligations to which we are subject. We will only transfer personal data
in accordance with the requirements of the DPA, and will apply appropriate technical and organizational information security measures
designed to protect against unauthorized or unlawful processing of the personal data and against the accidental loss, destruction or damage
to the personal data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our use of this personal data, we will be characterized
as a &ldquo;data controller&rdquo; for the purposes of the DPA, while our affiliates and service providers who may receive this personal
data from us in the conduct of our activities may either act as our &ldquo;data processors&rdquo; for the purposes of the DPA or may process
personal information for their own lawful purposes in connection with services provided to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may also obtain personal data from other
public sources. Personal data includes, without limitation, the following information relating to a shareholder and/or any individuals
connected with a shareholder as an investor: name, residential address, email address, contact details, corporate contact information,
signature, nationality, place of birth, date of birth, tax identification, credit history, correspondence records, passport number, bank
account details, source of funds details and details relating to the shareholder&rsquo;s investment activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Who this Affects</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a natural person, this will affect
you directly. If you are a corporate investor (including, for these purposes, legal arrangements such as trusts or exempted limited partnerships)
that provides us with personal data on individuals connected to you for any reason in relation your investment in the Company, this will
be relevant for those individuals and you should transmit the content of this Privacy Notice to such individuals or otherwise advise them
of its content.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How the Company May Use a Shareholder&rsquo;s
Personal Data</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company, as the data controller, may collect,
store and use personal data for lawful purposes, including, in particular:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">where this is necessary for the performance of our rights and
obligations under any purchase agreements;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">where this is necessary for compliance with a legal and regulatory
obligation to which we are subject (such as compliance with anti-money&nbsp;laundering and FATCA/CRS requirements); &copy;/or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">where this is necessary for the purposes of our legitimate interests
and such interests are not overridden by your interests, fundamental rights or freedoms.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Should we wish to use personal data for other
specific purposes (including, if applicable, any purpose that requires your consent), we will contact you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Why We May Transfer Your Personal Data</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In certain circumstances we may be legally obliged
to share personal data and other information with respect to your shareholding with the relevant regulatory authorities such as the Cayman
Islands Monetary Authority or the Tax Information Authority. They, in turn, may exchange this information with foreign authorities, including
tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate disclosing personal data to persons
who provide services to us and their respective affiliates (which may include certain entities located outside the US, the Cayman Islands
or the European Economic Area), who will process your personal data on our behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Data Protection Measures We Take</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any transfer of personal data by us or our duly
authorized affiliates and/or delegates outside of the Cayman Islands shall be in accordance with the requirements of the DPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and our duly authorized affiliates and/or delegates
shall apply appropriate technical and organizational information security measures designed to protect against unauthorized or unlawful
processing of personal data, and against accidental loss or destruction of, or damage to, personal data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We shall notify you of any personal data breach
that is reasonably likely to result in a risk to your interests, fundamental rights or freedoms or those data subjects to whom the relevant
personal data relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Anti-Takeover Provisions of Our Amended
and Restated Memorandum and Articles of Association</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated memorandum and articles
of association provide that our board of directors will be classified into three classes of directors. As a result, in most circumstances,
a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual general meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our authorized but unissued ordinary shares and
preference shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes,
including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued
and unreserved ordinary shares and preference shares could render more difficult or discourage an attempt to obtain control of us by means
of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Listing of Securities</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Class A ordinary shares, Units and public
warrants are listed on Nasdaq under the symbols &ldquo;PLMK,&rdquo; &ldquo;PLMKU&rdquo; and &ldquo;PLMKW,&rdquo; respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19
<SEQUENCE>3
<FILENAME>ea023531601ex19_plumacq4.htm
<DESCRIPTION>INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 19</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLUM ACQUISITION CORP. IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Insider
Trading POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Plum Acquisition Corp. IV
(the &ldquo;<U>Company</U>&rdquo;) has adopted the following policy and procedures for securities trading by the Company and the Company&rsquo;s
directors, employees and other individuals (our &ldquo;<U>Insider Trading Policy</U>&rdquo;). Our Insider Trading Policy is intended to
prevent the misuse of material nonpublic information, insider trading in securities, and the severe consequences associated with violations
of insider trading laws. It is your obligation to review, understand, and comply with this Insider Trading Policy and applicable laws.
Our Board of Directors has approved this Insider Trading Policy, and we have appointed the Company&rsquo;s Chief Financial Officer as
the Compliance Officer (with their designees, the &ldquo;<U>Compliance Officer</U>&rdquo;) to administer the policy and to be available
to answer your questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>PART I. OVERVIEW</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>A.   Who
Must Comply?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
applies to all of our employees and members of our Board of Directors, including anyone employed by or acting as a director of any of
the Company&rsquo;s subsidiaries, as well as any other individuals whom the Compliance Officer may designate as Insiders (defined below)
because they have access to material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, all of our directors,
executive officers (as defined by Section 16 of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;))
and other designated employees must comply with the Trading Procedures included in Part II of this Insider Trading Policy (the &ldquo;<U>Trading
Procedures</U>&rdquo;); we will refer to these individuals in this policy as &ldquo;<U>Insiders</U>.&rdquo; The Trading Procedures provide
rules for when Insiders can trade in our securities and explain the process for mandatory pre-clearance of proposed trades. You will be
notified if you are considered to be an Insider who is required to comply with the Trading Procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
and, for Insiders, the Trading Procedures also apply to the following persons (&ldquo;<U>Affiliated Persons</U>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">your &ldquo;<U>Family Members</U>&rdquo; (&ldquo;Family Members&rdquo;
are (a) your spouse or domestic partner, children, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws
who reside in the same household as you, (b) your children or your spouse&rsquo;s children who do not reside in the same household as
you but are financially dependent on you, (c) any of your other family members who do not reside in your household but whose transactions
are directed by you, and (d) any other individual over whose account you have control and to whose financial support you materially contribute.
(Materially contributing to financial support would include, for example, paying an individual&rsquo;s rent but not just a phone bill.).);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">all trusts, family partnerships and other types of entities
formed for your benefit or for the benefit of a member of your family and over which you have the ability to influence or direct investment
decisions concerning securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">all persons who execute trades on your behalf; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">all investment funds, trusts, retirement plans, partnerships,
corporations and other types of entities over which you have the ability to influence or direct investment decisions concerning securities;
<U>provided</U>, <U>however</U>, that the Trading Procedures do not apply to any such entity that engages in the investment of securities
in the ordinary course of its business (e.g., an investment fund or partnership) if the entity has established its own insider trading
controls and procedures in compliance with applicable securities laws and it (or an affiliated entity) has represented to the Company
that its affiliated entities: (a) engage in the investment of securities in the ordinary course of their respective businesses; (b) have
established insider trading controls and procedures in compliance with securities laws, including the establishment of internal information
barriers to ensure that any material nonpublic information concerning the Company of which you may become in possession is not shared
with the persons at such entity making investment decisions with respect to securities issued by the Company; and (c) are aware the securities
laws prohibit any person or entity who has material nonpublic information concerning the Company from purchasing or selling securities
of the Company or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that
such person is likely to purchase or sell securities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You are responsible for ensuring
compliance with this Insider Trading Policy, including the Trading Procedures contained herein, by all of your Affiliated Persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transactions in the Company&rsquo;s
securities by the Company are generally subject to approval by the Company&rsquo;s Board of Directors and compliance with applicable securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>B.   What
is Prohibited by this Insider Trading Policy?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You and your Affiliated Persons
are prohibited from engaging in insider trading and from trading in securities in violation of this Insider Trading Policy. &ldquo;Insider
trading&rdquo; is (1) trading (buying or selling) the securities of a company whether for your account or for the account of another,
while in the possession of material nonpublic information (see definition below) about that company or (2) disclosing material nonpublic
information about a company to others who may trade on the basis of that information. Insider trading can result in criminal prosecution,
jail time, significant fines and public embarrassment for you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Prohibition on Trading in
Company Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When you are in possession
of material nonpublic information about the Company, whether positive or negative, you are prohibited from trading (whether for your account
of for the account of another) in the Company&rsquo;s securities, which include ordinary shares, options to purchase ordinary shares,
any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants and exchange-traded
options), and any derivative securities that provide the economic equivalent of ownership of any the Company&rsquo;s securities or an
opportunity, direct or indirect, to profit from any change in the value of the Company&rsquo;s securities, except for trades made pursuant
to plans approved by the Compliance Officer in accordance with this policy that comply with Rule 10b5-1 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading prohibitions in
this Insider Trading Policy do <U>not</U> apply to: (1) an exercise of an employee stock option when payment of the exercise price is
made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted
stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement
or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading prohibitions in
this Insider Trading Policy <U>do</U> apply, however, to the use of outstanding Company securities to pay part or all of the exercise
price of a stock option, any sale of stock as part of a broker-assisted cashless exercise of an option, and any other market sale for
the purpose of generating the cash needed to pay the exercise price of an option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prohibition on Tipping</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Providing material nonpublic
information about the Company to another person who may trade or advise others to trade on the basis of that information is known as &ldquo;<U>tipping</U>&rdquo;
and is illegal. You are prohibited from providing material nonpublic information about the Company to a friend, relative, or anyone else
who might buy or sell a security or other financial instrument on the basis of that information, whether or not you intend to or actually
do realize a profit (or any other benefit) from such tipping. Additionally, you are prohibited from recommending to any person that such
person engage in or refrain from engaging in any transaction involving the Company&rsquo;s securities, or otherwise give trading advice
concerning the Company&rsquo;s securities, if you are in possession of material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prohibition on Trading in Securities of Other
Companies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This policy&rsquo;s prohibitions
against insider trading and tipping also apply to trading in securities of other companies, including the Company&rsquo;s customers, suppliers,
partners and other enterprises with which we are working (such as when negotiating an acquisition, investment or other transaction that
could be material to the other company). Whenever, during the course of your service to or employment by the Company, you become aware
of material nonpublic information about another company, including any confidential information that is reasonably likely to affect the
market price of that company&rsquo;s securities (for example, discussions of licensing a product or acquiring that other company), neither
you nor your Affiliated Persons may trade in any securities of that company, give trading advice about that company, tip or disclose that
information, pass it on to others, or engage in any other action to take advantage of that information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your work regularly involves
handling or discussing confidential information of one of our partners, suppliers or customers, you should consult with the Compliance
Officer before trading in any of that company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Duration of Trading Prohibitions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These trading prohibitions
continue whenever and for as long as you know or are in possession of material nonpublic information. Remember, anyone scrutinizing your
transactions will be doing so after the fact, with the benefit of hindsight. As a practical matter, before engaging in any transaction,
you should carefully consider even the appearance of improper insider trading and how enforcement authorities and others might view the
transaction in hindsight.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
applies to you and your Affiliated Persons so long as you are associated with the Company. If you leave the Company for any reason, this
Insider Trading Policy, including, if applicable, the Trading Procedures contained herein, will continue to apply to you and your Affiliated
Persons until the later of: (1) the first trading day following the public release of earnings for the fiscal quarter in which you leave
the Company or (2) the first trading day after any material nonpublic information known to you has become public or is no longer material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Restricted Trading Periods</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, in connection
with an announcement of material information about the Company or when significant developments or announcements are anticipated, we may
impose a temporary prohibition on trading in our securities that applies to specified groups of employees or, in rare instances, all persons
covered by this policy. In such event, you will be notified by e-mail and/or other means of the imposition and expected duration of the
trading prohibition. During that period, no person covered by such a notice may trade in our securities (subject to the limited exceptions
set forth in this policy).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>C.   What
is Material nonpublic Information?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
prohibits you from trading in a company&rsquo;s securities if you are in possession of information about the company that is both &ldquo;<I>material</I>&rdquo;
and &ldquo;<I>nonpublic</I>.&rdquo; If you have a question whether certain information you are aware of is material or has been made public,
you are encouraged to consult with the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&ldquo;Material&rdquo; Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information about us or any
other company is &ldquo;material&rdquo; if it could reasonably be expected to affect the investment decisions of a shareholder or potential
investor, or if the disclosure of the information could reasonably be expected to significantly alter the total mix of information in
the marketplace about us or any other company. We speak mostly in this Insider Trading Policy about determining whether information about
us is material and nonpublic, but the same analysis applies to information that would preclude you from trading in securities of other
companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In simple terms, material
information is any type of information that could reasonably be expected to affect the market price of our securities. Both positive and
negative information may be material. While it is not possible to identify all information that would be deemed &ldquo;material,&rdquo;
the following items are types of information that should be considered carefully to determine whether they are material:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">projections of future earnings or losses, or other earnings
guidance;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">quarterly financial results that are known but have not been
publicly disclosed;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">potential restatements of the Company&rsquo;s financial statements,
changes in auditors or auditor notification that the Company may no longer rely on an auditor&rsquo;s audit report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">pending or proposed corporate mergers, acquisitions, tender
offers, joint ventures or dispositions of significant assets;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in senior management or our Board of Directors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">significant actual or threatened litigation or governmental
investigations or major developments in such matters;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">cybersecurity risks and incidents, including the discovery
of significant vulnerabilities or breaches;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">significant developments regarding products, customers, suppliers,
orders, contracts or financing sources (e.g., the acquisition or loss of a contract);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in dividend policy, declarations of stock splits,
or securities offerings or other financings;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">potential defaults under our credit agreements or indentures,
or the existence of material liquidity deficiencies; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">bankruptcies or receiverships.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By including the list above,
we do not mean to imply that each of these items above is always material. Rather, the information and events on the list still require
determinations as to their materiality (although some determinations will be reached more easily than others). For example, some new products
or contracts may clearly be material to an issuer; yet that does not mean that all product developments or contracts will be material.
No &ldquo;bright-line&rdquo; standard or list of items can adequately address the range of situations that may arise. Furthermore, we
cannot create an exclusive list of events and information that have a higher likelihood of being considered material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&ldquo;Nonpublic&rdquo; Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Material information is &ldquo;nonpublic&rdquo;
if it has not been disseminated in a manner making it available to investors generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To show that information is
public, it is necessary to point to some fact that establishes that the information has become publicly available, such as the filing
of a report with the SEC, the distribution of a press release, publishing the information on our website or via social media if such posting
is a regular way we communicate with investors, or by other means that are reasonably designed to provide broad public access. Before
a person with material nonpublic information can trade, there also must be adequate time for the market as a whole to absorb the information
that has been disclosed. For the purposes of this Insider Trading Policy, information will be considered public after the completion of
one full day of trading following the Company&rsquo;s public release of the information. For such purposes, a full day of trading means
an entire calendar day in which a session of regular trading hours on the NYSE or Nasdaq between 9:30 a.m. and 4:00 p.m. Eastern Time
(or such earlier close time as has been set by exchange rules) has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For example, if the Company
announces material nonpublic information of which you are aware before trading begins on a Tuesday, the first time you can buy or sell
Company securities is the opening of the market on Wednesday. However, if the Company announces this material information after trading
begins on that Tuesday, the first time that you can buy or sell Company securities is the opening of the market on Thursday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> D. What are the Penalties for Insider Trading and Noncompliance with this Insider Trading Policy?</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Both the U.S. Securities and
Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) and the national securities exchanges, through the Financial Industry Regulatory Authority
(&ldquo;<U>FINRA</U>&rdquo;), investigate and are very effective at detecting insider trading. The U.S. government pursues insider trading
violations vigorously. For instance, cases have been successfully prosecuted against trading by employees in foreign accounts, trading
by family members and friends, and trading involving only a small number of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The penalties for violating
insider trading or tipping rules can be severe and include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">forfeiting any profit gained or loss avoided by the trading;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">payment of the loss suffered by the persons who, contemporaneously with the purchase or sale of securities
that are subject of such violation, have purchased or sold, as applicable, securities of the same class;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">payment of criminal penalties of up to $5,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">payment of civil penalties of up to three times the profit made or loss avoided; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">imprisonment for up to 20 years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and/or the supervisors
of the person engaged in insider trading may also be required to pay civil penalties of fines starting from more than $2 million up to
three times the profit made or loss avoided, as well as criminal penalties of up to $25,000,000, and could under certain circumstances
be subject to private lawsuits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Violation of this Insider
Trading Policy or any federal or state insider trading laws may subject you to disciplinary action by the Company, including termination
of your employment or other relationship with the Company. The Company reserves the right to determine, in our own discretion and on the
basis of the information available to us, whether this Insider Trading Policy has been violated. We may determine that specific conduct
violates this Insider Trading Policy, whether or not the conduct also violates the law. It is not necessary for the Company to await the
filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">E.   How
Do You Report a Violation of this Insider Trading Policy?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have a question about
this Insider Trading Policy, including whether certain information you are aware of is material or has been made public, you are encouraged
to consult with the Compliance Officer. In addition, if you violate this Insider Trading Policy or any federal or state laws governing
insider trading or know of any such violation by any director or employee of the Company, you should report the violation immediately
to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PART II. TRADING PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>A.   Special
Trading Restrictions Applicable to Insiders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to needing to
comply with the restrictions on trading in our securities set forth above, Insiders and their Affiliated Persons are subject to the following
special trading restrictions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.   [Reserved]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.   Special
Closed Trading Periods</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compliance Officer may
designate, from time to time, a &ldquo;Special Closed Window&rdquo; during what would temporally be a permitted trading window. During
a Special Closed Window, designated Insiders (which could be all Insiders or a subset of them) may not trade in the Company&rsquo;s securities.
The Compliance Officer may also apply a Special Closed Window to Insiders or a subset of them to the trading in the securities of certain
other companies, as deemed appropriate or advisable, including certain of the Company&rsquo;s peers or competitors. The existence of a
Special Closed Window will not be announced to the Company generally, should not be communicated to any other person, and may itself be
considered under this Insider Trading Policy to be material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.   Prohibited
Transactions</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">The
following transactions are prohibited unless authorized by the Audit Committee of the Board of Directors:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><B>No Short Sales</B><FONT STYLE="font-style: normal">. You many not at any time sell any securities of
the Company that are not owned by you at the time of the sale (a &ldquo;short sale&rdquo;). </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><B>No Purchases or Sales of Derivative Securities or Hedging Transactions</B>. <FONT STYLE="font-style: normal">You
may not buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent
of ownership of any of the Company&rsquo;s securities or an opportunity, direct or indirect, to profit from any change in the value of
our securities or engage in any other hedging transaction with respect to our securities, at any time.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><B>No Company Securities Subject to Margin Calls</B>. <FONT STYLE="font-style: normal">You may not use
the Company&rsquo;s securities as collateral in a margin account.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><B>No Pledges</B><FONT STYLE="font-style: normal">. You may not pledge Company securities as collateral
for a loan (or modify an existing pledge).</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal"><B>4.   Gifts
and Other Distributions in Kind</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Insider may donate or make
any other transfer of Company securities in kind without consideration during a period when the Insider is not permitted to trade. In
addition to charitable donations or gifts to family members, friends, trusts or others, this obligation applies to distributions by limited
partnerships that are subject to this Insider Trading Policy to their limited partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.   No
Trading During Retirement Plan Blackout Periods</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we adopt a policy to allow
ownership of Company stock in our 401(k) or other retirement plan, then no Insider may trade in any Company securities, which were acquired
in connection with such Insider&rsquo;s service or employment with the Company, during a retirement plan &ldquo;blackout period&rdquo;
except as specifically permitted below. A blackout period includes any period of more than three (3) consecutive business days during
which at least fifty percent (50%) of all participants and beneficiaries under all of the individual account plans maintained by the Company
and members of our controlled group are prohibited from trading in Company securities through their plan accounts. Insiders will receive
advance notice of any such blackout period from the Compliance Officer.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">B.    Pre-Clearance
Procedures</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">No
Insider may trade in our securities (including any purchases, sales, gifts, donations or charitable contributions), even during an open
trading window, unless the trade has been approved by the Compliance Officer under the procedures described below. In reviewing trading
requests, the Compliance Officer may consult with our other officers and/or outside legal counsel and will receive approval for his own
trades from the Chief Operating Officer. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Procedures. </B>No Insider may trade in our securities unless and
until:</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal">The Insider has notified
the Compliance Officer of the amount and nature of the proposed trade(s) using the Stock Transaction Request form attached to this Insider
Trading Policy. In order to provide adequate time for the preparation of any required reports under Section 16 of the Exchange Act, a
Stock Transaction Request form should, if practicable, be received by the Compliance Officer at least two (2) business days prior to
the intended trade date;</FONT></TD>
</TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal">The Insider has certified to the Compliance Officer in writing prior
to the proposed trade(s) that the Insider is not in possession of material nonpublic information concerning the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal">If the Insider is an executive officer or director, the Insider has informed
the Compliance Officer, using the Stock Transaction Request form attached hereto, whether, to the Insider&rsquo;s best knowledge, (a)
the Insider has (or is deemed to have) engaged in any opposite way transactions within the previous six months that were not exempt from
Section 16(b) of the Exchange Act and (b) if the transaction involves a sale by an &ldquo;affiliate&rdquo; of the Company or of &ldquo;restricted
securities&rdquo; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&ldquo;Rule 144&rdquo;)), whether
the transaction meets all of the applicable conditions of Rule 144; and</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal">The Compliance Officer has approved the trade(s) and has certified such
approval in writing (which may be by email). </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">The
Compliance Officer does not assume the responsibility for, and approval from the Compliance Officer does not protect the Insider from,
the consequences of prohibited insider trading.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Additional Information. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Insiders
shall provide to the Compliance Officer any documentation reasonably requested by the officer in furtherance of the foregoing procedures.
Any failure to provide such requested information will be grounds for denial of approval by the Compliance Officer.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Notification of Brokers of Insider Status</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Insiders
who are required to file reports under Section 16 of the Exchange Act shall inform all broker-dealers that may trade in our shares on
the Insider&rsquo;s or an Affiliated Person&rsquo;s behalf of their status as a Section 16 officer and affiliate of the Company, the requirement
that the broker confirm that any trade by the Insider has been approved by the Company pursuant to these pre-clearance procedures before
making any trade, and arrange for the broker to provide transaction information to the Insider and/or Compliance Officer on the day of
any executed transaction. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>No Obligation to Approve Trades.</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">The
existence of the foregoing approval procedures does not in any way obligate the Compliance Officer to approve any trade requested by an
Insider. The Compliance Officer may reject any trading request at their sole discretion. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">From
time to time, an event may occur that is material to the Company and is known by only by a limited number of directors and employees.
Insiders may not trade in our securities if they are notified by the Compliance Officer that a proposed trade has not been cleared because
of the existence of a material nonpublic development &ndash; even if that particular Insider is not aware of the material nonpublic development
involving the Company. If any Insider engages in a trade before a material nonpublic development is disclosed to the public or resolved,
the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute even if the Insider
was unaware of the development. So long as the event remains material and nonpublic, the Compliance Officer may determine not to approve
any transactions in the Company&rsquo;s securities. The Compliance Officer will subsequently notify the Insider once the material nonpublic
development is disclosed to the public or resolved. If an Insider requests clearance to trade in our securities during the pendency of
such an event, the Compliance Officer may reject the trading request without disclosing the reason.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Completion of Trades. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">After
receiving written clearance to engage in a trade signed by the Compliance Officer, an Insider must complete the proposed trade within
three (3) business days or make a new trading request. Notwithstanding that an Insider has received such clearance, the Insider shall
not engage in a trade if (i) such clearance has been rescinded by the Compliance Officer, (ii) the Insider has otherwise received notice
that the trading window has been closed or (iii) the Insider believes that they may have material nonpublic information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B></B></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Post-Trade Reporting. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">The
details of any transactions in our securities (including transactions effected pursuant to a Rule 10b5-1 Plan or any other purchases,
sales, gifts, donations or charitable contributions) by an Insider (or one of their Affiliated Persons) who is required to file reports
under Section 16 of the Exchange Act must be reported to the Compliance Officer by the Insider or their brokerage firm on the same day
on which a trade order is placed or such a transaction otherwise is entered into. Such report shall include the date of the transaction,
quantity of shares, the price and the name of any broker-dealer through which the transaction was effected. This reporting requirement
may be satisfied by providing (or having such Insider&rsquo;s broker provide) a trade order confirmation to the Compliance Officer if
such information is received by the Compliance Officer by the required date. Compliance by directors and executive officers with this
provision is imperative given the requirement of Section 16 of the Exchange Act that these persons generally must report changes in ownership
of Company securities within two (2) business days. The sanctions for noncompliance with this reporting deadline include mandatory disclosure
in the Company&rsquo;s proxy statement for the next annual meeting of shareholders, as well as possible civil or criminal sanctions for
chronic or egregious violators.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">C.   Exemptions</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Pre-Approved Rule 10b5-1 Plan. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Transactions
made pursuant to an approved Rule 10b5-1 Plan (as defined below) will not be subject to our trading windows, retirement plan blackout
periods or pre-clearance procedures, and Insiders are not required to complete a Stock Transaction Request form for such transactions.
Rule 10b5-1 of the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading
plans, arrangements or instructions that meet certain requirements. A trading plan, arrangement or instruction that meets the requirements
of Rule 10b5-1 (a &ldquo;Rule 10b5-1 Plan&rdquo;) enables Insiders to trade in Company securities outside of our trading windows, even
when in possession of material nonpublic information. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">If
an Insider intends to trade pursuant to a Rule 10b5-1 Plan, such plan, arrangement or instruction must:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">satisfy
the requirements of Rule 10b5-1 in effect at such time; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be documented
in writing; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be established
during a trading window; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be entered
into in good faith by the Insider, not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1, at a time when such Insider
does not possess material nonpublic information, and, if the Insider is a director or executive officer, such plan must include representations
by the Insider certifying the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">must
(a) specify the amount of securities to be sold, the price at which and the date on which the securities are to be sold, (b) include a
written formula or algorithm, or computer program, for determining the amount of securities to be sold and the price at which and the
date on which the securities are to be sold, or (c) not permit the Insider to exercise any subsequent influence over how, when, or whether
to effect transactions; provided, in addition, that any other person who, pursuant to such plan, arrangement or instruction, exercises
such influence must not have been aware of material nonpublic information when doing so;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">provide
                                            that no transactions may occur thereunder until the expiration of the applicable cooling-off
                                            period specified in Rule 10b5-1(c)(ii)(B) (the &ldquo;<U>Cooling-Off Period</U>&rdquo;)</FONT><SUP>1</SUP>
                                            <FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">(and
                                            no transactions thereunder occur until after that time);</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be the
only outstanding plan, arrangement or instruction entered into by the Insider (subject to the limited exceptions in Rule 10b5-1(c)(ii)(D));
and</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be pre-approved
by the Compliance Officer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to approving any 10b5-1
Plan, the Compliance Officer may require that the plan exclude or include certain additional provisions (e.g., longer cooling off periods,
minimum number of trades requirement, specified term) to ensure compliance with SEC regulations, best practices or otherwise as the Compliance
Officer deems to be in the best interests of the Company. Alternatively, the Compliance Officer may refuse to approve a 10b5-1 Plan that
does not meet applicable legal requirements or satisfy best practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any proposed deviation from
the specifications of an approved Rule 10b5-1 Plan (including, without limitation, the amount, price or timing of a purchase or sale)
must be reported immediately to, and be approved by, the Compliance Officer. <B>Any transaction pursuant to a Rule 10b5-1 Plan must be
timely reported following the transaction in accordance with the procedures set forth above.</B> The Compliance Officer may refuse to
approve a Rule 10b5-1 Plan as they deem appropriate including, without limitation, if they determine that such plan does not satisfy the
requirements of Rule 10b5-1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any modification or termination
of an Insider&rsquo;s existing Rule 10b5-1 Plan requires pre-approval by the Compliance Officer. The Compliance Officer shall require
as a condition to such approval that the modification or termination occur during a trading window and be entered into in good faith,
not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1, while such Insider is not aware of material nonpublic information.
In addition to the foregoing, any modifications of a Rule 10b5-1 Plan (including any changes to the pricing, amount of securities, or
timing of transactions, but not for purely ministerial changes such as changes in account information or adjustment for stock splits)
will be subject to the applicable Cooling-Off Period prior to any transaction occurring under the Rule 10b5-1 Plan as modified.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: italic 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">The appropriate Cooling-Off Period varies based on the status
of the Insider. For directors and executive officers, the cooling-off period ends on the later of (x) 90 days after adoption or modification
of the plan or (y) two business days following disclosure of the Company&rsquo;s financial results in a Form 10-K or Form 10-Q for the
completed fiscal quarter in which the plan was adopted (not to exceed 120 days). For all other Insiders, the Cooling-Off Period ends
30 days after adoption or modification of the plan. The Cooling-Off Period will apply to the entry into a new plan and any revision or
modification of a plan, including changes to the pricing, amount of securities, or timing of transactions, but not for purely ministerial
changes such as changes in account information or adjustment for stock splits.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-style: normal"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Employee Equity and Retirement Plans.</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Exercise of Stock
Options</B><FONT STYLE="font-style: normal">. The trading prohibitions and restrictions set forth in the Trading Procedures do not apply
to the exercise of an option to purchase securities of the Company when payment of the exercise price is made in cash. However, the exercise
of an option to purchase securities of the Company is subject to the current reporting requirements of Section 16 of the Exchange Act
and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction.
In addition, the securities acquired upon the exercise of an option to purchase Company securities are subject to all of the requirements
of this Insider Trading Policy, including the Trading Procedures contained herein. Moreover, the Trading Procedures apply to the use of
outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock
appreciation right, share withholding, any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market
sale for the purpose of generating the cash needed to pay the exercise price of an option.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Tax Withholding
on Restricted Stock/Units</B><FONT STYLE="font-style: normal">. The trading prohibitions and restrictions set forth in the Trading Procedures
do not apply to the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock
units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement
or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">D.   Waivers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A waiver of any provision
of this Insider Trading Policy, or the Trading Procedures contained herein, in a specific instance may be authorized in writing by the
Audit Committee of the Board of Directors, and any such waiver shall be reported to the Board of Directors.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-style: normal">PART
III. ACKNOWLEDGEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will deliver a copy of
this Insider Trading Policy to all current employees and directors and to future employees and directors at the start of their employment
or relationship with the Company. Upon first receiving a copy of this Insider Trading Policy, each individual must acknowledge that they
have received a copy and agree to comply with the terms of this Insider Trading Policy, and, if applicable, the Trading Procedures contained
herein. The acknowledgment attached hereto must be completed and submitted to the Company within ten (10) days of receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon our request, directors
and employees and consultants will be required to re-acknowledge and agree to comply with the Insider Trading Policy (including any amendments
or modifications). For such purpose, an individual will be deemed to have acknowledged and agreed to comply with the Insider Trading Policy,
as amended from time to time, when copies of such items have been delivered by regular or electronic mail (or other delivery option used
by the Company) to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Questions regarding this Insider
Trading Policy are encouraged and may be directed to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADOPTED: March &nbsp;&nbsp;&nbsp;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EFFECTIVE: March &nbsp;&nbsp;&nbsp;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>STOCK TRANSACTION REQUEST</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Plum Acquisition Corp. IV&rsquo;s
Insider Trading Policy, I hereby notify Plum Acquisition Corp. IV (the &ldquo;Company&rdquo;) of my intent to trade the securities of
the Company as indicated below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>REQUESTER INFORMATION</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Insider&rsquo;s Name:&nbsp; ______________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>INTENT TO PURCHASE</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of shares:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intended trade date:</P></TD>
    <TD COLSPAN="2" STYLE="padding-top: 3pt; border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt"><BR>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR>
&nbsp;__________________________</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;__________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; width: 20%; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Means of acquiring shares:</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; width: 76%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition through employee benefit plan (please specify): &nbsp; ___________________________________________________________ &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase through a broker on the open market <BR>
&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other (please specify): ________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B><U>INTENT TO SELL OR TRANSFER</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of shares:&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intended trade date:</P></TD>
    <TD COLSPAN="2" STYLE="padding-top: 3pt; border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR>
<BR>
<BR>
__________________________</P>
                                                                                                                   <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
                                                                                                                               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">__________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Means of selling shares:</FONT></TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sale through employee benefit plan (please specify): &nbsp; ___________________________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sale through a broker on the open market</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gift, Donation or Charitable Contribution</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-right: 3pt; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other (please specify): ________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp; &nbsp;</P></TD></TR>
  </TABLE>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding: 3pt; border-top: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 16</B></FONT></P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0">_____________________________________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B>&nbsp;</FONT></P></TD>
    <TD STYLE="padding: 3pt; border-top: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 3pt; border-right: Black 1pt solid; border-top: Black 1pt solid">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RULE 144 (Not applicable if transaction requested involves (i) a
    purchase, or (ii) a sale pursuant to an effective registration statement</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">________________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; text-align: center; width: 3%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 3pt; width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I am not subject to Section 16. &nbsp;</FONT></TD>
    <TD STYLE="padding: 3pt; width: 5%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 3pt; border-right: Black 1pt solid; width: 52%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
am not an &ldquo;affiliate&rdquo; of the Company and the transaction requested above does not involve the sale of &ldquo;restricted securities&rdquo;
(as such terms are defined under Rule 144 under the Securities Act of 1933, as amended). &uml;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; border-left: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;&nbsp;</FONT></TD>
    <TD STYLE="padding: 3pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the best of my knowledge, I have not (and am not deemed to have) engaged in an opposite way transaction within the previous 6 months that was not exempt from Section 16(b) of the Exchange Act.</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; &nbsp;</FONT></P></TD>
    <TD STYLE="padding: 3pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#9744;</TD>
    <TD STYLE="padding: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the best of my knowledge, the transaction requested above will meet all of the applicable conditions of Rule 144.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="5" STYLE="padding-top: 3pt; padding-right: 3pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; padding-left: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>CERTIFICATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby certify that I: (1) am not in possession of any material nonpublic information concerning the Company, as defined in the Company&rsquo;s Insider Trading Policy, (2) am not purchasing any securities of the Company on margin in contravention of the Company&rsquo;s trading procedures, and (3) have executed the Acknowledgement of the Company&rsquo;s Insider Trading Policy. I understand that, if I trade while possessing such information or in violation of such trading restrictions, I may be subject to severe civil and/or criminal penalties and may be subject to discipline by the Company including termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; border-left: Black 1pt solid; width: 3%; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; width: 37%; border-bottom: black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; width: 20%; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; width: 37%; border-bottom: black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; border-right: Black 1pt solid; width: 3%; text-align: justify; padding-left: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; border-left: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; text-align: justify; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider&rsquo;s Signature</FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; text-align: justify; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding-right: 3pt; border-right: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 3pt; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>AUTHORIZED APPROVAL</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; border-left: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; border-bottom: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; border-bottom: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; border-right: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 3pt; padding-right: 3pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt; padding-right: 3pt; border-bottom: Black 1pt solid; text-align: justify; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature of Compliance Officer (or designee)</FONT></TD>
    <TD STYLE="padding-bottom: 3pt; padding-right: 3pt; border-bottom: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt; padding-right: 3pt; border-bottom: Black 1pt solid; text-align: justify; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding-bottom: 3pt; padding-right: 3pt; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: justify; padding-left: 3pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><I>*</I></TD><TD STYLE="text-align: justify"><I>NOTE: Multiple lots must be listed on separate forms or broken
out herein.</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U STYLE="text-decoration: none">&nbsp;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ACKNOWLEDGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I hereby acknowledge that
I have read, that I understand, and that I agree to comply with, the Insider Trading Policy of Plum Acquisition Corp. IV (the &ldquo;Company&rdquo;).
I further acknowledge and agree that I am responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures
included therein by all of my &ldquo;Affiliated Persons.&rdquo; I also understand and agree that I will be subject to sanctions, including
termination of employment, that may be imposed by the Company, in its sole discretion, for violation of the Insider Trading Policy, and
that the Company may give stop-transfer and other instructions to the Company&rsquo;s transfer agent or any brokerage firm managing the
Company&rsquo;s equity incentive plan(s) against the transfer of any Company securities in a transaction that the Company considers to
be in contravention of the Insider Trading Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This acknowledgement will
constitute consent for the Company to impose sanctions for violation of the Insider Trading Policy, including the Trading Procedures,
and to issue any necessary stop-transfer orders to the Company&rsquo;s transfer agent to ensure compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify; font-size: 10pt">Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: justify; font-size: 10pt">Signature:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Title:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">16</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ea023531601ex31-1_plumacq4.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 31.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES
EXCHANGE ACT OF 1934, </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Kanishka Roy, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report
on Form&nbsp;10-K&nbsp;of Plum Acquisition Corp. IV;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;for
the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report
is being prepared; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Paragraph omitted pursuant to
SEC Release Nos.&nbsp;33-8238/34-47986&nbsp;and&nbsp;33-8392/34-49313);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of
the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change
in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter
(the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely
to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and
material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: March 31, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Kanishka Roy</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Kanishka Roy</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ea023531601ex31-2_plumacq4.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES
EXCHANGE ACT OF 1934, </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Steven Handwerker, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report
on Form&nbsp;10-K&nbsp;of Plum Acquisition Corp. IV;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;for
the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report
is being prepared; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Paragraph omitted pursuant to
SEC Release Nos.&nbsp;33-8238/34-47986&nbsp;and&nbsp;33-8392/34-49313);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of
the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change
in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter
(the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely
to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and
material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: March 31, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Steven Handwerker</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Steven Handwerker</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Principal Financial Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ea023531601ex32-1_plumacq4.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 32.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of Plum Acquisition Corp. IV (the
&ldquo;Company&rdquo;) on Form 10-K for the period ended December 31, 2024, as filed with the Securities and Exchange Commission (the
&ldquo;Report&rdquo;), we, Kanishka Roy, the Chief Executive Officer of the Company, and Steven Handwerker, the Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002, that, to
the best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the
period covered by the Report.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Dated: March 31, 2025 </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Kanishka Roy</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Kanishka Roy</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Steven Handwerker</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Steven Handwerker</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Principal Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>7
<FILENAME>ea023531601ex97-1_plumacq4.htm
<DESCRIPTION>CLAWBACK POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 97.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Plum Acquisition Corp. IV (&ldquo;the Company&rdquo;)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CLAWBACK POLICY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Introduction</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity
and accountability. The Board has therefore adopted this policy which provides for the recoupment of certain executive compensation in
the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities
laws (the &ldquo;<B>Policy</B>&rdquo;). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the
&ldquo;<B>Exchange Act</B>&rdquo;) and Rule 5608 of the Nasdaq Listing Rules (the &ldquo;<B>Clawback Listing Standards</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Administration</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Policy shall be administered by the Board
or, if so designated by the Board, the Compensation Committee, in which case references herein to the Board shall be deemed references
to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Covered Executives</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Policy applies to the Company&rsquo;s current
and former executive officers, as determined by the Board in accordance with the definition in Section 10D of the Exchange Act and the
Clawback Listing Standards, and such other employees who may from time to time be deemed subject to the Policy by the Board (&ldquo;<B>Covered
Executives</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Recoupment; Accounting Restatement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event the Company is required to prepare
an accounting restatement of its financial statements due to the Company&rsquo;s material noncompliance with any financial reporting requirement
under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements
that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected
in the current period or left uncorrected in the current period, the Board will require reimbursement or forfeiture of any excess Incentive
Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company
is required to prepare an accounting restatement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Incentive Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of this Policy, Incentive Compensation
means any of the following; provided that, such compensation is granted, earned, or vested based wholly or in part on the attainment of
a financial reporting measure:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Annual bonuses and other short- and long-term cash incentives.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Stock options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Stock appreciation rights.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Restricted stock.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Restricted stock units.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Performance shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Performance units.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> Financial reporting measures include:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Company stock price.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Total shareholder return.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Revenues.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Net income.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Earnings before interest, taxes, depreciation, and amortization
(EBITDA).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Funds from operations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Liquidity measures such as working capital or operating cash
flow.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Return measures such as return on invested capital or return
on assets.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Earnings measures such as earnings per share.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Excess Incentive Compensation: Amount Subject to Recovery</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amount to be recovered will be the excess of
the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have been
paid to the Covered Executive had it been based on the restated results, as determined by the Board, without regard to any taxes paid
by the Covered Executive in respect of the Incentive Compensation paid based on the erroneous data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Board cannot determine the amount of excess
Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make
its determination based on a reasonable estimate of the effect of the accounting restatement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Method of Recoupment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board will determine, in its sole discretion,
the method for recouping Incentive Compensation hereunder which may include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) requiring reimbursement of cash Incentive Compensation
previously paid;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) seeking recovery of any gain realized on the
vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) offsetting the recouped amount from any compensation
otherwise owed by the Company to the Covered Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) cancelling outstanding vested or unvested equity
awards; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) taking any other remedial and recovery action
permitted by law, as determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>No Indemnification</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company shall not indemnify any Covered Executives
against the loss of any incorrectly awarded Incentive Compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Interpretation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board is authorized to interpret and construe
this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended
that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act, any applicable
rules or standards adopted by the Securities and Exchange Commission, and the Clawback Listing Standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Effective Date</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Policy shall be effective as of the date it
is adopted by the Board (the &ldquo;<B>Effective Date</B>&rdquo;) and shall apply to Incentive Compensation that is received by Covered
Executives on or after the Effective Date, even if such Incentive Compensation was approved, awarded, or granted to Covered Executives
prior to the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Amendment; Termination</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board may amend this Policy from time to time
in its discretion and shall amend this Policy as it deems necessary to reflect final regulations adopted by the Securities and Exchange
Commission under Section 10D of the Exchange Act and to comply with the Clawback Listing Standards and any other rules or standards adopted
by a national securities exchange on which the Company&rsquo;s securities are listed. The Board may terminate this Policy at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Other Recoupment Rights</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any right of recoupment under this Policy is in
addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms
of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Relationship to Other Plans and Agreements </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board intends that this Policy will be applied
to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered
into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree
to abide by the terms of this Policy. In the event of any inconsistency between the terms of the Policy and the terms of any employment
agreement, equity award agreement, or similar agreement under which Incentive Compensation has been granted, awarded, earned or paid to
a Covered Executive, whether or not deferred, the terms of the Policy shall govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Acknowledgment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Covered Executive shall, if requested by the
Company, sign an acknowledgment form in the form attached hereto as Exhibit A in which they acknowledge that they have read and understand
the terms of the Policy and are bound by the Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Impracticability</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board shall recover any excess Incentive Compensation
in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Rule 10D-1 of
the Exchange Act and the listing standards of the national securities exchange on which the Company&rsquo;s securities are listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Successors</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Policy shall be binding and enforceable against
all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLAWBACK POLICY ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors of
Plum Acquisition Corp. IV has adopted the Plum Acquisition Corp. IV Clawback Policy (&ldquo;<B>Clawback Policy</B>&rdquo;) which is applicable
to the Company&rsquo;s Covered Executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, the undersigned, acknowledge
that I have received a copy of the Clawback Policy, as it may be amended, restated, supplemented or modified from time to time, and that
I have read it, understand it, and acknowledge that I am fully bound by, and subject to, all of the terms and conditions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any inconsistency
between the terms of the Clawback Policy and the terms of any employment agreement to which I am a party, or the terms of any compensation
plan, program, or arrangement under which Incentive Compensation has been granted, awarded, earned, or paid to me, whether or not deferred,
the terms of the Clawback Policy shall govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Board of Directors
determines that any Incentive Compensation I have received must be forfeited, repaid, or otherwise recovered by the Company, I shall promptly
take whatever action is necessary to effectuate such forfeiture, repayment, or recovery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I acknowledge that I am not
entitled to indemnification in connection with the Company&rsquo;s enforcement of the Clawback Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I understand that any delay
or failure by the Company to enforce any requirement contained in the Clawback Policy will not constitute a waiver of the Company&rsquo;s right
to do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any capitalized terms used
in this Acknowledgment that are not otherwise defined shall have the meaning ascribed to them in the Clawback Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>plmk-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:52 UTC 2025 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2024" targetNamespace="http://www.plumpartners.com/20241231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:plmk="http://www.plumpartners.com/20241231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="plmk-20241231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="plmk-20241231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="plmk-20241231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="plmk-20241231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet" id="plmk_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Balance Sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals" id="plmk_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Balance Sheet (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ConsolidatedIncomeStatement" id="plmk_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Statement of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ShareholdersEquityType2or3" id="plmk_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Statement of Changes in Shareholder&#8217;s Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ConsolidatedCashFlow" id="plmk_r_ConsolidatedCashFlow">
        <link:definition>995305 - Statement - Statement of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations" id="plmk_r_DescriptionofOrganizationandBusinessOperations">
        <link:definition>995306 - Disclosure - Description of Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies" id="plmk_r_SummaryofSignificantAccountingPolicies">
        <link:definition>995307 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/InitialPublicOffering" id="plmk_r_InitialPublicOffering">
        <link:definition>995308 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/PrivatePlacement" id="plmk_r_PrivatePlacement">
        <link:definition>995309 - Disclosure - Private Placement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/RelatedPartyTransactions" id="plmk_r_RelatedPartyTransactions">
        <link:definition>995310 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/CommitmentsandContingencies" id="plmk_r_CommitmentsandContingencies">
        <link:definition>995311 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ShareholdersDeficit" id="plmk_r_ShareholdersDeficit">
        <link:definition>995312 - Disclosure - Shareholder's Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SegmentReporting" id="plmk_r_SegmentReporting">
        <link:definition>995313 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SubsequentEvents" id="plmk_r_SubsequentEvents">
        <link:definition>995314 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/AccountingPoliciesByPolicy" id="plmk_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SegmentReportingTables" id="plmk_r_SegmentReportingTables">
        <link:definition>996001 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails" id="plmk_r_DescriptionofOrganizationandBusinessOperationsDetails">
        <link:definition>996002 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails" id="plmk_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996003 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/InitialPublicOfferingDetails" id="plmk_r_InitialPublicOfferingDetails">
        <link:definition>996004 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/PrivatePlacementDetails" id="plmk_r_PrivatePlacementDetails">
        <link:definition>996005 - Disclosure - Private Placement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1vy3nS50RwsABNfxMhuw7FiU=] CSR-->
      <link:roleType roleURI="http://www.plumpartners.com/role/RelatedPartyTransactionsDetails" id="plmk_r_RelatedPartyTransactionsDetails">
        <link:definition>996006 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/CommitmentsandContingenciesDetails" id="plmk_r_CommitmentsandContingenciesDetails">
        <link:definition>996007 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ShareholdersDeficitDetails" id="plmk_r_ShareholdersDeficitDetails">
        <link:definition>996008 - Disclosure - Shareholder's Deficit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SegmentReportingDetails" id="plmk_r_SegmentReportingDetails">
        <link:definition>996009 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable" id="plmk_r_ScheduleofKeyMetricIncludedinNetIncomeorLossTable">
        <link:definition>996010 - Disclosure - Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/SubsequentEventsDetails" id="plmk_r_SubsequentEventsDetails">
        <link:definition>996011 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.plumpartners.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:element name="ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract"/>
  <xs:element name="DeferredOfferingCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="plmk_DeferredOfferingCost"/>
  <xs:element name="AccruedOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_AccruedOfferingCosts"/>
  <xs:element name="PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty"/>
  <xs:element name="ProceedsFromSaleOfFounderShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="plmk_ProceedsFromSaleOfFounderShares"/>
  <xs:element name="DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty"/>
  <xs:element name="InitialPublicOfferingTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_InitialPublicOfferingTextBlock"/>
  <xs:element name="PrivatePlacementTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PrivatePlacementTextBlock"/>
  <xs:element name="LiquidityAndCapitalResourcesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_LiquidityAndCapitalResourcesPolicyTextBlock"/>
  <xs:element name="EmergingGrowthCompanyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_EmergingGrowthCompanyPolicyTextBlock"/>
  <xs:element name="DerivativeFinancialInstrumentsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_DerivativeFinancialInstrumentsPolicyTextBlock"/>
  <xs:element name="DescriptionofOrganizationandBusinessOperationsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
  <xs:element name="ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
  <xs:element name="YearOfInception" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_YearOfInception"/>
  <xs:element name="UnitsIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
  <xs:element name="AggregatePurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_AggregatePurchasePrice"/>
  <xs:element name="TransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_TransactionCosts"/>
  <xs:element name="SaleOfStockUnderwritingFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_SaleOfStockUnderwritingFees"/>
  <xs:element name="DeferredUnderwritingFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_DeferredUnderwritingFee"/>
  <xs:element name="OtherOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_OtherOfferingCosts"/>
  <xs:element name="PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount"/>
  <xs:element name="InitialAmountHeldInTrustAccount" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="plmk_InitialAmountHeldInTrustAccount"/>
  <xs:element name="AggregatePublicShareRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_AggregatePublicShareRate"/>
  <xs:element name="PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination"/>
  <xs:element name="InterestUsedToPayDissolutionExpensesMaximum" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_InterestUsedToPayDissolutionExpensesMaximum"/>
  <xs:element name="SharePricePerPublicShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_SharePricePerPublicShare"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="WorkingCapitalDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_WorkingCapitalDeficit"/>
  <xs:element name="InitialPublicOfferingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_InitialPublicOfferingDetailsTable"/>
  <xs:element name="NumberOfSharesIssuedPerUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfSharesIssuedPerUnit"/>
  <xs:element name="PrivatePlacementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_PrivatePlacementDetailsTable"/>
  <xs:element name="NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="NumberOfSharesSurrendered" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfSharesSurrendered"/>
  <xs:element name="PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering"/>
  <xs:element name="NumberOfSharesNoLongerSubjectToForfeiture" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
  <xs:element name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
  <xs:element name="ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
  <xs:element name="ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
  <xs:element name="CommonStockSharesTransferred" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_CommonStockSharesTransferred"/>
  <xs:element name="NumberOfIndependentDirector" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfIndependentDirector"/>
  <xs:element name="CommonStockValueTransferred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="plmk_CommonStockValueTransferred"/>
  <xs:element name="FairValueOfSharesGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_FairValueOfSharesGranted"/>
  <xs:element name="FairValueOfSharesGrantedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="plmk_FairValueOfSharesGrantedAmount"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="NumberOfAdditionalUnitsPurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NumberOfAdditionalUnitsPurchased"/>
  <xs:element name="UnderwritingDiscountPricePerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_UnderwritingDiscountPricePerUnit"/>
  <xs:element name="CashUnderwritingPaidPerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_CashUnderwritingPaidPerUnit"/>
  <xs:element name="PurchaseOfPrivatePlacementOfUnderwritersPerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit"/>
  <xs:element name="DeferredFeePerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_DeferredFeePerUnit"/>
  <xs:element name="ShareholdersDeficitDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_ShareholdersDeficitDetailsTable"/>
  <xs:element name="PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination"/>
  <xs:element name="PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission"/>
  <xs:element name="PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination"/>
  <xs:element name="ClassOfWarrantsOrRightsRedemptionPricePerWarrant" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant"/>
  <xs:element name="NoticePeriodToBeGivenPriorToRedemption" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_NoticePeriodToBeGivenPriorToRedemption"/>
  <xs:element name="EstablishedPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="plmk_EstablishedPerShare"/>
  <xs:element name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
  <xs:element name="PublicWarrantExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PublicWarrantExercisePrice"/>
  <xs:element name="TotalEquityProceedsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_TotalEquityProceedsPercentage"/>
  <xs:element name="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
  <xs:element name="PublicWarrantsAdjustedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PublicWarrantsAdjustedPercentage"/>
  <xs:element name="MarketValueInPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_MarketValueInPercentage"/>
  <xs:element name="SegmentReportingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_SegmentReportingDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="plmk_SubsequentEventsDetailsTable"/>
  <xs:element name="ClassAOrdinaryShares00001ParValuePerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_ClassAOrdinaryShares00001ParValuePerShareMember"/>
  <xs:element name="FounderSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_FounderSharesMember"/>
  <xs:element name="PlumPartnersIVLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PlumPartnersIVLLCMember"/>
  <xs:element name="PromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PromissoryNoteMember"/>
  <xs:element name="PublicWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PublicWarrantMember"/>
  <xs:element name="SponsorMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_SponsorMember"/>
  <xs:element name="UnderwritersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_UnderwritersMember"/>
  <xs:element name="UnderwritingAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_UnderwritingAgreementMember"/>
  <xs:element name="UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember"/>
  <xs:element name="WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember"/>
  <xs:element name="WorkingCapitalLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_WorkingCapitalLoansMember"/>
  <xs:element name="PrivatePlacementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_PrivatePlacementAbstract"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="plmk_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>plmk-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:53 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedBalanceSheet" roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedIncomeStatement" roleURI="http://www.plumpartners.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedCashFlow" roleURI="http://www.plumpartners.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Cash" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredOfferingCost" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="plmk_DeferredOfferingCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="plmk_AccruedOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_AccruedOfferingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="plmk_AccruedOfferingCosts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherNotesPayableCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1v9eEhlsWBxu7xi8vq6pHrN0=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliates" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="plmk_ProceedsFromSaleOfFounderShares" xlink:href="plmk-20241231.xsd#plmk_ProceedsFromSaleOfFounderShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="plmk_ProceedsFromSaleOfFounderShares" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>plmk-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:53 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedBalanceSheet" roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedIncomeStatement" roleURI="http://www.plumpartners.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersEquityType2or3" roleURI="http://www.plumpartners.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedCashFlow" roleURI="http://www.plumpartners.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_DescriptionofOrganizationandBusinessOperations" roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_InitialPublicOffering" roleURI="http://www.plumpartners.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_PrivatePlacement" roleURI="http://www.plumpartners.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_RelatedPartyTransactions" roleURI="http://www.plumpartners.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_CommitmentsandContingencies" roleURI="http://www.plumpartners.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersDeficit" roleURI="http://www.plumpartners.com/role/ShareholdersDeficit"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReporting" roleURI="http://www.plumpartners.com/role/SegmentReporting"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SubsequentEvents" roleURI="http://www.plumpartners.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_AccountingPoliciesByPolicy" roleURI="http://www.plumpartners.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReportingTables" roleURI="http://www.plumpartners.com/role/SegmentReportingTables"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ScheduleofKeyMetricIncludedinNetIncomeorLossTable" roleURI="http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_InitialPublicOfferingDetails" roleURI="http://www.plumpartners.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_PrivatePlacementDetails" roleURI="http://www.plumpartners.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_RelatedPartyTransactionsDetails" roleURI="http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_CommitmentsandContingenciesDetails" roleURI="http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersDeficitDetails" roleURI="http://www.plumpartners.com/role/ShareholdersDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReportingDetails" roleURI="http://www.plumpartners.com/role/SegmentReportingDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SubsequentEventsDetails" roleURI="http://www.plumpartners.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#DocumentAndEntityInformation" roleURI="http://www.plumpartners.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredOfferingCost" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="plmk_DeferredOfferingCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_AccruedOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_AccruedOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="plmk_AccruedOfferingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNotesPayableCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ProceedsFromSaleOfFounderShares" xlink:href="plmk-20241231.xsd#plmk_ProceedsFromSaleOfFounderShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="plmk_ProceedsFromSaleOfFounderShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/InitialPublicOffering" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialPublicOfferingTextBlock" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="plmk_InitialPublicOfferingTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/PrivatePlacement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementAbstract" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementAbstract"/>
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementTextBlock" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="plmk_PrivatePlacementAbstract" xlink:to="plmk_PrivatePlacementTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ShareholdersDeficit" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SegmentReporting" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_LiquidityAndCapitalResourcesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_EmergingGrowthCompanyPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_EmergingGrowthCompanyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="plmk_EmergingGrowthCompanyPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_DerivativeFinancialInstrumentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SegmentReportingTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_TitleOfIndividualAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_UnderwritersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_PlumPartnersIVLLCMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:href="plmk-20241231.xsd#plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_YearOfInception" xlink:href="plmk-20241231.xsd#plmk_YearOfInception"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_YearOfInception" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_AggregatePurchasePrice" xlink:href="plmk-20241231.xsd#plmk_AggregatePurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_AggregatePurchasePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_TransactionCosts" xlink:href="plmk-20241231.xsd#plmk_TransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_TransactionCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SaleOfStockUnderwritingFees" xlink:href="plmk-20241231.xsd#plmk_SaleOfStockUnderwritingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_SaleOfStockUnderwritingFees" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredUnderwritingFee" xlink:href="plmk-20241231.xsd#plmk_DeferredUnderwritingFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_DeferredUnderwritingFee" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_OtherOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_OtherOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_OtherOfferingCosts" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialAmountHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_InitialAmountHeldInTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_InitialAmountHeldInTrustAccount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_AggregatePublicShareRate" xlink:href="plmk-20241231.xsd#plmk_AggregatePublicShareRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_AggregatePublicShareRate" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_InterestUsedToPayDissolutionExpensesMaximum" xlink:href="plmk-20241231.xsd#plmk_InterestUsedToPayDissolutionExpensesMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_InterestUsedToPayDissolutionExpensesMaximum" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SharePricePerPublicShare" xlink:href="plmk-20241231.xsd#plmk_SharePricePerPublicShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="plmk_SharePricePerPublicShare" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_WorkingCapitalDeficit" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="plmk_WorkingCapitalDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/InitialPublicOfferingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialPublicOfferingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_InitialPublicOfferingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantMember" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantMember"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1v8iHCp4t8nyEe2lGz1ID+GE=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="plmk_PublicWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesIssuedPerUnit" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesIssuedPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_NumberOfSharesIssuedPerUnit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/PrivatePlacementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementDetailsTable" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="plmk_PrivatePlacementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_PrivatePlacementDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_PrivatePlacementDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_UnderwritersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_PlumPartnersIVLLCMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_SponsorMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantMember" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="plmk_PublicWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:href="plmk-20241231.xsd#plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_RelatedPartyTransactionsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_FounderSharesMember" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="plmk_FounderSharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_FounderSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_WorkingCapitalLoansMember" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_WorkingCapitalLoansMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PromissoryNoteMember" xlink:href="plmk-20241231.xsd#plmk_PromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="plmk_PromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="plmk_WorkingCapitalLoansMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesSurrendered" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesSurrendered"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_NumberOfSharesSurrendered" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:href="plmk-20241231.xsd#plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:href="plmk-20241231.xsd#plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_CommonStockSharesTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockSharesTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_CommonStockSharesTransferred" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfIndependentDirector" xlink:href="plmk-20241231.xsd#plmk_NumberOfIndependentDirector"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_NumberOfIndependentDirector" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_CommonStockValueTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockValueTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_CommonStockValueTransferred" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_FairValueOfSharesGranted" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_FairValueOfSharesGranted" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_FairValueOfSharesGrantedAmount" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGrantedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="plmk_FairValueOfSharesGrantedAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_UnsecuredDebt" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherNotesPayable" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherReceivables" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalAndContractServicesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProfessionalAndContractServicesExpense" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_CommitmentsandContingenciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritingAgreementMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritingAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="plmk_UnderwritingAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfAdditionalUnitsPurchased" xlink:href="plmk-20241231.xsd#plmk_NumberOfAdditionalUnitsPurchased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_NumberOfAdditionalUnitsPurchased" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritingDiscountPricePerUnit" xlink:href="plmk-20241231.xsd#plmk_UnderwritingDiscountPricePerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_UnderwritingDiscountPricePerUnit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_CashUnderwritingPaidPerUnit" xlink:href="plmk-20241231.xsd#plmk_CashUnderwritingPaidPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_CashUnderwritingPaidPerUnit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:href="plmk-20241231.xsd#plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredFeePerUnit" xlink:href="plmk-20241231.xsd#plmk_DeferredFeePerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="plmk_DeferredFeePerUnit" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/ShareholdersDeficitDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_ShareholdersDeficitDetailsTable" xlink:href="plmk-20241231.xsd#plmk_ShareholdersDeficitDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_ShareholdersDeficitDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_ShareholdersDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_ShareholdersDeficitDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NoticePeriodToBeGivenPriorToRedemption" xlink:href="plmk-20241231.xsd#plmk_NoticePeriodToBeGivenPriorToRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_NoticePeriodToBeGivenPriorToRedemption" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:href="plmk-20241231.xsd#plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_EstablishedPerShare" xlink:href="plmk-20241231.xsd#plmk_EstablishedPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_EstablishedPerShare" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantExercisePrice" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PublicWarrantExercisePrice" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_TotalEquityProceedsPercentage" xlink:href="plmk-20241231.xsd#plmk_TotalEquityProceedsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_TotalEquityProceedsPercentage" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="plmk-20241231.xsd#plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantsAdjustedPercentage" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsAdjustedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_PublicWarrantsAdjustedPercentage" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_MarketValueInPercentage" xlink:href="plmk-20241231.xsd#plmk_MarketValueInPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="plmk_MarketValueInPercentage" order="26" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SegmentReportingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_SegmentReportingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SegmentReportingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="plmk_SegmentReportingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:label="plmk_SubsequentEventsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="plmk_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="plmk_SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_FounderSharesMember" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_FounderSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_SponsorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="plmk_UnderwritersMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_SponsorMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_UnderwritersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="plmk_PlumPartnersIVLLCMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SponsorFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SponsorFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherReceivables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_AggregatePurchasePrice" xlink:href="plmk-20241231.xsd#plmk_AggregatePurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="plmk_AggregatePurchasePrice" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.plumpartners.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassAOrdinaryShares00001ParValuePerShareMember" xlink:href="plmk-20241231.xsd#plmk_ClassAOrdinaryShares00001ParValuePerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="plmk_ClassAOrdinaryShares00001ParValuePerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:href="plmk-20241231.xsd#plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:href="plmk-20241231.xsd#plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorOpinionTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>plmk-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:53 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholder&#8217;s Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDER&#8217;S DEFICIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash &#8211; Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash &#8211; Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Description of Organization and Business Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xml:lang="en-US">Initial Public Offering [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementAbstract" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PrivatePlacementAbstract_lbl" xml:lang="en-US">Private Placement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PrivatePlacementAbstract" xlink:to="plmk_PrivatePlacementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Shareholder&apos;s Deficit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityAbstract_lbl0" xml:lang="en-US">Shareholder&#8217;s Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Current asset - cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredOfferingCost" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_DeferredOfferingCost_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCost" xlink:to="plmk_DeferredOfferingCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDER&#8217;S DEFICIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Due to officer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_AccruedOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_AccruedOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_AccruedOfferingCosts_lbl" xml:lang="en-US">Accrued offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AccruedOfferingCosts" xlink:to="plmk_AccruedOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNotesPayableCurrent_lbl" xml:lang="en-US">Promissory note &#8212; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayableCurrent" xlink:to="us-gaap_OtherNotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preference shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preference shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preference shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preference shares, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preference shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preference shares, outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preference shares, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preference shares, issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Ordinary shares, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Share outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Formation and operating costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding, basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average shares outstanding, diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per ordinary shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per ordinary shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Class B ordinary shares to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Amount paid by sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Class B ordinary shares to Sponsor (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Issuance of shares in consideration (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl" xml:lang="en-US">Payment of formation and operating costs through promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:to="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates_lbl" xml:lang="en-US">Due to officer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ProceedsFromSaleOfFounderShares" xlink:href="plmk-20241231.xsd#plmk_ProceedsFromSaleOfFounderShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ProceedsFromSaleOfFounderShares_lbl" xml:lang="en-US">Proceeds from sale of founder shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ProceedsFromSaleOfFounderShares" xlink:to="plmk_ProceedsFromSaleOfFounderShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xml:lang="en-US">Deferred offering costs included in accrued offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl" xml:lang="en-US">Deferred offering costs paid through promissory note - related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:to="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of promissory note - related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Repayment of loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassAOrdinaryShares00001ParValuePerShareMember" xlink:href="plmk-20241231.xsd#plmk_ClassAOrdinaryShares00001ParValuePerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ClassAOrdinaryShares00001ParValuePerShareMember_lbl" xml:lang="en-US">Class A ordinary shares, $0.0001 par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassAOrdinaryShares00001ParValuePerShareMember" xlink:to="plmk_ClassAOrdinaryShares00001ParValuePerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:href="plmk-20241231.xsd#plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember_lbl" xml:lang="en-US">Warrants to purchase one share of Class A ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:to="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:href="plmk-20241231.xsd#plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember_lbl" xml:lang="en-US">Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:to="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Class A Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonClassAMember_lbl0" xml:lang="en-US">Class A ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US">Class A Ordinary Share [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl2" xml:lang="en-US">lass AOrdinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Class B Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonClassBMember_lbl0" xml:lang="en-US">Class B</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonClassBMember_lbl1" xml:lang="en-US">Class B Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl2" xml:lang="en-US">Class B ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialPublicOfferingTextBlock" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_InitialPublicOfferingTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialPublicOfferingTextBlock" xlink:to="plmk_InitialPublicOfferingTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementTextBlock" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PrivatePlacementTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PrivatePlacementTextBlock" xlink:to="plmk_PrivatePlacementTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDER&apos;S DEFICIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGEMENT REPORTING</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Key Metric Included in Net Income or Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">CODM [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:href="plmk-20241231.xsd#plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl" xml:lang="en-US">Condition for future business combination number of businesses minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:to="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_YearOfInception" xlink:href="plmk-20241231.xsd#plmk_YearOfInception"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_YearOfInception_lbl" xml:lang="en-US">Inception period description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_YearOfInception" xlink:to="plmk_YearOfInception_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Units sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Aggregate units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Purchase price per Unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl1" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl2" xml:lang="en-US">Price per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Gross proceeds from private placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Aggregate proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0" xml:lang="en-US">Restricted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_AggregatePurchasePrice" xlink:href="plmk-20241231.xsd#plmk_AggregatePurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_AggregatePurchasePrice_lbl" xml:lang="en-US">Aggregate purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePurchasePrice" xlink:to="plmk_AggregatePurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_TransactionCosts" xlink:href="plmk-20241231.xsd#plmk_TransactionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_TransactionCosts_lbl" xml:lang="en-US">Transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransactionCosts" xlink:to="plmk_TransactionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_SaleOfStockUnderwritingFees" xlink:href="plmk-20241231.xsd#plmk_SaleOfStockUnderwritingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_SaleOfStockUnderwritingFees_lbl" xml:lang="en-US">Underwriting fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SaleOfStockUnderwritingFees" xlink:to="plmk_SaleOfStockUnderwritingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredUnderwritingFee" xlink:href="plmk-20241231.xsd#plmk_DeferredUnderwritingFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_DeferredUnderwritingFee_lbl" xml:lang="en-US">Deferred underwriting fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredUnderwritingFee" xlink:to="plmk_DeferredUnderwritingFee_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_OtherOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_OtherOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_OtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_OtherOfferingCosts" xlink:to="plmk_OtherOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl" xml:lang="en-US">Percentage of net assets held in the trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:to="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of voting securities acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialAmountHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_InitialAmountHeldInTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_InitialAmountHeldInTrustAccount_lbl" xml:lang="en-US">Initial amount held in trust account (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialAmountHeldInTrustAccount" xlink:to="plmk_InitialAmountHeldInTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_AggregatePublicShareRate" xlink:href="plmk-20241231.xsd#plmk_AggregatePublicShareRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_AggregatePublicShareRate_lbl" xml:lang="en-US">Aggregate public share rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePublicShareRate" xlink:to="plmk_AggregatePublicShareRate_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl" xml:lang="en-US">Percentage of public shares to be redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:to="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_InterestUsedToPayDissolutionExpensesMaximum" xlink:href="plmk-20241231.xsd#plmk_InterestUsedToPayDissolutionExpensesMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl" xml:lang="en-US">Interest to pay dissolution expenses, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InterestUsedToPayDissolutionExpensesMaximum" xlink:to="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_SharePricePerPublicShare" xlink:href="plmk-20241231.xsd#plmk_SharePricePerPublicShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_SharePricePerPublicShare_lbl" xml:lang="en-US">Share price per public share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SharePricePerPublicShare" xlink:to="plmk_SharePricePerPublicShare_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_WorkingCapitalDeficit" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WorkingCapitalDeficit" xlink:to="plmk_WorkingCapitalDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Shares were subject to forfeiture (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0" xml:lang="en-US">Shares subject to forfeiture (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">FDIC coverage amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesIssuedPerUnit" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesIssuedPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfSharesIssuedPerUnit_lbl" xml:lang="en-US">Number of shares in a unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesIssuedPerUnit" xlink:to="plmk_NumberOfSharesIssuedPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:href="plmk-20241231.xsd#plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl" xml:lang="en-US">Number of days restricted private placement shares will be subject to transfer restrictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:to="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesSurrendered" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesSurrendered"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfSharesSurrendered_lbl" xml:lang="en-US">Number of shares surrendered (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesSurrendered" xlink:to="plmk_NumberOfSharesSurrendered_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:href="plmk-20241231.xsd#plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl" xml:lang="en-US">Percentage of shares issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:to="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl" xml:lang="en-US">Shares are no longer subject to forfeiture (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl0" xml:lang="en-US">(in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xml:lang="en-US">Stock price trigger to transfer (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl" xml:lang="en-US">Trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:to="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:href="plmk-20241231.xsd#plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl" xml:lang="en-US">Threshold consecutive trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:to="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_CommonStockSharesTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockSharesTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_CommonStockSharesTransferred_lbl" xml:lang="en-US">Number of shares transferred (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockSharesTransferred" xlink:to="plmk_CommonStockSharesTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfIndependentDirector" xlink:href="plmk-20241231.xsd#plmk_NumberOfIndependentDirector"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfIndependentDirector_lbl" xml:lang="en-US">Number of independent directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfIndependentDirector" xlink:to="plmk_NumberOfIndependentDirector_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_CommonStockValueTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockValueTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_CommonStockValueTransferred_lbl" xml:lang="en-US">Common stock value transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockValueTransferred" xlink:to="plmk_CommonStockValueTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_FairValueOfSharesGranted" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_FairValueOfSharesGranted_lbl" xml:lang="en-US">Fair value of shares granted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGranted" xlink:to="plmk_FairValueOfSharesGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_FairValueOfSharesGrantedAmount" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGrantedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_FairValueOfSharesGrantedAmount_lbl" xml:lang="en-US">Amount of fair value of shares granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGrantedAmount" xlink:to="plmk_FairValueOfSharesGrantedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnsecuredDebt_lbl" xml:lang="en-US">Aggregate principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNotesPayable_lbl" xml:lang="en-US">Owned amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayable" xlink:to="us-gaap_OtherNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Due from sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Amount returned from sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TravelAndEntertainmentExpense_lbl" xml:lang="en-US">Travel related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TravelAndEntertainmentExpense" xlink:to="us-gaap_TravelAndEntertainmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalAndContractServicesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalAndContractServicesExpense_lbl" xml:lang="en-US">Aggregate payment per month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="us-gaap_ProfessionalAndContractServicesExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NumberOfAdditionalUnitsPurchased" xlink:href="plmk-20241231.xsd#plmk_NumberOfAdditionalUnitsPurchased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NumberOfAdditionalUnitsPurchased_lbl" xml:lang="en-US">Number of additional unit purchased (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfAdditionalUnitsPurchased" xlink:to="plmk_NumberOfAdditionalUnitsPurchased_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritingDiscountPricePerUnit" xlink:href="plmk-20241231.xsd#plmk_UnderwritingDiscountPricePerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_UnderwritingDiscountPricePerUnit_lbl" xml:lang="en-US">Underwriting discount price per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritingDiscountPricePerUnit" xlink:to="plmk_UnderwritingDiscountPricePerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US">Aggregate underwriting discount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_CashUnderwritingPaidPerUnit" xlink:href="plmk-20241231.xsd#plmk_CashUnderwritingPaidPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_CashUnderwritingPaidPerUnit_lbl" xml:lang="en-US">Cash underwriting paid per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CashUnderwritingPaidPerUnit" xlink:to="plmk_CashUnderwritingPaidPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:href="plmk-20241231.xsd#plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl" xml:lang="en-US">Purchase of private placement of underwriters per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:to="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_DeferredFeePerUnit" xlink:href="plmk-20241231.xsd#plmk_DeferredFeePerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_DeferredFeePerUnit_lbl" xml:lang="en-US">Deferred fee per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredFeePerUnit" xlink:to="plmk_DeferredFeePerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock voting rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl" xml:lang="en-US">Public warrants exercisable after the completion of business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:to="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant expiration term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl" xml:lang="en-US">Number of business days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:to="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl" xml:lang="en-US">Effective business days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:to="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl" xml:lang="en-US">Price per warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:to="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_NoticePeriodToBeGivenPriorToRedemption" xlink:href="plmk-20241231.xsd#plmk_NoticePeriodToBeGivenPriorToRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl" xml:lang="en-US">Notice of redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NoticePeriodToBeGivenPriorToRedemption" xlink:to="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare_lbl" xml:lang="en-US">Preferred Stock, Redemption Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionPricePerShare" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_EstablishedPerShare" xlink:href="plmk-20241231.xsd#plmk_EstablishedPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_EstablishedPerShare_lbl" xml:lang="en-US">Established Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EstablishedPerShare" xlink:to="plmk_EstablishedPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl" xml:lang="en-US">Redemption trigger price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:to="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantExercisePrice" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PublicWarrantExercisePrice_lbl" xml:lang="en-US">Public warrant exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantExercisePrice" xlink:to="plmk_PublicWarrantExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_TotalEquityProceedsPercentage" xlink:href="plmk-20241231.xsd#plmk_TotalEquityProceedsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_TotalEquityProceedsPercentage_lbl" xml:lang="en-US">Total Equity Proceeds Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TotalEquityProceedsPercentage" xlink:to="plmk_TotalEquityProceedsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="plmk-20241231.xsd#plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl" xml:lang="en-US">Market price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantsAdjustedPercentage" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsAdjustedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PublicWarrantsAdjustedPercentage_lbl" xml:lang="en-US">Public Warrants Adjusted Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsAdjustedPercentage" xlink:to="plmk_PublicWarrantsAdjustedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_MarketValueInPercentage" xlink:href="plmk-20241231.xsd#plmk_MarketValueInPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_MarketValueInPercentage_lbl" xml:lang="en-US">Market value in percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_MarketValueInPercentage" xlink:to="plmk_MarketValueInPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SponsorFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SponsorFees_lbl" xml:lang="en-US">Paid sponsor balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_LiquidityAndCapitalResourcesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl" xml:lang="en-US">Liquidity and Capital Resources</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:to="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_EmergingGrowthCompanyPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_EmergingGrowthCompanyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EmergingGrowthCompanyPolicyTextBlock" xlink:to="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrant Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_DerivativeFinancialInstrumentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl" xml:lang="en-US">Derivative financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" xlink:to="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1vzVBHkOIqde7V5HfBn0v5LM=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_UnderwritersMember_lbl" xml:lang="en-US">Underwriters [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritersMember" xlink:to="plmk_UnderwritersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PlumPartnersIVLLCMember_lbl" xml:lang="en-US">Plum Partners IV, LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PlumPartnersIVLLCMember" xlink:to="plmk_PlumPartnersIVLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xml:lang="en-US">Short-Term Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PublicWarrantMember" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PublicWarrantMember_lbl" xml:lang="en-US">Public Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantMember" xlink:to="plmk_PublicWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SponsorMember" xlink:to="plmk_SponsorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_FounderSharesMember" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_FounderSharesMember_lbl" xml:lang="en-US">Founder Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FounderSharesMember" xlink:to="plmk_FounderSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PromissoryNoteMember" xlink:href="plmk-20241231.xsd#plmk_PromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PromissoryNoteMember" xlink:to="plmk_PromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_WorkingCapitalLoansMember" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_WorkingCapitalLoansMember_lbl" xml:lang="en-US">Working Capital Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WorkingCapitalLoansMember" xlink:to="plmk_WorkingCapitalLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_UnderwritingAgreementMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritingAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="plmk_UnderwritingAgreementMember_lbl" xml:lang="en-US">Underwriting Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritingAgreementMember" xlink:to="plmk_UnderwritingAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title and Position [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Schedule of Key Metric Included in Net Income or Loss [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable_lbl" xml:lang="en-US">Description of Organization and Business Operations (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Description of Organization and Business Operations [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="plmk_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangeInAccountingEstimateLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_ChangeInAccountingEstimateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_InitialPublicOfferingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_InitialPublicOfferingDetailsTable_lbl" xml:lang="en-US">Initial Public Offering (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialPublicOfferingDetailsTable" xlink:to="plmk_InitialPublicOfferingDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Initial Public Offering [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_PrivatePlacementDetailsTable" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PrivatePlacementDetailsTable_lbl" xml:lang="en-US">Private Placement (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PrivatePlacementDetailsTable" xlink:to="plmk_PrivatePlacementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Private Placement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_RelatedPartyTransactionsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_RelatedPartyTransactionsDetailsTable" xlink:to="plmk_RelatedPartyTransactionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transactions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_CommitmentsandContingenciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommitmentsandContingenciesDetailsTable" xlink:to="plmk_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="plmk_ShareholdersDeficitDetailsTable" xlink:href="plmk-20241231.xsd#plmk_ShareholdersDeficitDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ShareholdersDeficitDetailsTable_lbl" xml:lang="en-US">Shareholder&apos;s Deficit (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ShareholdersDeficitDetailsTable" xlink:to="plmk_ShareholdersDeficitDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl0" xml:lang="en-US">Shareholder&apos;s Deficit [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_SegmentReportingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SegmentReportingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SegmentReportingDetailsTable_lbl" xml:lang="en-US">Segment Reporting (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SegmentReportingDetailsTable" xlink:to="plmk_SegmentReportingDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl0" xml:lang="en-US">Segment Reporting [Line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_SubsequentEventsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SubsequentEventsDetailsTable" xlink:to="plmk_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_AccruedOfferingCosts_lbl0" xml:lang="en-US">Accrued offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AccruedOfferingCosts" xlink:to="plmk_AccruedOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_AggregatePublicShareRate_lbl0" xml:lang="en-US">Aggregate public share rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePublicShareRate" xlink:to="plmk_AggregatePublicShareRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_AggregatePurchasePrice_lbl0" xml:lang="en-US">The amount of aggregate purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePurchasePrice" xlink:to="plmk_AggregatePurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_CashUnderwritingPaidPerUnit_lbl0" xml:lang="en-US">Represent the cash underwriting paid per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CashUnderwritingPaidPerUnit" xlink:to="plmk_CashUnderwritingPaidPerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl0" xml:lang="en-US">Price of the entity&apos;s common stock which would be required to be attained to trigger the redemption of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:to="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl0" xml:lang="en-US">Class of warrants or rights redemption price per warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:to="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_CommonStockSharesTransferred_lbl0" xml:lang="en-US">Common Stock, Shares Transferred.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockSharesTransferred" xlink:to="plmk_CommonStockSharesTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_CommonStockValueTransferred_lbl0" xml:lang="en-US">Common Stock Value Transferred.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockValueTransferred" xlink:to="plmk_CommonStockValueTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl0" xml:lang="en-US">The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:to="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_DeferredFeePerUnit_lbl0" xml:lang="en-US">Represent the deferred fee per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredFeePerUnit" xlink:to="plmk_DeferredFeePerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_DeferredOfferingCost_lbl0" xml:lang="en-US">Deferred offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCost" xlink:to="plmk_DeferredOfferingCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl0" xml:lang="en-US">Amount of deferred offering costs paid through promissory note - related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:to="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_DeferredUnderwritingFee_lbl0" xml:lang="en-US">The amount of deferred underwriting fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredUnderwritingFee" xlink:to="plmk_DeferredUnderwritingFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl0" xml:lang="en-US">The disclosure of accounting policies for derivative financial instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" xlink:to="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for emerging growth company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EmergingGrowthCompanyPolicyTextBlock" xlink:to="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_EstablishedPerShare_lbl0" xml:lang="en-US">Established per share price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EstablishedPerShare" xlink:to="plmk_EstablishedPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_FairValueOfSharesGranted_lbl0" xml:lang="en-US">Fair value of shares granted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGranted" xlink:to="plmk_FairValueOfSharesGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_FairValueOfSharesGrantedAmount_lbl0" xml:lang="en-US">The amount of fair value of shares granted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGrantedAmount" xlink:to="plmk_FairValueOfSharesGrantedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_InitialAmountHeldInTrustAccount_lbl0" xml:lang="en-US">Initial amount held in trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialAmountHeldInTrustAccount" xlink:to="plmk_InitialAmountHeldInTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_InitialPublicOfferingTextBlock_lbl0" xml:lang="en-US">The entire disclosure of the initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialPublicOfferingTextBlock" xlink:to="plmk_InitialPublicOfferingTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl0" xml:lang="en-US">Interest Used To Pay Dissolution Expenses, Maximum.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InterestUsedToPayDissolutionExpensesMaximum" xlink:to="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for liquidity and capital resources.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:to="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_MarketValueInPercentage_lbl0" xml:lang="en-US">The market value in percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_MarketValueInPercentage" xlink:to="plmk_MarketValueInPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl0" xml:lang="en-US">Notice period to be given prior to redemption, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NoticePeriodToBeGivenPriorToRedemption" xlink:to="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfAdditionalUnitsPurchased_lbl0" xml:lang="en-US">Represent the number of additional units purchased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfAdditionalUnitsPurchased" xlink:to="plmk_NumberOfAdditionalUnitsPurchased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl0" xml:lang="en-US">Number of  days restricted private placement shares will be subject to transfer restrictions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:to="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfIndependentDirector_lbl0" xml:lang="en-US">Number Of Independent Director.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfIndependentDirector" xlink:to="plmk_NumberOfIndependentDirector_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfSharesIssuedPerUnit_lbl0" xml:lang="en-US">Represents the number of shares in a unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesIssuedPerUnit" xlink:to="plmk_NumberOfSharesIssuedPerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl1" xml:lang="en-US">The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_NumberOfSharesSurrendered_lbl0" xml:lang="en-US">Number of shares surrendered.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesSurrendered" xlink:to="plmk_NumberOfSharesSurrendered_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_OtherOfferingCosts_lbl0" xml:lang="en-US">The amount of other offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_OtherOfferingCosts" xlink:to="plmk_OtherOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl0" xml:lang="en-US">Amount of payment of formation and operating costs through promissory note &#8211; related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:to="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl0" xml:lang="en-US">The percentage of fair market value of assets held in the trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:to="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl0" xml:lang="en-US">Percentage of public shares to be redeemed on non completion of business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:to="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl0" xml:lang="en-US">The expected ownership percentage by the founders after completion of the proposed public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:to="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl0" xml:lang="en-US">Period within which the registration of warrants shall be effective from the closure of business combination, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:to="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl0" xml:lang="en-US">Period within which the warrants shall be registered with the securities exchange commission, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:to="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl0" xml:lang="en-US">Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PrivatePlacementTextBlock_lbl0" xml:lang="en-US">The entire disclosure of private placement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PrivatePlacementTextBlock" xlink:to="plmk_PrivatePlacementTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ProceedsFromSaleOfFounderShares_lbl0" xml:lang="en-US">Amount of proceeds from sale of founder shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ProceedsFromSaleOfFounderShares" xlink:to="plmk_ProceedsFromSaleOfFounderShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PublicWarrantExercisePrice_lbl0" xml:lang="en-US">Public warrant exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantExercisePrice" xlink:to="plmk_PublicWarrantExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PublicWarrantsAdjustedPercentage_lbl0" xml:lang="en-US">The public warrants adjusted percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsAdjustedPercentage" xlink:to="plmk_PublicWarrantsAdjustedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl0" xml:lang="en-US">Represent the public warrants exercisable after the completion of business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:to="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl0" xml:lang="en-US">Represent the purchase of private placement of underwriters per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:to="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_SaleOfStockUnderwritingFees_lbl0" xml:lang="en-US">Represents the amount of offering fees incurred and paid for underwriters.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SaleOfStockUnderwritingFees" xlink:to="plmk_SaleOfStockUnderwritingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_SharePricePerPublicShare_lbl0" xml:lang="en-US">Share price per public share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SharePricePerPublicShare" xlink:to="plmk_SharePricePerPublicShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl0" xml:lang="en-US">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:to="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl0" xml:lang="en-US">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:to="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_TotalEquityProceedsPercentage_lbl0" xml:lang="en-US">Total equity proceeds percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TotalEquityProceedsPercentage" xlink:to="plmk_TotalEquityProceedsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_TransactionCosts_lbl0" xml:lang="en-US">Represents the amount of transaction costs incurred.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransactionCosts" xlink:to="plmk_TransactionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl0" xml:lang="en-US">The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_UnderwritingDiscountPricePerUnit_lbl0" xml:lang="en-US">Underwriting discount price per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritingDiscountPricePerUnit" xlink:to="plmk_UnderwritingDiscountPricePerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl2" xml:lang="en-US">Number of new units issued during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_WorkingCapitalDeficit_lbl0" xml:lang="en-US">Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WorkingCapitalDeficit" xlink:to="plmk_WorkingCapitalDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="plmk_YearOfInception_lbl0" xml:lang="en-US">Year of inception.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_YearOfInception" xlink:to="plmk_YearOfInception_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl1" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_UnderwritersMember_lbl0" xml:lang="en-US">Underwriters Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritersMember" xlink:to="plmk_UnderwritersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl1" xml:lang="en-US">Number Of Days Restricted Private Placement Shares Will Be Subject To Transfer Restrictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:to="plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl0" xml:lang="en-US">Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl1" xml:lang="en-US">Threshold Consecutive Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combinations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:to="plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_UnderwritingDiscountPricePerUnit_lbl1" xml:lang="en-US">Underwriting Discount Price Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritingDiscountPricePerUnit" xlink:to="plmk_UnderwritingDiscountPricePerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl1" xml:lang="en-US">Purchase Of Private Placement Of Underwriters Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:to="plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfSharesIssuedPerUnit_lbl1" xml:lang="en-US">Number Of Shares Issued Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesIssuedPerUnit" xlink:to="plmk_NumberOfSharesIssuedPerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNotesPayableCurrent_lbl0" xml:lang="en-US">Other Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayableCurrent" xlink:to="us-gaap_OtherNotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl0" xml:lang="en-US">Payments for Underwriting Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl1" xml:lang="en-US">Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:to="plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_OtherOfferingCosts_lbl1" xml:lang="en-US">Other Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_OtherOfferingCosts" xlink:to="plmk_OtherOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract" xlink:href="plmk-20241231.xsd#plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract_lbl" xml:lang="en-US">Schedule Of Key Metric Included In Net Income Or Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract" xlink:to="plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl0" xml:lang="en-US">Common Stock, Voting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_EstablishedPerShare_lbl1" xml:lang="en-US">Established Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EstablishedPerShare" xlink:to="plmk_EstablishedPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl1" xml:lang="en-US">Public Warrants Exercisable After The Completion Of Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:to="plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_AccruedOfferingCosts_lbl1" xml:lang="en-US">Accrued Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AccruedOfferingCosts" xlink:to="plmk_AccruedOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl1" xml:lang="en-US">Percentage Of Fair Market Value Of Assets Held In Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:to="plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl1" xml:lang="en-US">Liquidity And Capital Resources Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:to="plmk_LiquidityAndCapitalResourcesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_CommonStockValueTransferred_lbl1" xml:lang="en-US">Common Stock Value Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockValueTransferred" xlink:to="plmk_CommonStockValueTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl1" xml:lang="en-US">Payment Of Formation And Operating Costs Through Promissory Note Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:to="plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl1" xml:lang="en-US">Threshold Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:to="plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl0" xml:lang="en-US">Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_MarketValueInPercentage_lbl1" xml:lang="en-US">Market Value In Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_MarketValueInPercentage" xlink:to="plmk_MarketValueInPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl1" xml:lang="en-US">Repayments of Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember_lbl0" xml:lang="en-US">Units Each Consisting Of One Share Of Class AOrdinary Shares And Onehalf Of One Redeemable Warrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:to="plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfSharesSurrendered_lbl1" xml:lang="en-US">Number Of Shares Surrendered</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesSurrendered" xlink:to="plmk_NumberOfSharesSurrendered_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl1" xml:lang="en-US">Percentage Of Shares Issued And Outstanding Shares After Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:to="plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl1" xml:lang="en-US">Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:to="plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_FairValueOfSharesGrantedAmount_lbl1" xml:lang="en-US">Fair Value Of Shares Granted Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGrantedAmount" xlink:to="plmk_FairValueOfSharesGrantedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl1" xml:lang="en-US">Interest Used To Pay Dissolution Expenses Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InterestUsedToPayDissolutionExpensesMaximum" xlink:to="plmk_InterestUsedToPayDissolutionExpensesMaximum_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SponsorFees_lbl0" xml:lang="en-US">Sponsor Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DeferredOfferingCost_lbl1" xml:lang="en-US">Deferred Offering Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCost" xlink:to="plmk_DeferredOfferingCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_AggregatePurchasePrice_lbl1" xml:lang="en-US">Aggregate Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePurchasePrice" xlink:to="plmk_AggregatePurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl0" xml:lang="en-US">Chief Financial Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl0" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl0" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SharePricePerPublicShare_lbl1" xml:lang="en-US">Share Price Per Public Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SharePricePerPublicShare" xlink:to="plmk_SharePricePerPublicShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl1" xml:lang="en-US">Condition For Future Business Combination Number Of Businesses Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:to="plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNotesPayable_lbl0" xml:lang="en-US">Other Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayable" xlink:to="us-gaap_OtherNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_UnderwritingAgreementMember_lbl0" xml:lang="en-US">Underwriting Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnderwritingAgreementMember" xlink:to="plmk_UnderwritingAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_TransactionCosts_lbl1" xml:lang="en-US">Transaction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransactionCosts" xlink:to="plmk_TransactionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PublicWarrantExercisePrice_lbl1" xml:lang="en-US">Public Warrant Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantExercisePrice" xlink:to="plmk_PublicWarrantExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_TotalEquityProceedsPercentage_lbl1" xml:lang="en-US">Total Equity Proceeds Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TotalEquityProceedsPercentage" xlink:to="plmk_TotalEquityProceedsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_WorkingCapitalLoansMember_lbl0" xml:lang="en-US">Working Capital Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WorkingCapitalLoansMember" xlink:to="plmk_WorkingCapitalLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_FairValueOfSharesGranted_lbl1" xml:lang="en-US">Fair Value Of Shares Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FairValueOfSharesGranted" xlink:to="plmk_FairValueOfSharesGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ClassAOrdinaryShares00001ParValuePerShareMember_lbl0" xml:lang="en-US">Class AOrdinary Shares00001 Par Value Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassAOrdinaryShares00001ParValuePerShareMember" xlink:to="plmk_ClassAOrdinaryShares00001ParValuePerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PublicWarrantsAdjustedPercentage_lbl1" xml:lang="en-US">Public Warrants Adjusted Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantsAdjustedPercentage" xlink:to="plmk_PublicWarrantsAdjustedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_WorkingCapitalDeficit_lbl1" xml:lang="en-US">Working Capital Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WorkingCapitalDeficit" xlink:to="plmk_WorkingCapitalDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare_lbl0" xml:lang="en-US">Preferred Stock, Redemption Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionPricePerShare" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember_lbl0" xml:lang="en-US">Warrants To Purchase One Share Of Class AOrdinary Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:to="plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_YearOfInception_lbl1" xml:lang="en-US">Year Of Inception</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_YearOfInception" xlink:to="plmk_YearOfInception_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_AggregatePublicShareRate_lbl1" xml:lang="en-US">Aggregate Public Share Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_AggregatePublicShareRate" xlink:to="plmk_AggregatePublicShareRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_CashUnderwritingPaidPerUnit_lbl1" xml:lang="en-US">Cash Underwriting Paid Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CashUnderwritingPaidPerUnit" xlink:to="plmk_CashUnderwritingPaidPerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_InitialPublicOfferingTextBlock_lbl1" xml:lang="en-US">Initial Public Offering Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialPublicOfferingTextBlock" xlink:to="plmk_InitialPublicOfferingTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl3" xml:lang="en-US">Units Issued During Period Shares New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="plmk_UnitsIssuedDuringPeriodSharesNewIssues_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl1" xml:lang="en-US">Period Within Which The Registration Of Warrants Shall Be Effective From The Closure Of Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:to="plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_CommonStockSharesTransferred_lbl1" xml:lang="en-US">Common Stock Shares Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_CommonStockSharesTransferred" xlink:to="plmk_CommonStockSharesTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfAdditionalUnitsPurchased_lbl1" xml:lang="en-US">Number Of Additional Units Purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfAdditionalUnitsPurchased" xlink:to="plmk_NumberOfAdditionalUnitsPurchased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PlumPartnersIVLLCMember_lbl0" xml:lang="en-US">Plum Partners IVLLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PlumPartnersIVLLCMember" xlink:to="plmk_PlumPartnersIVLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PrivatePlacementTextBlock_lbl1" xml:lang="en-US">Private Placement Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PrivatePlacementTextBlock" xlink:to="plmk_PrivatePlacementTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl0" xml:lang="en-US">Operating Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_FounderSharesMember_lbl0" xml:lang="en-US">Founder Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_FounderSharesMember" xlink:to="plmk_FounderSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebt_lbl0" xml:lang="en-US">Unsecured Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl1" xml:lang="en-US">Class Of Warrants Or Rights Redemption Price Per Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:to="plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_InitialAmountHeldInTrustAccount_lbl1" xml:lang="en-US">Initial Amount Held In Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_InitialAmountHeldInTrustAccount" xlink:to="plmk_InitialAmountHeldInTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl1" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PublicWarrantMember_lbl0" xml:lang="en-US">Public Warrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PublicWarrantMember" xlink:to="plmk_PublicWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SponsorMember_lbl0" xml:lang="en-US">Sponsor Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SponsorMember" xlink:to="plmk_SponsorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfIndependentDirector_lbl1" xml:lang="en-US">Number Of Independent Director</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfIndependentDirector" xlink:to="plmk_NumberOfIndependentDirector_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl1" xml:lang="en-US">Derivative Financial Instruments Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DerivativeFinancialInstrumentsPolicyTextBlock" xlink:to="plmk_DerivativeFinancialInstrumentsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl0" xml:lang="en-US">Cash, FDIC Insured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl0" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl0" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl1" xml:lang="en-US">Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DeferredUnderwritingFee_lbl1" xml:lang="en-US">Deferred Underwriting Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredUnderwritingFee" xlink:to="plmk_DeferredUnderwritingFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl1" xml:lang="en-US">Notice Period To Be Given Prior To Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NoticePeriodToBeGivenPriorToRedemption" xlink:to="plmk_NoticePeriodToBeGivenPriorToRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl1" xml:lang="en-US">Period Within Which The Warrants Shall Be Registered With The Securities Exchange Commission</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:to="plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalAndContractServicesExpense_lbl0" xml:lang="en-US">Professional and Contract Services Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="us-gaap_ProfessionalAndContractServicesExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl1" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_PromissoryNoteMember_lbl0" xml:lang="en-US">Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_PromissoryNoteMember" xlink:to="plmk_PromissoryNoteMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DeferredFeePerUnit_lbl1" xml:lang="en-US">Deferred Fee Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredFeePerUnit" xlink:to="plmk_DeferredFeePerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates_lbl0" xml:lang="en-US">Increase (Decrease) in Due to Affiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl1" xml:lang="en-US">Emerging Growth Company Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_EmergingGrowthCompanyPolicyTextBlock" xlink:to="plmk_EmergingGrowthCompanyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl1" xml:lang="en-US">Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Stock Price Trigger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_SaleOfStockUnderwritingFees_lbl1" xml:lang="en-US">Sale Of Stock Underwriting Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_SaleOfStockUnderwritingFees" xlink:to="plmk_SaleOfStockUnderwritingFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_ProceedsFromSaleOfFounderShares_lbl1" xml:lang="en-US">Proceeds From Sale Of Founder Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_ProceedsFromSaleOfFounderShares" xlink:to="plmk_ProceedsFromSaleOfFounderShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl2" xml:lang="en-US">Number Of Shares No Longer Subject To Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_NumberOfSharesNoLongerSubjectToForfeiture" xlink:to="plmk_NumberOfSharesNoLongerSubjectToForfeiture_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TravelAndEntertainmentExpense_lbl0" xml:lang="en-US">Travel and Entertainment Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TravelAndEntertainmentExpense" xlink:to="us-gaap_TravelAndEntertainmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl0" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl1" xml:lang="en-US">Deferred Offering Costs Paid Through Promissory Note Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:to="plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl0" xml:lang="en-US">Short-Term Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>plmk-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Mar 31 20:47:53 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedBalanceSheet" roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedIncomeStatement" roleURI="http://www.plumpartners.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersEquityType2or3" roleURI="http://www.plumpartners.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ConsolidatedCashFlow" roleURI="http://www.plumpartners.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_DescriptionofOrganizationandBusinessOperations" roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_InitialPublicOffering" roleURI="http://www.plumpartners.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_PrivatePlacement" roleURI="http://www.plumpartners.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_RelatedPartyTransactions" roleURI="http://www.plumpartners.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_CommitmentsandContingencies" roleURI="http://www.plumpartners.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersDeficit" roleURI="http://www.plumpartners.com/role/ShareholdersDeficit"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReporting" roleURI="http://www.plumpartners.com/role/SegmentReporting"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SubsequentEvents" roleURI="http://www.plumpartners.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_AccountingPoliciesByPolicy" roleURI="http://www.plumpartners.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReportingTables" roleURI="http://www.plumpartners.com/role/SegmentReportingTables"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ScheduleofKeyMetricIncludedinNetIncomeorLossTable" roleURI="http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_InitialPublicOfferingDetails" roleURI="http://www.plumpartners.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_PrivatePlacementDetails" roleURI="http://www.plumpartners.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_RelatedPartyTransactionsDetails" roleURI="http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_CommitmentsandContingenciesDetails" roleURI="http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_ShareholdersDeficitDetails" roleURI="http://www.plumpartners.com/role/ShareholdersDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SegmentReportingDetails" roleURI="http://www.plumpartners.com/role/SegmentReportingDetails"/>
  <roleRef xlink:type="simple" xlink:href="plmk-20241231.xsd#plmk_r_SubsequentEventsDetails" roleURI="http://www.plumpartners.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingCost" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="DeferredOfferingCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_AccruedOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="AccruedOfferingCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherNotesPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSaleOfFounderShares" xlink:href="plmk-20241231.xsd#plmk_ProceedsFromSaleOfFounderShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSaleOfFounderShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" xlink:href="plmk-20241231.xsd#plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/InitialPublicOffering" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingTextBlock" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="InitialPublicOfferingTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/PrivatePlacement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="PrivatePlacementAbstract" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementTextBlock" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementAbstract" xlink:to="PrivatePlacementTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ShareholdersDeficit" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SegmentReporting" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiquidityAndCapitalResourcesPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_LiquidityAndCapitalResourcesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="LiquidityAndCapitalResourcesPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthCompanyPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_EmergingGrowthCompanyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="EmergingGrowthCompanyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeFinancialInstrumentsPolicyTextBlock" xlink:href="plmk-20241231.xsd#plmk_DerivativeFinancialInstrumentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DerivativeFinancialInstrumentsPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SegmentReportingTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract" xlink:href="plmk-20241231.xsd#plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_ChiefFinancialOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="DescriptionofOrganizationandBusinessOperationsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="UnderwritersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="PlumPartnersIVLLCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofOrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:href="plmk-20241231.xsd#plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="YearOfInception" xlink:href="plmk-20241231.xsd#plmk_YearOfInception"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="YearOfInception" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregatePurchasePrice" xlink:href="plmk-20241231.xsd#plmk_AggregatePurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AggregatePurchasePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCosts" xlink:href="plmk-20241231.xsd#plmk_TransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="TransactionCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockUnderwritingFees" xlink:href="plmk-20241231.xsd#plmk_SaleOfStockUnderwritingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SaleOfStockUnderwritingFees" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredUnderwritingFee" xlink:href="plmk-20241231.xsd#plmk_DeferredUnderwritingFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="DeferredUnderwritingFee" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherOfferingCosts" xlink:href="plmk-20241231.xsd#plmk_OtherOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="OtherOfferingCosts" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfFairMarketValueOfAssetsHeldInTrustAccount" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialAmountHeldInTrustAccount" xlink:href="plmk-20241231.xsd#plmk_InitialAmountHeldInTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="InitialAmountHeldInTrustAccount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregatePublicShareRate" xlink:href="plmk-20241231.xsd#plmk_AggregatePublicShareRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AggregatePublicShareRate" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestUsedToPayDissolutionExpensesMaximum" xlink:href="plmk-20241231.xsd#plmk_InterestUsedToPayDissolutionExpensesMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="InterestUsedToPayDissolutionExpensesMaximum" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePricePerPublicShare" xlink:href="plmk-20241231.xsd#plmk_SharePricePerPublicShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SharePricePerPublicShare" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbRorytgdOsBs5EULMwHAlndETSOoA8uUETvKhIKg9JQXGK8Y2wYgRJgRwk3C1pAfZdR7VKNAbAlFXuiuEs636e2U2T3ZQ6nL4vdhqukqg7e9qCWYg3uoqMo7Nksr3glJH8rMnbXM9eBbnobftAFIbKDHDY+jmJ1NBsJo9RGfuPIo12hExcI3BQT8rQHLfTF/o3QUCJBTZbJ4XGdV0fa6UDBYuDrh6YoV9/1ihtsYC1v1n2h70W7iFug8GBgL8cwkk=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_ShortTermInvestmentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ChangeInAccountingEstimateLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalDeficit" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="WorkingCapitalDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/InitialPublicOfferingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_InitialPublicOfferingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="InitialPublicOfferingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantMember" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesIssuedPerUnit" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesIssuedPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfSharesIssuedPerUnit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/PrivatePlacementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="PrivatePlacementAbstract" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementDetailsTable" xlink:href="plmk-20241231.xsd#plmk_PrivatePlacementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementAbstract" xlink:to="PrivatePlacementDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantMember" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="UnderwritersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="PlumPartnersIVLLCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" xlink:href="plmk-20241231.xsd#plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FounderSharesMember" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="FounderSharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_DirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FounderSharesMember_0" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="FounderSharesMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalLoansMember" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="WorkingCapitalLoansMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PromissoryNoteMember" xlink:href="plmk-20241231.xsd#plmk_PromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalLoansMember_0" xlink:href="plmk-20241231.xsd#plmk_WorkingCapitalLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="WorkingCapitalLoansMember_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesSurrendered" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesSurrendered"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="NumberOfSharesSurrendered" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" xlink:href="plmk-20241231.xsd#plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesNoLongerSubjectToForfeiture" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="NumberOfSharesNoLongerSubjectToForfeiture" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:href="plmk-20241231.xsd#plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSharesTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockSharesTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="CommonStockSharesTransferred" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfIndependentDirector" xlink:href="plmk-20241231.xsd#plmk_NumberOfIndependentDirector"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="NumberOfIndependentDirector" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockValueTransferred" xlink:href="plmk-20241231.xsd#plmk_CommonStockValueTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="CommonStockValueTransferred" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfSharesGranted" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="FairValueOfSharesGranted" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfSharesGrantedAmount" xlink:href="plmk-20241231.xsd#plmk_FairValueOfSharesGrantedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="FairValueOfSharesGrantedAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_UnsecuredDebt" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherNotesPayable" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherReceivables" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalAndContractServicesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProfessionalAndContractServicesExpense" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="plmk-20241231.xsd#plmk_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="UnderwritingAgreementMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritingAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="UnderwritingAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumberOfAdditionalUnitsPurchased" xlink:href="plmk-20241231.xsd#plmk_NumberOfAdditionalUnitsPurchased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="NumberOfAdditionalUnitsPurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UnderwritingDiscountPricePerUnit" xlink:href="plmk-20241231.xsd#plmk_UnderwritingDiscountPricePerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="UnderwritingDiscountPricePerUnit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashUnderwritingPaidPerUnit" xlink:href="plmk-20241231.xsd#plmk_CashUnderwritingPaidPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="CashUnderwritingPaidPerUnit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfPrivatePlacementOfUnderwritersPerUnit" xlink:href="plmk-20241231.xsd#plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="PurchaseOfPrivatePlacementOfUnderwritersPerUnit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredFeePerUnit" xlink:href="plmk-20241231.xsd#plmk_DeferredFeePerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="DeferredFeePerUnit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/ShareholdersDeficitDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersDeficitDetailsTable" xlink:href="plmk-20241231.xsd#plmk_ShareholdersDeficitDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="ShareholdersDeficitDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SponsorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantsOrRightsRedemptionPricePerWarrant" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ClassOfWarrantsOrRightsRedemptionPricePerWarrant" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NoticePeriodToBeGivenPriorToRedemption" xlink:href="plmk-20241231.xsd#plmk_NoticePeriodToBeGivenPriorToRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NoticePeriodToBeGivenPriorToRedemption" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:href="plmk-20241231.xsd#plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" xlink:href="plmk-20241231.xsd#plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EstablishedPerShare" xlink:href="plmk-20241231.xsd#plmk_EstablishedPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="EstablishedPerShare" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:href="plmk-20241231.xsd#plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantExercisePrice" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PublicWarrantExercisePrice" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TotalEquityProceedsPercentage" xlink:href="plmk-20241231.xsd#plmk_TotalEquityProceedsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="TotalEquityProceedsPercentage" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="plmk-20241231.xsd#plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsAdjustedPercentage" xlink:href="plmk-20241231.xsd#plmk_PublicWarrantsAdjustedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PublicWarrantsAdjustedPercentage" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketValueInPercentage" xlink:href="plmk-20241231.xsd#plmk_MarketValueInPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="MarketValueInPercentage" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SegmentReportingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentReportingDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SegmentReportingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="SegmentReportingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDetailsTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.plumpartners.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="plmk-20241231.xsd#plmk_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FounderSharesMember" xlink:href="plmk-20241231.xsd#plmk_FounderSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="FounderSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SponsorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritersMember" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="UnderwritersMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember_0" xlink:href="plmk-20241231.xsd#plmk_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritersMember_0" xlink:href="plmk-20241231.xsd#plmk_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="UnderwritersMember_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlumPartnersIVLLCMember" xlink:href="plmk-20241231.xsd#plmk_PlumPartnersIVLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="PlumPartnersIVLLCMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesNoLongerSubjectToForfeiture" xlink:href="plmk-20241231.xsd#plmk_NumberOfSharesNoLongerSubjectToForfeiture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="NumberOfSharesNoLongerSubjectToForfeiture" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SponsorFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SponsorFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherReceivables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="plmk-20241231.xsd#plmk_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregatePurchasePrice" xlink:href="plmk-20241231.xsd#plmk_AggregatePurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="AggregatePurchasePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ClassAOrdinaryShares00001ParValuePerShareMember" xlink:href="plmk-20241231.xsd#plmk_ClassAOrdinaryShares00001ParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ClassAOrdinaryShares00001ParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:href="plmk-20241231.xsd#plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:href="plmk-20241231.xsd#plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ClassAOrdinaryShares00001ParValuePerShareMember" xlink:href="plmk-20241231.xsd#plmk_ClassAOrdinaryShares00001ParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ClassAOrdinaryShares00001ParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" xlink:href="plmk-20241231.xsd#plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" xlink:href="plmk-20241231.xsd#plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PLUM ACQUISITION CORP. IV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002030482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1795710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2021 Fillmore St. #2089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-7125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=plmk_ClassAOrdinaryShares00001ParValuePerShareMember', window );">Class A ordinary shares, $0.0001 par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PLMK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember', window );">Warrants to purchase one share of Class A ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase one share of Class A ordinary shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PLMKW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember', window );">Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PLMKU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,492,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=plmk_ClassAOrdinaryShares00001ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=plmk_ClassAOrdinaryShares00001ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">WithumSmith+Brown, PC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Opinion on the Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have audited the accompanying balance
sheet of Plum Acquisition Corp. IV (the &#8220;Company&#8221;) as of December 31, 2024 and the related statement of operations, changes
in shareholder&#8217;s deficit and cash flows for the period from June 10, 2024 (inception) through December 31, 2024 and the related
notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows
for the period from June 10, 2024 (inception) through December 31, 2024, in conformity with accounting principles generally accepted in
the United States of America.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet<br></strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Current asset - cash</a></td>
<td class="nump">$ 3,864<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_DeferredOfferingCost', window );">Deferred offering costs</a></td>
<td class="nump">438,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">442,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">42,445<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to officer</a></td>
<td class="nump">12,374<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_AccruedOfferingCosts', window );">Accrued offering costs</a></td>
<td class="nump">304,904<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">509,196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholder&#8217;s Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">24,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(91,980)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholder&#8217;s Deficit</a></td>
<td class="num">(66,980)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDER&#8217;S DEFICIT</a></td>
<td class="nump">442,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayableCurrent', window );">Promissory note &#8212; related party</a></td>
<td class="nump">149,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholder&#8217;s Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, Value</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholder&#8217;s Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, Value</a></td>
<td class="nump">$ 575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_AccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_AccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_DeferredOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_DeferredOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet (Parentheticals)<br></strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preference shares, par value (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preference shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Operations<br></strong></div></th>
<th class="th" colspan="2">7 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs | $</a></td>
<td class="nump">$ 91,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss | $</a></td>
<td class="num">$ (91,980)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, basic (in Shares) | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, diluted (in Shares) | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per ordinary shares (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per ordinary shares (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Excluded an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively&#160;&#160;presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statement of Changes in Shareholder&#8217;s Deficit - 7 months ended Dec. 31, 2024 - USD ($)<br></strong></div></th>
<th class="th">
<div>Ordinary Shares </div>
<div>Class B</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 09, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Jun. 09, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B ordinary shares to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">24,425<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B ordinary shares to Sponsor (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(91,980)<span></span>
</td>
<td class="num">(91,980)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 24,425<span></span>
</td>
<td class="num">$ (91,980)<span></span>
</td>
<td class="num">$ (66,980)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Cash Flows<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (91,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty', window );">Payment of formation and operating costs through promissory note &#8211; related party</a></td>
<td class="nump">20,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">42,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToAffiliates', window );">Due to officer</a></td>
<td class="nump">12,374<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(16,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ProceedsFromSaleOfFounderShares', window );">Proceeds from sale of founder shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of promissory note - related party</a></td>
<td class="num">(1,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="num">(3,500)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">20,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="nump">3,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Ending</a></td>
<td class="nump">3,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Deferred offering costs included in accrued offering costs</a></td>
<td class="nump">304,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty', window );">Deferred offering costs paid through promissory note - related party</a></td>
<td class="nump">$ 129,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred offering costs paid through promissory note - related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment of formation and operating costs through promissory note &#8211; related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ProceedsFromSaleOfFounderShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from sale of founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ProceedsFromSaleOfFounderShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Description of Organization and Business Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 1&#8201;&#8212;&#8201;DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Plum Acquisition Corp.&#160;IV (the &#8220;Company&#8221;)
is a blank check company incorporated as a Cayman Islands exempted corporation on June&#160;10, 2024. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses (&#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is not limited to a particular industry
or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and,
as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company had not commenced
any operations. All activity for the period from June&#160;10, 2024 (inception) through December 31, 2024 relates to the Company&#8217;s
formation and the initial public offering (&#8220;Initial Public Offering&#8221;), which is described below. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31
as its fiscal year end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The registration statement for the Company&#8217;s
Initial Public Offering was declared effective on January 14, 2025. On January 16, 2025, the Company consummated the Initial Public Offering
of 17,250,000 units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered, the
&#8220;Public Shares&#8221;), which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $10.00 per Unit, generating gross proceeds of $172,500,000, which is discussed in Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,728,750, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of 232,875 private placement units for an aggregate
purchase price of $2,328,750 and (ii) by and between the Company and Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase
by the Sponsor of an aggregate of 440,000 private placement units and 570,000 restricted Class A ordinary shares for an aggregate purchase
price of $4,400,000. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Transaction costs amounted to $10,932,289, consisting
of $3,450,000 of cash underwriting fee, $6,900,000 of deferred underwriting fee, and $582,289 of other offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company&#8217;s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Securities,
although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company
must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least
80% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting commissions held in the Trust
Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act&#160;of&#160;1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company
will be able to successfully effect a Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Following the closing of the Initial Public Offering,
on January 16, 2025, an amount of $174,225,000 ($10.10 per Unit) from the net proceeds of the sale of the Units and the sale of the Private
Placement Securities was placed in the trust account (the &#8220;Trust Account&#8221;) and invested or held in either (i)&#160;U.S.&#160;government
treasury bills with a maturity of 185&#160;days or less or in money market funds investing solely in U.S.&#160;Treasuries, (ii)&#160;uninvested
cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank, as determined by the Company, until the
earlier of: (i)&#160;the completion of a Business Combination or (ii)&#160;the distribution of the funds in the Trust Account to the Company&#8217;s
shareholders, as described below. No later than 18&#160;months after the closing of the Initial Public Offering or such earlier liquidation
date as the Company&#8217;s board of directors may approve, or such later time as provided for in any amendment to the Company&#8217;s
Amended and Restated Memorandum and Articles of Association, (an &#8220;Extension Period&#8221;), subject to applicable law, the amounts
held in the Trust Account are held as cash or cash items, including in demand deposit accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will provide its shareholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection
with a general meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether
the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders
will be entitled to redeem their shares for a pro&#160;rata portion of the amount held in the Trust Account (initially $10.10 per share),
calculated as of two&#160;business days prior to the completion of a Business Combination, including any pro&#160;rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#8217;s public warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If the Company seeks shareholder approval in connection
with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires
the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required
under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or
other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions
pursuant to the tender offer rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), and file tender offer documents containing
substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares
(as defined in Note&#160;5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination
and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination.
Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether
they vote for or against a proposed Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Notwithstanding the foregoing, if the Company
seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company&#8217;s
Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder
or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the
Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#8220;Exchange&#160;Act&#8221;)), will be restricted from redeeming its
shares with respect to more than an aggregate of 15% of the Public Shares without the Company&#8217;s prior written consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed to (i)&#160;waive its redemption
rights with respect to its private placement shares in connection with the completion of the initial business combination, (ii)&#160;waive
its redemption rights with respect to its private placement shares in connection with a shareholder vote to approve an amendment to the
amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the obligation to allow redemption
in connection with the initial Business Combination or to redeem 100% of the public shares if the Company fails to complete the initial
Business Combination within 18&#160;months from the closing of the Initial Public Offering or such earlier liquidation date as the Company&#8217;s
board of directors may approve, or during any Extension Period, subject to applicable law or (B)&#160;with respect to any other provision
relating to shareholders&#8217; rights or pre-initial business combination activity and (iii)&#160;waive its rights to liquidating distributions
from the Trust Account with respect to its private placement shares if the Company fails to complete the initial Business Combination
within the prescribed timeframe. In addition, the Sponsor has agreed to vote any private placement shares held by it in favor of the initial
Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will have until 18&#160;months from
the closing of the Initial Public Offering (the &#8220;Combination Period&#8221;) to complete a Business Combination. If the Company is
unable to complete a Business Combination within the Combination Period, the Company will (i)&#160;cease all operations except for the
purpose of winding up, (ii)&#160;as promptly as reasonably possible but no more than 10&#160;business days thereafter, redeem 100% of
the outstanding Public Shares, at a per-share price, payable in cash, including interest earned on the funds held in the Trust Account
(which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released
to the Company to pay its taxes, if any, divided by the number of then-outstanding Public Shares, which redemption will completely extinguish
public shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii)&#160;as
promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company&#8217;s
board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of
creditors and the requirements of other applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed to waive its liquidation rights with respect
to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires
Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust
Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their
rights to their deferred underwriting commission (see Note&#160;6) held in the Trust Account in the event the Company does not complete
a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust
Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the
per share value of the assets remaining available for distribution will be less than the initial amount held in the Trust Account ($10.10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed that it will be liable
to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective
target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account
to below (1)&#160;$10.10 per Public Share or (2)&#160;such lesser amount per Public Share held in the Trust Account as of the date of
the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which
may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any
and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended
(the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party,
the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than the Company&#8217;s independent auditors), prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The United&#160;States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the
Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#8220;NATO&#8221;)
deployed additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries,
including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel,
increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting
measures that have been taken, and could be taken in the future, by NATO, the United&#160;States, the United Kingdom, the European Union,
Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional
and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased
cyber-attacks against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect the global economy and financial
markets and lead to instability and lack of liquidity in capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company&#8217;s search for an initial
business combination and any target business with which the Company may ultimately consummate an initial business combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 2&#8201;&#8212;&#8201;SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company had $3,864
in cash and a working capital deficit of $505,332. Further, the Company has incurred and expects to continue to incur significant costs
in pursuit of its acquisition plans. There is no assurance that the Company&#8217;s plans to raise capital will be successful. In connection
with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, &#8220;Going
Concern,&#8221; as of December 31, 2024, and including the closing of the Initial Public Offering on January 16, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements. The Company cannot assure that its plans to raise capital or to consummate an Initial Business Combination will be successful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Emerging Growth Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the
&#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial statement in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers all short-term investments
with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $3,864 in cash and no cash
equivalents as of December 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Deferred Offering Costs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company complies
with the requirements of the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 340-10-S99 and SEC Staff Accounting
Bulletin (&#8220;SAB&#8221;) Topic 5A &#8212; &#8220;Expenses of Offering.&#8221; Deferred offering costs consist principally of
professional and registration fees that are directly related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with
Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and
debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of
the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary
equity, and offering costs allocated to Public Warrants (as defined below) and Private Placement Units were charged to
shareholders&#8217; deficit as the Public and Private Placement Warrants (as defined below), after management&#8217;s evaluation,
were accounted for under equity treatment. On January 16, 2025, deferred offering costs amounting to $582,289 were charged to
shareholder&#8217;s equity upon the completion of the Initial Public Offering (see Note 1). As of December 31, 2024, there were
$438,352 of deferred offering costs recorded in the accompanying balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 14.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for income taxes under ASC&#160;740,
&#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). ASC&#160;740 requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">ASC&#160;740 also clarifies the accounting for
uncertainty in income taxes recognized in an enterprise&#8217;s financial statement and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of December 31, 2024. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is considered an exempted Cayman Islands
Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States.
As such, the Company&#8217;s tax provision was zero for the period presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Net Loss Per Ordinary Share</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Net loss per ordinary
share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period,
excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 750,000
Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment
option is exercised (see Note 5). At December 31, 2024, the Company did not have any dilutive securities and other contracts that
could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result,
diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company&#8217;s financial condition, results of operations, and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Fair Value of Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The fair value of the Company&#8217;s assets and
liabilities, which qualify as financial instruments under ASC Topic&#160;820, &#8220;Fair Value Measurement,&#8221; approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Warrant Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will account for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering, on January 16, 2025 and the private placement in accordance
with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging.&#8221; Accordingly, the Company evaluated and
classified the warrant instruments under equity treatment at their assigned values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Share-Based Compensation</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company records share-based compensation in
accordance with FASB ASC Topic 718, &#8220;Compensation-Share Compensation&#8221; (&#8220;ASC 718&#8221;), guidance to account for its
share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument.
The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number
of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of
share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment,
which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which
is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed
in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending
on the nature of the services provided in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative financial instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates its financial instruments to determine if such
instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives
and Hedging.&#8221; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially
recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in
the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance
sheet date. The underwriters&#8217; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently
redeemable shares and would have been accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial
Public Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Recently Issued Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The amendments in this ASU require disclosures, on an annual and interim
basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;), as well
as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public
entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures
currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures
required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning
after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The
Company has adopted ASU 2023-07 for the year ended December 31, 2024. ASU 2023-07 does not have a material effect on the Company&#8217;s
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management does not
believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#8217;s financial statement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Initial Public Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_InitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 3&#8201;&#8212; INITIAL PUBLIC OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant to the Initial Public Offering on January
16, 2025, the Company sold 17,250,000&#160;Public Shares, which includes a full exercise by the underwriter of their over-allotment option
at a purchase price of $10.00 per Unit. Each Unit consists of one Class&#160;A ordinary share and one-half of one redeemable public warrant
(&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase one Class&#160;A ordinary share at an exercise
price of $11.50 per share, subject to adjustment (see Note&#160;6).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PrivatePlacementAbstract', window );"><strong>Private Placement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 4&#8201;&#8212;&#8201;PRIVATE PLACEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $10.00 per Private Placement Unit, or Non-Managing Investor Private Placement Security (as defined below) generating
gross proceeds of $6,728,750, as follows: (i) by and among the Company and each of the Underwriters for the purchase by the Underwriters
of an aggregate of 232,875 Private Placement units for an aggregate purchase price of $2,328,750 and (ii) by and between the Company and
Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase by the Sponsor of an aggregate of 440,000 Private Placement Units and
570,000 restricted Class A ordinary shares (the &#8220;Restricted Private Placement Shares,&#8221; the Restricted Private Placement Shares
together with the Private Placement Units purchased by the Sponsor, collectively, the &#8220;Non-Managing Investor Private Placement Securities&#8221;)
for an aggregate purchase price of $4,400,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Each Private Placement Unit has an offering price
of $10.00 and consists of one Class&#160;A ordinary share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles
the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement
Units and the Non-Managing Investor Private Placement Securities were added to the net proceeds from the Initial Public Offering held
in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale
of the Private Placement Units and the Non-Managing Investor Private Placement Securities held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants expire worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Restricted Private Placement Shares are held
by the Sponsor and will be transferred to the non-managing investors (or their designees) only upon the consummation of an initial business
combination. Other than such permitted transfer, the Restricted Private Placement Shares will be subject to transfer restrictions for
90 days following our initial business combination and will be entitled to registration rights.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 5&#8201;&#8212;&#8201;RELATED PARTY
TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On June&#160;26, 2024, the Sponsor paid $25,000,
or approximately $0.003 per share in consideration for 7,665,900 Class&#160;B ordinary shares (the &#8220;Founder Shares&#8221;) issued
to the Sponsor. On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration. All share and per share amounts
have been retroactively restated. The initial shareholders currently hold an aggregate of 5,750,000 Founder Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Founder Shares include an aggregate of up
to 750,000 shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters&#8217; over-allotment
option is exercised, so that the number of Founder Shares will collectively represent 25% of the Company&#8217;s issued and outstanding
shares upon the completion of the Initial Public Offering. On January 16, 2025, the underwriters exercised their over-allotment option
in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Sponsor has agreed, subject to limited exceptions,
not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of a Business
Combination; and (B)&#160;subsequent to a Business Combination, (x)&#160;if the last reported sale price of the Class&#160;A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after a Business Combination,
or (y)&#160;the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction that results in all of the Company&#8217;s shareholders having the right to exchange their Class&#160;A ordinary shares for
cash, securities or other property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During July and August 2024, the Sponsor transferred
75,000 Founder Shares to three director nominees (25,000 shares each) for an aggregate amount of $225, or approximately $0.003 per share.
The sale of the Founders Shares to the Company&#8217;s directors and director&#8217;s nominees is in the scope of FASB ASC Topic 718,
&#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified
awards is measured at fair value upon the grant date. The fair value of the 75,000 shares granted to the Company&#8217;s director nominees
was $36,750 or $0.49 per share. The Founders Shares were granted subject to a performance condition (i.e., named as directors at the occurrence
of the Initial Public Offering). Compensation expense related to the Founders Shares is recognized only when the performance condition
is probable of occurrence under the applicable accounting literature. Stock-based compensation was recognized upon the consummation of
the Initial Public Offering in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently
modified) less the amount initially received for the purchase of the Founder Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Promissory Note&#160;&#8212;&#160;Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;26, 2024, the Company issued an unsecured
promissory note to the Sponsor (as amended on January 6, 2025, the &#8220;Promissory Note&#8221;), pursuant to which the Company may borrow
up to an aggregate principal amount of $500,000. The Promissory Note was non-interest bearing and payable on the earlier of (i)&#160;February
1, 2025 (as amended) or (ii)&#160;the consummation of the Initial Public Offering. As of December 31, 2024, the Company owed $149,473
under the promissory note. Subsequent to the balance sheet date, on January 16, 2025, the Company overpaid the Sponsor by $1,295 resulting
in a due from Sponsor. On January 22, 2025, the Sponsor returned the $1,295 to the Company (Note 9).</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Due to Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company owes an officer
of the Company $12,374 for travel related expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Consulting Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Chief Executive officer and the Chief Financial
Officer entered into agreements with the Company, commencing on January 16, 2025 through the closing of the Company&#8217;s Business Combination,
to pay each officer an aggregate of $20,833 per month, subject to availability of sufficient funds from working capital held outside the
Trust Account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, any of their respective affiliates or certain of the Company&#8217;s
directors and officers may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;).
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s
discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit. The units would
be identical to the Private Placement Units. As of December 31, 2024, there are no Working Capital Loans outstanding.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 6&#8201;&#8212;&#8201;COMMITMENTS AND
CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The holders of the (i)&#160;Founder Shares, (ii)
Restricted Private Placement Shares, (iii)&#160;Private Placement Units, issued in a private placement simultaneously with the closing
of the Initial Public Offering, private placement shares, private placement warrants and the Class&#160;A ordinary shares underlying such
private placement warrants and (iv)&#160;private placement units that may be issued upon conversion of working capital loans are entitled
to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring
the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class&#160;A ordinary
shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that
the Company register such securities. In addition, the holders have certain piggy-back registration rights with respect to registration
statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such
securities pursuant to Rule&#160;415 under the Securities Act. However, the registration rights agreement provides that the Company will
not be required to effect or permit any registration or cause any registration statement to become effective until termination of the
applicable lock-up period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions
resulting from delays in registering the Company&#8217;s securities. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Underwriting Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company has granted the underwriters a 45-day
option to purchase up to 2,250,000 additional Units&#160;to cover over-allotments at the Initial Public Offering price, less the underwriting
commissions. As of January 16, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully
exercise the over-allotment option to purchase the additional 2,250,000 Units at a price of $10.00 per Unit</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The underwriters were entitled to (1) an underwriting
discount of $0.20 per Unit, or $3,450,000 in the aggregate, of which (i)&#160;$0.065 per unit was paid to the underwriters in cash at
the closing of the Initial Public Offering and (ii)&#160;$0.135 per Unit was used by the underwriters to purchase Private Placement Units,
and (2) a deferred fee of $0.40&#160;per&#160;Unit, or $6,900,000. The deferred fee will become payable to the underwriters from the amounts
held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting
agreement and will be based on the amount of funds remaining in the Trust Account after shareholder redemptions of public shares in connection
with the consummation of a Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholder's Deficit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDER'S DEFICIT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 7&#8201;&#8212;&#8201;SHAREHOLDER&#8217;S
DEFICIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Preference Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At December 31, 2024, there were
<span style="-sec-ix-hidden: hidden-fact-17"><span style="-sec-ix-hidden: hidden-fact-18">no</span></span> preference shares issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Class&#160;A Ordinary Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue 200,000,000 Class&#160;A ordinary shares, with a par value of $0.0001 per share. Holders of Class&#160;A
ordinary shares are entitled to one vote for each share. At December 31, 2024, there are <span style="-sec-ix-hidden: hidden-fact-19"><span style="-sec-ix-hidden: hidden-fact-20">no</span></span> Class&#160;A ordinary shares issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Class&#160;B Ordinary Shares&#160;&#8212;</b>&#160;The
Company is authorized to issue 20,000,000 Class&#160;B ordinary shares, with a par value of $0.0001 per share. Holders of the Class&#160;B
ordinary shares are entitled to one vote for each share. At December 31, 2024, there were 5,750,000 Class&#160;B ordinary shares issued
and outstanding (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Only holders of Class&#160;B ordinary shares will
have the right to vote on the election of directors prior to the Business Combination. Holders of Class&#160;A ordinary shares and holders
of Class&#160;B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company&#8217;s shareholders
except as otherwise required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares at the time of a Business Combination or earlier at the option of the holder, on a one-for-one
basis, subject to adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants&#160;&#8212;</b>&#160;There are no warrants
issued or outstanding as of December 31, 2024. Public Warrants may only be exercised for a whole number of shares. No fractional shares
will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a)&#160;30&#160;days
after the completion of a Business Combination and (b)&#160;12&#160;months from the closing of the Initial Public Offering. The Public
Warrants will expire <span style="-sec-ix-hidden: hidden-fact-16">seven</span>&#160;years from the completion of a Business Combination or earlier upon redemption or liquidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will not be obligated to deliver any Class&#160;A
ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless
a registration statement under the Securities Act covering the issuance of the Class&#160;A ordinary shares issuable upon exercise of
the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations
with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless
basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of
the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has agreed that as soon as practicable,
but in no event later than 15&#160;business days, after the closing of a Business Combination, it will use its commercially reasonable
efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class&#160;A ordinary shares
issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective
within 60&#160;business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.
Notwithstanding the above, if the Class&#160;A ordinary shares are, at the time of any exercise of a warrant, not listed on a national
securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the
Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless
basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will
not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or
qualify the shares under applicable blue sky laws to the extent an exemption is not available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Redemption of Public Warrants</i>&#160;&#8212;&#160;Once
the warrants become exercisable, the Company may redeem the outstanding Public Warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01 per Public Warrant;</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than 30&#160;days&#8217; prior written notice of redemption to each warrant holder; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the closing price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company sends the notice of redemption to warrant holders.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will not redeem the warrants for cash
unless a registration statement under the Securities Act covering the issuance of the shares of Class&#160;A ordinary shares issuable
upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout
the 30-day redemption period or the Company has elected to require the exercise of the public warrants on a cashless basis. If and when
the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Company calls the warrants for redemption as
described in this paragraph, its management will have the option to require any holder that wishes to exercise his, her or its warrant
following the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise
price by surrendering the Public Warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the
product of the number of Class&#160;A ordinary shares underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221;
less the exercise price of the warrants by (y)&#160;the fair market value. The &#8220;fair market value&#8221; as used in the preceding
sentence shall mean the volume weighted average price of the Class&#160;A ordinary shares for the 10&#160;trading days ending on the&#160;trading
day prior to the date on which the notice of redemption is sent to the holders of the public warrants. If its management takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class&#160;A ordinary
shares to be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has established the $18.00 per share (as
adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium
to the public warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public
Warrants, each Public Warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date.
However, the price of the Class&#160;A ordinary shares may fall below the $18.00 redemption trigger price as well as the $11.50 Public
Warrant exercise price after the redemption notice is issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, if (x)&#160;the Company issues additional
ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its Initial Business Combination
at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be
determined in good faith by its board of directors and, in the case of any such issuance to either of the Sponsor or its affiliates, without
taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly
Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of its Initial Business Combination on the date of the completion of its Initial Business
Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial business combination (such
price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the public warrants will be adjusted (to the nearest
cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price
will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Private Placement Warrants are identical to the
Public Warrants underlying the Units&#160;being sold in the Initial Public Offering, except that the Private Placement Warrants and the
Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until 30&#160;days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGEMENT REPORTING</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8&#8201;&#8212;&#8201;SEGEMENT REPORTING
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 280, &#8220;Segment Reporting,&#8221; establishes
standards for companies to report in their financial statement information about operating segments, products, services, geographic areas,
and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may
recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#8217;s
chief operating decision maker, or group, in deciding how to allocate resources and assess performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s chief operating decision maker
(&#8220;CODM&#8221;) has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has
determined that there is only one reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The CODM assesses performance for the single
segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as
net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the
Company&#8217;s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included
in net income or loss:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the<br/>
    period from<br/>
    June 10,<br/>
    2024 (inception)<br/>
    through<br/>
    December&#160;31,&#160;2024</b></span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formation
    and operating costs </span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,980</span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Formation and operating costs are reviewed and monitored
by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction
within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual
agreements to ensure costs are aligned with all agreements and budget. Formation and operating costs, as reported on the statement of
operations, are the significant segment expenses provided to the CODM on a regular basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0; font: 10pt/107% Times New Roman, Times, Serif">All other segment items included in net income or loss are reported
on the statement of operations and described within their respective disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 9&#8201;&#8212;&#8201;SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than
as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial
statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 16, 2025, the underwriters exercised
their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no
longer subject to forfeiture.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of January 16, 2025, the Company owed $284,023,
which were repaid simultaneously with the closing of the Initial Public Offering. The Company paid the Sponsor a note balance of $285,318
causing an overpayment of $1,295 due from Sponsor. Subsequent to the balance sheet date, on January 22, 2025, the Sponsor returned the
$1,295 to the Company. Borrowings under this note are no longer available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2025, the Company consummated the
Initial Public Offering of 17,250,000 units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the
Units being offered, the &#8220;Public Shares&#8221;), which includes the full exercise by the underwriters of their over-allotment option
in the amount of 2,250,000 Units, at $10.00 per Unit, which is discussed in Note 3, generating gross proceeds of $172,500,000. .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#8220;Private Placement
Unit&#8221;) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,728,750, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of 232,875 private placement units for an aggregate
purchase price of $2,328,750 and (ii) by and between the Company and Plum Partners IV, LLC (the &#8220;Sponsor&#8221;) for the purchase
by the Sponsor of an aggregate of 440,000 private placement units and 570,000 restricted Class A ordinary shares for an aggregate purchase
price of $4,400,000. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (91,980)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although, as a blank check company, we do not
have any operations, we are nonetheless subject to the risk of cybersecurity incidents. Among other things, the investments in our Trust
Account and bank deposits may be vulnerable to such incidents, and we may depend on the digital technologies of third parties. We and
third parties may be subject to cybersecurity attacks or security breaches. To the extent that we rely on the technologies of third parties,
we depend upon the personnel and the processes of such third parties to protect against cybersecurity incidents, and we have no personnel
or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#8217;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse
consequences on our business and lead to financial loss. We have not encountered any cybersecurity incidents since our initial public
offering. In addition to our own cybersecurity risks, any proposed business combination target may have been subject to, or may in the
future be subject to, cybersecurity incidents.<b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#8217;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#8217;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse
consequences on our business and lead to financial loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">We have not encountered any cybersecurity incidents since our initial public
offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_LiquidityAndCapitalResourcesPolicyTextBlock', window );">Liquidity and Capital Resources</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Liquidity and Capital Resources</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2024, the Company had $3,864
in cash and a working capital deficit of $505,332. Further, the Company has incurred and expects to continue to incur significant costs
in pursuit of its acquisition plans. There is no assurance that the Company&#8217;s plans to raise capital will be successful. In connection
with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, &#8220;Going
Concern,&#8221; as of December 31, 2024, and including the closing of the Initial Public Offering on January 16, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements. The Company cannot assure that its plans to raise capital or to consummate an Initial Business Combination will be successful.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Emerging Growth Company</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the
&#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial statement in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers all short-term investments
with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $3,864 in cash and no cash
equivalents as of December 31, 2024.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company complies
with the requirements of the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 340-10-S99 and SEC Staff Accounting
Bulletin (&#8220;SAB&#8221;) Topic 5A &#8212; &#8220;Expenses of Offering.&#8221; Deferred offering costs consist principally of
professional and registration fees that are directly related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with
Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and
debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of
the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary
equity, and offering costs allocated to Public Warrants (as defined below) and Private Placement Units were charged to
shareholders&#8217; deficit as the Public and Private Placement Warrants (as defined below), after management&#8217;s evaluation,
were accounted for under equity treatment. On January 16, 2025, deferred offering costs amounting to $582,289 were charged to
shareholder&#8217;s equity upon the completion of the Initial Public Offering (see Note 1). As of December 31, 2024, there were
$438,352 of deferred offering costs recorded in the accompanying balance sheet.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for income taxes under ASC&#160;740,
&#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). ASC&#160;740 requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">ASC&#160;740 also clarifies the accounting for
uncertainty in income taxes recognized in an enterprise&#8217;s financial statement and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of December 31, 2024. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is considered an exempted Cayman Islands
Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States.
As such, the Company&#8217;s tax provision was zero for the period presented.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Ordinary Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Net Loss Per Ordinary Share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Net loss per ordinary
share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period,
excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 750,000
Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment
option is exercised (see Note 5). At December 31, 2024, the Company did not have any dilutive securities and other contracts that
could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result,
diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company&#8217;s financial condition, results of operations, and cash flows.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The fair value of the Company&#8217;s assets and
liabilities, which qualify as financial instruments under ASC Topic&#160;820, &#8220;Fair Value Measurement,&#8221; approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrant Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Warrant Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will account for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering, on January 16, 2025 and the private placement in accordance
with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging.&#8221; Accordingly, the Company evaluated and
classified the warrant instruments under equity treatment at their assigned values.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Share-Based Compensation</b>&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company records share-based compensation in
accordance with FASB ASC Topic 718, &#8220;Compensation-Share Compensation&#8221; (&#8220;ASC 718&#8221;), guidance to account for its
share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument.
The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number
of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of
share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment,
which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which
is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed
in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending
on the nature of the services provided in the statement of operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_DerivativeFinancialInstrumentsPolicyTextBlock', window );">Derivative financial instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative financial instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates its financial instruments to determine if such
instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives
and Hedging.&#8221; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially
recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in
the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance
sheet date. The underwriters&#8217; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently
redeemable shares and would have been accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial
Public Offering.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Recently Issued Accounting Standards</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In November 2023, the FASB issued ASU 2023-07, &#8220;Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The amendments in this ASU require disclosures, on an annual and interim
basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;), as well
as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public
entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures
currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures
required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning
after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The
Company has adopted ASU 2023-07 for the year ended December 31, 2024. ASU 2023-07 does not have a material effect on the Company&#8217;s
financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management does not
believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#8217;s financial statement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_DerivativeFinancialInstrumentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounting policies for derivative financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_DerivativeFinancialInstrumentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_LiquidityAndCapitalResourcesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liquidity and capital resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_LiquidityAndCapitalResourcesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Key Metric Included in Net Income or Loss</a></td>
<td class="text">the
Company&#8217;s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included
in net income or loss:<table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the<br/>
    period from<br/>
    June 10,<br/>
    2024 (inception)<br/>
    through<br/>
    December&#160;31,&#160;2024</b></span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formation
    and operating costs </span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,980</span></td>
    <td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 16, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum', window );">Condition for future business combination number of businesses minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_YearOfInception', window );">Inception period description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">June&#160;10, 2024 (inception) through December 31, 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,932,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_SaleOfStockUnderwritingFees', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,450,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_DeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_OtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 582,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount', window );">Percentage of net assets held in the trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_InitialAmountHeldInTrustAccount', window );">Initial amount held in trust account (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_AggregatePublicShareRate', window );">Aggregate public share rate.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination', window );">Percentage of public shares to be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_InterestUsedToPayDissolutionExpensesMaximum', window );">Interest to pay dissolution expenses, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_SharePricePerPublicShare', window );">Share price per public share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting securities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember', window );">Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,328,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="nump">17,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="nump">$ 284,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Class A ordinary shares [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="nump">$ 172,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">672,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,728,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_AggregatePurchasePrice', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,328,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Plum Partners IV, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares) | shares</a></td>
<td class="nump">174,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_AggregatePublicShareRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate public share rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_AggregatePublicShareRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_AggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of aggregate purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_AggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_DeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_DeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_InitialAmountHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial amount held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_InitialAmountHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_InterestUsedToPayDissolutionExpensesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Used To Pay Dissolution Expenses, Maximum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_InterestUsedToPayDissolutionExpensesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_OtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_OtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of fair market value of assets held in the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares to be redeemed on non completion of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_SaleOfStockUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees incurred and paid for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_SaleOfStockUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_SharePricePerPublicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share price per public share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_SharePricePerPublicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_YearOfInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Year of inception.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_YearOfInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 3,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">505,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">FDIC coverage amount</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-Term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 3,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 582,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares were subject to forfeiture (in Shares)</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 438,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Initial Public Offering (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Jan. 16, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Units sold</a></td>
<td class="nump">17,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price per Unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=plmk_PublicWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=plmk_PublicWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement (Details)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions', window );">Number of days restricted private placement shares will be subject to transfer restrictions</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember', window );">Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds (in Dollars) | $</a></td>
<td class="nump">$ 2,328,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=plmk_PublicWarrantMember', window );">Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Aggregate units | shares</a></td>
<td class="nump">672,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds (in Dollars) | $</a></td>
<td class="nump">$ 6,728,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares | shares</a></td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Aggregate units | shares</a></td>
<td class="nump">232,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds (in Dollars) | $</a></td>
<td class="nump">$ 2,328,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Plum Partners IV, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Aggregate units | shares</a></td>
<td class="nump">440,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds (in Dollars) | $</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Class A Ordinary Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of  days restricted private placement shares will be subject to transfer restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=plmk_PublicWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=plmk_PublicWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 06, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 22, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 16, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Amount paid by sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering', window );">Percentage of shares issued and outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Trading days</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations', window );">Threshold consecutive trading days</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfIndependentDirector', window );">Number of independent directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_FairValueOfSharesGranted', window );">Fair value of shares granted (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_FairValueOfSharesGrantedAmount', window );">Amount of fair value of shares granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TravelAndEntertainmentExpense', window );">Travel related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalAndContractServicesExpense', window );">Aggregate payment per month</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=plmk_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Aggregate principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayable', window );">Owned amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,473<span></span>
</td>
<td class="nump">$ 149,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=plmk_WorkingCapitalLoansMember', window );">Working Capital Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion per unit (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_CommonStockSharesTransferred', window );">Number of shares transferred (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due from sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Amount returned from sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=plmk_FounderSharesMember', window );">Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares in consideration (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfSharesSurrendered', window );">Number of shares surrendered (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,915,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_CommonStockValueTransferred', window );">Common stock value transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=plmk_WorkingCapitalLoansMember', window );">Working Capital Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_CommonStockSharesTransferred', window );">Number of shares transferred (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B ordinary shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares subject to forfeiture (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B ordinary shares [Member] | Founder Shares [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Amount paid by sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares in consideration (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,665,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=plmk_FounderSharesMember', window );">Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares subject to forfeiture (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfSharesNoLongerSubjectToForfeiture', window );">Shares are no longer subject to forfeiture (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_CommonStockSharesTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_CommonStockSharesTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_CommonStockValueTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Value Transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_CommonStockValueTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_FairValueOfSharesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of shares granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_FairValueOfSharesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_FairValueOfSharesGrantedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value of shares granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_FairValueOfSharesGrantedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfIndependentDirector">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Independent Director.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfIndependentDirector</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfSharesNoLongerSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfSharesNoLongerSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfSharesSurrendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares surrendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfSharesSurrendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected ownership percentage by the founders after completion of the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalAndContractServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalAndContractServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TravelAndEntertainmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses incurred for travel and entertainment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TravelAndEntertainmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=plmk_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=plmk_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=plmk_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=plmk_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=plmk_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=plmk_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 16, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnderwritingDiscountPricePerUnit', window );">Underwriting discount price per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Aggregate underwriting discount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,450,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_CashUnderwritingPaidPerUnit', window );">Cash underwriting paid per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit', window );">Purchase of private placement of underwriters per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_DeferredFeePerUnit', window );">Deferred fee per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=plmk_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Aggregate underwriting discount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfAdditionalUnitsPurchased', window );">Number of additional unit purchased (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfAdditionalUnitsPurchased', window );">Number of additional unit purchased (in Shares)</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_CashUnderwritingPaidPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the cash underwriting paid per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_CashUnderwritingPaidPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_DeferredFeePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the deferred fee per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_DeferredFeePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfAdditionalUnitsPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of additional units purchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfAdditionalUnitsPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the purchase of private placement of underwriters per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_UnderwritingDiscountPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discount price per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_UnderwritingDiscountPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=plmk_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=plmk_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's Deficit (Details)<br></strong></div></th>
<th class="th" colspan="2">7 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholder's Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preference shares, shares authorized (in Shares) | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preference shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, issued (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, outstanding (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination', window );">Public warrants exercisable after the completion of business combination</a></td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant expiration term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission', window );">Number of business days</a></td>
<td class="text">15 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination', window );">Effective business days</a></td>
<td class="text">60 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant', window );">Price per warrant</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NoticePeriodToBeGivenPriorToRedemption', window );">Notice of redemption</a></td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Trading days</a></td>
<td class="text">20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionPricePerShare', window );">Preferred Stock, Redemption Price Per Share</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations', window );">Threshold consecutive trading days</a></td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_EstablishedPerShare', window );">Established Per Share</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Redemption trigger price</a></td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PublicWarrantExercisePrice', window );">Public warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_TotalEquityProceedsPercentage', window );">Total Equity Proceeds Percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice', window );">Market price per share</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_PublicWarrantsAdjustedPercentage', window );">Public Warrants Adjusted Percentage</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_MarketValueInPercentage', window );">Market value in percentage</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholder's Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per unit</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">lass AOrdinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholder's Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in Shares) | shares</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">one<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Share outstanding (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing share price</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholder's Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in Shares) | shares</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">one<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Share outstanding (in Shares) | shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option was exercised (see Note 5).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights redemption price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_EstablishedPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Established per share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_EstablishedPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_MarketValueInPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The market value in percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_MarketValueInPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NoticePeriodToBeGivenPriorToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notice period to be given prior to redemption, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NoticePeriodToBeGivenPriorToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period within which the registration of warrants shall be effective from the closure of business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period within which the warrants shall be registered with the securities exchange commission, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PublicWarrantExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public warrant exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PublicWarrantExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PublicWarrantsAdjustedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The public warrants adjusted percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PublicWarrantsAdjustedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the public warrants exercisable after the completion of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_TotalEquityProceedsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total equity proceeds percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_TotalEquityProceedsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">CODM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Schedule of Key Metric Included in Net Income or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs</a></td>
<td class="nump">$ 91,980<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 16, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Paid sponsor balance</a></td>
<td class="nump">$ 285,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due from sponsor</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Amount returned from sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember', window );">Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,328,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Amount returned from sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due from sponsor</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_NumberOfSharesNoLongerSubjectToForfeiture', window );">(in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Initial public offering</a></td>
<td class="nump">$ 284,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="nump">17,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="nump">$ 172,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">672,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,728,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_AggregatePurchasePrice', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,328,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Plum Partners IV, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues', window );">Sale of units (in Shares)</a></td>
<td class="nump">174,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per unit (in Dollars per share)</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_AggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of aggregate purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_AggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_NumberOfSharesNoLongerSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_NumberOfSharesNoLongerSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plmk_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plmk_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plmk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=plmk_PlumPartnersIVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=plmk_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=plmk_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>46
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /.*?UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /.*?UK5CH?V\0   "L"   1
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MSX25>]9@<66A[UI#9M<"*@JOJ)H!%^5J3M+^10F0=7L JA9"J:E,I0MP![F
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MJ&.02D'GZ#96^9,8#GO[^#WTTH<+T9B[LMTF!R34LB$EE1M$.Q49)>NY1OP
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MB(L(L(H1W"LQG)%3E"O+UK9X&7S41<3Q=,0!)ZCYC-W:1PWON^36?DUW-UR
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M?]<XKYJF*OCC"K65JFD WB^JJG%?: /_0]=W_PM02P,$%     @ \XI_6O2
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M5_DD/O5O:3+P!1>JK)A\ J-$!O&'03*)!E$4[0'N"D:C&D!3\+0 +E-19VB
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M)M<B;;6T$I2\ +^D"DR!Y*+/I$&ETSYQ]H2.UJU I[:!4R+;$MRU";Z5!J7
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ME",T&9^A-$FGZ&FU0"<?3X]P)T/?D\"=_*^^(V[Z-LZ/SLPTM(0<N]DPH'>
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M7Z?H.E\W4;RVW6;/E>Y==ECJGP4($Z"?YYRKX\1L,/Q^DC=02P,$%     @
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M%VGE@RT;8R HE:G_R_N&B*\QF#0&DXB[#A11OI%!GITXNQ".9\,;_XBI1FN
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M/,3DE!?LEC:O*!S -X]!2)3JC%M@EXJ9;-U#D*!1\9@1E\.)0SWJWPK T5
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M3XO;-1#]>6,FZ/=+SM7[P"Q0GX=&?P-02P,$%     @ \XI_6MFH DRQ#
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M?FY*0XDY;,;43]^YS%D EQU\O"2(>^C,GCZAX\$+!^-AS7CH0I_=XEH' 5D
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M3="L17DB6OY0/#>'B@NN%$_-UP@8)E3?@->7')-1_= #U.?2LW\!4$L#!!0
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MXYK4#'T_&*C;T&L'C:YSP[)Q5P48[^#.*ZWQ9/@$T^63_P902P,$%     @
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MO4HE+%6*3+B=T''H>^.+_G;7%S"8JR](8I8O8>-+"/IR5UOR]0-/[[GH/*-
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M:,"0.+;OP9WW4;1Z3T7K_SB'SU!+ P04    " #SBG]:EXJ[',     3 @
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " #SBG]:F5R<(Q &  "<)P  $P
M            @ 'C 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M /.*?UJ?FD5!8PD  -E)   8              " @20(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #SBG]:2ANY>ZX#  !("0  &
M            @(&]$0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ \XI_6G<8<KB;!0  AA0  !@              ("!H14  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( /.*?UHX@(V0-00  &(/
M   8              " @7(;  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " #SBG]:TJ>['0L$    "P  &               @('='P
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ \XI_6BVU.$9^
M!    Q$  !@              ("!'B0  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( /.*?UKWG"8N,00  !@/   8              "
M@=(H  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #SBG]:
M]?K,4$@6   :1   &               @($Y+0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ \XI_6JG%!M)/%0  ]#H  !@
M     ("!MT,  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M /.*?UKT@ UX,0,  ,X&   9              " @3Q9  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ \XI_6E)JY/!C!0  [@T  !D
M             ("!I%P  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " #SBG]:^ PYO;L*  "2&P  &0              @($^8@  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( /.*?UK-T$D3CP8
M &<0   9              " @3!M  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ \XI_6FSNDT^@#   /B4  !D              ("!
M]G,  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #SBG]:
MIT<[\)D%   U#0  &0              @('-@   >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( /.*?UH7F)-RO@4  +D-   9
M      " @9V&  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ \XI_6EV[B,L2 @  E@0  !D              ("!DHP  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #SBG]:+'5HOD,"  "*!@
M&0              @(';C@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( /.*?UK'QH26$ (  -P$   9              " @561  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ \XI_6N>W"O<@
M!@  Q14  !D              ("!G),  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " #SBG]:/],M=/05  #@00  &0
M@('SF0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( /.*
M?UI:Z&X8G (  )P%   9              " @1ZP  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ \XI_6FYIF_2_!P  A38  !D
M         ("!\;(  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " #SBG]:VO6-]/<#  "F$P  &0              @('GN@  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( /.*?UJ:KS$:] (  ! *
M   9              " @16_  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ \XI_6A[=A+1"!   &Q4  !D              ("!0,(
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #SBG]:V:@"
M3+$,  #!D@  &0              @(&YQ@  >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( /.*?UIP2,?__P,  +L3   9
M  " @:'3  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
M\XI_6F(NG [0!@  HQX  !D              ("!U]<  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " #SBG]:!)N%&PX"  "(!   &0
M            @('>W@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( /.*?UI:@&]:7P(  )D%   9              " @2/A  !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ \XI_6N+>(4B^!P
M;DD  !D              ("!N>,  'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " #SBG]:@[C>44H#  #P%   #0              @ &N
MZP  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /.*?UJ7BKL<P    !,"   +
M              "  2/O  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /.*?UK
MFG5H@P,  ,$5   /              "  0SP  !X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    " #SBG]:BA.#9&,!  "W$P  &@              @ &\\P
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #SBG]:52F2
MCXD!  !>%   $P              @ %7]0  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     *  H ,\*   1]P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>71</ContextCount>
  <ElementCount>192</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>29</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Balance Sheet</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Balance Sheet</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Balance Sheet (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Balance Sheet (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Statement of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Statement of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Statement of Changes in Shareholder???s Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Statement of Changes in Shareholder???s Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Private Placement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/PrivatePlacement</Role>
      <ShortName>Private Placement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Shareholder's Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ShareholdersDeficit</Role>
      <ShortName>Shareholder's Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/SegmentReporting</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/InitialPublicOffering</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Private Placement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/PrivatePlacementDetails</Role>
      <ShortName>Private Placement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/PrivatePlacement</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/RelatedPartyTransactions</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/CommitmentsandContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Shareholder's Deficit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ShareholdersDeficitDetails</Role>
      <ShortName>Shareholder's Deficit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/ShareholdersDeficit</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/SegmentReportingTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable</Role>
      <ShortName>Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ea0235316-10k_plumacq4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plumpartners.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.plumpartners.com/role/SubsequentEvents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ea0235316-10k_plumacq4.htm">ea0235316-10k_plumacq4.htm</File>
    <File>plmk-20241231.xsd</File>
    <File>plmk-20241231_cal.xml</File>
    <File>plmk-20241231_def.xml</File>
    <File>plmk-20241231_lab.xml</File>
    <File>plmk-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="154">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>53
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0235316-10k_plumacq4.htm": {
   "nsprefix": "plmk",
   "nsuri": "http://www.plumpartners.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "ea0235316-10k_plumacq4.htm"
     ]
    },
    "schema": {
     "local": [
      "plmk-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "plmk-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "plmk-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "plmk-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "plmk-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 137,
   "keyCustom": 55,
   "axisStandard": 12,
   "axisCustom": 0,
   "memberStandard": 14,
   "memberCustom": 11,
   "hidden": {
    "total": 24,
    "http://fasb.org/us-gaap/2024": 21,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 71,
   "entityCount": 1,
   "segmentCount": 29,
   "elementCount": 506,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 154,
    "http://xbrl.sec.gov/dei/2024": 46,
    "http://xbrl.sec.gov/cyd/2024": 8,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Balance Sheet",
     "shortName": "Balance Sheet",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "plmk:DeferredOfferingCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Balance Sheet (Parentheticals)",
     "shortName": "Balance Sheet (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R5": {
     "role": "http://www.plumpartners.com/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Statement of Operations",
     "shortName": "Statement of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.plumpartners.com/role/ShareholdersEquityType2or3",
     "longName": "995304 - Statement - Statement of Changes in Shareholder\u2019s Deficit",
     "shortName": "Statement of Changes in Shareholder\u2019s Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c16",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c16",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.plumpartners.com/role/ConsolidatedCashFlow",
     "longName": "995305 - Statement - Statement of Cash Flows",
     "shortName": "Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations",
     "longName": "995306 - Disclosure - Description of Organization and Business Operations",
     "shortName": "Description of Organization and Business Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "995307 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.plumpartners.com/role/InitialPublicOffering",
     "longName": "995308 - Disclosure - Initial Public Offering",
     "shortName": "Initial Public Offering",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "plmk:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "plmk:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.plumpartners.com/role/PrivatePlacement",
     "longName": "995309 - Disclosure - Private Placement",
     "shortName": "Private Placement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "plmk:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "plmk:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.plumpartners.com/role/RelatedPartyTransactions",
     "longName": "995310 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.plumpartners.com/role/CommitmentsandContingencies",
     "longName": "995311 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.plumpartners.com/role/ShareholdersDeficit",
     "longName": "995312 - Disclosure - Shareholder's Deficit",
     "shortName": "Shareholder's Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.plumpartners.com/role/SegmentReporting",
     "longName": "995313 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.plumpartners.com/role/SubsequentEvents",
     "longName": "995314 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.plumpartners.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.plumpartners.com/role/SegmentReportingTables",
     "longName": "996001 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
     "longName": "996002 - Disclosure - Description of Organization and Business Operations (Details)",
     "shortName": "Description of Organization and Business Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "plmk:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "996003 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "plmk:WorkingCapitalDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
     "longName": "996004 - Disclosure - Initial Public Offering (Details)",
     "shortName": "Initial Public Offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c41",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "plmk:InitialPublicOfferingTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c41",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "plmk:InitialPublicOfferingTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.plumpartners.com/role/PrivatePlacementDetails",
     "longName": "996005 - Disclosure - Private Placement (Details)",
     "shortName": "Private Placement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "plmk:NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
     "longName": "996006 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
     "longName": "996007 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "plmk:UnderwritingDiscountPricePerUnit",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:UnderwritingDiscountPricePerUnit",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
     "longName": "996008 - Disclosure - Shareholder's Deficit (Details)",
     "shortName": "Shareholder's Deficit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "plmk:PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.plumpartners.com/role/SegmentReportingDetails",
     "longName": "996009 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable",
     "longName": "996010 - Disclosure - Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)",
     "shortName": "Segment Reporting - Schedule of Key Metric Included in Net Income or Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c66",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c66",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.plumpartners.com/role/SubsequentEventsDetails",
     "longName": "996011 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c67",
      "name": "us-gaap:SponsorFees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c67",
      "name": "us-gaap:SponsorFees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235316-10k_plumacq4.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "plmk_AccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "AccruedOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued offering costs",
        "documentation": "Accrued offering costs.",
        "label": "Accrued Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r447",
      "r633"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r601",
      "r602",
      "r603",
      "r604",
      "r617",
      "r634"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_AggregatePublicShareRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "AggregatePublicShareRate",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate public share rate.",
        "documentation": "Aggregate public share rate.",
        "label": "Aggregate Public Share Rate"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_AggregatePurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "AggregatePurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price",
        "documentation": "The amount of aggregate purchase price.",
        "label": "Aggregate Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r487",
      "r498",
      "r514",
      "r549"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r490",
      "r501",
      "r517",
      "r552"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r544",
      "r553",
      "r557",
      "r565"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r70",
      "r83",
      "r99",
      "r128",
      "r136",
      "r141",
      "r144",
      "r151",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r260",
      "r262",
      "r274",
      "r298",
      "r369",
      "r432",
      "r433",
      "r447",
      "r458",
      "r615",
      "r616",
      "r626"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r256",
      "r443",
      "r444"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r256",
      "r443",
      "r444"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of voting securities acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r474",
      "r494"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current asset - cash",
        "verboseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r302",
      "r340",
      "r363",
      "r447",
      "r458",
      "r597"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash \u2013 Beginning",
        "periodEndLabel": "Cash \u2013 Ending",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r53",
      "r96"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Change in Cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r53"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FDIC coverage amount",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_CashUnderwritingPaidPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "CashUnderwritingPaidPerUnit",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash underwriting paid per unit",
        "documentation": "Represent the cash underwriting paid per unit.",
        "label": "Cash Underwriting Paid Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingEstimateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingEstimateLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "srt_ChiefFinancialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefFinancialOfficerMember",
     "presentation": [
      "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CODM [Member]",
        "label": "Chief Financial Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ClassAOrdinaryShares00001ParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ClassAOrdinaryShares00001ParValuePerShareMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A ordinary shares, $0.0001 par value per share",
        "label": "Class AOrdinary Shares00001 Par Value Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r84",
      "r85",
      "r86",
      "r99",
      "r120",
      "r121",
      "r123",
      "r125",
      "r130",
      "r131",
      "r151",
      "r162",
      "r164",
      "r165",
      "r166",
      "r169",
      "r170",
      "r188",
      "r189",
      "r192",
      "r195",
      "r202",
      "r274",
      "r321",
      "r322",
      "r323",
      "r324",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r355",
      "r378",
      "r400",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r596",
      "r598",
      "r605"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Line Items]",
        "terseLabel": "Shareholder's Deficit [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r130",
      "r188",
      "r189",
      "r190",
      "r192",
      "r195",
      "r200",
      "r202",
      "r321",
      "r322",
      "r323",
      "r324",
      "r442",
      "r596",
      "r598"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in Dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption trigger price",
        "documentation": "Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.",
        "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ClassOfWarrantsOrRightsRedemptionPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ClassOfWarrantsOrRightsRedemptionPricePerWarrant",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per warrant",
        "documentation": "Class of warrants or rights redemption price per warrant.",
        "label": "Class Of Warrants Or Rights Redemption Price Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r67",
      "r301",
      "r354"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r160",
      "r161",
      "r425",
      "r610",
      "r614"
     ]
    },
    "plmk_CommitmentsandContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "CommitmentsandContingenciesDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A Ordinary Shares",
        "verboseLabel": "Class A ordinary shares [Member]",
        "netLabel": "Class A Ordinary Share [Member]",
        "label": "lass AOrdinary Shares [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class B Ordinary Shares",
        "verboseLabel": "Class B",
        "netLabel": "Class B Ordinary Shares [Member]",
        "label": "Class B ordinary shares [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r601",
      "r602",
      "r604",
      "r617",
      "r631",
      "r634"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in Dollars per share)",
        "verboseLabel": "Ordinary shares, par value",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized",
        "verboseLabel": "Ordinary shares, shares authorized (in Shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r355"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares issued",
        "verboseLabel": "Shares issued (in Shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding",
        "verboseLabel": "Share outstanding (in Shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r43",
      "r355",
      "r375",
      "r634",
      "r635"
     ]
    },
    "plmk_CommonStockSharesTransferred": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "CommonStockSharesTransferred",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares transferred (in Shares)",
        "documentation": "Common Stock, Shares Transferred.",
        "label": "Common Stock Shares Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, Value",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r304",
      "r447"
     ]
    },
    "plmk_CommonStockValueTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "CommonStockValueTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock value transferred",
        "documentation": "Common Stock Value Transferred.",
        "label": "Common Stock Value Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock voting rights",
        "label": "Common Stock, Voting Rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r75"
     ]
    },
    "plmk_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition for future business combination number of businesses minimum",
        "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.",
        "label": "Condition For Future Business Combination Number Of Businesses Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r483",
      "r577"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r477",
      "r571"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r476",
      "r570"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r476",
      "r570"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r476",
      "r570"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r478",
      "r572"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r480",
      "r574"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r480",
      "r574"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]",
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r481",
      "r575"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Role of Management [Text Block]",
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r482",
      "r576"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]",
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r479",
      "r573"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r64",
      "r66",
      "r103",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r446",
      "r599",
      "r611",
      "r612",
      "r613",
      "r622",
      "r623"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion per unit (in Dollars per share)",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r173"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r103",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r446",
      "r599",
      "r611",
      "r612",
      "r613",
      "r622",
      "r623"
     ]
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs included in accrued offering costs",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r13"
     ]
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Offering Costs",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "plmk_DeferredFeePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DeferredFeePerUnit",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred fee per unit",
        "documentation": "Represent the deferred fee per unit.",
        "label": "Deferred Fee Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_DeferredOfferingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DeferredOfferingCost",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "documentation": "Deferred offering costs.",
        "label": "Deferred Offering Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Offering Costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "plmk_DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs paid through promissory note - related party",
        "documentation": "Amount of deferred offering costs paid through promissory note - related party.",
        "label": "Deferred Offering Costs Paid Through Promissory Note Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_DeferredUnderwritingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DeferredUnderwritingFee",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred underwriting fee",
        "documentation": "The amount of deferred underwriting fees.",
        "label": "Deferred Underwriting Fee"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r506",
      "r507",
      "r521"
     ]
    },
    "plmk_DerivativeFinancialInstrumentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DerivativeFinancialInstrumentsPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments",
        "documentation": "The disclosure of accounting policies for derivative financial instruments.",
        "label": "Derivative Financial Instruments Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r29",
      "r30",
      "r31",
      "r32",
      "r102",
      "r117"
     ]
    },
    "plmk_DescriptionofOrganizationandBusinessOperationsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "DescriptionofOrganizationandBusinessOperationsDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director [Member]",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r607",
      "r632"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r506",
      "r507",
      "r521"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494",
      "r545"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494",
      "r545"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic net loss per ordinary shares (in Dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r120",
      "r123",
      "r124",
      "r125",
      "r127",
      "r254",
      "r258",
      "r272",
      "r273",
      "r297",
      "r310",
      "r427"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted net loss per ordinary shares (in Dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r120",
      "r123",
      "r124",
      "r125",
      "r127",
      "r254",
      "r258",
      "r272",
      "r273",
      "r297",
      "r310",
      "r427"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Ordinary Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r126"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "plmk_EmergingGrowthCompanyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Growth Company",
        "documentation": "Disclosure of accounting policy for emerging growth company.",
        "label": "Emerging Growth Company Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder's Deficit [Abstract]",
        "terseLabel": "Shareholder\u2019s Deficit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r80",
      "r91",
      "r92",
      "r93",
      "r104",
      "r105",
      "r106",
      "r108",
      "r113",
      "r115",
      "r117",
      "r129",
      "r152",
      "r153",
      "r159",
      "r204",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r309",
      "r312",
      "r313",
      "r314",
      "r329",
      "r400"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r487",
      "r498",
      "r514",
      "r549"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r484",
      "r495",
      "r511",
      "r546"
     ]
    },
    "plmk_EstablishedPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "EstablishedPerShare",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Established Per Share",
        "documentation": "Established per share price.",
        "label": "Established Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "plmk_FairValueOfSharesGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "FairValueOfSharesGranted",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of shares granted (in Shares)",
        "documentation": "Fair value of shares granted.",
        "label": "Fair Value Of Shares Granted"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_FairValueOfSharesGrantedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "FairValueOfSharesGrantedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of fair value of shares granted",
        "documentation": "The amount of fair value of shares granted.",
        "label": "Fair Value Of Shares Granted Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r553"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r553"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r553"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r553"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r553"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r473",
      "r505"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_FounderSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "FounderSharesMember",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder Shares [Member]",
        "label": "Founder Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering [Member]",
        "verboseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r471",
      "r474",
      "r494"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax provision",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r78",
      "r116",
      "r117",
      "r128",
      "r137",
      "r144",
      "r242",
      "r243",
      "r250",
      "r311",
      "r445"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r240",
      "r241",
      "r244",
      "r245",
      "r246",
      "r247",
      "r320"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueToAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDueToAffiliates",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to officer",
        "label": "Increase (Decrease) in Due to Affiliates",
        "documentation": "The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r544",
      "r553",
      "r557",
      "r565"
     ]
    },
    "plmk_InitialAmountHeldInTrustAccount": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "InitialAmountHeldInTrustAccount",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial amount held in trust account (in Dollars per share)",
        "documentation": "Initial amount held in trust account.",
        "label": "Initial Amount Held In Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_InitialPublicOfferingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "InitialPublicOfferingDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_InitialPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "InitialPublicOfferingTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INITIAL PUBLIC OFFERING",
        "documentation": "The entire disclosure of the initial public offering.",
        "label": "Initial Public Offering Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r475",
      "r569"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r475",
      "r569"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r475",
      "r569"
     ]
    },
    "plmk_InterestUsedToPayDissolutionExpensesMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "InterestUsedToPayDissolutionExpensesMaximum",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest to pay dissolution expenses, maximum",
        "documentation": "Interest Used To Pay Dissolution Expenses, Maximum.",
        "label": "Interest Used To Pay Dissolution Expenses Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r450"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r450"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r99",
      "r151",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r261",
      "r262",
      "r263",
      "r274",
      "r353",
      "r428",
      "r458",
      "r615",
      "r626",
      "r627"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDER\u2019S DEFICIT",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r68",
      "r306",
      "r447",
      "r600",
      "r608",
      "r621"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_LiquidityAndCapitalResourcesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "LiquidityAndCapitalResourcesPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity and Capital Resources",
        "documentation": "Disclosure of accounting policy for liquidity and capital resources.",
        "label": "Liquidity And Capital Resources Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_MarketValueInPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "MarketValueInPercentage",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market value in percentage",
        "documentation": "The market value in percentage.",
        "label": "Market Value In Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Financing Activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r55"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Operating Activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow",
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r55",
      "r69",
      "r81",
      "r88",
      "r89",
      "r93",
      "r99",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r122",
      "r151",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r254",
      "r258",
      "r273",
      "r274",
      "r308",
      "r377",
      "r398",
      "r399",
      "r456",
      "r615"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r491",
      "r502",
      "r518",
      "r544",
      "r553"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "plmk_NoticePeriodToBeGivenPriorToRedemption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NoticePeriodToBeGivenPriorToRedemption",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notice of redemption",
        "documentation": "Notice period to be given prior to redemption, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period To Be Given Prior To Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_NumberOfAdditionalUnitsPurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfAdditionalUnitsPurchased",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional unit purchased (in Shares)",
        "documentation": "Represent the number of additional units purchased.",
        "label": "Number Of Additional Units Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of days restricted private placement shares will be subject to transfer restrictions",
        "documentation": "Number of  days restricted private placement shares will be subject to transfer restrictions.",
        "label": "Number Of Days Restricted Private Placement Shares Will Be Subject To Transfer Restrictions"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_NumberOfIndependentDirector": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfIndependentDirector",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of independent directors",
        "documentation": "Number Of Independent Director.",
        "label": "Number Of Independent Director"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.plumpartners.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r436",
      "r606"
     ]
    },
    "plmk_NumberOfSharesIssuedPerUnit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfSharesIssuedPerUnit",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares in a unit",
        "documentation": "Represents the number of shares in a unit.",
        "label": "Number Of Shares Issued Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_NumberOfSharesNoLongerSubjectToForfeiture": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfSharesNoLongerSubjectToForfeiture",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares are no longer subject to forfeiture (in Shares)",
        "verboseLabel": "(in Shares)",
        "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.",
        "label": "Number Of Shares No Longer Subject To Forfeiture"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_NumberOfSharesSurrendered": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "NumberOfSharesSurrendered",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares surrendered (in Shares)",
        "documentation": "Number of shares surrendered.",
        "label": "Number Of Shares Surrendered"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement",
      "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Formation and operating costs",
        "label": "Operating Costs and Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r62",
      "r317",
      "r318"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due from sponsor",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r299",
      "r349",
      "r350",
      "r458",
      "r629",
      "r632"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to officer",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r447"
     ]
    },
    "us-gaap_OtherNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Owned amount",
        "label": "Other Notes Payable",
        "documentation": "Amount of long-term notes payable classified as other."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r66",
      "r628"
     ]
    },
    "us-gaap_OtherNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note \u2014 related party",
        "label": "Other Notes Payable, Current",
        "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "plmk_OtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "OtherOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other offering costs",
        "documentation": "The amount of other offering costs.",
        "label": "Other Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount returned from sponsor",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r364",
      "r433",
      "r630"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r489",
      "r500",
      "r516",
      "r551"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r492",
      "r503",
      "r519",
      "r554"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r492",
      "r503",
      "r519",
      "r554"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option [Member]",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "plmk_PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of formation and operating costs through promissory note \u2013 related party",
        "documentation": "Amount of payment of formation and operating costs through promissory note \u2013 related party.",
        "label": "Payment Of Formation And Operating Costs Through Promissory Note Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForUnderwritingExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate underwriting discount (in Dollars)",
        "label": "Payments for Underwriting Expense",
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "plmk_PercentageOfFairMarketValueOfAssetsHeldInTrustAccount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PercentageOfFairMarketValueOfAssetsHeldInTrustAccount",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of net assets held in the trust account",
        "documentation": "The percentage of fair market value of assets held in the trust account.",
        "label": "Percentage Of Fair Market Value Of Assets Held In Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of public shares to be redeemed",
        "documentation": "Percentage of public shares to be redeemed on non completion of business combination.",
        "label": "Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of shares issued and outstanding",
        "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.",
        "label": "Percentage Of Shares Issued And Outstanding Shares After Initial Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective business days",
        "documentation": "Period within which the registration of warrants shall be effective from the closure of business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Period Within Which The Registration Of Warrants Shall Be Effective From The Closure Of Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of business days",
        "documentation": "Period within which the warrants shall be registered with the securities exchange commission, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Period Within Which The Warrants Shall Be Registered With The Securities Exchange Commission"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PlumPartnersIVLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PlumPartnersIVLLCMember",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plum Partners IV, LLC [Member]",
        "label": "Plum Partners IVLLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, par value (in Dollars per share)",
        "verboseLabel": "Preference shares, par value",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r188"
     ]
    },
    "us-gaap_PreferredStockRedemptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockRedemptionPricePerShare",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock, Redemption Price Per Share",
        "label": "Preferred Stock, Redemption Price Per Share",
        "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares authorized",
        "verboseLabel": "Preference shares, shares authorized (in Shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r355"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares issued",
        "verboseLabel": "Preference shares, issued (in Shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r188"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares outstanding",
        "verboseLabel": "Preference shares, outstanding (in Shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r355",
      "r375",
      "r634",
      "r635"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r303",
      "r447"
     ]
    },
    "plmk_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market price per share",
        "documentation": "Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price.",
        "label": "Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PrivatePlacementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PrivatePlacementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PrivatePlacementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PrivatePlacementDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PrivatePlacementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PrivatePlacementTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRIVATE PLACEMENT",
        "documentation": "The entire disclosure of private placement.",
        "label": "Private Placement Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "verboseLabel": "Initial public offering",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from private placement",
        "verboseLabel": "Aggregate proceeds (in Dollars)",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "plmk_ProceedsFromSaleOfFounderShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ProceedsFromSaleOfFounderShares",
     "crdr": "debit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of founder shares",
        "documentation": "Amount of proceeds from sale of founder shares.",
        "label": "Proceeds From Sale Of Founder Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfessionalAndContractServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalAndContractServicesExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate payment per month",
        "label": "Professional and Contract Services Expense",
        "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PromissoryNoteMember",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Note [Member]",
        "label": "Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PublicWarrantExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PublicWarrantExercisePrice",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public warrant exercise price",
        "documentation": "Public warrant exercise price.",
        "label": "Public Warrant Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PublicWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PublicWarrantMember",
     "presentation": [
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Warrant [Member]",
        "label": "Public Warrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PublicWarrantsAdjustedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PublicWarrantsAdjustedPercentage",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Warrants Adjusted Percentage",
        "documentation": "The public warrants adjusted percentage.",
        "label": "Public Warrants Adjusted Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public warrants exercisable after the completion of business combination",
        "documentation": "Represent the public warrants exercisable after the completion of business combination.",
        "label": "Public Warrants Exercisable After The Completion Of Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_PurchaseOfPrivatePlacementOfUnderwritersPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "PurchaseOfPrivatePlacementOfUnderwritersPerUnit",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of private placement of underwriters per unit",
        "documentation": "Represent the purchase of private placement of underwriters per unit.",
        "label": "Purchase Of Private Placement Of Underwriters Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r484",
      "r495",
      "r511",
      "r546"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r205",
      "r288",
      "r289",
      "r300",
      "r307",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r374",
      "r376",
      "r407"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r288",
      "r289",
      "r290",
      "r291",
      "r300",
      "r307",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r374",
      "r376",
      "r407"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r625"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r381",
      "r382",
      "r385"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r205",
      "r288",
      "r289",
      "r300",
      "r307",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r374",
      "r376",
      "r407",
      "r625"
     ]
    },
    "plmk_RelatedPartyTransactionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "RelatedPartyTransactionsDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RELATED PARTY TRANSACTIONS",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r289",
      "r292",
      "r326",
      "r327",
      "r328",
      "r383",
      "r384",
      "r385",
      "r404",
      "r406"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedCashFlow",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of promissory note - related party",
        "terseLabel": "Repayment of loan",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r485",
      "r496",
      "r512",
      "r547"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r486",
      "r497",
      "r513",
      "r548"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r493",
      "r504",
      "r520",
      "r555"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r61",
      "r305",
      "r315",
      "r316",
      "r325",
      "r356",
      "r447"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r104",
      "r105",
      "r106",
      "r108",
      "r113",
      "r115",
      "r117",
      "r152",
      "r153",
      "r159",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r258",
      "r264",
      "r266",
      "r267",
      "r269",
      "r271",
      "r282",
      "r283",
      "r312",
      "r314",
      "r329",
      "r634"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per unit (in Dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_SaleOfStockUnderwritingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SaleOfStockUnderwritingFees",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting fees",
        "documentation": "Represents the amount of offering fees incurred and paid for underwriters.",
        "label": "Sale Of Stock Underwriting Fees"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ScheduleOfKeyMetricIncludedInNetIncomeOrLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Key Metric Included In Net Income Or Loss Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Key Metric Included in Net Income or Loss",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_SegmentReportingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SegmentReportingDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGEMENT REPORTING",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r128",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable",
      "http://www.plumpartners.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Key Metric Included in Net Income or Loss [Line Items]",
        "terseLabel": "Segment Reporting [Line items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Member]",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r210",
      "r229",
      "r230",
      "r231",
      "r232",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing share price",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_SharePricePerPublicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SharePricePerPublicShare",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price per public share (in Dollars per share)",
        "documentation": "Share price per public share.",
        "label": "Share Price Per Public Share"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ShareholdersDeficitDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ShareholdersDeficitDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder's Deficit (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price per unit (in Dollars per share)",
        "verboseLabel": "Purchase price per Unit (in Dollars per share)",
        "netLabel": "Price per share (in Dollars per share)",
        "label": "Price per unit",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestmentsMember",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Investments [Member]",
        "label": "Short-Term Investments [Member]",
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r426"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r97"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_SponsorFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SponsorFees",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paid sponsor balance",
        "label": "Sponsor Fees",
        "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "plmk_SponsorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SponsorMember",
     "presentation": [
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor [Member]",
        "label": "Sponsor Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r84",
      "r85",
      "r86",
      "r99",
      "r120",
      "r121",
      "r123",
      "r125",
      "r130",
      "r131",
      "r151",
      "r162",
      "r164",
      "r165",
      "r166",
      "r169",
      "r170",
      "r188",
      "r189",
      "r192",
      "r195",
      "r202",
      "r274",
      "r321",
      "r322",
      "r323",
      "r324",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r355",
      "r378",
      "r400",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r596",
      "r598",
      "r605"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r43",
      "r46",
      "r47",
      "r80",
      "r91",
      "r92",
      "r93",
      "r104",
      "r105",
      "r106",
      "r108",
      "r113",
      "r115",
      "r117",
      "r129",
      "r152",
      "r153",
      "r159",
      "r204",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r309",
      "r312",
      "r313",
      "r314",
      "r329",
      "r400"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r129",
      "r283",
      "r296",
      "r319",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r379",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r400",
      "r451"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r129",
      "r150",
      "r283",
      "r296",
      "r319",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r379",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r400",
      "r451"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r488",
      "r499",
      "r515",
      "r550"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Class B ordinary shares to Sponsor (in Shares)",
        "verboseLabel": "Issuance of shares in consideration (in Shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r42",
      "r43",
      "r61",
      "r321",
      "r400",
      "r420"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted shares (in Shares)",
        "verboseLabel": "Restricted shares",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r61"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares were subject to forfeiture (in Shares)",
        "verboseLabel": "Shares subject to forfeiture (in Shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Class B ordinary shares to Sponsor",
        "verboseLabel": "Amount paid by sponsor",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r42",
      "r43",
      "r61",
      "r329",
      "r400",
      "r420",
      "r457"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedBalanceSheet",
      "http://www.plumpartners.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholder\u2019s Deficit",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r46",
      "r47",
      "r57",
      "r357",
      "r375",
      "r401",
      "r402",
      "r447",
      "r458",
      "r600",
      "r608",
      "r621",
      "r634"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDER'S DEFICIT",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r98",
      "r187",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r204",
      "r270",
      "r403",
      "r405",
      "r424"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r294"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r294"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r294"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r294"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_SubsequentEventsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SubsequentEventsDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.plumpartners.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r295"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails",
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "plmk_ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Threshold consecutive trading days",
        "documentation": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.",
        "label": "Threshold Consecutive Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combinations"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading days",
        "documentation": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination.",
        "label": "Threshold Trading Days For Transfer Assign Or Sale Of Shares Or Warrants After Completion Of Initial Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails",
      "http://www.plumpartners.com/role/ScheduleofKeyMetricIncludedinNetIncomeorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r607",
      "r624"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_TotalEquityProceedsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "TotalEquityProceedsPercentage",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Equity Proceeds Percentage",
        "documentation": "Total equity proceeds percentage.",
        "label": "Total Equity Proceeds Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "plmk_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "TransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "documentation": "Represents the amount of transaction costs incurred.",
        "label": "Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price trigger to transfer (in Dollars per share)",
        "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.",
        "label": "Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Stock Price Trigger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TravelAndEntertainmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TravelAndEntertainmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Travel related expenses",
        "label": "Travel and Entertainment Expense",
        "documentation": "Expenses incurred for travel and entertainment during the period."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "plmk_UnderwritersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "UnderwritersMember",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriters [Member]",
        "label": "Underwriters Member"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting Agreement [Member]",
        "label": "Underwriting Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_UnderwritingDiscountPricePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "UnderwritingDiscountPricePerUnit",
     "presentation": [
      "http://www.plumpartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discount price per unit",
        "documentation": "Underwriting discount price per unit.",
        "label": "Underwriting Discount Price Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "plmk_UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant",
        "label": "Units Each Consisting Of One Share Of Class AOrdinary Shares And Onehalf Of One Redeemable Warrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_UnitsIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://www.plumpartners.com/role/InitialPublicOfferingDetails",
      "http://www.plumpartners.com/role/PrivatePlacementDetails",
      "http://www.plumpartners.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of units (in Shares)",
        "verboseLabel": "Units sold",
        "netLabel": "Aggregate units",
        "documentation": "Number of new units issued during the period.",
        "label": "Units Issued During Period Shares New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount",
        "label": "Unsecured Debt",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r66",
      "r628"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.plumpartners.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r73",
      "r74",
      "r76",
      "r77"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.plumpartners.com/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant expiration term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r618",
      "r619",
      "r620"
     ]
    },
    "plmk_WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase one share of Class A ordinary shares",
        "label": "Warrants To Purchase One Share Of Class AOrdinary Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares outstanding, diluted (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r125"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.plumpartners.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares outstanding, basic (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r125"
     ]
    },
    "plmk_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.plumpartners.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital deficit",
        "documentation": "Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.",
        "label": "Working Capital Deficit"
       }
      }
     },
     "auth_ref": []
    },
    "plmk_WorkingCapitalLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "WorkingCapitalLoansMember",
     "presentation": [
      "http://www.plumpartners.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working Capital Loans [Member]",
        "label": "Working Capital Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "plmk_YearOfInception": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.plumpartners.com/20241231",
     "localname": "YearOfInception",
     "presentation": [
      "http://www.plumpartners.com/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inception period description",
        "documentation": "Year of inception.",
        "label": "Year Of Inception"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "SubTopic": "320",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>54
<FILENAME>0001213900-25-026434-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-026434-xbrl.zip
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MY;F)TZ[>[DOV]:9=1X1T9L[=VR?L9DJ?%0G-99J^7&Q$A>CJ@WS4)RQ_N&Q
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M 1%LHJ@J,,YIGUQ2QF5=;2P, R7)N+'UR"=U1GE.L)0=IIRD"_Y59RVHH?G
MBRJM+BBE47&Y==E1?.MJ:[%"M]3;H9<Y038)1,;@'D?ME"W]F@IQ+Y,"2R[1
MW<D\=V28ZJ^)9)7A)4SZV!BSC&]*05*/!>9">T2!?2U#*I)V][RC7&HH:K4
M6@W:/MH$JPS1=%1W$$V9&HK ?$B_,BD6$:1 .8_6H3GFZH(!E9A89D4VLO!
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MW4+>C/I6A&:1E)4MKN;V5D/&K:78 7%=U-*>EL6=_&,@'%4("EJ3?BD[1;_
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M\T'P9U<#]>H:#4G;(6S2W'[,%+&,J=H(&[$(K&L&A,\4@D>S>9$>;(OEO&2
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M9_ZXUS'OWUIP+ %T&#P(H,-@=4"'CUY6F4/$3<',A@>112>',H"'8@77'H'
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M S SED-T[9P\_DT078.E$5T?MU'Q.4N3+\AO:#D3@_?!F?D2#BXTB$LW4,J
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MZNU6'I(, O4'EIRB7UM=Y47\J2+("$>X@6;B)R?;?V%*>*)6M*@M9C3C,+Q
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M J*75'5UD1>,'A;(@UEG"N@(_UL8('0,P)@KG4B(A.TI%<47P#ZE>2#L-TC
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M#7NE>7-B#WEG.WCO2A3*YO+]875DSM"0*[0M@!/*"S$VB.'<%!D[ 9$*A0V
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MDMBZ:,/!@NJ,$X&:8:[8)*0-XN0;0HKD=9ER#VT6N(O,V8*J9&Q#8)(,WD+
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MAHXLK>UE[9=@3>^ZV(:,'1V?2BY4,.S26P-_6$2*0WD -_T M"^$+290%MV
M9(8<H'+M XS[SX9RY!(?P1[]*DO<7,%]A"7N#7]X9X04D\FHD-J2]2JIV\!<
MY>B$:;L_Z[)4(1?SA*ORKN>S[[:M%\@^FN:T')D=$HUMI\=!OO-,_,)^*NEQ
MQN<?<CHFA_W[;LN:P/1V4^X&6U)YG94K1XD;+\L%D>EYA\$_WDT)>I>Q!"F2
MTT.CZN,\;K40[%9$< P8QX)1<,$H^.>N5LMC=_W#.N2$*S;N!1G9>W_(32R?
M4%>1 6 YT1W[]%B&WF]WV(7I%09<=<,,N(24[.H/Z5GW[> Q+@6J 5B\2TCQ
M( /_(,ZO(U;O_3R_3D46&88"<W*E1U01P/MHYP,?P$(1_':A,5EHSGR0;H>T
MO(3UJKMGENT>-[)[SF<_\161F&)==_L(<J-%Q2B1$=#@>VT]=_S62Q[G+BM_
M/:ACY)50"2Q(MJ2]88K/4GG;4EX!%XC7M&''\KH SH (7Y"UMA7'9$T6U;+D
MK'"''(SM]"?YD9!(IEU4;[:2Y<HX4YRP0< =DEB\&,M",V?S2!ZZT+R*WXJ(
M]^]_U!#;%<0P1(Z]'&*9&ETMLJNQ(G/8Q_31^)QQ!D-^R1GZ"L) C%QHN,U1
MX!EG]1,>C,CQ'IFEW89@*=MNEW""24YY3=DN6*;E[-GG+_FW8 S6:CPL-K7!
M5#O-L_$HJ&)YJ-5']GL.%'[8KBH1G"F??N:B>HU1K7DME+2O_&KDU)E@/?0-
M1>EI[,5F8R]6^,'0T2CI2<+84;H2.6S_A?"-)G1O^W'F-E2:'NWC\U:6J$XL
M+D3H>_D/0J=&/X'=7OL!N"K%+".GJMG--6G.T%P2]S+#?BZK3#E*^7DI%27]
MD[TFU\?'3/L2<:O8CP<\<-M<<81+UGR6264-7 /-KZ,_%G1)!#$Y"ZNPT60[
M4 EY%XW&+L?ARI]@I5-&/CY'!6!XY&L&T8QYYCVP47!\^BN4* G@;3=VKPY_
M0JN5DM>\MD<6@1N??Q:.0I^K51>*-$:8!YDQG4V&O2H]3:68,F,]0(&X;;AG
M63JO X&S2N51*)R!6L+Q%V%EO+IF^U;7H7TX5C1UZ$IBZT3-F]VB:A"*<S\E
MJRI9GFNUA&AU90APN"1S Y$O%]E@T4M3;P[R&N_E!TM:>4C\#Y.L*X>.R\%F
M#P2Q%;69ZA]U<].3"0@3O-G1?_R6%1!F?Y$%\J;QA@C#\+KU&Y=/R: 4^>U?
MWKQ6H4A G/FK0#53^OHZ$#!L$K:W*)PX< "*_/AWT3:->24MM66,$H0>=QPQ
M*4&[$H96VELLY0+64'8GHJ^3_%1H=N.%!Y[0[*IJ6%"B2%P@\CZV:^0ML<5H
M$M13TOK@VQIR=?KX2D?,U327%PZD)JA'^$3,P+7 N$+'R>_2TE;<S^(P%6;:
MW)AOQ>4\=9]233K_\=\()RXZ:Q?06?N$?7M:33,J-Q./F0B/_UC[E>E_]-]^
M$/U!_36=8=?E@ADDT')-P36&X[5W;/RB:6I2Z*0P92TJ,[%M[GOA,Y.'?./O
M=2LXQG^&4O?5MJ3R2E5%%.[Q2\GA4$G74ZP*&V)DG4_1(WD@T<5)>+#/']71
M3L>#O7C$@_VN=H1V*AWMYQR,-Z; 81_?SW&G^SD/N_/G='_6[9OGPXYH<+F^
M_/COB/]]\3D9@I&7E3]Z)Z:BJS]]_B*S LFS,&'CO%JM;JBHU5S]GS]<_.%]
MGV^O@?[*G\:+S35=[^)/X4CPEI&P)/2-=U_Y7;GI].;>Y01%C+Z>O_;$Y+K_
MV"ST5W*/B_/G+^OF#W_^SZF/TDNMJB7&Z(M//_O"#])F87\W>L\1'64%^H10
M-<2: -;CLG[8-YW?91CVQV7Q()8%.9J!^S5@C+[ZV=?#;\/R0@W+O_E1)Y8[
MY<2ZIR>511>(/X$XD=F:%]PLYD<K^A+..A"/1\_]MS&1B5!2?4,GYN<W+X]+
MX==?"N6B#81[)3,E>I,*@D]6;^+,(9%H"ES]T15Y*&LC=!(4P+IUB]G;JKK!
MOV];_CMQ%.Q4R))R>MLNC4:-B <K[K*Z0)#</7\@3LQWS>R_RF9;=CLI/[Y
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MG]\(RO(W8)F_CK3WJLZF[9*4\S!LJ2ZT&<J\!^15YB97"<$K";10%OBP1U^
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M]G9T2S1S*28S@LQ"=VK0CE2=E,=E_A"6.8 16@OG9;9<5>]J,8E<J&G0%\<
MMP7 =4!W4%8,#=V] K 3>*2DE )Y7I #O-/:7_6XQA["&E,9I<7L=KLB<V/
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M::]S:R8H=S/X-,1U_G=+M2\4H+H:K<5L&\8GM&2Z=$!T.-$P_CU:KWB12)V
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M'K9W3<JKX)Y/CK4H6&&GLS"H)"RPF#ZF7?]SV[E\B0$R0'%B:"DF:="NTOI
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M]5:LZIA <Y#YN[>46V^BNU',C'*'.(UH1#7MB7$%G#RYW*PC_;'I.IWP5:@
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MS;<__%@(?1O@97+*6NL>:&7-HCIAC,OM0IJ$9]D0\RH*3R5']_=\8@E\SKR
M^PYD5E?7&WZ!V=EP<!G4^?WK5]]]+8,ZN2;2 !C6DMJ9.;1O6Z268U_TP+XY
M,;'**Z+1+"RC4,4,TTCJ1U@O*QU$6C=TB,>F&-E.>W[D1L9VS#0I@_WQN4IM
M9^H [KQ4#V/9^;W_4 [ID[ E+QZQ)2=C2YY?/&)+?E<[@K$E9$AJYF8TXI/Q
MA/ZQ['S@7_5/OWNWJG;NU7QSF)[H1%!?8<+6V(0>321:T,K&SXQ8?*'*+40B
M2<HY 8D8^88"6_.&T[^6(.3>N[8_LK_&=WUQ\4*/YG1&9Z_FX1#MG7:85J1
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M!:U1J;N8F0;'$?P(Y2[W_J#W8OR/_'"V6Q@H?VWALKK<*<YWUXYA!AZ2K'N
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MMCV0@#(3U5=Q;FNE=+AD)7LY3$?TEA74:-0T];04F0I-/$7^_*G#E7KQ58&
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M]Z:7EJ2^LBWX,+&^W&[X[45G8!YI($2< JU6(,"IJK?Y5IV]3DA&'.%E;RJ
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MWZ1L:-:)PT\O:'X5P&8C]W 1C6BVA1#9F*AF:HM$'?(U6F5*[XL(#BSP^*8
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MU7)Z^Y]@=N-B21 BY]PN*.\TM1OS'24I%Y@;%_" CK1B,4!':C6@(U\C."
M"T26SZV,0F?C#/8DEG=Z2L)"L7'%[H('5ZEM1E@+!UND:WSM)CAM7RU+JU:H
MB'&*TYI+<%J:=%N*Q2J=NXI[X0OB#W2P!.@\1WUBB&'[;1!' ]23JU7 9G&$
MRO'8IWO0UH2C[[3)<(-U-D["CI(T?N0!KX]%112M2[]$,9*J+/U2OA@KR*7[
MF38%(:W]KB-/:;%5YP8*F@PW*C0;@6C,FGSX:H44<@STP4LK#8I,%9>5M9[B
MB])8@W/=B UV^L0-T=V99,8-4+TQLEN3A^Y4M9C+URG650YBK\&U;EJES0J
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MR.@\L+GQ4HB\%&U]/H=M1H\'FSHQBD0H))W@P\(7.$INL8"23)%JJ\!0W+.
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MDKD&ATL /90K^9*.=N,7)/C&X"6YY@VOKQY?\U)$3,E 74XK)-NV3+0TX^V
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M6W8QL.!#4*/Q!0&^86O'$-XYG08&T9LI>^1+V O0\$7E?-&@4X,L4YUV0Y
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MEQKC?_?C-!UC+WYV^8]GV\]6'\E-,IA<X4>W?S:JNI^G:30N007I?YD_P5G
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MP&#UDC25WHS&-Q@1><4BLKL=ZN63?3A\=ZJB27 .^S@!Y4]Z VFNDBUY]M8
M \1%T#TV(LPLRJ0R91PC&8<&D(O@CZAVIB6K(L2ST917PO71-ZK8JD=%^%%@
MV"0#> C^SH(N(* /<571Z&#)@\LXOX3/7F%UK+]RH/.HC<LN+2N.4A^ . ,Y
MHU]/@LE-;O] WYR.RU#U\LF5!5BC,DPZ#E(/21M=U,ITA?<(CS*B^O&FF:M
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M1;D9%_D0U +5:RIMS\ QBT:](L&#U"W+O(]$+[ ?,"Z4W9U7KU[)BD4LT9U
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MOOWXXNA#L+/3"8[^[]'AIXOC/X^"P],/'X].SKL7QZ<G/QHT"<VIKL]<^L?
MO;A_M/FU.$0GA%I59;/+G:8>N32QV#8>* Q#4O>0Y\T2)9@&MRTPLE:PX8JN
M\5MF1B0R7JKAFEYBA)(I52D,S)2E:,5FY3 N\+N[!^'V]G:5'1$1/Z/^E3)H
MX@U\/<$&HF9<7H+M*ZR(+YJ>M4G&!7, 1:6F0\.RL2*!5</V#;'[$=F?<WL_
M;7>VM_>PI8H?P@1B,ORPDBC4"QB:"N.AO$%CAETS&U^:< !=!QZ*.!GUI@4V
M[FH6RWPZV<J'6^.\_SEF5H:LC-'J(;IXZCL!LRB3FAK&&\072&F9, 3&5U$J
MV!S(B.8$=<<Y1=EATA.,<4Q,&$@[2(SS@1\=3#&\#U+$Q<YP/4P33K(U4>B6
M3 A7I52@J4HP@O)+%JB*,TR863+V%5MP(%(@T8.8$8QUN*.^^-;-4KH_;9GU
M?Z0Q"/+#*>R?3]"-)#L,)0MM5EAACCC-..VR8<H)%16N(X\ _F$SM$+)6T(Q
M9Z>'L+8=1GWD?C30[ AOA2O_C4I$D1)QV""+H$'8ZYS.B\/OE8K\/$USRG?J
M*86:I96\\U E0Q8_,Y2O>:D)+J*_07LP!*54(L$U(0.6S"8(_U^@CA2HM75Q
MYR/-L8NL<?.+?VFAOYD'/QUL;]/EA>A*.8+*H S*H>C-W#/'/N,U \@0/L26
MYO:AZZBXC++DOSKGIN^0=07%NC[EX:SN"EVZSL43.XS,;0!A%%W#OZD:12I9
M=KO;X<L]-NU&L.I7=!M)]QC%2IJM6\KJP$"H7Y@R0X@HD5A69'T=2$9%'\U0
M3:Z*?'HI5U?S=YJO$ =,*KJ.DC2R*(+E%&>4H$;A:X5N&&ROH^;,:)P@Z*U[
MUZC:7;,6V;5">#BKN[Q"8'X3?9OZMFCA83-;FU-7CYA/<K12;%_3 'N3E'&3
MU;GHK'(J%U:-2K"80!M=W*AO*;1 C[%')CS8Z+.@*T:.6X09IXB!K(=,GHO#
MH^ T>T6HH>##TPE]&O88_4,=UQ4=-AI'!2?GG9>O!7%]S!_.ZJY\[^/)[</O
M8$W$1R5AMQD@X[_JB_M7M2[&7@O]0UK=51Q%)_BR*"BHG3ZG8)<,3H<)P509
M<?""?IQ[D_TJU03.Z6-OE"L7L+2H9Z-S$FSS[F#^G<)")??^+>S]6(U!NS%4
M[@+D,BCG%H,AEIS\K44_,RK4S+!^JSHQY9G39 !C:;$)]=A"W%X<9RYG;P;C
MY60NS.:FP%@F>NU%+%$Q^CPG@:5NS,+*PNT?3_).\(G]^IU0/'NEX9*U>T]+
M"?,AD<3S A,!5R.CI9M0VEJ'HW<P'DT^"_Y9EVGE8QV/HF0O^2M/I;J^.YQ(
MZGO%R)SRDA^5)G:GYV<21^!176$5[@C%5I.2R;Y17,^ZC:'[55,SY*=.T$63
M ?>(OUFZAXB4V_^LCAX.IU@=+O"%?-3=*N101R<1\81KES,JF<Y,004=#8D4
M!9JFI10^% 2MHO(HKI=6]N_#:9%Q.;J.]SJO;3R'^+PQ#;)IV3O!\02YM*=9
MFGR.4ZYI$/M6GPL/#D>O ,U&"_P$Q 0A8OK1M.3HJ;.9? I@"),MUS0WH[%9
M%[]3P04IK]5UJ,BKOG9&B)@$LR:,,)(,635;!_:5XJI'K1SEA(JW#;+&N@D#
MZA'!/,NL.7WV)/(@4<'U_:C''?UMO#J+#>[?0NAR25TP"8G (I8<^M&--+*)
M7."'3^X$%W0:J>^^3YZHN7(,Z)']>."'GES,185Z)LF&*9="^,K)%.>.<A#6
M2#.1N8D^2K&D0E@45;-]TL2#I<%R_Z5)3.T'NDV?8TVJ02_6-*(KVS"7T2A:
M6KK+*RK7@E,3>>>089,"0=D;Q/VDE!X'JN#4=RXNJ<UH-NJ=.RX/JN1/MCMH
M']ZUP%?>MEJ!TOZZ0&GE J6#[76!TNV<@$JUTFYSM5)CHO+;2YAV.UA&^>GL
M^.)?P>E?)T=GY[\??PQ.WP6'1V<7W>.3X,W1R=&[X\/C[GOY>] ]>1M\Z)YT
M?SOZ<'1RH?#'LZ/WW8NCM\'YQ>GA'[^?OG][= 8?N;B CR_0,;<[K>_0SFIS
MY^S@ES&# U,I*=?X)]0S<QD55%S S71X=5*L!DPYN%VODK&^'+BY'X,W7/83
MT4WY@9I%][9#+!TZ  -FG19_E-$.2N=Q.%SL?%/QTXN#)MFARG!0GB!8<!T<
M_&R,#"1-E/3W=$)A<3:"//%:QZW64<&'L[HKGI,%83,TW.UI ;</S@OFF/P#
ML,8I61^"![6Z*Y >8(U>^P' A&Z V +CIQ(!_92EZ.RZB>L!XD/$ VQG\EUZ
M6#PE>6?JN1R8\"!)(X6Z"5+D.C=) TXCD,\_SF_@[JVRI]&.5 RXJ@HR#4PC
M#HT8"U+QFP<Y? DC$$4\Q&@%=6 A@$'1:C<R33.&/6*D..IS6.*&@B<3H9UE
MAICF3U* _?L'O^;J 3FK?5BM:%R"KZC_53G3RP^U^?2#JSA' ; N>28.I3V?
MY%/?Q A3@1]*!TL% 6[/@^^]1@>=1D5M!H-!02=A&+RQ,G.*,O/W<CI^O;&S
M"5[Z="P=EN*O^RJG84JR+=81Q]GX:EZO"^P./O4?SW:K.]BZ(+ZTZ%A(;1C/
M7I],,4.!D_M[K_C;:W7.!XU_>.,>-_X5SGM0G5[C7!I?UWSA/=SEZ2+.T)<$
M,Q>R !_C C\?70I]NUFY4\<SD-]H[>4N[>VL'=X^RYRN7QU0'#SO>?%+4%SV
M-G:W]\/=O9?A[L'!9OT$BA)X\?SGIFOU]H[:QW0Z"CY&Q03U+T_O^,\P>/_^
MD$_6[N;&GCE<C0=+JZN?FT6C^JGE;3#YRJO*5P@\Y]GKY^'SE]0,U#J>E=]T
MWU/8?=%YOM+H?UY5\JQ<W:+(_$&XW9\C^/A,"TFCA,Q;S*\QQ!?M_*)GWM%X
MFK;Q%O;N:[1&_;7G$VRX#WX'K0@6WF>X,.]V,2AQM3OWD_>X-5\UFJ\Y7NU/
MMACX=RV&#^E,W)ZV^=\MU\YM[>'M'#.7O6"]SP]QG^N[V&+V-6RNRU2QE/$X
MUXY8S3*>MR&K/>F;Y.>'G>[=2^C2<O3]%%3=F:-T%U:E+8RV!1L'+BW%YJ+I
M[W^-/,"7@D$^[:7Q-XI#VX.,[?CB^7:3_%=GL=NVB6SQ[AN+]P=>##!<7WWU
M.E3L63\,^_ Q-!84U2!*TI9;3M%4,;,H*K][  ZE^V57I3B%-?2PAH":GCL-
MKE[M41OC$TE!-$GC_UXJP_ >@XB46,8FLC&'D;QLPK<.]+;R2_I<!;6C]51W
MF&*\2RQB+6F2Y90PH6(#73\8V8"R3KTB+INM?C%]>U2C:"X_+'#N_RT/*&K6
M[3,;-Q;$(%E<QX;/=K=W=^"<IBEU*9Y/.L'_[&Z_? 7+#K+WKL#&IK*?A\$A
MC'Z8%UD2!:_V=W8.UK+X8\CB[G*RZ$ *H>0P;2YEO[C.'N7N('S>"&H4JOU]
MQHNH);A*G8O39-5HK6$A='OR3'I.P,([>,%/15S%(NEC&7G]X_S\3J!#?>HL
MGX72E!\EQ2C*;!=^O4,_U).EHF(\3MR$4>LDHDX:+)4, _HT]5T,L(2;ZNLI
M:6F3A*J6)#Q,(SC$;ZHYRK!U1IJO;]',N;'>4!_XZ!P==80ZPY]3M:\DH2;>
MIFG3&*X,DYO&H$4M0S^#@""$=-^!IY<J::<#:V# LS#SROTC43(JJ6"Z.:_*
M3<MX^?DM)? ,Q'$<PR:"'BIFYKUK9?1C**.]Y931!=&19%OF4'+Z'ST_#8\V
MX(76>!:V/J!4=1'T,6YV.21_6ZJ'V^-T'Y7IDU-.GUSC7)H>R!#.LV#CI]WP
MY8'!X*$F"#V%3:DL=/4U%1Q*^QB>(',>%0V.<=YKV')RN%I66O."+X4LHDLF
M^!&.,G 7'W7 ;KC[<KL)9(_46$5[!?,$ 3N;LMS@ZT>6'=NB _(U5MU"5;\]
MYKR((."P*N02:SHT)XKM0+,==N2K\JQE4+S$Q+XZ'.*AL\U8^ WELF^8-CKN
MABD0Y@X4^IS-]<6<*F)@00QC!P*?%WGJB0K\WS5">N<:0YQ$E0EX#'QXPU;4
M@<L6;MY:)3\@E;QR-1R%C998W#/-55.">?CBH/%H&^/$%1-1),KKY1RGTS+X
M?L:DLH"?8-WI.NY5].#=U_O1?[$%8+6V@#M^[6IM7P?KMJ_5V[YVUFU?MWPF
M*OU?>W>%5KW7,4U=U*]U?'J"S5[<T*4[N"[.NB?GW4/Z8TA_>7M\=G1X<7JF
MCD_>'GT\@O^<'![=&;#\+0CW"W>QK4C>]DA[KP\%O>,L%IH1,(M8RY\)#,F%
M SKUU)>LQ4PXS8)_3C.I2]Q]'@HTMFLMDHW]$V=AE0'ZK&"G&!< U]_VW1F0
ME%BS06B#'.]5S5O[(GS^_"!\U8BY7453BVQU93I3-51LMN%-@6KE>7*9WV P
MPT$O0$]24[LCEDU?B*Q-[WGE,<SH80CZU"ZW?>EI+6[[$KC&5MR%JE^U@9Z'
M;WM3*(FWK6L>KTV7Y2K.#2G'$O[M9B<XG_9*NF_ B N#02.RNLB/\K!AEX56
MMZOP#=#J=3!UY3N\G0!D_FW<)U>*%[!1[$N$-Q>\S9WPU4ZC@#+CH>]S,NRX
MWDK7LE4$F9Z1$0R_J<4DVFSG>^1+_+&UV7$S/'<K$*JGYG1,J;8MK:[(MX2*
M*DA*BEA]&E] 6J\>6@J^(;3$:).&BXL4ZT_[X;[ 0E6#32%S'-6?QSB0# 14
M)J-I"OHN9E8CBXV^K,NT%O$E1=R22;; T?MKK(R\TQ])L2" &+K:TY+9J/+"
MP>U*"OLAHEW W!_"(@EPVR@A8ELBA].JM19>W=L-7[XX:/"NET 38WG<#?=V
M7Z)&K 4_;T,>U5H>;PV$H54Q%K$@ /61WH,"S;+_)=Y_$J-OLWK 9HS'$XU\
MU/R*#=\J<@P?&\K<I$P=F% N@+72!FR:C(B5@M_&=(6]V+5:4%L*'R+:!7EJ
M*-!TQ H.1Y(&>]N\!8-HMAJ\EHL*Z'&94U8_Y7@QB'X"=XO@65"0F:W=I:X<
MV D==W-I;]R7.3-6\Y,"&X9#0X@B<8TI3LU85 VX2PM 'L%FLND^C4E, &(P
M%AE7N*RM:F;DP)7KAYCO$PHRFF^OM@/:,%M+<:M;M-8C2]YK0Q>[LYD.JH?L
MXRC--[#-J,"C9@RO?(P7&BJ(&6N/880T]'@%R%6"C,#X+O-U04.CW21X-H'C
MI"1)B4<]HA*!;$ML^&"8#*9]S#\KADR#?>]/D%DP!RUV&8DFL0^0:@%D;TX*
M3:W*!.\D\(MGD@M8&X_1<,'(4_!.6_I!4R%':BFF=?P4+&G0JK*(T_@Z<N<.
M;J"N.G*60#E+P!N DY]$GX7!AB@#KF.C1/@9/*SU>5EN^!_FPH2R*]O+$8D=
M/F$Q!4T6QJG@X+[XJFLK91YSG)Z0>!L(5@DC KC'C%"+LC"$JYQ2,CI1B;>]
M ZBG;JYB4OD1)6^2_C2-BBHH(%6E9!SS@8'@.!SP3##H^)1B_ ",!I2]2;P0
MXF\M8LO&!I?A- D,IXG2?Z.KD0(Z&GMT37&B*4[6PK>"\"W/;JCNB-VP$5=X
M'KNANDMV0U=2%[,;JI79#9?@-718]!;S&N(,&3;91-M%8YN%-L3P!GC9_(D'
M5]LZ<GK0L2PI\AJ-&<D=7HE'/!,GP06MIW/O;+.J;W//9T)99=O7)WK)X7_T
MR N7U.->'2JB)=/-@'CU",M7(:IC^P7_E)'W3SYBCN$J9./ NGJ0:<H,UG->
MP0:&1$<,VP\;_,\H@Y,STPD"A;B/FRA[6'KJ/Y3R25.C52K1-"O0"R).Y,P+
MM0%7FV5;QGCJQ1$OB)V:J1!#Q2&)*OA4FG#JZUW<*^P,=@2Y4I^W):.RU3$A
M#0/<YW@5J^735W#Z]&+\].I@CV)Z^!7]=T%0UD<^(BV5$W"4R1<Z] ].@(A7
M5FTXQ<)>Z-)&*\M-*M^CVUDC3:TOYEL(0%/1S5R2C$:*X#DD&;Y!%B>TM\VD
M'L'RI!X^G#HX*R&\<&)PV<5E)?T2&@7#=EY45KWW3G \1$@S.0.+G0X"0(.'
M*"(RL:P;>([IZBO=4V(.A/SL22JYX5%I2:Y/=>M0V,#F(2>6HG/R!IJ4FD_[
M"A.4?/BU":POQ$XWT&D4@M=31M58UXIB-JLFL[EASA1=:ULYW,<LMZM&=CF.
MUG_&C49VGY8Z7J>?J/PGUJE2#"7$W5*EJ L*8N-#S&BK$?1@Z0BZY\VTQ[L#
M*H<H^T72TS!\2:FZ68;1K+,8-XXO D,<8%<"5 !%SL)VYAH\=[ [#9PUQ$I0
M _&S#^\$?\5*^ "X+H/^'L>?91N$2;I@J\S> 95B9PPA:!U1:VXI&TD'DF)@
M'HPVJ.JQ;4V)!C% :*"B(;*!(6>(X 9+,+H57<)ZH_QE7"*!IK=4A^MI@&A2
MBV<NSY']7-],7T_ LU@32Q5]$Y/$+3#L,"%<E5DG$&8=RQ(A$J&,$HN)9J).
MKU/ENEF58J>16,<2[U1K =1<HIU567."5M8<CDMB,@;4MVA"^CH/7C7P U6^
M'07@*L<%[/,H9BHQND0FMAYG"6&H%$*@^VZ]SNE89\)68/6!;UAWMT;?$[33
M]ZS/^=)L.G394-DVW5@8K&O*OMG+1E5OF7I97[A,;K&I5=-6 ?&_I 90:OS0
M0BA%OJM&#]]B&WR%;MZC *Q4J/]\7:B_>J'^[KI0?U6AO!=>I(:WZG+QCT3-
M]1%OR=F]CN'^V<B,L3Z+P<X<@"]"=6!4N UN!"V!#KTH#B>'G(:[Q@QW$:":
M'2*VMV@VS?PI]&9.X7TGZ+I90G;M'"9JM'6F)=6A]7(8E>FTY-=2^0V].!XH
M\V+V4SC]2$$'8U9Q&)<F\/T1M1]2)!6\'+W1A(N0#\B(.@)?IU]*8(/2;"7G
MOO($4=LQU(Z^#)@[Q$\8DA>C\[NEF^"%.4C%%M^JEU,PP;#0@FPW^$2>DJ%7
M*KV?N@NPGJ?6)49>ZM=F.62N]>]M!NS260-:/"I9CB&E"3AY3,FY\Z-#@4'Y
ME&F#T5^:L#F;72:8;4XX64"-B"1^E@7:$?+0Y='CQ; M*\HI8<,G8/5[#W:)
MRU)P&2-J.8[Y]?:/FUB1E:?7NO9-<W<^5JGW H]Y0^XK*5TF336DA48=HOM2
M6.ZX4;U-7=6<*\J0L:W)EB8[*;Z&XP #=;U<Q])<C0[**/HWE;L(\(5+[DK2
M79F!+@BB ))V:G  E#3#9%Y>3 FK0W_2YL>DK,B-R,HY(]N8YJMJ\X6QFT$&
MS8/$Z%-1'RN]V9)[FM%U@K_@<&&HT4Q!%QY'60*>8JET* B_+3%]8FY8:HUJ
M,VZ::'UC&].ERDF7!K>7+G6+UL+%&5-E ]B/]O!>7,6EQ+4'4UV1:C( GLLL
MA4'*W.:M>QHDH/&2HI2B=]TUU)?#9[QLBH!(?WI+<9(DCG4?N?URJ)@<-8Z=
M77V\VX2!R(+B6%BF-0(OJ/FRQ^"^XFHOSLJBQ2:1%ZK[C1>5_)H\D*ZYQ,.5
M.-D<AU&UFOQQ3YHR.9TI(ZG=<#]+Y-L+;E,9AV!*/9=XX%8ZT*3R'L;*N1<H
M'\,T-%LV3<H^R2+.J%Z441T07@.BL"N82N^.3\ZZ$H_VAL-Q7O/EY9(M\/ A
M"']3D$[Q4!UC9)PGK&=1TU%NQUZEX__/WKMV-8YD:\+?]2NTF-.S8,90OG+)
M[,-:3@-5]&0"+Y!=<^9++=F602=MR2W9D/2O?_<M0B%9LF7C"Y ^:Z:Z"MM2
M7';LV)=G/WL<8BDF;=^5$W6=?]E]+Z+AA.,^"M#,L0S&E**V3</.L<Q[);>N
M[\,>);/G<Q@\>FW*NDC&XD59>Q0MCBU R^D^>00LP _V2DDD"^<WG>C1N)+2
M%;(&3L>$[^@[B"\?$QW5H\;,*?R=1;G%&&3,K8^SBHWF;'8_02&C4/=J2B5E
M"] 9*EE>CV_;8<+IF?.ERFB@"#[M >=;IF<=MTT^/V3?-O/PF'7',[&NEL:Z
MZL\PO[L%M\IYF=UJ<'M\WO_Q<?T'G?1,V65XS?AD*!./K G,H6]:,7R'@?U\
MV^GDJ30-G+AG9AH@5)FJ@#^, S!]>DK/.TF,)P83-6NN8T=.'^M9 DK@*LXZ
MSFMR5:GV=,FH<T+$"Q._ \:@>I++<T(2*O/EVT/Q*QP* Y[8@;_!FH@-1Z(1
M&^+:OE.7PF>K2 /<K8B\?Q%)@M)G%""HF ?<U$8Y 5C#Y'!2<9T$-94I3/\Y
M54M^%C9A0U8%VDO>JH!<R-A&_RW#[Y9BB^*@RU1+Z"D@T4S(_120J)4P;$8F
M.DU*-_/P:#Z,ER,7",>91*71]QFWH6(0&C> Z9!1, D/M-8##_Q%^@@CUI"3
M@=I4EQ5%TQ2A%9'R'WUW9)EHV6DP=(5]AZO>C9&V.1PIGD!9<P'C-AZ(%(^3
M"O-/M\(ED/2B\:N,-J/XC\*-S8, 3AT=$E(4VQ6$5E;:WZ1]>J8BMI=&,'=5
MS&UK%NI4:$V9CBKUJMIB)U)&.<G1MIN(I4E=.UK>+ZX3SC@&E*W"/H/5\N>L
MB!Q]5/F,\<6NVT.-:0G,#IF^T/AE ]K$VV*45#G$8%7K@'G/3$Q2# F!R^,V
MN(^>$TKA.'U$SXH;5Z""IB.;3)5*6-47#<EQV>1;J(/BT><H8]U*@JFFN&\/
MTS@ZB&5.GGX-^C_L>-%$Z/B_Q]T'"O?BF7/"\$75MP@W!6<?T:OVV.N),PF(
M9N:+!_QW6)TI>Q"I37#T)JA9)\7(BL5($IR"9,3$-H=O.?'%J_&8)+XCB5,1
MD+CO8\DVNP,RNYO944ZJLHV!6SK5(B58&>/0ZC?O(+S_2#!7K6;3UU$$DG8_
M=!^PUAU.4]1Y=+OC/A%[DP6'MH$(.=-^9SX*P\J2SSI8W50VU,AJ GUXM$4?
MSH\^K&W1A_-+-OTC9@*NKXH)N'Y@W]Q>7K4N;YI?[6:K=?W]ZKYY=6]?G)\S
M&_#=^>T_+UOG=Q_$\D%SGA*;<,L@-F0\N!O __SO+R'5+-RT*'#(GY0L!S/-
M3C21,61X-X7/Q:))Y4VY1BE.*%'VE9+1(7FR%(VA!!!8S?RV[-S7^[^(\K"N
MWFF3 # 7L!1__\T[/;#/F,:57 YX4"#9L;@^NE*FVN<Z)2FY8&S/5@D(1:-J
MURJ*0E7'O.;>/T;6)/A][?\XJ94.B0\UI'2#WBO9/Z%/R"9J*.(+,B!(+.:)
MZ1B!.S!31JYJ+2.-!Z14SDZ6RJUS.Y4 >6L$3(L0[2O8- K3 0XA1YBLA##9
M\PC3_#+4];H"'F9#-(K&(06<D(I"!=6,$Z^C;#)H0D +@LB0CU"#Q'J9,O&1
M5<:]\W.5"N/5>ZQWDX,AA%J'(5-4QL.]+%GXWQAY9SF@CX?@[?AK)?K<@+('
MEX-Y%6?MWRO.*(6;%&J?U3_XOWVA;@!EWAUWI#Q*[Y24RAIM8&)7<O;^FYWA
MJ*U2Y%(\'2/&&#5\?W&OF]#=;ZKJBE46H!281V9^Z%4.\02"UZ%3FG-K$^28
MV-R\)Y<B_7([)^K[M.HU;(V\<%=$821$8Y0R$<5*GX!/O:^1Q#$>&9V?AX""
M+2*_"%%"B/.#E)Q,X#L26*6X&X),9&(]M-TSM2;BP+[#$VD5>2;W#R-$,PU]
M'W[PC \D5'/V,CPZ4<QLFEX+_K*>*=ZFFJ&5F&I27^#F2;%YAKL$REDF1U^F
MB%P*#>:J.!'E<DBUP 1W32)7^!JHMJXK -7(0KUFD!DP)?_$@%($!ZY]KCI2
M-#L:8)_:AVR(?B8,S3+MA=57<G(L8EUWBGK;?(&;XVW@9O[ 37T;N)E3)I>W
M7\GZTYR:]E20J+'4(-$:IIAX&+VMBQV>Z3+YQ/3IGN_NG-XT;^^MRW_J=9BR
M)&]]UC-8"E([>KCLL-\R=P\#B%:E<6"?_]\_+K]<WG.\\.+RJGG5NFQ^M>_N
MF_"-\ZM[^Z[UQ_G9]Z\JB+BZ1ESKVJ8M["B&'2UOT7>=/;WB!3!,RWOQ_:/+
M+5@+_E\<U^T&G3&#0M!>ZWG]= M0J@/%4!Q7+8!V&Z*"@Z^A/0GF'YAVH8L)
M8#14S.FO$EJS/2JO/RH;/2F5#9T4<*'G.BEQD<*=CD_24<&,.Y.;HD%H7^Q7
M]'E)1+#7=2)2L%/>WG=W2K(.0 >4E3.,8"3JW_+.!NSL]..Q(U9V+&XRVGVB
M.((7'Y0;RW5<4NN&4I :0LH3:Z<]L<]VYB#78-ZBZY&P>(Q^W[/T4!MF\1 B
M)Q1N8!!^LO]'JW5^?G&Q@3T @_01[JC_W/D?O;_*Y0JUV(:C2>. 0WMI!,QO
MXX#I#<>^FG' ],(+!VS.YN_F1O;J8K\Z_QYM?".J.Z=?G#XF%6@@=X\N\N<0
MT&LB-/Y&E[WVL8Y&;>=47W/J=%P/I15G%--'IW)5]GQICC>ZE_5W>(3J&1O6
MHD@L 9GOXCIV#<8\<[$T<;3@9MJ)[:17ON$M;7RLX]G(VFVL8+\ ;^ZC'\_#
M=W@\#W=.KX*1&]$P1D&F-_%&E_LH<[D3KLO6<]GZ]WG^?75#_GW<0&L>+]_P
M[>\$1OX!(UD+#W4?Q0,%YX@$9\VIOZO 1Q1*>E++K>:M':S6[U\-]8D:]5RI
MY)-M*GG^5')CFTI^6P=H>VVOXMJN;>C:/O])G%[1VA)([TSKIV[@M RL78=B
MPC$OB:@1_0Y6?O*^,L8KG1OYM-KK<=V>Q%('_1XS+"QLDU[W[ S'I$#K<?YM
MR4D-434TQJO@()W?2(]=C6.IPUA&4B@36BRC/3Y9]JJ=$>*30D?+RPB%#^W=
M:KE>JM:.2]5&8V]2<E9YV=4.*G^/QD/)18^'F6*PUDU?\26K8U./H]$P^O3;
M;\_/SP>1VSEX")Y^:X:=1^_)C7YSNP].^%O7&3F_5<NU<OVX^ENY7*Y4*[63
M<KG:*)?KU>KQ;ZY3KE:/CH^KY8K[L[9?^6O8'P_J!X\C./Y-;OQ)LT/\\:U+
M /.N_<T=!"'\93S@.G@4DCY7]C>C* "WG>7+64B^UBL]=24]U5]1>A83GGJE
M?'QR6"?AJ93AY)<;[L^Z"(_3^9?(S]W0[<!8?)K@=Z3Q:>%^4X<,=U'I>&O:
MIWY0W<K/<N2G.DU^6GTGBGCR3?L:.Z=@!3,EQI8A5NL6FMI6:)9Q8]63-U9"
M8OZD_B()I:-(I;G@12Q(NWY0W_LXZJB^-896(5HB332[IN+%TYW3N2^Z7:ES
M1_&2W79'STB9AWG<EE ]H:UTW7V)(O?%OD>JOY[P*-\3CYE\[;UHL,;_>J.B
MI00"=[/6J,%#:#<;J=ME>0,U?"HT@>]BKCRI?[N5(DUJ6RO3<=ZWGJF4MU[7
MDA1-I9S4-&@I1PFG2]IODK$3V7?C=BQOKU!%-_!*:N_G(PWIY3]+]M>O+11,
M^^VK'Q"_ZE;\EB5^U6SQ6Y:@M0)LQOP_G0&(B?I[2[CSOQ%G.!:/VUWOR5,]
M8?]Q\,^#+P<TBAAK\SOHOZ&6TH]@K8$8U[9BO"PQKJU6C.]<A^JG?N\';41^
MQ=?\*R1R[?*V=0^6)F^'IKQ]=4<C-RSJ'CB#0-@=1,*8?4(XQ4G<% 6I29V<
M['B?0R@>]!BF&#_\ ZG+QE9\ER6^=5-\+^.>;3C#;XZOVIFP<RK5,Z\S [#Z
M!GY*L-F@\R-V@MDV>(=N,$CDX58BER61#5,B;PUF(YKC+0*GHR5I5^+*)LJL
M/UB=VKL&K?2(:Z+W[ B6T1EA:Q+I<O"!5.G15G"7);A'IN!>!.' +$D<^-A-
MS!#;XBK3M 'T_<Z-.G6OS]XR;OJU"]_Q+YS_6%SX*H=U,VMVS,&C=-[,S-LW
MS;S]31@,O(@Z+6$Y2UJ!'BIQA.^,F0 T-T;T(73@R;L*85=.5A;!OO2Q=V&(
M!AG1SBFVQ<5BU6N&_U0.*N]J'VN5":3$\D8:)SLEDI;7OU-WBF^_V+?COFM7
M:LY^I;[K["%!#/^ET>6_;#AK 3M<_5_)K54;\NJ=2.O.G/6;['$ZY_J][2-4
MA2/TOLY0]2V<(=T#=P[Y:$_(!_P%'U0YMK\?W!VT#N";C?*'212>'+TS]7QR
MM$K1ZCO/N$/OZH:ME"L'EU=W;W47EV@%(<NC_7^_W'X%QPU;,'5<^TQJ(@X^
MA,4+.WG7^N.7VLE[YV?@!X,7T-\CUX]4- GK@P?.0KNZ_CUK-;_^FGO6<OJ=
M<3^. 7[U_!]M)W(_S&G\VOSR:^[L5Z?M<G'_JS3L^G?LYO;\E]HQY!G"]&/J
M!'Z\B_'L_&*[L:_=V'5O6_W#;UDK@(4F"@,P2D=NZ% /$-:<SL@!UQ-<R5WN
M?3'B:EUSE[D;NH^-R).H=Q#YO>PM7@4YT$8*>3\JM\ &F042QVV==$!]26@4
M_3^CW[=Q=#.8"%;;ZF<KZ^]8UC<E[.,0^TIO!7XK\.L5^(VQN5\:_0CF$GJS
M:0'FJV$\0E6BNE'%M3>:.;4U#D/FB.9^"+Z-D W[>/__V+MD35T%!W.-HERN
M[->K]:/J7DE:+^BF;=CI'5Z@(1^28]\>TNTA?6^4C.L]I";\+^9UU(?U;E]8
MBXO^'_;Q8UQ,?,CM6JVV7SVN5.KUF2?W:,&#^_;/Z!*&.JM]U-'.Z5MO'W5X
M8%]<WWZ#/\,U</?]V[?F[7]]E"Y1;VFH.2R@;W"D,Q9U"C4G_&Q+S3DW->?A
MEIHS7ZQ7V&EYB>R&TPVT3*KS]NG-U^_?[&;K__M^>7=Y?WE]9;>N;V\.;&RS
MV%Z!BL@=A]GG<L-+<M_\\O7<OKZ I;BZ/[^ZOUMWX^MW0%*XE!X/>H@GQ$^8
M[B\TJ1%-+:?\QSD[#]DWK>;U%_ORS+X:4\,&6)XT$*C@X+-4_73"Q4UV&\KD
M=S<XVS]-R[+,T3[! (<NGH\L*D?E@Y-X(*KWP?'!86.RBT1UUJ)(%Z59'926
M)"JSQ6.!KDC+7*_:K!$:;F&ZOY&UE 8J:UOI!7H6K4EHZW-M0MRSB$%62^];
M-+%)*2M]]5NU0"^B9>Y'8[[]2'05TG7A[^=@+- M:$T'XW#6X*EC4'ZWH+4M
MX1&-8;^RODY &79E$:^Y\AF4.&GP3_BB.[>#_[%)5[KX_!=VNB_V%W&6*U-\
MY74YR0M/^0TXU-,-QRG13.48+"&:N9AK>'M^<WU[C[[AY=79^<TY_./JWKX]
M__WR[O[\]OS,OOG^Y>ME"QSJUO7WJ_O+J]^MB\O;;^MT:U<0K9ACK73FXYYS
M"X8-HBO_OP1.V"7K6M516T%O?<M#5;7-SK_&7D3X.[L5A$..>&QZA[R?G_S
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MC3Z[C#-I!WU0L<V[NW/$''-Y62;9)DP!S<C_W*GN9&D<@JTDD9C)!Q6 \O"
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MQ]7U_?F=?7]M7UQ>-:]:E\VOM@;_+QOO/VLL&\7HY\M JFSD,%$VPM?AU7@
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MV @;CKC>DTNA,YTSAYT(^NQ),7%MJIH+3'-Y7W[<7B$+)507D=IS>CV/*@%
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M8PA<(N[ZSD,E1)<7^X'YH;KY>%SG>J)Y\Y^\*O **S2M8%&-*3M<MXH@2MZ
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M<UHY*N4ACGDG$J1%*B,C5AKEF, !UOZONK,-;U_L*2_,=O<ML="8QI1R*P7
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M7VLB5.UW5()%IPNN8N,H9[JA?G@>KW!"0.*Q9"EP]M%5)@E_5N#[UBAX8("
MMCWR]B#N-I*40^Q1U.]SO%'5ZLB Y[Q\/$T/N6>]6GG4JV]">8!?72_5RSEE
MW9MR4=YN65&:^_;P@,LUWL68IE4 5;<50%D50-5?M0+H;9WP7,!GD1#$FN=
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M*H+7[8I=V,E%5Y383F;,M[$V\()I=1M[?"\F93QRS6%D$6)@BRXQEPB0"O8
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ML5P0K%IXFN!.8*F'IM70=N6DR>+6CSK+!^%H[ *.<@CO"[#BK0 2!4DE!)(
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M2I^A_IJ9R=C_%UB*&Y@,=2!/$F4V-/3]T=!@"GQT4X64AMD7@P<_8.?63+4
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M:JK:&\J+""'H-^D"<ZAA)CYC)&)S?PJTG@6V*DEP?M!680%VR.9_&W(R8XR
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M'4&)UH\_]\YZ+N(;)]M;G'*BSG$HZL<6GBXA'$FO=GNLV]X1XGWQW:Y25EM
MFLPH98<-'OUHTQ0/XX 62Q;#*2LXI!!/O5T-L$!,Q^GT_O'PZ'37G=@ D2$X
MK@1-E:@$,4]/<<$!5Q!(+<H@E_*/"KI#SSLWVU &W04EGL,8M>YXMF]*1C;
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M&)2!U)1D3(>(X.TERIQR#I[AQG!9OG'CSE',LLH^H')[ D<M:4LY4$68NVM
M"/[OKJZ.0QB7=7ENW2L9S5K!O(0'4RK!JM;ZG"ZS([WY;C\W]@60X3W1)GIU
MI*[+37J;F_V4;K:Y)LX%/BM=.9]X[=X>;MWJ%]A:;D56[<C6=$V0GD Z%51]
M+E_A"F>>5:>2;PCR21'D243\ZYHZD5#;A'_95*94H3'H\+#NHX38,XI)QTG
MO19B,9X98HR'ZMP-Z=VFC5*S1A^\347K?07C]6_A,,^DU],Q2[%]IP:>"TS^
M'B+ID%C0DK?Z/MV!1]8W)<DM2:R]1V/_"TKGK?1GJ3^48IFF@KW8^T)#LT(
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M)]W1==Z9LX C2O_;=415%FFK?G_\<+S_3_9__GK^Z;?W_Q]02P,$%     @
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M_[I:M9!\>*]#UW2\UWOA:)\'3T.MTC@L!2I2^I+-1C(1!T3](T2=[1%1-]P
M1\#">,Z>8C6+1#@410>L!:)"A<V-5<("C.8R!N+F+(T3G0IF$IZ(,=PN \ X
M-A;^5P*- QZ@23,U1G1.E)/;$HA%((SA>DXB8_XD,/&*3H.V$-9@RHA"/L ]
ML!*!U$$ZAER,\3 E%)H0%8R82>G?4@%<HLBTT K&TD2"AS(>XKR3$99H)B*P
M%I+>"6Q3(=:)0\>V].>K&_$=EARPZ["[H/0+H+DBNK6?AQU]H3>H_@AO(-A
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M^L'EI#^5C4=M5)F!G,"\+4./7V'I&[JD4_H&U'T42M^._@]02P,$%     @
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MT>P]^[[_4O\'(3_P5^+] R_):@_] [)ZP2.WJ=\Y92^A]+NJ?P%02P,$%
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MU$J\#!TIRZ#HQ>H \>U&J"Y<SJOJ)B>Q*>M*(H5V128JF(@H0QFDC3G/HUO
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MK&0UG)5(W_:.E9T'#LQME1AYE^27I?A:#B\/#Y1WR"H6R>J#4X4AS=?>\!/
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M%U\??_7?+'.80&,6V(FR5H?;^.@<*>@0(80U*=LLT<XAB48E9X B.M,&NE[
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MX?2@+$'#W:=MC[>_;<IRL56X8^Q6:35+'.U /ZFQY.!86G!6U$T[$/D8C1.
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MH,:SF^I!:0&='I,8V,8,=>ZVAO*-8>CC))QFD8KK8IY?RNIO4]RD 3^ZV1B
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MENPRKKJ]*60P-K_!([R;R)>)J-'-4YGF0C0.2I0.0[/1NW3[FHO*C"7( ]'
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MK/E$1]7"]2#L7%+($0V43@O>SDB/E0N"N(LVZ]PU?I &2M';4>$=X43T(%7
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M!"! ?MH  M!6&) V_=\0TA8-\L-LZN??__+BGQPE__OY3S]^]_\ 4$L#!!0
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M-L%#!,M".M,%#TBVF%UWS*)[IR49OP:1O$7HAB$4_!NYY=.U1^N5T!ATHV@
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M\W7SY*#WO7_R_MNQ\67#1%O7AP<WWB&SMF[HEYU*E5@NOVE6[\=UI[NY<?7
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M3!4%QG9&RO.UH%QDN;JH/@]8'KUF0BE,FOP8G_\-*6FQ_P]02P,$%     @
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M$;RE#_N+"5I:'OP[VE6U/&<88N@!C)-UO^]5Y*Q5O%&>$;@[TXGW=*=D>4O
MCWXEJ][8G[/<+2NF3F/T]$EU%[*6]#.(J>:$",P(-T,BZ6N;P"GK7J,&7*OZ
MY>[_:V>1?TAE[II?N%Y;:.,O;N#2@PMH6UXPL&T_C.J<3,F[92O"%$R#4IQD
MH7E#@[U"D&K 6A5(IH:EH-!FYU,^J;G0#T$<&QP88_J@Y4[#.>E5.O'KGB)S
M,>1;RV!J//"D20Z*R#4JA8DQ$A@^)*>)1B<108*VGB(/#I' <S/Z/$5D"1J
MJ6O9W,Q'"F<Z^<;+%9AYF,-X6&G!L]^:G"ZRGVY$#87 S1PG,5^].;W+KH8R
MJUW-%3)84@Q94JZX&A<4RELV[_W+2&[6UQ EFU7AG(NK6,"]J>C';;U!BU&7
M45NRNHK:ACM<3#DC4K+K78KCRC$UIB2%-[<'KJ0)@F4R58?887+;[!6OTS,=
MQ==&#(V<O<;5TZ?L7W.AFY?FQX2XW.:&0SE_U9>$F.@U.9O<Q(EWKL&MCP(#
M"]C]]DT%T;/$*"O_7H,'4'L!B<T>>'&HS&F_"'R-[FK.,?@6TCPO=]F3;FUJ
MO]>^*;5GB5%6^[T&C2D[4TZS*LZA+:?B;*@:5.SB;NEP$_VTT:WB'=ZEITDM
M\62QUW""DRF5%Q3:I5UZ41R%QH/<+MXE)#Z50WTPLIB(,T-< ^R'R :XDD?&
MOIY,>UV@2!XDW3?8HQZ<KP%:DJZ^1?Y]L*+I)2RO>IPQ^!%JJ+GU@ 0I8I"8
MN>7T$8/)XAP'<&W@2M->XPWFF)&S8ON@&+I/G@3^[<>)&IUSQ&0V&? M1Y4@
MAMQ;26KADW&,UVAEH25GDM$0&UDIK%$G68XR'FRF;C#%=[QGUH-9HIAB.F/^
MV$ )7%C2D?7=+$$\:6WW&811$[FRI'A XMG$S,9!H-<0?QV1X0P#^I/VTQ"V
MI Y-4E5X<2\AJ3!T84$49<7)1!2./=+#<+V;'S5S)2:S.ZP)8FCDDLX9B (S
MX)UYMX(IJ"MVL HK_LT9Y22$0XNT0Q=KP,-Q\.YM$M$[CD8[Z<_4M3PS8TVE
M!UWA4PE=_D48A7LPJ5ZQA[_<EH5<BQUPZ55P$KO=HG"/^C[39^1[Y,<XI@T?
M8B]76GP7M@S5L4U)YFR9'.8$.ZH(H#\4JK,'V?8*."%-';+?]-A;I$FTAIOD
M0V/G?8J]Z,Z!MRK,31Z")WWV%^_!Y@.@]Y')=.N&9*! ;YLFST<T45Z^SH:6
M&*@*H"Y-%?H2$:GJ)LII@(G:8 H],.0FLNN'29!>8WPU478,H^#/&0QH'\>>
M ^^@$UJN:&$>\G"&8O+;CEYVNP:]"O%*/.IJ3_FM $UW'H1249]AL(I"OVFL
M]PK>SOQSXO<$&_'R/;+,<20>H'Y,23$?KNXRN>(!J+62AD(/Q&K^&""QD3)
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M 9J978$^;7R!@V+:>)ZY;_0>5^4[<0>]+B^CI&SSI4\Z)F%-V4\W.I#EL*Z
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M2%[M/IV!X:5+92J#JO382BL9/[#<\V\A##93Y-L .'A7,5G,PZALH?5S"@>
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MBA#PXR)4@4[KK'D!#2K7 /9>@QUP9LJ!$(AJ4$-\[-D^(J,GZE2TI3GR0R]
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M%9Y$R@5$ZW&]!56^I0X9BO3=4WRK(XP9"51^.:%-SRT,Z-?^'U!+ P04
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MWD+Q"T)P3K[#<3A-YMF6%!VGK-2@W\S.-:47FKH.0>5<$)*3X!P%; *TIC-
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MZ]\.O<T<C(\'0^I@I+MV03M!E597\R,. #WL$(!HC/)\GQQ,U5K;JW5F?=]
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M!MP@M#,<EK\WN7#BK*4C\\+YV2+J'G <OL-Q.$WFV984I9AT$BK*)0@IK>E
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M9'F9K.COPLX.^])6DQ^%Q63[;OCCL;V4='>PJ@Q\<QFH45XG[O$*T+IC+7;
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M)1TM&UR3Y*,HJ7Z;\C=->G:6-0"(E/;/5_L\954"KN)@U2ENMH""2C!PA%6
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M%PT%U2<"W9I:.:'!#B'SE_-*M)MU\JJE8VKM*1*W&HO5T87=^F,J@@8NCWJ
M<N*GB)Z;<$73H28%(0TM,TYQ<)B"%.P*U_P"DJ=K<^W(E.*6EE\GMJAKM& K
M_0K=A%$,?>C>'=Q4,001&>U%LC/@ 9:'!$7;:60U8&ZM$AD!=N%BZCJ9$?0M
MH0.<W98SOF"6Q\[@II:'B(SV\M@9T-BB$-*QO11J@-M:"F)A=6$![%\M#]?I
M3VO0I=#AB 9KBD3&\YV!<R&96AJ21&U? ZA%-&0E:2?UY )3=\]C[B$]%&6=
M!*X0"9/(1:02;,%EI\IXW<!124)P>2)J,)ZM4+2@$WD3A7?QDI6E=X+JQ2K
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M<X1C\)3J1JS8KEZ@IQ/-I&^I3VIY8S\_'9V, I)0PEDVL &O9Y]&!RVY0%B
M?4@-9EMQRR&8:;6W%?C!Q/5#)B]3^55UU!3=_RHYR>=4U8_2I-==:<9["FM
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M,S$M,E]P;'5M86-Q-"YH=&U02P$"% ,4    " #SBG]:M4G[&2P$  "R$@
M'@              @ $>/P( 96$P,C,U,S$V,#%E>#,R+3%?<&QU;6%C<30N
M:'1M4$L! A0#%     @ \XI_6MM_^8Q_9   J24" !T              ( !
MAD," &5A,#(S-3,Q-C Q97@T+35?<&QU;6%C<30N:'1M4$L! A0#%     @
M\XI_6D/:8=0Y$0  ['@  !X              ( !0*@" &5A,#(S-3,Q-C Q
M97@Y-RTQ7W!L=6UA8W$T+FAT;5!+ 0(4 Q0    ( /.*?UJ5RR5Q-P\  .Z%
M   1              "  ;6Y @!P;&UK+3(P,C0Q,C,Q+GAS9%!+ 0(4 Q0
M   ( /.*?UJ7DU%G<@8  %4M   5              "  1O) @!P;&UK+3(P
M,C0Q,C,Q7V-A;"YX;6Q02P$"% ,4    " #SBG]:*?<(\4,K  "ZSP( %0
M            @ ' SP( <&QM:RTR,#(T,3(S,5]D968N>&UL4$L! A0#%
M  @ \XI_6G50NFV,6P  ?!\$ !4              ( !-OL" '!L;6LM,C R
M-#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( /.*?UJM"L7\"RL  +C5 @ 5
M          "  ?56 P!P;&UK+3(P,C0Q,C,Q7W!R92YX;6Q02P4&      P
,# !8 P  ,X(#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>ea0235316-10k_plumacq4_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:plmk="http://www.plumpartners.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="plmk-20241231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:ClassAOrdinaryShares00001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:WarrantsToPurchaseOneShareOfClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:UnitsEachConsistingOfOneShareOfClassAOrdinarySharesAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-09</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-09</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-09</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <instant>2024-06-09</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-16</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-16</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-16</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:PlumPartnersIVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-16</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">plmk:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-26</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-06</startDate>
            <endDate>2024-12-06</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">plmk:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">plmk:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-22</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">plmk:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">plmk:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
        </entity>
        <period>
            <startDate>2025-01-16</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">plmk:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-22</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002030482</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">plmk:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-7295">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-7296">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-7297">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-7298">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-7299">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-7300">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-7301">001-42472</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-58">PLUM ACQUISITION CORP. IV</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-68">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-73">98-1795710</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-88">2021 Fillmore St. #2089</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-7302">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-7303">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-7304">94115</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-7305">(929)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-7306">529-7125</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c1" id="ixv-127">Class A ordinary shares, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c1" id="ixv-7307">PLMK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c1" id="ixv-135">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c2" id="ixv-7308">Warrants to purchase one share of Class A ordinary shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-7309">PLMKW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-146">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-150">Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-154">PLMKU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-158">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-7310">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-7311">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-7312">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-7313">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-7314">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-7315">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-7316">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-7317">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-7318">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-7319">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-7320">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c4" decimals="0" id="ixv-7321" unitRef="usd">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-7322"
      unitRef="shares">18492875</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-7323"
      unitRef="shares">5750000</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-3846">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Although, as a blank check company, we do not
have any operations, we are nonetheless subject to the risk of cybersecurity incidents. Among other things, the investments in our Trust
Account and bank deposits may be vulnerable to such incidents, and we may depend on the digital technologies of third parties. We and
third parties may be subject to cybersecurity attacks or security breaches. To the extent that we rely on the technologies of third parties,
we depend upon the personnel and the processes of such third parties to protect against cybersecurity incidents, and we have no personnel
or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#x2019;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse
consequences on our business and lead to financial loss. We have not encountered any cybersecurity incidents since our initial public
offering. In addition to our own cybersecurity risks, any proposed business combination target may have been subject to, or may in the
future be subject to, cybersecurity incidents.&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-7324">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c0" id="ixv-7325">false</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-7326">In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#x2019;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse
consequences on our business and lead to financial loss.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c0" id="ixv-7327">In the event of a cybersecurity incident impacting us, our management team will report to the
board of directors and provide updates on the management team&#x2019;s incident response plan for addressing and mitigating any risks associated
with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently
protected against such occurrences.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c0" id="ixv-7328">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-7329">We have not encountered any cybersecurity incidents since our initial public
offering.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-7330">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c22" id="ixv-7331">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c22" id="ixv-7332">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c22" id="ixv-7333">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c22" id="ixv-7334">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c22" id="ixv-7335">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-5789">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Opinion on the Financial Statements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;We have audited the accompanying balance
sheet of Plum Acquisition Corp. IV (the &#x201c;Company&#x201d;) as of December 31, 2024 and the related statement of operations, changes
in shareholder&#x2019;s deficit and cash flows for the period from June 10, 2024 (inception) through December 31, 2024 and the related
notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows
for the period from June 10, 2024 (inception) through December 31, 2024, in conformity with accounting principles generally accepted in
the United States of America.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-7336">WithumSmith+Brown, PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-7337">New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c0" id="ixv-7338">100</dei:AuditorFirmId>
    <us-gaap:Cash contextRef="c7" decimals="0" id="ixv-7339" unitRef="usd">3864</us-gaap:Cash>
    <plmk:DeferredOfferingCost contextRef="c7" decimals="0" id="ixv-7340" unitRef="usd">438352</plmk:DeferredOfferingCost>
    <us-gaap:Assets contextRef="c7" decimals="0" id="ixv-7341" unitRef="usd">442216</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c7" decimals="0" id="ixv-7342" unitRef="usd">42445</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c7" decimals="0" id="ixv-7343" unitRef="usd">12374</us-gaap:OtherLiabilitiesCurrent>
    <plmk:AccruedOfferingCosts contextRef="c7" decimals="0" id="ixv-7344" unitRef="usd">304904</plmk:AccruedOfferingCosts>
    <us-gaap:OtherNotesPayableCurrent contextRef="c8" decimals="0" id="ixv-7345" unitRef="usd">149473</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:Liabilities contextRef="c7" decimals="0" id="ixv-7346" unitRef="usd">509196</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c7"
      decimals="4"
      id="ixv-7347"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c7"
      decimals="INF"
      id="ixv-7348"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c9"
      decimals="4"
      id="ixv-7349"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c9"
      decimals="INF"
      id="ixv-7350"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c10"
      decimals="4"
      id="ix_4_fact"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c10"
      decimals="INF"
      id="ix_1_fact"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c10"
      decimals="INF"
      id="ix_2_fact"
      unitRef="shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c10"
      decimals="INF"
      id="ix_3_fact"
      unitRef="shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c10" decimals="0" id="ix_0_fact" unitRef="usd">575</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c7" decimals="0" id="ixv-7356" unitRef="usd">24425</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c7" decimals="0" id="ixv-7357" unitRef="usd">-91980</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="0" id="ixv-7358" unitRef="usd">-66980</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c7" decimals="0" id="ixv-7359" unitRef="usd">442216</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses contextRef="c11" decimals="0" id="ixv-7360" unitRef="usd">91980</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:NetIncomeLoss contextRef="c11" decimals="0" id="ixv-7361" unitRef="usd">-91980</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c11"
      decimals="INF"
      id="ix_5_fact"
      unitRef="shares">5000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c11"
      decimals="INF"
      id="ix_6_fact"
      unitRef="shares">5000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c11"
      decimals="2"
      id="ixv-7364"
      unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c11"
      decimals="2"
      id="ixv-7365"
      unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c16"
      decimals="INF"
      id="ix_7_fact"
      unitRef="shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c16" decimals="0" id="ix_8_fact" unitRef="usd">575</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c17" decimals="0" id="ix_9_fact" unitRef="usd">24425</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c11" decimals="0" id="ix_10_fact" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss contextRef="c18" decimals="0" id="ixv-7370" unitRef="usd">-91980</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c11" decimals="0" id="ixv-7371" unitRef="usd">-91980</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c19"
      decimals="INF"
      id="ixv-7372"
      unitRef="shares">5750000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="0" id="ixv-7373" unitRef="usd">575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c20" decimals="0" id="ixv-7374" unitRef="usd">24425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="0" id="ixv-7375" unitRef="usd">-91980</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="0" id="ixv-7376" unitRef="usd">-66980</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c11" decimals="0" id="ixv-7377" unitRef="usd">-91980</us-gaap:NetIncomeLoss>
    <plmk:PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty contextRef="c11" decimals="0" id="ixv-7378" unitRef="usd">20820</plmk:PaymentOfFormationAndOperatingCostsThroughPromissoryNoteRelatedParty>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c11" decimals="0" id="ixv-7379" unitRef="usd">42445</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToAffiliates contextRef="c11" decimals="0" id="ixv-7380" unitRef="usd">12374</us-gaap:IncreaseDecreaseInDueToAffiliates>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c11" decimals="0" id="ixv-7381" unitRef="usd">-16341</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <plmk:ProceedsFromSaleOfFounderShares contextRef="c11" decimals="0" id="ixv-7382" unitRef="usd">25000</plmk:ProceedsFromSaleOfFounderShares>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c11" decimals="0" id="ixv-7383" unitRef="usd">1295</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c11" decimals="0" id="ixv-7384" unitRef="usd">3500</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c11" decimals="0" id="ixv-7385" unitRef="usd">20205</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c11" decimals="0" id="ixv-7386" unitRef="usd">3864</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c7" decimals="0" id="ixv-7387" unitRef="usd">3864</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c11" decimals="0" id="ixv-7388" unitRef="usd">304904</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <plmk:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty contextRef="c11" decimals="0" id="ixv-7389" unitRef="usd">129948</plmk:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0" id="ixv-6572">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 1&#x2009;&#x2014;&#x2009;DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Plum Acquisition Corp.&#160;IV (the &#x201c;Company&#x201d;)
is a blank check company incorporated as a Cayman Islands exempted corporation on June&#160;10, 2024. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses (&#x201c;Business Combination&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company is not limited to a particular industry
or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and,
as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As of December 31, 2024, the Company had not commenced
any operations. All activity for the period from June&#160;10, 2024 (inception) through December 31, 2024 relates to the Company&#x2019;s
formation and the initial public offering (&#x201c;Initial Public Offering&#x201d;), which is described below. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31
as its fiscal year end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The registration statement for the Company&#x2019;s
Initial Public Offering was declared effective on January 14, 2025. On January 16, 2025, the Company consummated the Initial Public Offering
of 17,250,000 units (the &#x201c;Units&#x201d; and, with respect to the Class A ordinary shares included in the Units being offered, the
&#x201c;Public Shares&#x201d;), which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $10.00 per Unit, generating gross proceeds of $172,500,000, which is discussed in Note 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#x201c;Private Placement
Unit&#x201d;) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,728,750, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of 232,875 private placement units for an aggregate
purchase price of $2,328,750 and (ii) by and between the Company and Plum Partners IV, LLC (the &#x201c;Sponsor&#x201d;) for the purchase
by the Sponsor of an aggregate of 440,000 private placement units and 570,000 restricted Class A ordinary shares for an aggregate purchase
price of $4,400,000. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Transaction costs amounted to $10,932,289, consisting
of $3,450,000 of cash underwriting fee, $6,900,000 of deferred underwriting fee, and $582,289 of other offering costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company&#x2019;s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Securities,
although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company
must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least
80% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting commissions held in the Trust
Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company
will be able to successfully effect a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Following the closing of the Initial Public Offering,
on January 16, 2025, an amount of $174,225,000 ($10.10 per Unit) from the net proceeds of the sale of the Units and the sale of the Private
Placement Securities was placed in the trust account (the &#x201c;Trust Account&#x201d;) and invested or held in either (i)&#160;U.S.&#160;government
treasury bills with a maturity of 185&#160;days or less or in money market funds investing solely in U.S.&#160;Treasuries, (ii)&#160;uninvested
cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank, as determined by the Company, until the
earlier of: (i)&#160;the completion of a Business Combination or (ii)&#160;the distribution of the funds in the Trust Account to the Company&#x2019;s
shareholders, as described below. No later than 18&#160;months after the closing of the Initial Public Offering or such earlier liquidation
date as the Company&#x2019;s board of directors may approve, or such later time as provided for in any amendment to the Company&#x2019;s
Amended and Restated Memorandum and Articles of Association, (an &#x201c;Extension Period&#x201d;), subject to applicable law, the amounts
held in the Trust Account are held as cash or cash items, including in demand deposit accounts.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company will provide its shareholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection
with a general meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether
the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders
will be entitled to redeem their shares for a pro&#160;rata portion of the amount held in the Trust Account (initially $10.10 per share),
calculated as of two&#160;business days prior to the completion of a Business Combination, including any pro&#160;rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#x2019;s public warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;If the Company seeks shareholder approval in connection
with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires
the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required
under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or
other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions
pursuant to the tender offer rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;), and file tender offer documents containing
substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares
(as defined in Note&#160;5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination
and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination.
Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether
they vote for or against a proposed Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Notwithstanding the foregoing, if the Company
seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company&#x2019;s
Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder
or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the
Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#x201c;Exchange&#160;Act&#x201d;)), will be restricted from redeeming its
shares with respect to more than an aggregate of 15% of the Public Shares without the Company&#x2019;s prior written consent.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Sponsor has agreed to (i)&#160;waive its redemption
rights with respect to its private placement shares in connection with the completion of the initial business combination, (ii)&#160;waive
its redemption rights with respect to its private placement shares in connection with a shareholder vote to approve an amendment to the
amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the obligation to allow redemption
in connection with the initial Business Combination or to redeem 100% of the public shares if the Company fails to complete the initial
Business Combination within 18&#160;months from the closing of the Initial Public Offering or such earlier liquidation date as the Company&#x2019;s
board of directors may approve, or during any Extension Period, subject to applicable law or (B)&#160;with respect to any other provision
relating to shareholders&#x2019; rights or pre-initial business combination activity and (iii)&#160;waive its rights to liquidating distributions
from the Trust Account with respect to its private placement shares if the Company fails to complete the initial Business Combination
within the prescribed timeframe. In addition, the Sponsor has agreed to vote any private placement shares held by it in favor of the initial
Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company will have until 18&#160;months from
the closing of the Initial Public Offering (the &#x201c;Combination Period&#x201d;) to complete a Business Combination. If the Company is
unable to complete a Business Combination within the Combination Period, the Company will (i)&#160;cease all operations except for the
purpose of winding up, (ii)&#160;as promptly as reasonably possible but no more than 10&#160;business days thereafter, redeem 100% of
the outstanding Public Shares, at a per-share price, payable in cash, including interest earned on the funds held in the Trust Account
(which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses) and not previously released
to the Company to pay its taxes, if any, divided by the number of then-outstanding Public Shares, which redemption will completely extinguish
public shareholders&#x2019; rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii)&#160;as
promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company&#x2019;s
board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of
creditors and the requirements of other applicable law.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Sponsor has agreed to waive its liquidation rights with respect
to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires
Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust
Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their
rights to their deferred underwriting commission (see Note&#160;6) held in the Trust Account in the event the Company does not complete
a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust
Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the
per share value of the assets remaining available for distribution will be less than the initial amount held in the Trust Account ($10.10).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Sponsor has agreed that it will be liable
to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective
target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account
to below (1)&#160;$10.10 per Public Share or (2)&#160;such lesser amount per Public Share held in the Trust Account as of the date of
the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which
may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any
and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended
(the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party,
the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than the Company&#x2019;s independent auditors), prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The United&#160;States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the
Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#x201c;NATO&#x201d;)
deployed additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries,
including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel,
increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting
measures that have been taken, and could be taken in the future, by NATO, the United&#160;States, the United Kingdom, the European Union,
Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional
and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased
cyber-attacks against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect the global economy and financial
markets and lead to instability and lack of liquidity in capital markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company&#x2019;s search for an initial
business combination and any target business with which the Company may ultimately consummate an initial business combination.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <plmk:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum contextRef="c11" decimals="0" id="ixv-7390" unitRef="pure">1</plmk:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <plmk:YearOfInception contextRef="c11" id="ixv-7391">June&#160;10, 2024 (inception) through December 31, 2024</plmk:YearOfInception>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c23"
      decimals="0"
      id="ixv-7392"
      unitRef="shares">17250000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c24"
      decimals="0"
      id="ixv-7393"
      unitRef="shares">2250000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c25"
      decimals="2"
      id="ixv-7394"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c26" decimals="0" id="ixv-7395" unitRef="usd">172500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c27"
      decimals="0"
      id="ixv-7396"
      unitRef="shares">672875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c28"
      decimals="2"
      id="ixv-7397"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c27" decimals="0" id="ixv-7398" unitRef="usd">6728750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c29"
      decimals="0"
      id="ixv-7399"
      unitRef="shares">232875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c30" decimals="0" id="ixv-7400" unitRef="usd">2328750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c31"
      decimals="0"
      id="ixv-7401"
      unitRef="shares">440000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c27"
      decimals="0"
      id="ixv-7402"
      unitRef="shares">570000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <plmk:AggregatePurchasePrice contextRef="c27" decimals="0" id="ixv-7403" unitRef="usd">4400000</plmk:AggregatePurchasePrice>
    <plmk:TransactionCosts contextRef="c7" decimals="0" id="ixv-7404" unitRef="usd">10932289</plmk:TransactionCosts>
    <plmk:SaleOfStockUnderwritingFees contextRef="c7" decimals="0" id="ixv-7405" unitRef="usd">3450000</plmk:SaleOfStockUnderwritingFees>
    <plmk:DeferredUnderwritingFee contextRef="c7" decimals="0" id="ixv-7406" unitRef="usd">6900000</plmk:DeferredUnderwritingFee>
    <plmk:OtherOfferingCosts contextRef="c7" decimals="0" id="ixv-7407" unitRef="usd">582289</plmk:OtherOfferingCosts>
    <plmk:PercentageOfFairMarketValueOfAssetsHeldInTrustAccount contextRef="c11" decimals="2" id="ixv-7408" unitRef="pure">0.80</plmk:PercentageOfFairMarketValueOfAssetsHeldInTrustAccount>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c32" decimals="2" id="ixv-7409" unitRef="pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c33"
      decimals="0"
      id="ixv-7410"
      unitRef="shares">174225000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c34"
      decimals="2"
      id="ixv-7411"
      unitRef="usdPershares">10.1</us-gaap:SharesIssuedPricePerShare>
    <plmk:InitialAmountHeldInTrustAccount
      contextRef="c7"
      decimals="2"
      id="ixv-7412"
      unitRef="usdPershares">10.1</plmk:InitialAmountHeldInTrustAccount>
    <plmk:AggregatePublicShareRate contextRef="c11" decimals="2" id="ixv-7413" unitRef="pure">0.15</plmk:AggregatePublicShareRate>
    <plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination contextRef="c11" decimals="2" id="ixv-7414" unitRef="pure">1</plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination>
    <plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination contextRef="c11" decimals="2" id="ixv-7415" unitRef="pure">1</plmk:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination>
    <plmk:InterestUsedToPayDissolutionExpensesMaximum contextRef="c11" decimals="0" id="ixv-7416" unitRef="usd">100000</plmk:InterestUsedToPayDissolutionExpensesMaximum>
    <plmk:InitialAmountHeldInTrustAccount
      contextRef="c7"
      decimals="2"
      id="ixv-7417"
      unitRef="usdPershares">10.1</plmk:InitialAmountHeldInTrustAccount>
    <plmk:SharePricePerPublicShare
      contextRef="c11"
      decimals="2"
      id="ixv-7418"
      unitRef="usdPershares">10.1</plmk:SharePricePerPublicShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-6657">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 2&#x2009;&#x2014;&#x2009;SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Liquidity and Capital Resources&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As of December 31, 2024, the Company had $3,864
in cash and a working capital deficit of $505,332. Further, the Company has incurred and expects to continue to incur significant costs
in pursuit of its acquisition plans. There is no assurance that the Company&#x2019;s plans to raise capital will be successful. In connection
with the Company&#x2019;s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, &#x201c;Going
Concern,&#x201d; as of December 31, 2024, and including the closing of the Initial Public Offering on January 16, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements. The Company cannot assure that its plans to raise capital or to consummate an Initial Business Combination will be successful.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the
&#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The preparation of financial statement in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company considers all short-term investments
with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $3,864 in cash and no cash
equivalents as of December 31, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company complies
with the requirements of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 340-10-S99 and SEC Staff Accounting
Bulletin (&#x201c;SAB&#x201d;) Topic 5A &#x2014; &#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of
professional and registration fees that are directly related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with
Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and
debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of
the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary
equity, and offering costs allocated to Public Warrants (as defined below) and Private Placement Units were charged to
shareholders&#x2019; deficit as the Public and Private Placement Warrants (as defined below), after management&#x2019;s evaluation,
were accounted for under equity treatment. On January 16, 2025, deferred offering costs amounting to $582,289 were charged to
shareholder&#x2019;s equity upon the completion of the Initial Public Offering (see Note 1). As of December 31, 2024, there were
$438,352 of deferred offering costs recorded in the accompanying balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 14.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company accounts for income taxes under ASC&#160;740,
&#x201c;Income Taxes&#x201d; (&#x201c;ASC&#160;740&#x201d;). ASC&#160;740 requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;ASC&#160;740 also clarifies the accounting for
uncertainty in income taxes recognized in an enterprise&#x2019;s financial statement and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of December 31, 2024. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company is considered an exempted Cayman Islands
Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States.
As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Net Loss Per Ordinary Share&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Net loss per ordinary
share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period,
excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 750,000
Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment
option is exercised (see Note 5). At December 31, 2024, the Company did not have any dilutive securities and other contracts that
could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result,
diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company&#x2019;s financial condition, results of operations, and cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and
liabilities, which qualify as financial instruments under ASC Topic&#160;820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Warrant Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company will account for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering, on January 16, 2025 and the private placement in accordance
with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and
classified the warrant instruments under equity treatment at their assigned values.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Share-Based Compensation&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company records share-based compensation in
accordance with FASB ASC Topic 718, &#x201c;Compensation-Share Compensation&#x201d; (&#x201c;ASC 718&#x201d;), guidance to account for its
share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument.
The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number
of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of
share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment,
which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which
is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed
in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending
on the nature of the services provided in the statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Derivative financial instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company evaluates its financial instruments to determine if such
instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives
and Hedging.&#x201d; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially
recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in
the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance
sheet date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently
redeemable shares and would have been accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial
Public Offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;In November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The amendments in this ASU require disclosures, on an annual and interim
basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;), as well
as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public
entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures
currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures
required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning
after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The
Company has adopted ASU 2023-07 for the year ended December 31, 2024. ASU 2023-07 does not have a material effect on the Company&#x2019;s
financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Management does not
believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#x2019;s financial statement.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-6661">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <plmk:LiquidityAndCapitalResourcesPolicyTextBlock contextRef="c0" id="ixv-6668">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Liquidity and Capital Resources&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As of December 31, 2024, the Company had $3,864
in cash and a working capital deficit of $505,332. Further, the Company has incurred and expects to continue to incur significant costs
in pursuit of its acquisition plans. There is no assurance that the Company&#x2019;s plans to raise capital will be successful. In connection
with the Company&#x2019;s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, &#x201c;Going
Concern,&#x201d; as of December 31, 2024, and including the closing of the Initial Public Offering on January 16, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements. The Company cannot assure that its plans to raise capital or to consummate an Initial Business Combination will be successful.&lt;/p&gt;</plmk:LiquidityAndCapitalResourcesPolicyTextBlock>
    <us-gaap:Cash contextRef="c7" decimals="0" id="ixv-7419" unitRef="usd">3864</us-gaap:Cash>
    <plmk:WorkingCapitalDeficit contextRef="c7" decimals="0" id="ixv-7420" unitRef="usd">505332</plmk:WorkingCapitalDeficit>
    <plmk:EmergingGrowthCompanyPolicyTextBlock contextRef="c0" id="ixv-6676">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the
&#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.&lt;/p&gt;</plmk:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-6686">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The preparation of financial statement in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-6696">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company considers all short-term investments
with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $3,864 in cash and no cash
equivalents as of December 31, 2024.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash contextRef="c35" decimals="0" id="ixv-7421" unitRef="usd">3864</us-gaap:Cash>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c0" id="ixv-6720">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company complies
with the requirements of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 340-10-S99 and SEC Staff Accounting
Bulletin (&#x201c;SAB&#x201d;) Topic 5A &#x2014; &#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of
professional and registration fees that are directly related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with
Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and
debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of
the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary
equity, and offering costs allocated to Public Warrants (as defined below) and Private Placement Units were charged to
shareholders&#x2019; deficit as the Public and Private Placement Warrants (as defined below), after management&#x2019;s evaluation,
were accounted for under equity treatment. On January 16, 2025, deferred offering costs amounting to $582,289 were charged to
shareholder&#x2019;s equity upon the completion of the Initial Public Offering (see Note 1). As of December 31, 2024, there were
$438,352 of deferred offering costs recorded in the accompanying balance sheet.&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts contextRef="c36" decimals="0" id="ixv-7422" unitRef="usd">582289</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="c37" decimals="0" id="ixv-7423" unitRef="usd">438352</us-gaap:DeferredOfferingCosts>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-6727">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company accounts for income taxes under ASC&#160;740,
&#x201c;Income Taxes&#x201d; (&#x201c;ASC&#160;740&#x201d;). ASC&#160;740 requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;ASC&#160;740 also clarifies the accounting for
uncertainty in income taxes recognized in an enterprise&#x2019;s financial statement and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of December 31, 2024. The Company is currently not aware of any issues under review
that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
by major taxing authorities since inception.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company is considered an exempted Cayman Islands
Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States.
As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c11" decimals="0" id="ixv-7424" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-6740">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Net Loss Per Ordinary Share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Net loss per ordinary
share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period,
excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 750,000
Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment
option is exercised (see Note 5). At December 31, 2024, the Company did not have any dilutive securities and other contracts that
could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result,
diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c38"
      decimals="0"
      id="ixv-7425"
      unitRef="shares">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-6747">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company&#x2019;s financial condition, results of operations, and cash flows.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="c7" decimals="0" id="ixv-7426" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0" id="ixv-6754">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and
liabilities, which qualify as financial instruments under ASC Topic&#160;820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c0" id="ixv-6761">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Warrant Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company will account for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering, on January 16, 2025 and the private placement in accordance
with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and
classified the warrant instruments under equity treatment at their assigned values.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-6787">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Share-Based Compensation&lt;/b&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company records share-based compensation in
accordance with FASB ASC Topic 718, &#x201c;Compensation-Share Compensation&#x201d; (&#x201c;ASC 718&#x201d;), guidance to account for its
share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument.
The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number
of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of
share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment,
which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which
is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed
in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending
on the nature of the services provided in the statement of operations.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <plmk:DerivativeFinancialInstrumentsPolicyTextBlock contextRef="c0" id="ixv-6794">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Derivative financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company evaluates its financial instruments to determine if such
instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#x201c;Derivatives
and Hedging.&#x201d; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially
recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in
the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance
sheet date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently
redeemable shares and would have been accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial
Public Offering.&lt;/p&gt;</plmk:DerivativeFinancialInstrumentsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-6801">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;In November 2023, the FASB issued ASU 2023-07, &#x201c;Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The amendments in this ASU require disclosures, on an annual and interim
basis, of significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;), as well
as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public
entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures
currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures
required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning
after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The
Company has adopted ASU 2023-07 for the year ended December 31, 2024. ASU 2023-07 does not have a material effect on the Company&#x2019;s
financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Management does not
believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#x2019;s financial statement.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <plmk:InitialPublicOfferingTextBlock contextRef="c0" id="ixv-6813">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 3&#x2009;&#x2014; INITIAL PUBLIC OFFERING&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Pursuant to the Initial Public Offering on January
16, 2025, the Company sold 17,250,000&#160;Public Shares, which includes a full exercise by the underwriter of their over-allotment option
at a purchase price of $10.00 per Unit. Each Unit consists of one Class&#160;A ordinary share and one-half of one redeemable public warrant
(&#x201c;Public Warrant&#x201d;). Each whole Public Warrant entitles the holder to purchase one Class&#160;A ordinary share at an exercise
price of $11.50 per share, subject to adjustment (see Note&#160;6).&lt;/p&gt;</plmk:InitialPublicOfferingTextBlock>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c23"
      decimals="0"
      id="ixv-7427"
      unitRef="shares">17250000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c39"
      decimals="2"
      id="ixv-7428"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <plmk:NumberOfSharesIssuedPerUnit
      contextRef="c23"
      decimals="0"
      id="ixv-7429"
      unitRef="shares">1</plmk:NumberOfSharesIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c40"
      decimals="0"
      id="ixv-7430"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c41"
      decimals="2"
      id="ixv-7431"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <plmk:PrivatePlacementTextBlock contextRef="c0" id="ixv-6821">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 4&#x2009;&#x2014;&#x2009;PRIVATE PLACEMENT&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#x201c;Private Placement
Unit&#x201d;) at a price of $10.00 per Private Placement Unit, or Non-Managing Investor Private Placement Security (as defined below) generating
gross proceeds of $6,728,750, as follows: (i) by and among the Company and each of the Underwriters for the purchase by the Underwriters
of an aggregate of 232,875 Private Placement units for an aggregate purchase price of $2,328,750 and (ii) by and between the Company and
Plum Partners IV, LLC (the &#x201c;Sponsor&#x201d;) for the purchase by the Sponsor of an aggregate of 440,000 Private Placement Units and
570,000 restricted Class A ordinary shares (the &#x201c;Restricted Private Placement Shares,&#x201d; the Restricted Private Placement Shares
together with the Private Placement Units purchased by the Sponsor, collectively, the &#x201c;Non-Managing Investor Private Placement Securities&#x201d;)
for an aggregate purchase price of $4,400,000.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Each Private Placement Unit has an offering price
of $10.00 and consists of one Class&#160;A ordinary share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles
the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement
Units and the Non-Managing Investor Private Placement Securities were added to the net proceeds from the Initial Public Offering held
in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale
of the Private Placement Units and the Non-Managing Investor Private Placement Securities held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants expire worthless.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Restricted Private Placement Shares are held
by the Sponsor and will be transferred to the non-managing investors (or their designees) only upon the consummation of an initial business
combination. Other than such permitted transfer, the Restricted Private Placement Shares will be subject to transfer restrictions for
90 days following our initial business combination and will be entitled to registration rights.&lt;/p&gt;</plmk:PrivatePlacementTextBlock>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c27"
      decimals="0"
      id="ixv-7432"
      unitRef="shares">672875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c28"
      decimals="2"
      id="ixv-7433"
      unitRef="usdPershares">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c27" decimals="0" id="ixv-7434" unitRef="usd">6728750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c29"
      decimals="0"
      id="ixv-7435"
      unitRef="shares">232875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c29" decimals="0" id="ixv-7436" unitRef="usd">2328750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c31"
      decimals="0"
      id="ixv-7437"
      unitRef="shares">440000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c27"
      decimals="0"
      id="ixv-7438"
      unitRef="shares">570000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c42" decimals="0" id="ixv-7439" unitRef="usd">4400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c43"
      decimals="2"
      id="ixv-7440"
      unitRef="usdPershares">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c44"
      decimals="2"
      id="ixv-7441"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <plmk:NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions contextRef="c11" id="ixv-7442">P90D</plmk:NumberOfDaysRestrictedPrivatePlacementSharesWillBeSubjectToTransferRestrictions>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-6850">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 5&#x2009;&#x2014;&#x2009;RELATED PARTY
TRANSACTIONS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On June&#160;26, 2024, the Sponsor paid $25,000,
or approximately $0.003 per share in consideration for 7,665,900 Class&#160;B ordinary shares (the &#x201c;Founder Shares&#x201d;) issued
to the Sponsor. On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration. All share and per share amounts
have been retroactively restated. The initial shareholders currently hold an aggregate of 5,750,000 Founder Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Founder Shares include an aggregate of up
to 750,000 shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters&#x2019; over-allotment
option is exercised, so that the number of Founder Shares will collectively represent 25% of the Company&#x2019;s issued and outstanding
shares upon the completion of the Initial Public Offering. On January 16, 2025, the underwriters exercised their over-allotment option
in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Sponsor has agreed, subject to limited exceptions,
not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of a Business
Combination; and (B)&#160;subsequent to a Business Combination, (x)&#160;if the last reported sale price of the Class&#160;A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after a Business Combination,
or (y)&#160;the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction that results in all of the Company&#x2019;s shareholders having the right to exchange their Class&#160;A ordinary shares for
cash, securities or other property.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;During July and August 2024, the Sponsor transferred
75,000 Founder Shares to three director nominees (25,000 shares each) for an aggregate amount of $225, or approximately $0.003 per share.
The sale of the Founders Shares to the Company&#x2019;s directors and director&#x2019;s nominees is in the scope of FASB ASC Topic 718,
&#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity-classified
awards is measured at fair value upon the grant date. The fair value of the 75,000 shares granted to the Company&#x2019;s director nominees
was $36,750 or $0.49 per share. The Founders Shares were granted subject to a performance condition (i.e., named as directors at the occurrence
of the Initial Public Offering). Compensation expense related to the Founders Shares is recognized only when the performance condition
is probable of occurrence under the applicable accounting literature. Stock-based compensation was recognized upon the consummation of
the Initial Public Offering in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently
modified) less the amount initially received for the purchase of the Founder Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June&#160;26, 2024, the Company issued an unsecured
promissory note to the Sponsor (as amended on January 6, 2025, the &#x201c;Promissory Note&#x201d;), pursuant to which the Company may borrow
up to an aggregate principal amount of $500,000. The Promissory Note was non-interest bearing and payable on the earlier of (i)&#160;February
1, 2025 (as amended) or (ii)&#160;the consummation of the Initial Public Offering. As of December 31, 2024, the Company owed $149,473
under the promissory note. Subsequent to the balance sheet date, on January 16, 2025, the Company overpaid the Sponsor by $1,295 resulting
in a due from Sponsor. On January 22, 2025, the Sponsor returned the $1,295 to the Company (Note 9).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Due to Officer&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As of December 31, 2024, the Company owes an officer
of the Company $12,374 for travel related expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Consulting Services&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Chief Executive officer and the Chief Financial
Officer entered into agreements with the Company, commencing on January 16, 2025 through the closing of the Company&#x2019;s Business Combination,
to pay each officer an aggregate of $20,833 per month, subject to availability of sufficient funds from working capital held outside the
Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, any of their respective affiliates or certain of the Company&#x2019;s
directors and officers may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;).
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s
discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit. The units would
be identical to the Private Placement Units. As of December 31, 2024, there are no Working Capital Loans outstanding.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c45" decimals="0" id="ixv-7443" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c46"
      decimals="3"
      id="ixv-7444"
      unitRef="usdPershares">0.003</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c45"
      decimals="0"
      id="ixv-7445"
      unitRef="shares">7665900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <plmk:NumberOfSharesSurrendered
      contextRef="c47"
      decimals="0"
      id="ixv-7446"
      unitRef="shares">1915900</plmk:NumberOfSharesSurrendered>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c47"
      decimals="0"
      id="ixv-7447"
      unitRef="shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c48"
      decimals="0"
      id="ixv-7448"
      unitRef="shares">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <plmk:PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering contextRef="c11" decimals="2" id="ixv-7449" unitRef="pure">0.25</plmk:PercentageOfSharesIssuedAndOutstandingSharesAfterInitialPublicOffering>
    <plmk:NumberOfSharesNoLongerSubjectToForfeiture
      contextRef="c49"
      decimals="0"
      id="ixv-7450"
      unitRef="shares">750000</plmk:NumberOfSharesNoLongerSubjectToForfeiture>
    <plmk:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="c11"
      decimals="2"
      id="ixv-7451"
      unitRef="usdPershares">12</plmk:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination contextRef="c11" id="ixv-7452">P20D</plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations contextRef="c11" id="ixv-7453">P30D</plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations>
    <plmk:CommonStockSharesTransferred
      contextRef="c50"
      decimals="0"
      id="ixv-7454"
      unitRef="shares">75000</plmk:CommonStockSharesTransferred>
    <plmk:NumberOfIndependentDirector contextRef="c51" decimals="0" id="ixv-7455" unitRef="pure">3</plmk:NumberOfIndependentDirector>
    <plmk:CommonStockSharesTransferred
      contextRef="c52"
      decimals="0"
      id="ixv-7456"
      unitRef="shares">25000</plmk:CommonStockSharesTransferred>
    <plmk:CommonStockValueTransferred contextRef="c53" decimals="0" id="ixv-7457" unitRef="usd">225</plmk:CommonStockValueTransferred>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c54"
      decimals="3"
      id="ixv-7458"
      unitRef="usdPershares">0.003</us-gaap:SharesIssuedPricePerShare>
    <plmk:FairValueOfSharesGranted
      contextRef="c11"
      decimals="0"
      id="ixv-7459"
      unitRef="shares">75000</plmk:FairValueOfSharesGranted>
    <plmk:FairValueOfSharesGrantedAmount contextRef="c11" decimals="0" id="ixv-7460" unitRef="usd">36750</plmk:FairValueOfSharesGrantedAmount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c55"
      decimals="2"
      id="ixv-7461"
      unitRef="usdPershares">0.49</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:UnsecuredDebt contextRef="c56" decimals="0" id="ixv-7462" unitRef="usd">500000</us-gaap:UnsecuredDebt>
    <us-gaap:OtherNotesPayable contextRef="c56" decimals="0" id="ixv-7463" unitRef="usd">149473</us-gaap:OtherNotesPayable>
    <us-gaap:OtherLiabilities contextRef="c57" decimals="0" id="ixv-7464" unitRef="usd">1295</us-gaap:OtherLiabilities>
    <us-gaap:OtherReceivables contextRef="c58" decimals="0" id="ixv-7465" unitRef="usd">1295</us-gaap:OtherReceivables>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c0" decimals="0" id="ixv-7466" unitRef="usd">12374</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:ProfessionalAndContractServicesExpense contextRef="c0" decimals="0" id="ixv-7467" unitRef="usd">20833</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c59" decimals="0" id="ixv-7468" unitRef="usd">1500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c60"
      decimals="2"
      id="ixv-7469"
      unitRef="usdPershares">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-6906">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 6&#x2009;&#x2014;&#x2009;COMMITMENTS AND
CONTINGENCIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The holders of the (i)&#160;Founder Shares, (ii)
Restricted Private Placement Shares, (iii)&#160;Private Placement Units, issued in a private placement simultaneously with the closing
of the Initial Public Offering, private placement shares, private placement warrants and the Class&#160;A ordinary shares underlying such
private placement warrants and (iv)&#160;private placement units that may be issued upon conversion of working capital loans are entitled
to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring
the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class&#160;A ordinary
shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that
the Company register such securities. In addition, the holders have certain piggy-back registration rights with respect to registration
statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such
securities pursuant to Rule&#160;415 under the Securities Act. However, the registration rights agreement provides that the Company will
not be required to effect or permit any registration or cause any registration statement to become effective until termination of the
applicable lock-up period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions
resulting from delays in registering the Company&#x2019;s securities. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company has granted the underwriters a 45-day
option to purchase up to 2,250,000 additional Units&#160;to cover over-allotments at the Initial Public Offering price, less the underwriting
commissions. As of January 16, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully
exercise the over-allotment option to purchase the additional 2,250,000 Units at a price of $10.00 per Unit&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The underwriters were entitled to (1) an underwriting
discount of $0.20 per Unit, or $3,450,000 in the aggregate, of which (i)&#160;$0.065 per unit was paid to the underwriters in cash at
the closing of the Initial Public Offering and (ii)&#160;$0.135 per Unit was used by the underwriters to purchase Private Placement Units,
and (2) a deferred fee of $0.40&#160;per&#160;Unit, or $6,900,000. The deferred fee will become payable to the underwriters from the amounts
held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting
agreement and will be based on the amount of funds remaining in the Trust Account after shareholder redemptions of public shares in connection
with the consummation of a Business Combination.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <plmk:NumberOfAdditionalUnitsPurchased
      contextRef="c61"
      decimals="0"
      id="ixv-7470"
      unitRef="shares">2250000</plmk:NumberOfAdditionalUnitsPurchased>
    <plmk:NumberOfAdditionalUnitsPurchased
      contextRef="c24"
      decimals="0"
      id="ixv-7471"
      unitRef="shares">2250000</plmk:NumberOfAdditionalUnitsPurchased>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c62"
      decimals="2"
      id="ixv-7472"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <plmk:UnderwritingDiscountPricePerUnit
      contextRef="c11"
      decimals="2"
      id="ixv-7473"
      unitRef="usdPershares">0.2</plmk:UnderwritingDiscountPricePerUnit>
    <us-gaap:PaymentsForUnderwritingExpense contextRef="c11" decimals="0" id="ixv-7474" unitRef="usd">3450000</us-gaap:PaymentsForUnderwritingExpense>
    <plmk:CashUnderwritingPaidPerUnit
      contextRef="c11"
      decimals="3"
      id="ixv-7475"
      unitRef="usdPershares">0.065</plmk:CashUnderwritingPaidPerUnit>
    <plmk:PurchaseOfPrivatePlacementOfUnderwritersPerUnit
      contextRef="c11"
      decimals="3"
      id="ixv-7476"
      unitRef="usdPershares">0.135</plmk:PurchaseOfPrivatePlacementOfUnderwritersPerUnit>
    <plmk:DeferredFeePerUnit
      contextRef="c11"
      decimals="2"
      id="ixv-7477"
      unitRef="usdPershares">0.4</plmk:DeferredFeePerUnit>
    <us-gaap:PaymentsForUnderwritingExpense contextRef="c63" decimals="0" id="ixv-7478" unitRef="usd">6900000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-6936">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 7&#x2009;&#x2014;&#x2009;SHAREHOLDER&#x2019;S
DEFICIT&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Preference Shares&#160;&#x2014;&lt;/b&gt;&#160;The
Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other
rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. At December 31, 2024, there were
&lt;span style="-sec-ix-hidden: hidden-fact-17"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-18"&gt;no&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Class&#160;A Ordinary Shares&#160;&#x2014;&lt;/b&gt;&#160;The
Company is authorized to issue 200,000,000 Class&#160;A ordinary shares, with a par value of $0.0001 per share. Holders of Class&#160;A
ordinary shares are entitled to one vote for each share. At December 31, 2024, there are &lt;span style="-sec-ix-hidden: hidden-fact-19"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-20"&gt;no&lt;/span&gt;&lt;/span&gt; Class&#160;A ordinary shares issued or outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;Class&#160;B Ordinary Shares&#160;&#x2014;&lt;/b&gt;&#160;The
Company is authorized to issue 20,000,000 Class&#160;B ordinary shares, with a par value of $0.0001 per share. Holders of the Class&#160;B
ordinary shares are entitled to one vote for each share. At December 31, 2024, there were 5,750,000 Class&#160;B ordinary shares issued
and outstanding (see Note&#160;5).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Only holders of Class&#160;B ordinary shares will
have the right to vote on the election of directors prior to the Business Combination. Holders of Class&#160;A ordinary shares and holders
of Class&#160;B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company&#x2019;s shareholders
except as otherwise required by law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares at the time of a Business Combination or earlier at the option of the holder, on a one-for-one
basis, subject to adjustment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Warrants&#160;&#x2014;&lt;/b&gt;&#160;There are no warrants
issued or outstanding as of December 31, 2024. Public Warrants may only be exercised for a whole number of shares. No fractional shares
will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a)&#160;30&#160;days
after the completion of a Business Combination and (b)&#160;12&#160;months from the closing of the Initial Public Offering. The Public
Warrants will expire &lt;span style="-sec-ix-hidden: hidden-fact-16"&gt;seven&lt;/span&gt;&#160;years from the completion of a Business Combination or earlier upon redemption or liquidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will not be obligated to deliver any Class&#160;A
ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless
a registration statement under the Securities Act covering the issuance of the Class&#160;A ordinary shares issuable upon exercise of
the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations
with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless
basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of
the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption
is available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has agreed that as soon as practicable,
but in no event later than 15&#160;business days, after the closing of a Business Combination, it will use its commercially reasonable
efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class&#160;A ordinary shares
issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective
within 60&#160;business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.
Notwithstanding the above, if the Class&#160;A ordinary shares are, at the time of any exercise of a warrant, not listed on a national
securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)&#160;of the
Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless
basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will
not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or
qualify the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Redemption of Public Warrants&lt;/i&gt;&#160;&#x2014;&#160;Once
the warrants become exercisable, the Company may redeem the outstanding Public Warrants:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $0.01 per Public Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
not less than 30&#160;days&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the closing price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company sends the notice of redemption to warrant holders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will not redeem the warrants for cash
unless a registration statement under the Securities Act covering the issuance of the shares of Class&#160;A ordinary shares issuable
upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout
the 30-day redemption period or the Company has elected to require the exercise of the public warrants on a cashless basis. If and when
the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company calls the warrants for redemption as
described in this paragraph, its management will have the option to require any holder that wishes to exercise his, her or its warrant
following the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise
price by surrendering the Public Warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the
product of the number of Class&#160;A ordinary shares underlying the warrants, multiplied by the excess of the &#x201c;fair market value&#x201d;
less the exercise price of the warrants by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; as used in the preceding
sentence shall mean the volume weighted average price of the Class&#160;A ordinary shares for the 10&#160;trading days ending on the&#160;trading
day prior to the date on which the notice of redemption is sent to the holders of the public warrants. If its management takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class&#160;A ordinary
shares to be received upon exercise of the warrants, including the &#x201c;fair market value&#x201d; in such case.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has established the $18.00 per share (as
adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium
to the public warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public
Warrants, each Public Warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date.
However, the price of the Class&#160;A ordinary shares may fall below the $18.00 redemption trigger price as well as the $11.50 Public
Warrant exercise price after the redemption notice is issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, if (x)&#160;the Company issues additional
ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its Initial Business Combination
at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be
determined in good faith by its board of directors and, in the case of any such issuance to either of the Sponsor or its affiliates, without
taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#x201c;Newly
Issued Price&#x201d;), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of its Initial Business Combination on the date of the completion of its Initial Business
Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial business combination (such
price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the public warrants will be adjusted (to the nearest
cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price
will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Private Placement Warrants are identical to the
Public Warrants underlying the Units&#160;being sold in the Initial Public Offering, except that the Private Placement Warrants and the
Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until 30&#160;days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c7" decimals="0" id="ixv-7479" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c7"
      decimals="4"
      id="ixv-7480"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c9" decimals="0" id="ixv-7481" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c9"
      decimals="4"
      id="ixv-7482"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="c64" id="ixv-7483">one</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c10"
      decimals="0"
      id="ixv-7484"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c10"
      decimals="4"
      id="ixv-7485"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="c38" id="ixv-7486">one</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="c10"
      decimals="0"
      id="ixv-7487"
      unitRef="shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c10"
      decimals="0"
      id="ixv-7488"
      unitRef="shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <plmk:PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination contextRef="c11" id="ixv-7489">P30D</plmk:PublicWarrantsExercisableAfterTheCompletionOfBusinessCombination>
    <plmk:PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission contextRef="c11" id="ixv-7490">P15D</plmk:PeriodWithinWhichTheWarrantsShallBeRegisteredWithTheSecuritiesExchangeCommission>
    <plmk:PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination contextRef="c11" id="ixv-7491">P60D</plmk:PeriodWithinWhichTheRegistrationOfWarrantsShallBeEffectiveFromTheClosureOfBusinessCombination>
    <plmk:ClassOfWarrantsOrRightsRedemptionPricePerWarrant
      contextRef="c7"
      decimals="2"
      id="ixv-7492"
      unitRef="usdPershares">0.01</plmk:ClassOfWarrantsOrRightsRedemptionPricePerWarrant>
    <plmk:NoticePeriodToBeGivenPriorToRedemption contextRef="c11" id="ixv-7493">P30D</plmk:NoticePeriodToBeGivenPriorToRedemption>
    <us-gaap:SharePrice
      contextRef="c9"
      decimals="2"
      id="ixv-7494"
      unitRef="usdPershares">18</us-gaap:SharePrice>
    <plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination contextRef="c11" id="ixv-7495">P20D</plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <us-gaap:PreferredStockRedemptionPricePerShare
      contextRef="c7"
      decimals="0"
      id="ixv-7496"
      unitRef="usdPershares">30</us-gaap:PreferredStockRedemptionPricePerShare>
    <plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations contextRef="c11" id="ixv-7497">P30D</plmk:ThresholdConsecutiveTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombinations>
    <plmk:EstablishedPerShare
      contextRef="c7"
      decimals="2"
      id="ixv-7498"
      unitRef="usdPershares">18</plmk:EstablishedPerShare>
    <plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="c11"
      decimals="2"
      id="ixv-7499"
      unitRef="usdPershares">18</plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <plmk:PublicWarrantExercisePrice
      contextRef="c11"
      decimals="2"
      id="ixv-7500"
      unitRef="usdPershares">11.5</plmk:PublicWarrantExercisePrice>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c65"
      decimals="2"
      id="ixv-7501"
      unitRef="usdPershares">9.2</us-gaap:SharesIssuedPricePerShare>
    <plmk:TotalEquityProceedsPercentage contextRef="c11" decimals="2" id="ixv-7502" unitRef="pure">0.60</plmk:TotalEquityProceedsPercentage>
    <plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination contextRef="c11" id="ixv-7503">P20D</plmk:ThresholdTradingDaysForTransferAssignOrSaleOfSharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <plmk:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
      contextRef="c11"
      decimals="2"
      id="ixv-7504"
      unitRef="usdPershares">9.2</plmk:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice>
    <plmk:PublicWarrantsAdjustedPercentage contextRef="c11" decimals="2" id="ixv-7505" unitRef="pure">1.15</plmk:PublicWarrantsAdjustedPercentage>
    <plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="c11"
      decimals="2"
      id="ixv-7506"
      unitRef="usdPershares">18</plmk:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <plmk:MarketValueInPercentage contextRef="c11" decimals="2" id="ixv-7507" unitRef="pure">1.80</plmk:MarketValueInPercentage>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-7037">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8&#x2009;&#x2014;&#x2009;SEGEMENT REPORTING
&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes
standards for companies to report in their financial statement information about operating segments, products, services, geographic areas,
and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may
recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s
chief operating decision maker, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s chief operating decision maker
(&#x201c;CODM&#x201d;) has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has
determined that there is only one reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The CODM assesses performance for the single
segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as
net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the
Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included
in net income or loss:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the&lt;br/&gt;
    period from&lt;br/&gt;
    June 10,&lt;br/&gt;
    2024 (inception)&lt;br/&gt;
    through&lt;br/&gt;
    December&#160;31,&#160;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 89%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Formation
    and operating costs &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Formation and operating costs are reviewed and monitored
by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction
within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual
agreements to ensure costs are aligned with all agreements and budget. Formation and operating costs, as reported on the statement of
operations, are the significant segment expenses provided to the CODM on a regular basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; font: 10pt/107% Times New Roman, Times, Serif"&gt;All other segment items included in net income or loss are reported
on the statement of operations and described within their respective disclosures.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c11" decimals="0" id="ixv-7508" unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c0" id="ixv-7509">the
Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included
in net income or loss:&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the&lt;br/&gt;
    period from&lt;br/&gt;
    June 10,&lt;br/&gt;
    2024 (inception)&lt;br/&gt;
    through&lt;br/&gt;
    December&#160;31,&#160;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 89%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Formation
    and operating costs &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingCostsAndExpenses contextRef="c66" decimals="0" id="ixv-7510" unitRef="usd">91980</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-7083">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;b&gt;NOTE 9&#x2009;&#x2014;&#x2009;SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than
as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial
statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On January 16, 2025, the underwriters exercised
their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no
longer subject to forfeiture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As of January 16, 2025, the Company owed $284,023,
which were repaid simultaneously with the closing of the Initial Public Offering. The Company paid the Sponsor a note balance of $285,318
causing an overpayment of $1,295 due from Sponsor. Subsequent to the balance sheet date, on January 22, 2025, the Sponsor returned the
$1,295 to the Company. Borrowings under this note are no longer available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 16, 2025, the Company consummated the
Initial Public Offering of 17,250,000 units (the &#x201c;Units&#x201d; and, with respect to the Class A ordinary shares included in the
Units being offered, the &#x201c;Public Shares&#x201d;), which includes the full exercise by the underwriters of their over-allotment option
in the amount of 2,250,000 Units, at $10.00 per Unit, which is discussed in Note 3, generating gross proceeds of $172,500,000. .&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 672,875 private placement units (each, a &#x201c;Private Placement
Unit&#x201d;) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,728,750, as follows: (i) by and among the
Company and each of the Underwriters for the purchase by the Underwriters of an aggregate of 232,875 private placement units for an aggregate
purchase price of $2,328,750 and (ii) by and between the Company and Plum Partners IV, LLC (the &#x201c;Sponsor&#x201d;) for the purchase
by the Sponsor of an aggregate of 440,000 private placement units and 570,000 restricted Class A ordinary shares for an aggregate purchase
price of $4,400,000. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions
as described in the prospectus.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <plmk:NumberOfSharesNoLongerSubjectToForfeiture
      contextRef="c49"
      decimals="0"
      id="ixv-7511"
      unitRef="shares">750000</plmk:NumberOfSharesNoLongerSubjectToForfeiture>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c23" decimals="0" id="ixv-7512" unitRef="usd">284023</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SponsorFees contextRef="c67" decimals="0" id="ixv-7513" unitRef="usd">285318</us-gaap:SponsorFees>
    <us-gaap:OtherLiabilities contextRef="c68" decimals="0" id="ixv-7514" unitRef="usd">1295</us-gaap:OtherLiabilities>
    <us-gaap:OtherReceivables contextRef="c69" decimals="0" id="ixv-7515" unitRef="usd">1295</us-gaap:OtherReceivables>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c23"
      decimals="0"
      id="ixv-7516"
      unitRef="shares">17250000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c24"
      decimals="0"
      id="ixv-7517"
      unitRef="shares">2250000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c25"
      decimals="2"
      id="ixv-7518"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c24" decimals="0" id="ixv-7519" unitRef="usd">172500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c27"
      decimals="0"
      id="ixv-7520"
      unitRef="shares">672875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c28"
      decimals="2"
      id="ixv-7521"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c27" decimals="0" id="ixv-7522" unitRef="usd">6728750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c70"
      decimals="0"
      id="ixv-7523"
      unitRef="shares">232875</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c30" decimals="0" id="ixv-7524" unitRef="usd">2328750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <plmk:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c31"
      decimals="0"
      id="ixv-7525"
      unitRef="shares">440000</plmk:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c27"
      decimals="0"
      id="ixv-7526"
      unitRef="shares">570000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <plmk:AggregatePurchasePrice contextRef="c27" decimals="0" id="ixv-7527" unitRef="usd">4400000</plmk:AggregatePurchasePrice>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c7"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c7"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c7"
      id="hidden-fact-2"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c7"
      id="hidden-fact-3"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c9"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="c9"
      id="hidden-fact-5"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c9"
      id="hidden-fact-6"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c12"
      id="hidden-fact-7"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c12"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c13"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c14"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c15"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c18"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c16"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c17"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c15"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c7" id="hidden-fact-16">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c7"
      id="hidden-fact-17"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c7"
      id="hidden-fact-18"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="c9"
      id="hidden-fact-19"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c9"
      id="hidden-fact-20"
      unitRef="shares"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-7551">0002030482</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-7552">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-7553">FY</dei:DocumentFiscalPeriodFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">Excluded an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively&#160;&#160;presented (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-12"
          xlink:label="hidden-fact-12"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">Included an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-12"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">On December 6, 2024, the Sponsor surrendered 1,915,900 Founder Shares for no consideration, such that the initial shareholders own an aggregate of 5,750,000 Founder Shares. All share and per share data has been retroactively presented (see Note 5).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-12"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
